User Image Cart Icon 0 Search Image
  • Home > Blog > Hypoactive Sexual Desire (Why People Have Zero Sex Drive)

Hypoactive Sexual Desire (Why People Have Zero Sex Drive)

  1. Female sexual dysfunction-Medical and psychological treatments, Committee 14: Erratum.
  2. I am no male or female or any other, I have no sex: a case report on asexuality.
  3. It’s complicated: the lived experience of female sexual desire: a thesis presented in partial fulfilment of the requirements for the degree of Masters of Science in …
  4. Methodological issues for studying asexuality: Reply to Hinderliter (2009).
  5. Sick, Dead, or Lying: A critical textual analysis of asexuality in popular culture
  6. The nature of the body: anatomizing heterogender in sexual medicine
  7. They Need Labels: Contemporary Institutional and Popular Frameworks for Gender Variance
  8. Women’s sexual desire and arousal disorders: Erratum.
  9. ? Maybe all these random experiences form a cohesive picture?: towards a grounded theory of asexual college students? identity development
  10. … -67: Validation of the “Decreased sexual desire Screener”(DSDS): A brief diagnostic instrument for generalized, acquired hypoactive sexual desire disorder in women
  11. … , AND THE EFFECTIVENESS OF ORGASM CONSISTENCY TRAINING IN THE TREATMENT OF WOMEN REPORTING hypoactive sexual desire.
  12. … : A Randomized, Double-Blind, Placebo-Controlled Study on Efficacy and Safety of Bupropion for the Treatment of hypoactive sexual desire Disorder in Menstruating …
  13. … : The sexual Interest and desire Inventory—Female (SIDI‐F): Item Response Analyses of Data from Women Diagnosed with hypoactive sexual desire Disorder
  14. … and evaluation of the Women’s sexual Interest Diagnostic Interview (WSID): a structured interview to diagnose hypoactive sexual desire disorder (HSDD) in …
  15. … as Measured by the Profile of Female sexual Function, sexual Activity Log, and Personal Distress Scale in Postmenopausal Women with hypoactive sexual desire …
  16. … Decarbonylative Ring Contraction of Quinoxalinediones: Application to the Synthesis of Flibanserin, A Drug for Treating hypoactive sexual desire Disorder in Women …
  17. … desire and the Female sexual Function Index (FSFI): A sexual desire cutpoint for clinical interpretation of the FSFI in women with and without hypoactive sexual desire …
  18. … estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire
  19. … factors for major adverse cardiovascular events in subjects with sexual dysfunction: low education and reported partner’s hypoactive sexual desire in comparison with …
  20. … HYPOTENSION-AND-SYNCOPE-RELATED ADVERSE EVENTS IN FLIBANSERIN-TREATED PREMENOPAUSAL WOMEN WITH hypoactive sexual desire …
  21. … lubrication problems in women with clinically diagnosed hypoactive sexual desire disorder: preliminary findings from the hypoactive sexual desire disorder registry for …
  22. … of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the hypoactive sexual desire Disorder Registry for …
  23. … perspective on clinical trials and end points for female sexual dysfunction, in particular, hypoactive sexual desire disorder: formulating recommendations in an …
  24. … randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire …
  25. … sexual Interest Diagnostic Interview—Short Form (WSID-SF) and a Daily Log of sexual Activities (DLSA) in Postmenopausal Women with hypoactive sexual desire …
  26. … sexual response: current models, neurobiological underpinnings and agents currently approved or under investigation for the treatment of hypoactive sexual desire …
  27. … single-center pilot study of HIV-infected men who have sex with men on highly active anti-retroviral therapy (HAART) with hypoactive sexual desire disorder and raised …
  28. “Adopting self-sacrifice”: how Iranian women cope with the sexual problems during the menopausal transition? An exploratory qualitative study
  29. “And now I’m just different, but there’s nothing actually wrong with me”: Asexual marginalization and resistance
  30. “Asexy and we know it”: The Emergence of Asexual Activism as a sexual and Gender Social Movement
  31. “Do I really have to talk about sex?” Encouraging beginning therapists to integrate sexuality into couples therapy
  32. “I am no male or female or any other, I have no sex”: a case report on asexuality
  33. “I Just Go with It”: Negotiating sexual desire Discrepancies for Women in Partnered Relationships
  34. “I want to feel like I used to feel”: a qualitative study of causes of low libido in postmenopausal women
  35. “Informed choice” in a time of too much medicine—no panacea for ethical difficulties
  36. “It takes two to tango”: The relational domain in a cohort of subjects with erectile dysfunction (ED)
  37. “Macho” beliefs moderate the association between negative sexual episodes and activation of incompetence schemas in sexual context, in gay and heterosexual men
  38. “Online” and “at-home” versus traditional models of health care: enhancing access or impeding optimal therapeutics?
  39. “She exploded into a million pieces”: a qualitative and quantitative analysis of orgasms in contemporary romance novels
  40. “The pleasure is better as I’ve gotten older”: sexual health, sexuality, and sexual risk behaviors among older women living with HIV
  41. “This is Torah, and I Must Learn”: Evaluation of Women’s Premarital sexual Education and sexual Satisfaction in the Orthodox Jewish Community.
  42. “Til’I can get my satisfaction”: The Role of sexual Assertiveness in the Relationship between Attachment Orientation and sexual Satisfaction
  43. “Ukuthwala” the sexual-cultural practice with negative effects on the personality of adolescent females in Africa
  44. “Was It Good for You?”: Recasting Catholic sexual Ethics in Light of Women’s sexual Pain Disorders
  45. “What do you mean when you say that you are sexually satisfied?” A mixed methods study
  46. “You Freud, Me Jane?” The Representation of Trauma and Asexuality in Hitchcock’s Marnie
  47. (2009) Self-reported sexual difficulties and their association with depression and other factors among gay men attending high-HIV-caseload general practices in …
  48. @ TOG
  49. 001 Composite Endpoints for Clinical Trials of Women with HSDD: Content, Responder Values, and Remitter Cutoffs
  50. 003 Two-Arm, Prospective, Open-Label, Pilot Study of Flibanserin versus Flibanserin and sex Therapy in Pre-and Postmenopausal Women with HSDD
  51. 003 Use of Ospemifene is Associated with Improvements to the Vulva, Vestibule, and Vagina in Women with Genitourinary Syndrome of Menopause (GSM): A …
  52. 004 Safety and Efficacy of High Intensity Focused Ultrasound Treatment for Vagina-3 Months Results
  53. 005 Neuromodulation for Female sexual Dysfunction: Preliminary Pilot Clinical Trial and Patient Interest Survey
  54. 005 The effects of learned sex-disgust associations on female sexual response
  55. 006 Bremelanotide for hypoactive sexual desire Disorder: Integrated Subgroup Analysis According to FSFI Total Score at Screening
  56. 006 Genital and subjective sexual response in women with the Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome with a non-surgically created neo-vagina
  57. 007 A Review of Microorganisms Isolated at Salvage or Explant of IPPs: Are We Covering the Correct Bugs?
  58. 007 Use of Neurogenital Testing to Assess for Cauda Equina-Based Sacral and Lumbar Pathologies Potentially Causing Unusual sexual Dysfunctions
  59. 008 Investigating Peripheral Nerve Stimulation as a Treatment for Female sexual Dysfunction using a Preclinical Model
  60. 009 Comparing symptom networks of women with reduced, increased, and stable sexual desire
  61. 009 Retrospective Chart Review of Treatment Outcome Following Low-Intensity Shockwave Therapy for the Treatment of Vestibulodynia with Urogold 100™ MTS
  62. 009 The Fertility Quality of Life (FertiQol) in Chinese Infertile Women: The First Validation Study of Mainland China Ferti-Qol
  63. 01. Prevalence and Risk Factor Profile for Human Papillomavirus Infection Among Uyghur Women in Xinjiang
  64. 010 A Team-based Model of Care for Management of Female sexual Dysfunction
  65. 010 New Drug for Treatment of Female hypoactive sexual desire Disorder-Results of Phase I Clinical Study
  66. 010 The Moderation Effect of Couple-level sexual Satisfaction on Physiological Synchrony During Conversation-based Tasks
  67. 011 Correlation Between Validated Instruments Used in the RECONNECT Studies
  68. 011 Hormonal and Psychosocial Factors Associated to sexual Dysfunctions in Premenopausal Women
  69. 012 Bremelanotide Treatment Provided Clinically Meaningful Benefits in Premenopausal Women With hypoactive sexual desire Disorder
  70. 012 Eye Dynamics in Patients with Female hypoactive sexual desire Disorder (HSDD): Evidence towards the Top-Down NeuroFunctional Self-Attention-Model (SAM) …
  71. 012 Meta-Analysis of Orgasmic and Overall sexual Function Post Mid-Urethral Sling Surgery
  72. 012 Potential sexual Changes Resulting from LEEP
  73. 013 Associations Between Partner Responses to Low Interest/Arousal and the sexual and Relationship Wellbeing of Women with sexual Interest/Arousal Disorder …
  74. 013 Product Acceptability and Women’s Satisfaction with a Low-dose Solubilized Vaginal Estradiol Softgel Capsule, TX-004H
  75. 013 The Development and Implementation of a Gynecologic Cancer Survivorship Tool
  76. 014 A Phase 2 Program on Female sexual Arousal Disorder and hypoactive sexual desire Disorder: Patient Characteristics and Implications for Diagnosis and …
  77. 014 Do experts for vulva diseases integrate sexual health problems in daily diasease-managment _ self-assessment results at the 10th anniversary of the …
  78. 014 The Investigational Drug Bremelanotide for hypoactive sexual desire Disorder (HSDD): Efficacy Analyses from the RECONNECT Studies
  79. 015 A randomized, wait list-controlled trial suggests that two psychobehavioral interventions are effective for women’s hypoactive sexual desire
  80. 015 Combined Data of Intravaginal Prasterone against Vulvovaginal Atrophy of Menopause
  81. 015 The Impact of Incontinence Procedures at the Time of Vaginal Vault Suspension on Pelvic Pain and Dyspareunia: A Study of sexually Active Women with Post …
  82. 016 Antifibrotic effect of mycophenolate mofetil experimentally induced Peyronie’s Disease with TGF-B
  83. 016 Effectiveness of Medications for Female sexual Dysfunction: Number Needed To Treat (NNT)
  84. 016 Fidgetin-like 2, a Novel Microtubule Regulator, can be Targeted to Promote Nerve Regeneration and Improve Erectile Function after Cavernous Nerve Injury
  85. 016 Vulvoscopic Findings, Patient Reported Outcome (PRO) Measures, and Hormonal Blood Test Values in Menopausal Women with Female sexual Dysfunction Pre …
  86. 017 Bremelanotide (BMT) for hypoactive sexual desire Disorder (HSDD) in the RECONNECT Study: Efficacy Analyses in Study Completers and Responders
  87. 020 Bremelanotide Treatment Provided Clinically Meaningful Benefits in Premenopausal Women With hypoactive sexual desire Disorder
  88. 020 sexual Distress and Vaginal Symptom Severity in Women Diagnosed with Cancer: Impact of a Vaginal Health Workshop
  89. 021 Do Prior Anti-incontinence Procedures Influence the Success of Artificial Urinary Sphincter Placement?
  90. 021 Flibanserin in Premenopausal Women With hypoactive sexual desire Disorder: Pooled Analysis of Safety From Phase 3, Placebo-Controlled Studies
  91. 022 Predictors and Moderators of sexual Distress in Women with Persistent Genital Arousal Disorder
  92. 022 The Importance of the Developmental Stage of Nonconsensual sexual Experiences in Women’s sexual Adjustment
  93. 023 Reflections of Women Successfully Treated by Flibanserin at a Single Center
  94. 024 Motivations for sexual Intercourse among Women with a History of Childhood sexual Abuse
  95. 025 Direct Determination of Kinetic and Equilibrium Binding of Flibanserin to 5HT1A and 5HT2A Receptors
  96. 025 Lysis of Vulvar Adhesions for Lichen Sclerosus: A Series of 5 Patients
  97. 027 Effect of Alcohol Consumption on the Safety and Tolerability of Flibanserin in Premenopausal Female Volunteers
  98. 027 Preliminary Evidence for a Relationship between Physiological Synchrony and sexual Satisfaction
  99. 028 A Novel Technique for Assessing Vaginal Lubrication
  100. 028 What is the Relation Between Depressive Disorders, Dyspareunia and Other sexual Dysfunctions?
  101. 029 Bremelanotide for hypoactive sexual desire Disorders in the RECONNECT Studies: Analysis of Baseline Free Testosterone Level Quartile Subgroups
  102. 030 Improving Practitioner Knowledge and Clinical Competence in Managing Menopause-Associated Dyspareunia and Female sexual Dysfunction Through …
  103. 035 Patient Reported Outcomes of a Robotic-Assisted Double-Skin Flap Vaginoplasty Technique for Transfeminine Genital Reconstructive Surgery
  104. 036 Two-Arm, Prospective, Open-Label, Pilot Study of Flibanserin versus Flibanserin and sex Therapy in Pre-and Postmenopausal Women with HSDD
  105. 037 Open-Label Pilot, Prospective Vulvoscopic Study of Daily Administration of Prasterone Vaginal Inserts in Women with Moderate to Severe Dyspareunia
  106. 038 Effect Size of Bremelanotide Treatment in the Phase 3 RECONNECT Studies
  107. 039 Effects of sex Steroids on Relaxant/Contractile Pathways in Rat Vagina
  108. 043 Hormonal and Psychosocial Characteristics of Female sexual Dysfunction
  109. 044 FSFI Assessment of Minimally invasive, Fractional CO2 laser treatment for Vulvovaginal Atrophy and Dyspareunia
  110. 045 An Association between the Pain Domain of the Female sexual Function Index (FSFI) and Its Other Domains in Postmenopausal Women with Vulvar and Vaginal …
  111. 046 Cervical Ectropion may be a Cause of Desquamative Inflammatory Vaginitis
  112. 047 Responder Values for Clinical Trials in Female sexual Interest/Arousal Disorder
  113. 048 Evaluation of Common sexual Dysfunctions and Treatment Outcome in a Canadian sexual Medicine Practice
  114. 049 A Double-Blind, Sham Controlled Prospective Pilot Study of Urinary Stress Incontinence and sexual Function in Women After 6 Treatments with HIFEM …
  115. 050 The Effects of Radiofrequency on Female sexual Health
  116. 055 Does Participation in Faith-Based sexual Abstinence Programs Lead to Female sexual Dysfunction
  117. 056 Inflammation May Alter Perception of sexual Arousal and Pleasure in Healthy Women
  118. 057 Mercy sex: How Much Is “Normal” Depends Upon Where You Live
  119. 058 The Impact of Childhood Experiences on Emotional Responses to Partnered Genital Touch in the Laboratory
  120. 062 ColorDoppler Ultrasound in the Evaluation of the Cardiometabolic Profile in Women With sexual Dysfunction: A Gender Perspective
  121. 062 Temperature Controlled Radiofrequency Electrocoagulation for the Treatment of Vulvovaginal Tissue Laxity
  122. 063 Brain Dynamics of Female hypoactive sexual desire Disorder (HSDD)
  123. 063 Flibanserin: Enhanced Pharmacovigilance Study to Assess and Analyze the Risks of Adverse Events of Special Interest
  124. 064 Attitude of Women Nurse Practitioners for Embarrassing Female sexual and Urinary Symptoms in Korea
  125. 064 Brain Dynamics and Predictors of Female hypoactive sexual desire Disorders (HSDD): Two Routes in the Top-Down Neurofunctional Self-Attention Model (SAM) …
  126. 065 Vulvar Findings in GSM Patients Correlate with Severity of Overactive Bladder
  127. 066 Anatomic Sites and Risk Factors for Deep Dyspareunia
  128. 066 Pudendal Neuromodulation for Treatment of Female Orgasmic Disorder
  129. 067 Number Needed to Harm for Treatments of Female sexual Dysfunction
  130. 068 Female sexual Dysfunctions Associated With Male Premature Ejaculation
  131. 069 Hormonal Contraceptive Use and sexual Functioning among Young Women Who Experienced sexual Victimization
  132. 076 Perceptions and Attitudes About Low sexual desire Among Premenopausal Women: Results From a Consumer Survey
  133. 077 On the Initial Treatment Experience of CO2 Fractional Laser for Vulvovaginal Atrophy Symptom in a Single Institute
  134. 078 Exo-clinical Trials to Test Nutraceuticals for sexual Dysfunction
  135. 078 Why Core Emotions Matter: Understanding Subcortical Affective Circuits as Key to Treatment of sexual Disorders
  136. 079 Evaluating the Performance of a Low-cost Mobile Phone Attachable Microscope in Cervical Cytology
  137. 079 Temporal Frequency-Based Typology of Female Orgasm
  138. 079 Vulvar Crohn’s: A Rare Presentation of Crohn’s Disease
  139. 080 Patient Reported Satisfaction Rating After Attending a Multidisciplinary Psychoeducational sexual Wellness Program
  140. 080 Successful Management of Clitorodynia Closed Compartment Syndrome
  141. 080 Women’s Experiences With Bremelanotide Administered, On Demand, for the Treatment of hypoactive sexual desire Disorder
  142. 081 Lorexys Phase 2a Results: Patient’s Global Impression of Change (PGIC)
  143. 082 Nomegestrol Acetate/17beta-estradiol does not Negatively alter the Vascular Resistance of Clitoral Arteries
  144. 083 The Effect of Ristela Supplementation on Female sexual Function in Women Taking Antidepressants: An Open Label Trial
  145. 084 Improvements in Female sexual Function Index (FSFI) Domains Over Time after Flibanserin Treatment in Premenopausal Women with hypoactive sexual desire …
  146. 090 Effects of Bipolar Radiofrequency Treatment on Subjective and Objective Endpoints in Post-Partum Pelvic Floor Disorders
  147. 095 Rethinking the Techno Vagina: A Case Series of Patient Complications Following Vaginal Laser Treatment for Atrophy
  148. 096 Effect of CO2 Fractional Laser on Female Lower Urinary Tract Symptoms by Genitourinary Syndrome of Menopause
  149. 099 Flibanserin vs. Mini-Dose Trazodone for Female sexual Dysfunction? A Challenge
  150. 1 PREVALENCE OF ADULT DISORDERS
  151. 1, 25 dihydroxyvitamin D3 disorganizes actin fibers in human immortalized uterine leiomyoma cells
  152. 1.6 THE SOCIAL ORIGINS OF sexual DEVELOPMENT
  153. 10 Female sexual Dysfunction
  154. 10 Hormone Treatment of Adult Transgender People
  155. 10 Jahre Women’s Health Initiative (WHI): Was haben wir gelernt?
  156. 10 Lust, Romance, Attachment: Do the Side Effects of Serotonin-Enhancing Antidepressants Jeopardize Romantic Love, Marriage, and Fertility?
  157. 10 sexuality and ageing
  158. 10 Things You Aren’t Telling Him
  159. 10 Years in History
  160. 10. Testosteronbehandling till kvinnor
  161. 103 The Effect of Evening Alcohol Consumption and Bedtime Administration of Flibanserin on the Safety of Flibanserin
  162. 104 Flibanserin Subset Analyses and the Androgenics of hypoactive sexual desire Disorder
  163. 105 Preoperative Evaluation
  164. 105 Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Genital Arousal Disorder
  165. 1075: ATM Sequence Variants are Predictive of the Development of Erectile Dysfunction Among Patients Treated for Prostate Cancer with 125Iodine Brachytherapy
  166. 1076: Smooth Muscle Specific Expression of HSLO Restores Erectile Dysfunction in Diabetic and Aged Rats
  167. 1077: Facilitation of Proceptivity/sexual Motivation in Female Rats by a Serotonin 2A/2C (5-HT2A/2C) Receptors Agonist
  168. 1078: Increase in Proceptivity/sexual Motivation by Melanotan-II (MT-II) in Female Rats
  169. 10Evaluation and management of neurogenic sexual dysfunction
  170. 11 sex Steroids and Mood
  171. 11.4 Two Fundamental Human Motivations: Eating and Mating
  172. 118: THE ASSOCIATION BETWEEN BODY IMAGE AND hypoactive sexual desire DISORDER AMONG REPRODUCTIVE AGE WOMEN: AN IRANIAN …
  173. 12 Asexualities and Disabilities in Constructing sexual Normalcy
  174. 12 How altruism undermines mental health and happiness
  175. 12 sexual Disorders
  176. 12 sexual Disorders among sexual and Gender Minority Populations
  177. 12. M. Workshop: Health and integration of young refugees in Nordic Welfare countries–an equity perspective
  178. 13 ‘More Labels Than a Jam Jar’: The Gendered Dynamics of Diagnosis for Girls and Women with Autism1
  179. 13 Asexuality and Disability
  180. 13 sexual Counseling and Infertility
  181. 13 sexual Response
  182. 13.6 Somatoform, Factitious, and sexual Disorders
  183. 136 Cross-sectional Association between Testosterone and Metabolic Syndrome
  184. 139 Effects of Alcohol Administered With Flibanserin in Healthy Premenopausal Women: A Randomized, Double-Blind, Single-Dose, Seven-Way Crossover Study
  186. 14 sexual Distress in Obesity
  187. 14 Testosterone and sexual Function
  188. 14 The Female sexual Dysfunction Debate: Different ‘Problems,’New Drugs–More Pressures?
  189. 146 Conversations With Participants in the RECONNECT Studies About Their Experiences With Bremelanotide for Treatment of hypoactive sexual desire Disorder
  190. 148 Retrospective Study of the Prevalence and Risk Factors of Clitoral Adhesions: Why Women’s Health Providers Should Routinely Examine the Glans Clitoris
  191. 15 Neurocognitive Disorders
  192. 150 BP101 New Molecule for HSDD Treatment-Results of Proof-of-concept Phase 2a Study
  193. 15Chapter
  194. 16 Toward an Asexual Narrative Structure
  195. 16 Treatment of psychosexual problems
  196. 17β-Estradiol and testosterone levels in axillary perspiration of men: Environmental factors, inter-and intra-individual variation
  197. 18 sexual disorders
  198. 18 Vulvovaginal Pain after Breast Cancer Treatment
  199. 19 Female sexual Dysfunction
  200. 19 Female sexual dysfunctions: Future of medical therapy
  201. 19 sexuality in Older Adults
  202. 19 Transgender Health Care and Human Rights
  203. 19. A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF LIBIGEL® FOR …
  204. 193 Bremelanotide for hypoactive sexual desire Disorder: Contraceptive Subgroups Efficacy Analysis
  205. 194 Effect Size of Bremelanotide Treatment in the Phase 3 RECONNECT Studies
  206. 1Chapter
  207. 2 Inhibition, Lack of Excitation, or Suppression
  208. 2 Seven Leadership Skills for sexuality Educators
  209. 2007 UK guidelines for the management of sexual and reproductive health (SRH) of people living with HIV infection
  210. 2010 Sandra Leiblum Presidential Address
  211. 2011 Sandra Leiblum Presidential Address
  212. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
  213. 2016 NEI SYNAPSE—NEW!
  214. 2017-2018 NAMS President
  215. 2018 ICD-10-CM Hospital Professional Edition-E-Book
  216. 2018 ICD-10-CM Physician Professional Edition-E-Book
  217. 2018 ICD-10-CM Standard Edition-E-Book
  218. 2019 FDA TIDES (peptides and oligonucleotides) harvest
  219. 2020 FDA TIDES (Peptides and Oligonucleotides) Harvest
  220. 21 Ejaculatory Disorders
  221. 21 Evolutionary Cognitive Neuroscience
  222. 21 sex and Gender Disorders
  223. 21 The Endocrinology of Female Competition
  224. 213 A Prosthesis-Specific Survey Study: The sexual Quality of Life Benefits of the Inflatable Penile Prosthesis are Generalizable Across Multiple Patient …
  225. 221 A Retrospective Single Center Study of Vulvoscopic Findings, Female sexual Function Index (FSFI) Scores and Hormonal Blood Test Values in Menopausal …
  226. 223 How much Girth is too much Girth? Dimensions of Bestselling Insertive sex Toys to Guide Maximal Phalloplasty Dimensions
  227. 225 Unlocking Female sexual Dysfunction in Muslim Women in America: A Retrospective Look at the Incidence of Vaginismus in this Population
  228. 226 Effect of Flibanserin on Body Weight During Treatment for hypoactive sexual desire Disorder in Premenopausal and Postmenopausal Women
  229. 23 Implications for training, research and service provision
  230. 238 A 10-Year Interval Study to compare the Prevalence and Risk Factors of Female sexual Dysfunction in Korea
  231. 239 sexual and Non-sexual Improvements in Women with HSDD: Personal Experiences with Flibanserin Treatment
  232. 24 DIRECTED MASTURBATION: A TREATMENT OF FEMALE ORGASMIC DISORDER
  233. 24-Hour Urine Comprehensive Hormone Profile Handbook
  234. 240 Alcohol Use and sexual Health Concerns in a sexual Health Clinic
  235. 25 sexual Function, Dysfunction, and Difficulties
  236. 25 years and sex is still hot.
  237. 260 Diabetes and level of fasting blood sugar has no relationship to the development of subsequent penile prosthesis infection in Korean men
  238. 261 Efficacy of metacognitive therapy for hypoactive sexual desire disorder among Iranian couples
  239. 262 Viewing time and penile plethysmography measurement in a group of admitting pedophiles
  240. 27 Mental Health for Asexual Individuals
  241. 27. EVALUATION OF sexual DYSFUNCTION
  242. 28th Annual Meeting of The North American Menopause Society October 11-14, 2017, Philadelphia, PA
  243. 29Arthritis
  244. 2D: 4D digit ratio and its relations to cross-sex and same-sex friendship choices
  245. 2nd Joint Puerto Rican SPED/AACE International Endocrine Update and 28th SPED Post Graduate Diabetes Course: December 8–11, 2005, San Juan, Puerto Rico …
  246. 3 “There’s No Such Thing as a sexual Relationship”
  247. 3-Oxopiperazinium derivatives as agonists of nerve growth factor and their use as medicaments
  248. 3-oxopiperazinium derivatives as agonists of nerve growth factor receptors and their use as medicaments
  249. 31 Days to Great sex: Love. Friendship. Fun.
  250. 32 Integrative Medicine in Gynecologic Oncology
  251. 341 Mercy sex: How Much Is “Normal”
  252. 376 Vasal Vessels Preserving Microsurgical Vasoepididymostomy
  253. 4 Hypnotherapy and depression
  254. 4.8. G03X Other sex Hormones and Modulators of the Genital System
  255. 40 Psychological abnormalities of male sexual function
  256. 490 HANDBOOK OF CLINICAL INTERVIEWING WITH ADULTS
  257. 4th International Consultation on sexual Medicine June 19–21, 2015 Melia Castilla Hotel, Madrid, Spain
  258. 5 th EURASIAN ANDROLOGY SUMMIT
  259. 5-HT 2A receptor gene polymorphism is associated with food and alcohol intake in obese people
  260. 5-HT1A and 5-HT2A receptors affinity, docking studies and pharmacological evaluation of a series of 8-acetyl-7-hydroxy-4-methylcoumarin derivatives
  261. 5-HT1A receptor ligands and their therapeutic applications: review of new patents
  262. 5-HT1A Receptor: An Old Target as a New Attractive Tool in Drug Discovery from Central Nervous System to Cancer
  263. 50+ INCREDIBLE Benefits (And Warnings) for Women When They Take Natural Progesterone (P4)
  264. 54 SENSATE FOCUS FOR sexual DYSFUNCTION
  265. 5α-Reductase-2 deficiency: is gender assignment recommended in infancy? Two case-reports and review of the literature
  266. 6. sexual Medicine in Finland
  267. 61 SENSATE FOCUS
  268. 62nd Annual Meeting of the American Society for Reproductive Medicine: October 23–25, 2006, New Orleans, LA, USA
  269. 689 Illustrated evaluation of scientific productions of sexual medicine researchers during 2012 till the end of 2016
  270. 690 HIV-related healthcare needs and access barriers for Brazilian transgender and gender diverse people
  271. 691 High serum testosterone is associated with poor pathological outcomes in patients with prostate cancer in Japanese populations
  272. 7 Keys to Lifelong sexual Vitality: The Hippocrates Institute Guide to sex, Health, and Happiness
  273. 7Chapter
  274. 882: Relationship of Self-Diagnosed Premature Ejaculation to Other Indicators of Male sexual Function
  275. 883: The Utility of “Estimated Intra-Vaginal Ejaculatory Latency Time” and “DSM-IV Criteria” in Identifying Premature Ejaculation
  276. 884: Phase I, Double-Blind, Placebo-Controlled Study in Healthy Male Subjects to Investigate the Safety, Tolerability, and Pharmacokinetics of DA-8159
  277. 885: Prevalence of Female sexual Dysfunction in Germany
  278. 9 Hypnotherapy and sexual problems
  279. 910 THE ROLE OF MAJOR PELVIC GANGLION IN THE NEURAL PATHWAY OF ELECTRICAL STIMULATION OF LESSER SPLANCHNIC NERVE-INDUCED …
  280. 911 SCREENING FOR hypoactive sexual desire DISORDER (HSDD) IN THE UROLOGY OFFICE SETTING
  281. 912 IN-VITRO ANALYSIS OF THE EFFICACY OF PENILE TRACTION ON PEYRONIE’S DISEASE: ASSESSING CELLULAR CHANGES IN PEYRONIE’S PLAQUE IN A …
  282. 9Chapter
  283. 9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology
  284. A 15-item short form of the psychological and interpersonal relationship scales
  285. A 60-year-old woman with sexual difficulties
  286. A baseline-controlled, open-label, flexible dose-escalation study to assess the safety and efficacy of sildenafil citrate (Viagra®) in patients with erectile …
  287. A Bedroom of One’s Own: Morality and sexual Privacy after Lawrence v. Texas
  288. A behavioral systems approach to romantic love relationships: Attachment, caregiving, and sex
  289. A Bibliography of 34 Counter-Narrative Sources Prepared for the FDA ‘Patient-Focused Drug Development Public Meeting and Scientific workshop on Female …
  290. A Bibliography of Randomized Controlled Experiments in Social Work (1949–2013) Solvitur Ambulando
  291. A biopsychosocial approach to women’s sexual function and dysfunction at midlife: A narrative review
  292. A Brief Description of the Disorders
  293. A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer
  294. A Brief Version of the sexual Interest and desire Inventory–Female With 4 Core Items
  295. A Canadian Cost-Utility Analysis of two Trabecular Micro-Bypass Stents in Patients with Mild-to-Moderate Open-Angle Glaucoma
  296. A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder
  297. A Case of desire Disparity
  298. A case of enhancing sexual confidence: both the client and the therapist are the experts
  299. A case of inguinal endometriosis in the absence of previous gynecologic surgery
  300. A case of premature ejaculation: too little, too late?
  301. A case series of androgen use in breast cancer survivors with sexual dysfunction
  302. A Case with Male Erectile Disorder and hypoactive sexual desire Disorder Treated by Psychotherapy Using Hypnosis
  303. A clinical update on female androgen insufficiency—testosterone testing and treatment in women presenting with low sexual desire
  304. A clinician’s guide to systemic sex therapy
  305. A clinician’s guide to systemic sex therapy
  306. A Clinician’s Guide to Systemic sex Therapy
  307. A cognitive-behavioral approach to sex therapy
  308. A cognitive-motivational approach to understanding gendered sexual response: The role of attentional mechanisms
  309. A combined-constructionist therapeutic approach to couples experiencing erectile dysfunction: Part II
  310. A commentary on sexual well-being, happiness and satisfaction in women: The case for a new conceptual paradigm
  311. A commentary on transdermal drug delivery systems in clinical trials
  312. A Comparative study of sexual Dysfunction in Remitted Patients Taking Antipsychotics Versus Antidepressants
  313. A comparative study of the sexual functioning of women with primary headache in India
  314. A comparative study using orgasm consistency training in the treatment of women reporting hypoactive sexual desire
  315. A Comparison between Males/Females and Divorcing ones on sexual Functioning in Isfahan
  316. A comparison of 19th century and current attitudes to female sexuality
  317. A comparison of DSM‐IV‐TR and DSM‐5 definitions for sexual dysfunctions: Critiques and challenges
  318. A comparison of five-factor personality dimensions in males with sexual dysfunction and males with paraphilia
  319. A comparison of medical comorbidities, psychosocial, and sexual well-being in an online cross-sectional sample of women experiencing persistent genital arousal …
  320. A comparison of mindfulness-based cognitive therapy vs cognitive behavioral therapy for the treatment of provoked vestibulodynia in a hospital clinic setting
  321. A comparison of sexual desire in opiate-dependent men receiving methadone and buprenorphine maintenance treatment
  322. A comparison of sexual function in primiparous and multiparous women
  323. A Comparison of Spontaneous and Responsive Models of sexual desire in Women Who Meet Screened Criteria for Female sexual Interest/Arousal Disorder
  324. A Comparison of the sexual Well-Being of New Parents With Community Couples
  325. A COMPREHENSIVE GUIDE TO UNDERSTANDING LESBIAN sexual HEALTH: REACHING A VULNERABLE POPULATION
  326. A comprehensive review of erectile dysfunction in men with diabetes
  327. A comprehensive review of sexual health concerns after cancer treatment and the biopsychosocial treatment options available to female patients
  328. A Comprehensive Review of the Phytochemical, Pharmacological, and Toxicological Properties of Tribulus terrestris L.
  329. A COST EFFECTIVENESS ANALYSIS OF A GENERAL VACCINATION PROGRAMME WITH THE NEW 10-VALENT PNEUMOCOCCAL NON-TYPEABLE …
  330. A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment—a systematic review
  331. A critical discourse analysis of herbal sexual medicine websites marketing to women: a thesis presented in partial fulfilment of the requirements for the degree of …
  332. A critical evaluation of the evidence for ovarian conservation versus removal at the time of hysterectomy for benign disease
  333. A critical examination of popular assumptions about the benefits and outcomes of monogamous relationships
  334. A critical examination of the relationship between vaginal orgasm consistency and measures of psychological and sexual functioning and sexual concordance in …
  335. A critical feminist analysis of madness
  336. A critical review of repurposing apomorphine for smoking cessation
  337. A cross-cultural study of midlife relational and sexual health: Comparing Ukraine to the US and Turkey
  338. A cross-national examination of sexual desire: The roles of ‘gendered cultural scripts’ and ‘sexual pleasure’in predicting heterosexual women’s desire for sex
  339. A cross-sectional study of female sexual function and dysfunction during pregnancy
  340. A Culturally Grounded Approach to Psychotherapy with Chaldean Americans
  341. A current perspective into young female sex hormone replacement: a review
  342. A Current Study on Benzimidazole Derivatives
  343. A Delicate Balance
  344. A Descriptive Analysis of sexual Problems in Long-Term Heterosexual Relationships
  345. A diagnosis of denial: How mental health classification systems have struggled to recognise family violence as a serious risk factor in the development of mental …
  346. A discordant monozygotic twin approach to testing environmental influences on sexual dysfunction in women
  347. A discursive look at the friend/partner distinction: Implications for asexual people
  348. A dose-response and meta-analysis of dehydroepiandrosterone (DHEA) supplementation on testosterone levels: perinatal prediction of randomized clinical trials
  349. A double blind placebo controlled study of granisetron in antidepressant induced sexual dysfunction
  350. A double blind randomized control trial, comparing effect of drospirenone and gestodene to sexual desire and libido
  351. A double-blind placebo-controlled trial of maca root as treatment for antidepressant-induced sexual dysfunction in women
  352. A double-blind, randomised-placebo, controlled, parallel group, multicentre, flexible-dose escalation study to assess the efficacy and safety of sildenafil …
  353. A dvances in cancer screening and treatments have resulted in an increase
  354. A Dyadic Examination of Female Partners’ Accommodation of Male Service Members’ Posttraumatic Stress Symptoms and Caregiver Burden as Correlates of Military …
  355. A dyadic longitudinal study of child maltreatment and sexual well-being in adult couples: the buffering effect of a satisfying relationship
  356. A dyadic perspective on childhood maltreatment for women with provoked vestibulodynia and their partners: Associations with pain and sexual and psychosocial …
  357. A facile route of synthesis for making Flibanserin
  358. A Feminist Contestation of Ableist Assumptions: Implications for Biomedical Ethics, Disability Theory, and Phenomenology
  359. A feminist perspective on sexuality and body image in females with colorectal cancer: an integrative review
  360. A feminist revision of contemporary sex therapy
  361. A field trial of the effectiveness of behavioral treatment for sexual dysfunctions
  362. A further examination of Levine’s model of sexual desire
  363. A general look at female orgasm and anorgasmia
  364. A grounded theory study of the psychological impact of taking part in sexual actions which are accepted versus those which are desired
  365. A group therapy format for the simultaneous treatment of marital and sexual dysfunctions: A case illustration
  366. A history of erotic philosophy
  367. A holistic treatment approach to male erectile disorder
  368. A journey into the dangers of orthodoxy from the former director of the Freud Archives
  369. A Journey Through Psyche’s sexual Energy
  370. A language and methodology for studying the hierarchies in the DSMs
  371. A large-scale test of the replicability and generalizability of survey measures in close relationship and sexuality science
  372. A lexicon of lunacy
  373. A literature review and case reports series on the use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction
  374. A literature review on the relationship between infertility and sexual dysfunction: does fun end with baby making?
  375. A literature review on vulvodynia and distress
  376. A Longitudinal Examination: The Relationship between sexuality and Mental Health-Related Quality of Life for Breast Cancer Survivors
  377. A longitudinal study of problems in sexual functioning and related sexual distress among middle to late adolescents
  378. A longitudinal study of sexual function in women with newly diagnosed inflammatory bowel disease
  379. A longitudinal study of the effects of free testosterone and other psychosocial variables on sexual function during the natural traverse of menopause
  380. A MedFT-informed sex therapy for treating sexual problems associated with chronic illness
  381. A methodology study to validate a structured diagnostic method used to diagnose female sexual dysfunction and its subtypes in postmenopausal women
  382. A mindfulness psychoeducational group intervention targeting sexual adjustment for women with multiple sclerosis and spinal cord injury: a pilot study
  383. A mindfulness-based group psychoeducational intervention targeting sexual arousal disorder in women
  384. A Mixed Methods Analysis of the Concept of Female sexual Health
  385. A Mixed-Methods Inquiry into the Intimate Practices of Partnered Mature Students and Influences on Relationship, sexual, and School Satisfaction.
  386. A model for the capacity building of Somalia midwifery educators through a blended, web-based Master Programme
  387. A model for the management of female sexual dysfunctions
  388. A model of female sexual desire: Internalized working models of parent–child relationships and sexual body self-representations
  389. A model of physician intentions toward initiating a dialogue about sexual health with women
  390. A more radical proposal: Dyspareunia is not a mental disorder
  391. A multidisciplinary approach to sexual behavior profiles: The sex360 model
  392. A multidisciplinary approach to sexual dysfunction in female athletes
  393. A multidisciplinary approach to the evaluation and management of interstitial cystitis/bladder pain syndrome: an ideal model of care
  394. A multivariate analysis of the factors that influence the modification of sexual desire in oral hormonal contraceptive (OC) users
  395. A mystery wrapped in an enigma–asexuality: a virtual discussion
  396. A nationwide study on breast cancer risk in postmenopausal women using hormone therapy in Finland
  397. A neglected issue: The sexual side-effects of current treatments for breast cancer.
  398. A neutral odor may become a sexual incentive through classical conditioning in male rats
  399. A new deal on disease definition
  400. A new editorial structure for sexual and Marital Therapy
  401. A new female rat animal model for hypoactive sexual desire disorder; behavioral and pharmacological evidence
  402. A new glucose monitoring option
  403. A new instrument to measure sexual competence and interaction competence in youth: psychometric properties in female adolescents
  404. A new measure of sexual function in women with pelvic floor disorders (PFD): the Pelvic Organ Prolapse/Incontinence sexual Questionnaire, IUGA-Revised …
  405. A new non-pharmacological vacuum therapy for female sexual dysfunction
  406. A new view of women’s sexual problems: Why new? Why now?
  407. A novel collaborative protocol for successful management of penile pain mediated by radiculitis of sacral spinal nerve roots from Tarlov cysts
  408. A novel design and facile synthesis of nature inspired poly (dopamine-Cr3+) nanocubes decorated reduced graphene oxide for electrochemical sensing of flibanserin
  409. A Novel LC-ESI-MS/MS Method for the Quantification of Flibanserin in Bulk and Pharmaceutical Formulations
  410. A Panoramic View
  412. A Phase 2a Multicenter, Double‐Blind, Placebo‐Controlled, Crossover Trial to Investigate the Efficacy, Safety, and Toleration of CP‐866,087 (a High‐Affinity Mu …
  413. A phenomenological defense of sexual pharmakotherapy
  414. A phenomenological inquiry into the lived experience of low sexual desire in women: Implications for clinical practice
  415. A phenomenological study of women in same-sex relationships who were previously married to men
  416. A phenomenology of sexual experiencing
  417. A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy
  418. A pilot study of a topical intervention for treatment of female sexual dysfunction
  419. A pilot study of eight-session mindfulness-based cognitive therapy adapted for women’s sexual interest/arousal disorder
  420. A pilot study of soft gel technology: a new vaginal device to improve the symptomatology of vulvovaginal atrophy in post-partum, menopause and in patients …
  421. A Pilot Study on Evaluation of Standardized Ayurveda formulation Ashwagandhadi lehya as Aphrodisiac and in treatment of Oligospermia
  422. A place for sexual dysfunctions in an empirical taxonomy of psychopathology
  423. A place of androgen deficiency in a clinical portrait of the modern urological patient
  424. A Placebo-Controlled, Randomized, Double-Blind, Three Period, Three-Way Crossover Study on the Hemodynamic and Pharmacokinetic Interactions of …
  425. A PLISSIT-model intervention in people with type 2 diabetes with sexual problems: results from a cluster-randomized controlled trial in primary care
  426. A population-based epidemiologic study of female sexual dysfunction risk in Mainland China: prevalence and predictors
  427. A PORTFOLIO OF STUDY, PRACTICE AND RESEARCH
  428. A positive approach toward asexuality: Some first steps, but still a long way to go
  429. A potential aphrodisiac for female macaques
  430. A practical approach to desire problems
  431. A practical approach to managing hypoactive sexual desire disorder in women with diabetes
  432. A Practical Cognitive-Behavioral Treatment Approach
  433. A practical guide to female sexual dysfunction: An evidence-based review for physicians in Canada
  434. A practical guide to gynecologic and reproductive health in women undergoing hematopoietic stem cell transplant
  435. A practical solution for dyspareunia in breast cancer survivors: a randomized controlled trial
  436. A practitioner’s toolkit for managing the menopause
  437. A preclinical model of menopause: the ovariectomized female rat
  438. A preliminary investigation of affective and cognitive response to erotic stimulation in men before and after sex therapy
  439. A preliminary investigation on the evaluation of psychopathologies in a group of ex-pet and ex-performer chimpanzees (Pan troglodytes): A rating approach based on …
  440. A preliminary study of women with persistent sexual arousal syndrome
  441. A program for the treatment of inhibited sexual desire in males.
  442. A Prospective Clinical Observational Study on Assessment of Risk Factors, Diagnosis and Prescribing Patterns of Medications for Migraine
  443. A prospective exploration of symptom burden clusters in women with breast cancer during chemotherapy treatment
  444. A prospective study of outcomes after hysterectomy in mid-aged Australian-born women
  445. A prospective study of psychiatric aspects of early HIV disease in women
  446. A Psychiatric Diagnosis Primer: An Easy Guide to Identifying Psychiatric Illness
  447. A psychiatrist’s guide to sexual dysfunction in women
  448. A psychobiosocial model for assessment, treatment, and relapse prevention for female sexual interest/arousal disorder
  449. A psychophysiological investigation of sexual arousal in women with lifelong vaginismus
  450. A psychophysiological perspective on vulvodynia.
  451. A qualitative comparison of young women’s maintained versus decreased sexual desire in longer-term relationships
  452. A qualitative exploration of factors that affect sexual desire among men aged 30 to 65 in long-term relationships
  453. A qualitative exploration of men’s experiences of sexual desire in heterosexual long-term relationships
  454. A Qualitative Exploration of the Distress and Consequences Experienced by Women with Low sexual desire and their Partners in Long-Term Relationships
  455. A qualitative exploration of the distress experienced by long-term heterosexual couples when women have low sexual desire
  456. A qualitative exploration of the meaning and experience of sexual desire among partnered women
  457. A qualitative investigation of male partners’ experience of relationships with women suffering from vaginismus
  458. A randomized clinical trial for women with vulvodynia: Cognitive-behavioral therapy vs. supportive psychotherapy
  459. A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual
  460. A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized …
  461. A randomized controlled intervention trial of a sexual health approach to long-term HIV risk reduction for men who have sex with men: effects of the intervention on …
  462. A randomized pilot trial of a couple-based intervention addressing sexual concerns for breast cancer survivors
  463. A Randomized Study Comparing Video-Based Mindfulness-Based Cognitive Therapy With Video-Based Traditional Cognitive Behavioral Therapy in a Sample of …
  464. A randomized trial of low-cost mesh in groin hernia repair
  465. A randomized trial of oral DHEA treatment for sexual function, well-being, and menopausal symptoms in postmenopausal women with low libido
  466. A randomized trial of the effect of testosterone and estrogen on verbal fluency, verbal memory, and spatial ability in healthy postmenopausal women
  467. A randomized, double‐blind, placebo‐controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating women
  468. A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal …
  469. A randomized, placebo-controlled laboratory study of the effects of D-cycloserine on sexual memory consolidation in women
  470. A randomized, waiting-list-controlled study shows that brief, mindfulness-based psychological interventions are effective for treatment of women’s low sexual desire
  471. A rapid and sensitive stability-indicating green RP-HPTLC method for the quantitation of flibanserin compared to green NP-HPTLC method: Validation studies and …
  472. A rapid and sensitive UPLC-MS/MS method for the determination of flibanserin in rat plasma: application to a pharmacokinetic study
  473. A rare cause of difficulty with sexual intercourse: large retroperitoneal leiomyoma
  474. A rare cause of infertility: A late complication of female genital mutilation
  475. A reasoned action approach to understand vaccination intention among healthcare professions students
  476. A reflexive action research project to investigate the development of an educational public health website with an integrated online advice service
  477. A reintroduction to clinical sexuality
  478. A relational-feminist psychodynamic approach to sexual desire
  479. A replication study of obsessional followers and offenders with mental disorders
  480. A Rethinking of Gray Asexuality: What do we Learn from an Undefinable Identity?
  481. A Review of “Clinical Handbook of Couple Therapy” Alan S. Gurman (Ed).(2008). New York: Guilford Press, 736 pp., $90.00
  482. A review of affecting factors on sexual satisfaction in women
  483. A review of antidepressant therapy in primary care: current practices and future directions
  484. A review of anxiety and sexual arousal in human sexual dysfunction
  485. A review of breast cancer survivorship issues from survivors’ perspectives
  486. A review of experimental research on anxiety and sexual arousal: Implications for the treatment of sexual dysfunction using cognitive behavioral therapy
  487. A review of infrared thermography as applied to human sexual psychophysiology
  488. A review of male and female sexual function following colorectal surgery
  489. A review of mindfulness-based sex therapy interventions for sexual desire and arousal difficulties: From research to practice
  490. A review of patient-reported outcome labeling in the United States (2011–2015)
  491. A review of recent innovations in the treatment of low sexual desire
  492. A review of traditional pharmacological uses, phytochemistry, and pharmacological activities of Tribulus terrestris
  493. A review of treatment-related outcomes in female partners of men with Peyronie’s disease—an Opportunity for improved Assessment
  494. A Review of: “Principles and Practice of sex Therapy. Fourth Edition” edited by Sandra R. Leiblum, The Guilford Press, New York, New York; 2007; ISBN 978-1-59385 …
  495. A Review of” Systemic sex Therapy”
  496. A Review on the role of Tribulus terrestris in the reproductive biology
  497. A role for melanocortin agonists in treating male and female sexual dysfunction
  498. A rose by any other name: Should dyspareunia be reclassified?
  499. A s an extension of their study demonstrating that topira
  500. A Selection of Notable Papers from the Past 25 Years
  501. A selective role for right insula—basal ganglia circuits in appetitive stimulus processing
  502. A selective serotonin receptor agonist for weight loss and management of menopausal vasomotor symptoms in overweight midlife women: a pilot study
  503. A sex-specific dose-response curve for testosterone: could excessive testosterone limit sexual interaction in women?
  504. A sexual masquerade: the performance of desire and femininity in a Fifty Shades of Grey era: a thesis presented in partial fulfilment of the requirements for the degree …
  505. A sexual medicine health care model and nurse practitioner role.
  506. A short review on potential activities of benzimidazole derivatives
  507. A Short Term Cognitive and Behavorial Treatment Approach to sexual desire Phase Dysfunction
  508. A simple test for the treatment effect in clinical trials with a sequential parallel comparison design and negative binomial outcomes
  509. A skeptical view of desire norms and disorders promotes clinical success
  510. A slightly different idea
  511. A socio-cognitive approach of human sexual desire
  512. A Sociological Perspective on Impulsivity: Some Cautionary
  513. A specific nursing educational program in patients with Cushing’s syndrome
  514. A Standard for Terminology in Chronic Pelvic Pain Syndromes (CPPS): A Report from the Working Group of the International Continence Society …
  515. A standard for terminology in chronic pelvic pain syndromes: A report from the chronic pelvic pain working group of the international continence society
  516. A standardized diagnostic interview for hypoactive sexual desire disorder in women: standard operating procedure (SOP Part 2)
  517. A stepped-care approach to symptomatic endometriosis management: a participatory research initiative
  518. A streetcar named “Derousal”? A psychophysiological examination of the desire–arousal distinction in sexually functional and dysfunctional women
  519. A strong pelvic floor is associated with higher rates of sexual activity in women with pelvic floor disorders
  520. A structural equation modeling analysis of the relationships between depression, anxiety, and sexual problems over time
  521. A study assessing the quality of life related to voiding symptoms and sexual functions in menopausal women
  522. A Study of Correlation of sexual Dysfunction with Serum Uric Acid Level in Alcohol Dependent Individuals
  523. A study of marriage and family counselling services of Pentecostal and Charismatic churches in Cape Coast metropolis
  524. A study of possible associations between single nucleotide polymorphisms in the estrogen receptor 2 gene and female sexual desire
  525. A study of prevalence of sexual dysfunction & assessment of related factors in women referring to mother-baby clinics in Tehran
  526. A Study of sexual Dysfunction among Male Alcohol Dependent Patients.
  527. A Study of sexual Dysfunction in a Sample of Medicated and non Medicated Egyptian Female Patients with Schizophrenia
  528. A study of sexual related determinants and marital quality among married couple in Malaysia
  529. A STUDY OF THE CONNECTION BETWEEN INSECURE ATTACHMENT
  530. A study of the Libidinal impulses and its Management in adolescents
  531. A study of various factors associated with sexual dysfunction in males with type 2 diabetes mellitus
  532. A Study on the Development of
  533. A STUDY ON THE FACTORS THAT INFLUENCE ASCHENBACH’S sexual ORIENTATION IN MANN’S DEATH IN VENICE
  534. A study protocol of vaginal laser therapy in gynecological cancer survivors
  535. A Survey of Biological, Psychological, Sociological, and Cultural Factors
  536. A survey of Relate psychosexual therapy clients, January to March 2002
  537. A survey of urban middle-aged women’s sexual function and sexual distress
  538. A Swiss longitudinal study of the prevalence of, and overlap between, sexual problems in men and women aged 20 to 50 years old
  539. A symptomatic approach to understanding women’s health experiences: a cross-cultural comparison of women aged 20 to 70 years
  540. A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal …
  541. A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal …
  542. A systematic review of sexual distress measures
  543. A systematic review of the correlates and management of nonpremature ejaculatory dysfunction in heterosexual men
  544. A systematic review of the literature on female sexual dysfunction prevalence and predictors
  545. A systemic approach to sensate focus
  546. A Systemic Approach to sex Therapy
  547. A test of three hypotheses concerning attributions toward female promiscuity
  548. A Textual Analysis of Online Asexual Representation and Visibility on Reddit
  549. A theory of love and sexual desire
  550. A Traditional Masters and Johnson behavioral approach to sex therapy
  551. A Transdiagnostic Approach to sexual Distress and sexual Pleasure: A Preliminary Mediation Study with Repetitive Negative Thinking
  552. A Turkish study of prevalence and risk factors for low sexual function in women.
  553. A Typology of Women with Low sexual desire
  554. A unique patient presenting with concomitant Klinefelter syndrome, Alport syndrome, and craniopharyngioma
  555. A validated UPLC–MS/MS method for flibanserin in plasma and its pharmacokinetic interaction with bosentan in rats
  556. A Woman Complaining of Lack of sexual desire: sexological Counseling
  557. A-Identity Politics: Asexual Exceptionalism, Precarity, and Activism
  558. A172 Abstracts
  559. A182 Abstracts
  560. AB029. Meeting sexual health requirements in menopause
  561. AB033. Comparing male and female sexual arousal, utilizing fMRI: a theoretical perspective
  562. Abdullah A, Wolfe R, Mannan H, Stoelwinder JU, Stevenson
  563. Aberrant baseline brain activity in psychogenic erectile dysfunction patients: a resting state fMRI study
  564. Aberrant insula-centered functional connectivity in psychogenic erectile dysfunction patients: a resting-state fMRI study
  565. Aberrant topological patterns of structural cortical networks in psychogenic erectile dysfunction
  566. Abnormal degree centrality in lifelong premature ejaculation patients: an fMRI study
  567. Abnormal desire or normal for females? Addressing women’s disinterest in sex
  568. Abnormal Libido
  569. Abnormal psychology
  570. Abnormal sexuality in Parkinson’s disease: fact or fancy?
  571. Abnormalities of sexual function and interest: origins and interventions
  572. About Ochsner
  573. About Ochsner
  574. Above and beyond short-term mating, long-term mating is uniquely tied to human personality
  575. Abraham E, Laterre PF, Garg R, Levy H, Talwar D, Trzaskoma BL, Francois B, Guy JS, Bruckmann M, Rea-Neto A, Rossaint R, Perrotin D, Sablotzki A, Arkins N …
  576. ABSTR ACT PRESENTATIONS
  577. Abstracts 32nd Annual Meeting of the North American Society for Psychosocial Obstetrics and Gynecology
  578. Abstracts from the 2017 American College of Medical Toxicology (ACMT) annual scientific meeting
  579. Abstracts from the XVII World Congress of sexology
  580. Abstracts from Women’s Health 2012: The 20th Annual CongressMarch 16–18, 2012 Washington, DC
  581. Abstracts from Women’s Health 2016: The 24th Annual Congress April 14–17, 2016 Washington, DC
  582. Abstracts from Women’s Health 2017: The 25th Annual Congress April 28–30, 2017 Washington, DC
  583. Abstracts from Women’s Health 2018: Translating Research into Clinical Practice May 4–6, 2018 Washington, DC
  584. Abstracts fromWomen’s Health 2013: The 21st Annual CongressMarch 22–24, 2013Washington, DC
  585. Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy
  586. Accessing health care on the asexual spectrum: A feminist analysis of patient-practitioner relationships and compulsory sexuality in medical discourse
  587. Accounts of the impact of erectile dysfunction on heterosexual couples from men seeking erectogenic treatment and their partners
  588. Accreditation rules safeguard continuing medical education from commercial influence
  589. Ace and aro: understanding differences in romantic attractions among persons identifying as asexual
  590. ACE angiotensin-converting enzyme AED anti-epileptic drug AFP α-fetoprotein ALT alanine transaminase
  591. Ace: What Asexuality Reveals About desire, Society, and the Meaning of sex
  592. Acetylcholinesterase inhibitory and antioxidant activities of Ferula caspica and F. halophila extracts
  593. Achievement of and Failure to Achieve Orgasm in sexual Relationship: Exploring Iranian Women’s Experiences
  594. Acknowledging female sexual dysfunction in women with cancer.
  595. ACOG guideline on sexual dysfunction in women
  596. ACR, ACRUX LIMITED
  597. Acromegaly is associated with higher frequency of female sexual dysfunction: experience of a single center
  598. ACT for Gender Identity: The Comprehensive Guide
  599. Activation of sensory cortex by imagined genital stimulation: an fMRI analysis
  600. Acupuncture and female sexual dysfunction: a time-series study of symptom relief
  601. Acupuncture in premenopausal women with hypoactive sexual desire disorder: a prospective cohort pilot study
  602. Acupuncture in premenopausal women with hypoactive sexual desire disorder: a prospective cohort study
  603. Acute Aortic Dissection in a Postmenopausal Female in the Setting of Parenteral Testosterone, Estradiol, and Progesterone Therapy
  604. Acute Cannabis Intoxication and the Brain’s Response to Visual Erotica: An Fmri Study
  605. Acute dehydroepiandrosterone (DHEA) effects on sexual arousal in postmenopausal women
  606. Acute exercise improves physical sexual arousal in women taking antidepressants
  607. Acute withdrawal but not long-term withdrawal from methamphetamine affects sexual behavior in female rats
  608. Adaptación, validación y fiabilidad del Cuestionario de funcionamiento sexual del Hospital General de Massachusetts en una muestra colombiana y equivalencia …
  609. Adaptation and validation of the sexual Assertiveness Scale (SAS) in a sample of male drug users
  610. Adaptation, validation and reliability of the Massachusetts General Hospital-sexual Functioning Questionnaire in a Colombian sample and factorial …
  611. Adapting a couple-based intimacy enhancement intervention to breast cancer: A developmental study.
  612. Addiction is not just a brain disease
  613. Addiction or compulsion: politics or illness?
  614. Adding insult to injury: The classification of dyspareunia as a sexual dysfunction in the DSM
  615. Addressing both genders in sexual medicine diagnosis and treatment
  617. Addressing sexual Dysfunction After Childhood sexual Abuse: A Clinical Approach from an Attachment Perspective
  618. Addressing sexual dysfunction in colorectal cancer survivorship care
  619. Addressing sexuality with clients: A manual for therapists in training
  620. Addressing the sexual function of women during first six month after delivery: Aquasi-experimental study
  621. Addressing the sexual problems of Iranian women in a primary health care setting: A quasi-experimental study
  622. Addressing vulvovaginal atrophy (VVA)/genitourinary syndrome of menopause (GSM) for healthy aging in women
  623. Adiposity, chronic inflammation, and the prepubertal decline of sex hormone binding globulin in children: evidence for associations with the timing of puberty …
  624. Adjudicating sex crimes as mental disease
  625. Adjuvant Rosa damascena has a small effect on SSRI-induced sexual dysfunction in female patients suffering from MDD
  626. Adolescence as a risk factor for maternal and perinatal complications in Cali, Colombia, 2002-2007: a cross-sectional study
  627. Adolescent and pediatric
  628. Adolescent stalking: A review
  629. Adrenal androgens and aging
  630. Adrenal androgens impact on neurosteroids
  631. Adrenal cortex
  632. Adrenal cortex
  633. Adrenal cortex
  634. Adrenal disorders, female androgen deficiency, hirsutism, and endocrine hypertension
  635. Adrenocortical effects of oral estrogens and soy isoflavones in female monkeys
  636. Adult hypothyroidism
  637. Adult-onset hypogonadism
  638. Adulteration of herbal sexual enhancers and slimmers: The wish for better sexual well-being and perfect body can be risky
  639. Adulteration of Synthetic Substances in Dietary Supplements
  640. Advanced symptom management in multiple sclerosis
  641. Advances in hormone replacement therapy: making the menopause manageable
  642. Advances in neurosteroids: role in clinical practice
  643. Advances in pharmacotherapy for treating female sexual dysfunction
  644. Advances in the treatment of vulvovaginal atrophy
  645. Advancing sexual Health for the Christian Client: Data and Dogma
  646. Advise Against Flibanserin
  647. Advocating for a transdisciplinary perspective in sexual medicine
  648. Aetiology, diagnostic algorithms and prognosis of female sexual dysfunction
  649. Affective and Autonomic Responses to Erotic Images among Young Women with and without sexual Difficulties
  650. Affective and autonomic responses to erotic images: evidence of disgust-based mechanisms in female sexual interest/arousal disorder
  651. Affirmative practice and alternative sexual orientations: Helping clients navigate the coming out process
  652. African American women living with HIV/AIDS: Mental health issues
  653. African and European HIV-positive women: psychological and psychosocial differences
  654. Aftershock: The lived experience of chemotherapy, induced menopause for breast cancer survivors and its impact on their sexuality
  655. Age and Decline of sexuality
  656. Age and gender considerations in psychiatric diagnosis: A research agenda for DSM-V
  657. Age and psychologic disorders: variables associated to post-infarction sexual dysfunction
  658. Age and sex
  659. Age-related changes in the male reproductive system
  660. Age-related differences in health complaints: the Hilo women’s health study
  661. Age-related prevalence rates of sexual difficulties, sexual dysfunctions and sexual distress in heterosexual men: results from an online survey in Flanders
  662. Age‐related prevalence rates of sexual difficulties, sexual dysfunctions, and sexual distress in heterosexual women: Results from an online survey in Flanders
  663. Age, gender, depression, and sexual dysfunction in Taiwan
  664. Ageing, infertility and gynaecological conditions: how do they affect sexual function?
  665. Ageratum conyzoides L. inhibits 5‐alpha‐reductase gene expression in human prostate cells and reduces symptoms of benign prostatic hypertrophy in otherwise …
  666. Aging and erectile function
  667. Aging and male sexuality
  668. Aging and pathogenesis of erectile dysfunction
  669. Aging and sexual response in the laboratory in patients with erectile dysfunction
  670. Aging and sexuality
  671. Aging is a powerful predictor of sexual dysfunction. Age-related changes in sexual behavior in men, with attention
  672. Aging, androgens, and female sexual desire: Can we restore what time takes away?
  673. Agreement of self-reported and genital measures of sexual arousal in men and women: A meta-analysis
  674. AIDS. Pediatr Pathol. 1988; 8: 417–421. Degano B, Guillaume M, Savale L, Montani D, et al. HIV-associated pul-monary arterial hypertension: survival and prognostic …
  675. Alcohol and drug effects on sexual response: Human experimental and clinical studies
  676. Alcohol and sexual health behavior:“What we know and how we know it”
  677. Alessandra Graziottin
  678. Alexithymia, negative emotions, and sexual behavior in heterosexual university students from Italy
  679. ali zobozdravniški poslanci v skupščini
  680. All his sexless patients: Persons with mental disabilities and the competence to have sex
  681. Allogeneic mesenchymal stem cells ameliorate aging frailty: a phase II randomized, double-blind, placebo-controlled clinical trial
  682. Allosteric ligands for G protein‐coupled receptors: A novel strategy with attractive therapeutic opportunities
  683. Alterations in grip strength during male sexual arousal
  684. Alterations in sexual function
  685. Alterations of sexual function in women with cancer
  686. Alterations of the Monoaminergic Systems by Sustained Triple Reuptake Inhibition
  687. Altered sexual health and quality of life in women prior to hematopoietic cell transplantation
  688. Altered states of consciousness are related to higher sexual responsiveness
  689. Alternative formats
  690. Alternative therapies for male and female sexual dysfunction
  691. Alternative treatment modalities for the hypogonadal patient
  692. Alters and Schiff Essential Concepts for Healthy Living
  693. Am I a father? A husband’s miscarriage
  694. Amalgamation of stress degradation and metabolite profiling in rat urine and feces for characterization of oxidative metabolites of flibanserin using UHPLC-Q-TOF-MS …
  695. Ambulatory blood pressure
  696. Amelioration of erectile dysfunction following a switch from carbamazepine to oxcarbazepine: recent clinical experience
  697. Amelioration of sexual adverse effects in the early breast cancer patient
  698. Amenorrhoea, oligomenorrhoea and hypothalamic–pituitary dysfunction
  699. American Association for Cancer Research And American College of Obstetricians and Gynecologists
  700. American sexual histories
  701. Amit Garg A Mechanism Based Population Pharmacokinetic-Pharmacodynamic Model for Epoetin Alfa and Darbepoetin Alfa in Chronic Kidney Disease …
  702. Amygdala–frontal interactions and reward expectancy
  703. An Analysis of the Development and Validation of the Decreased sexual desire Screener for the Diagnosis of hypoactive sexual desire Disorder
  704. An analysis of the MMPI-2 profiles of individuals entering treatment at a sexual addiction treatment facility
  705. An Analysis of the Theoretical Origins and Persistance of Asexuality in Humans
  706. An approach to sexual dysfunction in menopausal women
  707. AN ARCHETYPAL AND INNER CAST OF CHARACTERS APPROACH TO sex THERAPY WITH WOMEN WHO HAVE LOW sexual desire
  708. An assessment of rates of psychiatric morbidity and functioning in HIV disease
  709. An Ayurvedic personalized prophylactic protocol in COVID-19
  710. An easy method to define the cervical borders during postpartum hysterectomy
  711. An epidemiological study of sexual disorders in south Indian rural population
  712. An Evaluation and Comparison of Methods Assessing Erectile Dysfunction
  713. An Evaluation of sexual Victimization History and Psychological Adjustment on sexual Health in Women
  714. An evaluation of the quality of life and sexual status functions of females with urinary incontinence
  715. An Evaluation of the Readability of Drug Trials Snapshots
  716. An evaluation of the relationship between body image and sexual avoidance
  717. An evidence-based review updating the various treatment and management approaches to serotonin reuptake inhibitor-associated sexual dysfunction
  718. An evidence‐based unified definition of lifelong and acquired premature ejaculation: Report of the second International Society for sexual Medicine Ad Hoc …
  719. An evolutionary functional analysis of the hormonal predictors of women’s sexual motivation
  720. An Examination of Disgust, Its Measures, and Gender Differences in the Experience of Disgust Sensitivity
  721. An Examination of sexual Fantasy with Specific Emphasis on both Fluid and Constant Variables: The Effect of Gender, Age, sexual Orientation, Ethnicity …
  722. An Examination of sexuality in Women with an Elevated Risk for Breast Cancer Development
  723. An Examination Of The Effect Of Professional License Type And Gender On The Self-efficacy And Comfort Level Of Counseling Skills In Addressing sexual Issues …
  724. An Examination of the Negative Impact of the Western Cultural sex Paradigm on Female sexuality
  725. An Examination of the Relationship between Authenticity and Female sexual Dysfunction
  726. An examination of the sexual double standard pertaining to masturbation and the impact of assumed motives
  727. An Experimental Examination of Automatic Interpretation Biases in Major Depression
  728. An experimental investigation of the impact of body image on subjective sexual arousal among sexually dysfunctional women
  729. An exploratory study of the relationship between second toe length and androgen-linked behaviors.
  730. An exploratory study on the central nervous correlates of sexual excitation and sexual inhibition
  731. An immunological insight into premature ovarian failure (POF)
  732. An injury-induced cell model of early uterine fibroid development
  733. An intake interview and assessment instrument for adults presenting with a history of childhood sexual abuse
  734. An integrated model to assess and treat compulsive sexual behaviour disorder
  735. An integrative cognitive-behavioral approach to understanding, assessing, and treating female sexual dysfunction
  736. An integrative medicine approach to the treatment of HSDD: introducing the HURT Model™
  737. An integrative model for treatment of sexual desire disorders: An update of the masters and Johnson institute approach
  738. An integrative theoretical framework for understanding sexual motivation, arousal, and behavior
  739. An interactional approach to sexual dysfunctions
  740. An Internally Validated Nomogram for Predicting the Likelihood of Improvement of Clinical Global Impression in Patients With Lifelong Premature Ejaculation …
  741. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the assessment of sexual health of …
  742. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and …
  743. An introduction to psychology for attorneys
  744. An introduction to sexual Medicine
  745. An investigation of sexual dysfunction in female partners of men with erectile dysfunction: how interviews expand on questionnaire responses
  746. An investigation of sexual motivation in the female rat
  747. An investigation of the relationship between assertiveness, sex-role values, fantasy, sexual beliefs and sexual satisfaction in females
  748. An investigation of the relationship between physical fitness, self-concept, and sexual functioning
  749. An objective measure of vaginal lubrication in women with and without sexual arousal concerns
  750. An old problem with a new cause-5 alpha reductase inhibitors and persistent sexual dysfunction
  751. An online, mindfulness-based, cognitive-behavioral therapy for female sexual difficulties: impact on relationship functioning
  752. An open-label, fixed-dose study of bupropion effect on sexual function scores in women treated for breast cancer
  753. An open‐label, randomized, flexible‐dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men …
  754. An update on drugs for the treatment of menopausal symptoms
  755. An update on menopause management
  756. An update on sexual function and dysfunction in women
  757. An update on the pharmacological management of female sexual dysfunction
  758. Analysis of a French female sexuality reference population
  759. Analysis of factors that influence the quality of sexual life of climacteric women in China
  760. Analysis of low sexual desire in Chinese women: a national population-based epidemiological survey in mainland China
  761. Analysis Regarding Quality of Life of Menopausal Women on Clinical Disorders during Menopausal Period, on Sukomanunggal Sub-District Surabaya in 2019
  762. Anandamide transforms noncopulating rats into sexually active animals
  763. Anatomic variation and orgasm: Could variations in anatomy explain differences in orgasmic success?
  764. Anatomical study of the obturator foramen and dorsal nerve of the clitoris and their relationship to minimally invasive slings
  765. Anatomy and Physiology of Arousal
  766. Anatomy and physiology of female sexual function and dysfunction
  767. Anatomy and physiology of female sexual function and dysfunction
  768. Anatomy and physiology of genital organs–women
  769. Anatomy and Physiology of the Hypothalamic-Pituitary-Gonadal (HPG) Axis
  770. Anatomy and physiology of women’s sexual function
  771. Anatomy/physiology: Childhood sexual abuse, selective attention for sexual cues and the effects of testosterone with or without Vardenafil on physiological sexual …
  772. ANATOMY/PHYSIOLOGY: Induction of sexual Arousal in Women Under Conditions of Institutional and Ambulatory Laboratory Circumstances: A Comparative Study
  773. Anatomy/physiology: Satisfaction (sexual, life, relationship, and mental health) is associated directly with penile–vaginal intercourse, but inversely with other sexual …
  774. AND DEVIATION
  775. and Erectile Dysfunction
  776. and Long—Term Romantic Partners?
  777. and Mario Maggi
  778. and Paraphilic Disorders
  779. and reported less psychological distress than did those with eating disturbances. The findings suggest that eating problems may be more prevalent among males than …
  780. and Shah Dupesh
  781. And Spirit of My Father
  782. and the Placebo Effect: A Copyright ª by t he American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. Unauthorized …
  783. Androgen actions in the female-They don’t just make a man out of you
  784. Androgen and menopause
  785. Androgen Deficiency
  786. Androgen deficiency and phosphodiesterase type 5 expression changes in aging male: therapeutic implications
  787. Androgen deficiency and therapy in women
  788. Androgen Deficiency in Aging Male (ADAM)
  789. Androgen deficiency in men
  790. Androgen deficiency in menopause: should it be treated?
  791. Androgen deficiency in the aging male
  792. Androgen Deficiency in the Aging Male
  793. Androgen deficiency in women in urogynecologic practice: Pathophysiology, clinical «masks», and pharmacotherapy using transdermal testosterone formulations.
  794. Androgen deficiency in women; role of accurate testosterone measurements
  795. Androgen deficiency in women.
  796. Androgen Deficiency Syndromes in Men Guideline Task Force: Shalender Bhasin, Glenn R. Cunningham
  797. Androgen deficiency: effects on body composition
  798. Androgen deprivation therapy for prostate cancer: recommendations to improve patient and partner quality of life
  799. Androgen in postmenopausal women
  800. Androgen Insufficiency and Female sexual Motivation
  801. Androgen insufficiency in women
  802. Androgen insufficiency in women: summary of critical issues
  803. Androgen receptor expression in the human vagina under different physiological and treatment conditions
  804. Androgen receptor gene polymorphism and sexual function in midlife women
  805. Androgen receptor polymorphism and female sexual function and desire
  806. Androgen Replacement in Women: Safe and Efficacious?
  807. Androgen replacement therapy
  808. Androgen replacement therapy in androgen-deficient women with hypopituitarism
  809. ANDROGEN REPLACEMENT THERAPY IN POSTMENOPAUSE
  810. Androgen replacement therapy in postmenopause.
  811. Androgen replacement therapy in the aging male—a critical evaluation
  812. Androgen replacement therapy in women
  813. Androgen replacement therapy in women
  814. Androgen supplementation in practice: the treatment of erectile dysfunction associated with hypotestosteronemia
  815. Androgen synthesis, metabolism and action in the developing ovarian follicle
  816. Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?
  817. Androgen therapy for low female libido
  818. Androgen therapy for postmenopausal women
  819. Androgen Therapy for Women
  820. Androgen Therapy in Menopause
  821. Androgen therapy in women
  822. Androgen therapy in women
  823. Androgen therapy in women
  824. Androgen therapy in women, beyond libido
  825. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline
  826. Androgen therapy in women: an Endocrine Society Clinical Practice guideline
  827. Androgen therapy in women: for whom and when
  828. Androgen therapy in women: what we think we know
  829. Androgen Treatment for hypoactive sexual desire?
  830. Androgen treatment in women
  831. Androgen Treatment in Women
  832. Androgen treatment of postmenopausal women
  833. Androgen use for low sexual desire in midlife women
  834. Androgenassays: of mice and men
  835. Androgenetic alopecia: effects of oral finasteride on hormone profile, reproduction and sexual function
  836. Androgenic action of dehydroepiandrosterone (DHEA) on nerve density in the ovariectomized rat vagina
  837. Androgenic deficiency and its impact on womens health status
  838. Androgenic hormones and aging—the link with female sexual function
  839. Androgenic maintenance of rat penile erection
  840. Androgens and breast cancer in men and women
  841. Androgens and breast cancer risk
  842. Androgens and cardiovascular disease in postmenopausal women: a systematic review
  843. Androgens and cardiovascular disease in women and men
  844. Androgens and cardiovascular disease: gender-related differences
  845. Androgens and female sexual function
  846. Androgens and female sexual function and dysfunction—findings from the Fourth International Consultation of sexual Medicine
  847. Androgens and menopause: more fuel for the fire
  848. Androgens and psychosocial factors related to sexual dysfunctions in premenopausal women∗:∗ 2016 ISSM Female sexual Dysfunction Prize
  849. Androgens and sexual function during menopause
  850. Androgens and sexual function: a placebo-controlled, randomized, double-blind study of testosterone vs. dehydroepiandrosterone in men with sexual dysfunction …
  851. Androgens and the breast
  852. Androgens are fundamental in the maintenance of male sexual health
  853. Androgens are vital to female sexual health
  854. Androgens from physiology, through pharmacy and pharmacology to the status of lifestyle drugs-are we going in the right direction?
  855. Androgens in Gynecological Practice
  856. Androgens in postmenopausal women
  857. Androgens in postmenopausal women: a review
  858. Androgens in premenopausal women and women with premature ovarian insufficiency
  859. Androgens in women after allogeneic hematopoietic cell transplantation: impact of chronic GvHD and glucocorticoid therapy
  860. Androgens in women are essentially made from DHEA in each peripheral tissue according to intracrinology
  861. Androgens in women before and after the menopause and post bilateral oophorectomy: clinical effects and indications for testosterone therapy
  862. Androgens in Women: Too Much, Too Little, Just Right
  863. Androgens in Women: Too Much, Too Little, Just Right, An Issue of Endocrinology and Metabolism Clinics of North America, E-Book
  864. Androgens inhibit the stimulatory action of 17β-estradiol on normal human breast tissue in explant cultures
  865. Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa
  866. Androgens, health and sexuality in women and men
  867. Androgens, Use, Misuse, and Abuse
  868. Androgens/female clinical/female basic science
  869. Andrology and Infertility
  870. Anethum graveolens as a possible modulator of testicular steroidogenesis
  871. Anger and anxiety
  872. Anger and sexual behavior
  873. Animal models for the study of female sexual dysfunction
  874. Animal models in sexual medicine: The need and importance of studying sexual motivation
  875. Animal models of female sexual dysfunction: basic considerations on drugs, arousal, motivation and behavior
  876. Anodyspareunia, the unacknowledged sexual dysfunction: A validation study of painful receptive anal intercourse and its psychosexual concomitants in homosexual …
  877. Anorectic and bulimic patients suffer from relevant sexual dysfunctions
  878. Another major function of the anterior cingulate cortex: the representation of requirements
  879. Another Option for hypoactive sexual desire
  880. Another procrustean bed for female sexual functioning
  881. Antagonizing hepatitis
  882. Antecedents of sexual Infidelity in Romantic Relationships. A Literature Review of the Latest Empirical Results, Prevailing Explanatory Models, and Proposal of …
  883. Anterior pituitary failure
  884. Anterior pituitary hormone replacement therapy—a clinical review
  885. Anterior vaginal introitoplasty for an acquired sensation of wide vagina: a case report and new surgical intervention.
  886. Anti-insomniac Botanicals and Natural Products: Pre-clinical and Clinical Evidences
  887. Anti-tumor activities of Panax quinquefolius saponins and potential diagnostic markers in prostate cancer
  888. Anticonceptive problems in Bangladesh: An approach by case reports
  889. Antidepressant use during development may impair women’s sexual desire in adulthood
  890. Antidepressant-induced sexual dysfunction: review, classification, and suggestions for treatment
  891. Antidepressants
  892. Antidepressants and sexual dysfunction: mechanisms and clinical implications
  893. Antioxidants in Male sexual Dysfunctions
  894. Anxiety and female sexual functioning: An empirical study
  895. Anxiety attacks following surgical menopause
  896. Anxiety attacks following surgical menopause: a case report
  897. Anxiety in Natural and Surgical Menopause-Physiologic and Therapeutic Bases
  898. Anxiety, dispositional mindfulness, and sexual desire in men consulting in clinical sexology: A mediational model
  899. Anxiety, Dispositional Mindfulness, and sexual desire in Men Consulting in Clinical sexology: A Mediational Model Anxiety, Dispositional Mindfulness, and …
  900. AOFS NEWSLETTER
  901. Aphrodisiac activity and screening for acute toxicity of Asian swamp eel, Monopterus albus extracts on male mice
  902. Aphrodisiac and Spermatogenic Potential of Ayurveda Formulation-Ashwagandhadi Lehya
  903. Appendix 1 (as supplied by the authors): Full-text guidelines Multidisciplinary Canadian Clinical Practice Guideline on the Diagnosis and Management of …
  904. Appetitive responses to sexual stimuli are attenuated in individuals with low levels of sexual desire
  905. Apples and oranges:“sexual Medicine” and the effort to deny that counting and classifying are political acts
  906. Application of mesocolon rotation and reverse puncture in total laparoscopic sigmoid vaginoplasty
  907. Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route
  908. Application of sex aids in men with sexual dysfunction: a review
  909. Application of the intersystem approach for combat veterans experiencing sexual problems related to trauma and injuries of war
  910. Application of the sexual health model in the long-term treatment of hypoactive sexual desire and female orgasmic disorder
  911. Applications of Flow Chemistry in the Pharmaceutical Industry—Highlights of the Recent Patent Literature
  912. Applied Reproductive System: Scientific Aspects……. 83 Chapter 6 sexually Transmitted Infections and Associated Reproductive Tract Infections …
  913. Applying a sexual health model to the assessment and treatment of Internet sexual compulsivity
  914. Applying Machine Learning to Increase Efficiency and Accuracy of Meta-Analytic Review
  915. Approach of Evolutionary Psychology to Research of Human sexuality and Mate Choice
  916. Approaches to Human Behavior
  917. Appropriate Perspective and Context for Newly Approved Medications, Including Flibanserin
  918. Appropriate perspective and context for newly approved medications, including flibanserin
  919. Appropriate perspective and context for newly approved medications, including flibanserin—Reply
  920. Aptitudes and Attitudes among Licensed Professional Counselors Regarding Human sexuality and sexual Counseling in Puerto Rico: An Exploratory Study
  921. Arabic translation of Female sexual Function Index and validation in an Egyptian population
  922. Are all estrogens created equal? A review of oral vs. transdermal therapy
  923. Are aspects of study design associated with the reported prevalence of female sexual difficulties?
  924. Are gynaecologists confident addressing sexual issues with menopausal women?
  925. Are Healthy Parental Attachments and Resilience to Societal Objectification Basic to Women’s sexual Health?
  926. Are hormonal components of oral contraceptives associated with impaired female sexual function? A questionnaire-based online survey of medical students in …
  927. Are hormones the answer to low libido?
  928. Are meta-analyses clinically useful?
  929. Are our definitions of women’s desire, arousal and sexual pain disorders too broad and our definition of orgasmic disorder too narrow?
  930. Are Personality Traits Effective in Marital Adjustment in Couples with sexual Dysfunction? The Mediating Effect of sexual Satisfaction
  931. Are Personality Traits Effective in Marital Adjustment in Couples with sexual Dysfunction? The Mediating Effect of sexual Satisfaction.
  932. Are role and gender related to sexual function and satisfaction in men and women practicing BDSM?
  933. Are sexual problems a form of internalizing psychopathology? A structural equation modeling analysis
  934. Are some patients trying to” medicalize” chronic fatigue?
  935. Are the academic institutions of public health in Africa able to prepare graduates for UHC?
  936. Are the complexities of women’s sexual function reflected in the new consensus definitions of dysfunction?
  937. Are the Endocrine Society’s Clinical Practice Guidelines on Androgen Therapy in Women Misguided? A Commentary
  938. Are UK services meeting the need of patients with sexual problems and where should psychosexual services be provided?
  939. Are urology residents ready to treat premature ejaculation after their training?
  940. Are we ready for this classification system?
  941. Arginase: structure, mechanism, and physiological role in male and female sexual arousal
  942. Aromatase inhibitors are associated with low sexual desire causing distress and fecal incontinence in women: an observational study
  943. Aromatization is not required for the facilitation of appetitive sexual behaviors in ovariectomized rats treated with estradiol and testosterone
  944. Arousal and desire problems: Conceptual, research and clinical considerations or the more things change the more they stay the same
  945. Arousal and orgasm are intimately linked as important com-ponents in healthy female sexual function. Disorders of
  946. Arousal disorders in women: complaints and complexities
  947. Arousal, sexual
  948. Arriving at a “new view” of women’s sexual problems: Background, theory, and activism
  949. Arriving at the diagnosis of female sexual dysfunction
  950. Arterial hypertension and female sexual dysfunction in postmenopausal women
  951. Article 2 Computer-generated stimuli: Profile analysis and classification accuracy comparison based on penile plethysmography
  952. Articles That Could Change Your Practice
  953. AS: Classification, Interpellation
  954. Ascr: This review defines sexual desire, distinguishes sexual desire from other sexual experiences (eg arousal, activity), discusses common operationalizations …
  955. Asexual Activism
  956. Asexual Experiences of Microaggressions Scale: Instrument Development and Evaluation
  957. Asexual people’s experience with microaggressions
  958. Asexual scripts: A grounded theory inquiry into the intrapsychic scripts asexuals use to negotiate romantic relationships
  959. Asexual-identified clients in clinical settings: Implications for culturally competent practice.
  960. Asexual-Identified People’s Interactions with Health Care Practitioners
  961. Asexualities: Socio-cultural perspectives
  962. Asexuality
  963. Asexuality
  964. Asexuality
  965. Asexuality
  966. Asexuality and boundaries in online discourse
  967. Asexuality and disability: Strange but compatible bedfellows
  968. Asexuality and Its Discontents: Making the’Invisible Orientation’Visible in Comics
  969. Asexuality and its implications for LGBTQ-parent families
  970. Asexuality and its implications for sexuality studies
  971. Asexuality and sexual normativity: An anthology
  972. Asexuality and sexual normativity: an anthology, edited by Mark Carrigan, Kristina Gupta and Todd G. Morrison, London and New York, Routledge, 2014, 141 pp …
  973. Asexuality and the feminist politics of ‘not doing it’
  974. Asexuality and the Re/Construction of sexual Orientation
  975. Asexuality special theme issue editorial
  976. Asexuality, the Internet, and the changing lexicon of sexuality
  977. Asexuality: A mixed-methods approach
  978. Asexuality: A multidimensional approach
  979. Asexuality: A possible background and how it relates to autism and neurodiversity
  980. Asexuality: An extreme variant of sexual desire disorder?
  981. Asexuality: Classification and characterization
  982. Asexuality: Few facts, many questions
  983. Asexuality: From pathology to identity and beyond
  984. Asexuality: investigations into a lack of sexual attraction
  985. Asexuality: Prevalence and associated factors in a national probability sample
  986. Asexuality: sexual Health Does Not Require sex
  987. Asexuality: sexual orientation, paraphilia, sexual dysfunction, or none of the above?
  988. Asexuality: To Include or Not to Include a Slice of Cake in the LGBTQ+ Community
  989. Asexuality: Towards a Freudian-Lacanian Understanding
  990. Asexuality: What it is and why it matters
  991. Asexually: On being an ally to the asexual community
  992. Asian sildenafil efficacy and safety study (ASSESS-1): a double-blind, placebo-controlled, flexible-dose study of oral sildenafil in Malaysian, Singaporean, and Filipino …
  993. ASKING OPEN-ENDED QUESTIONS CONNECTING WITH YOUNG MOTHERS
  994. Aspects of immorality in the depiction of urban Central European settings in the fiction by North American writers (1918-1939)
  995. ASPECTS OF MULTIDISCIPLINARY TREATMENT, METASTATIC DISEASE AND sexual FUNCTION
  996. ASSESS-3: a randomised, double-blind, flexible-dose clinical trial of the efficacy and safety of oral sildenafil in the treatment of men with erectile dysfunction in Taiwan
  997. Assessing & managing female sexual dysfunction
  998. Assessing and addressing sexual concerns in individuals diagnosed with coronary artery disease
  999. Assessing and managing male sexual problems
  1000. Assessing and treating sexual dysfunction
  1001. Assessing and Treating sexual Problems in an Integrated Care Environment
  1002. Assessing cognitive appraisals related to sexual function: A scenario-based approach
  1003. Assessing female sexual dysfunction in epidemiological studies: why is it necessary to measure both low sexual function and sexually-related distress?
  1004. Assessing Help-Seeking Attitudes, Service Utilization, and Provider Preferences Among Undergraduate Students With Self-Reported sexual Functioning Concerns
  1005. Assessing Mental Health Provider Bias toward Clients with Understudied Marginalized sexual Identities and Practices
  1006. Assessing predictors of sexual function in mid-aged sexually active women
  1007. Assessing psychiatric adverse effects during clinical drug development
  1008. Assessing sexual aversion in college students: The sexual Aversion Scale
  1009. Assessing sexual Dysfunction in Asian Clients
  1010. Assessing sexual dysfunction in Hispanic clients
  1011. Assessing sexual function and dyspareunia with the Female sexual Function Index (FSFI) in women with vulvodynia
  1012. Assessing sexual problems in women at midlife using the short version of the female sexual function index
  1013. Assessing the clinical efficacy of sildenafil for the treatment of female sexual dysfunction
  1014. Assessing the impact of pregnancy on sexuality using the pregnancy sexual response inventory
  1015. Assessing the role of relationship conflict in sexual dysfunction
  1016. Assessing women’s sexual arousal in the context of sexual assault history and acute alcohol intoxication
  1017. Assessment & management of sexual problems in women
  1018. Assessment and Context: Consideration of Client and Environmental Factors within the Assessment Process.
  1019. Assessment and management of sexual dysfunction in the context of depression
  1020. Assessment and sex counseling in libido disorders
  1021. Assessment and treatment of male and female sexual dysfunction
  1022. Assessment of a neuropathic factor in HIV-1 associated impotence: penile electrodiagnosis.
  1023. ASSESSMENT OF A PATIENT WITH sexual DYSFUNCTION History
  1024. Assessment of body image, sexual function, and attractiveness in women with genital prolapse: a cross-sectional study with validation of the Body Image in the Pelvic …
  1025. Assessment of brain metabolites change during visual sexual stimulation in healthy women using functional MR spectroscopy
  1026. Assessment of cerebrocortical regions associated with sexual arousal in premenopausal and menopausal women by using BOLD-based functional MRI.
  1027. Assessment of Female sexual Dysfunction
  1028. Assessment of female sexual function and quality of life among breast cancer survivors who underwenthormone therapy
  1029. Assessment of female sexual function and quality of life in predialysis, peritoneal dialysis, hemodialysis, and renal transplant patients
  1030. Assessment of health-related quality of life in menopause and aging
  1031. Assessment of life quality of menopausal women and its relative factors
  1032. Assessment of premature menopause on the sexual function and quality of life in women
  1033. Assessment of sexual activity and dysfunction in medically underserved women with gynecologic cancers
  1034. Assessment of sexual activity and menopausal symptoms in middle-aged Chinese women using the Menopause Rating Scale
  1035. Assessment of sexual behavior in rats: The potentials and pitfalls
  1036. Assessment of sexual desire for clinical trials of women with hypoactive sexual desire disorder: measures, desire-related behavior, and assessment of clinical …
  1037. Assessment of sexual difficulties associated with multi-modal treatment for cervical or endometrial cancer: A systematic review of measurement instruments
  1038. Assessment of sexual dysfunction in patients with inflammatory bowel disease
  1039. Assessment of sexual dysfunction in women diagnosed with breast cancer
  1040. Assessment of sexual fantasies in psychiatric inpatients with mood and psychotic disorders and comorbid personality disorder traits
  1041. Assessment of sexual function and related factors in mid-aged sexually active Spanish women with the six-item Female sex Function Index
  1042. Assessment of sexual function in the medically ill: psychosomatic approach to sexual functioning
  1043. Assessment of sexual function in women with neurological disorders: A review
  1044. Assessment of sexual function in women with pelvic floor dysfunction
  1045. Assessment of sexual function/dysfunction via patient reported outcomes
  1046. Assessment of sexual knowledge, attitude, and functioning among urology clinic patients in Imam Reza Hospital of Tehran
  1047. Assessment of sexual problems
  1048. Assessment of sexual satisfaction in fibromyalgia patients
  1049. Assessment of sexuality after hysterectomy using the Female sexual Function Index
  1050. Assessment of sexually related personal distress accompanying premenopausal sexual dysfunction with an Arabic version of the Female sexual Distress Scale
  1051. Assessment of the aging man with sexual dysfunction
  1052. Assessment of the effects of Tribulus terrestris on sexual function of menopausal women
  1053. Assessment of the relational factor in male patients consulting for sexual dysfunction: the concept of couple sexual dysfunction
  1054. Assessment Scales for sexual Disorders—A Review
  1055. Assessment, treatment, and relapse prevention: Male hypoactive sexual desire disorder
  1056. associated with female
  1057. Association among metabolic syndrome, testosterone level and severity of erectile dysfunction
  1058. Association between 5HT2A polymorphism and selective serotonin re‐uptake inhibitor (SSRI)‐induced sexual desire disorder (SDD) among M alaysian women
  1059. Association Between Alcohol Use and Female sexual Dysfunction From the Data Registry on Experiences of Aging, Menopause, and sexuality (DREAMS)
  1060. Association Between Body Mass Index and Female sexual Dysfunction: A Cross-sectional Study from the Data Registry on Experiences of Aging, Menopause, and …
  1061. Association between infertility and sexual dysfunction in men and women
  1062. Association between multiple sclerosis and risk of female sexual dysfunction: a systematic review and meta-analysis
  1063. Association between psychiatric symptoms and erectile dysfunction
  1064. Association between psychiatric symptoms and erectile dysfunction
  1065. Association Between PTSD Symptom Clusters, Substance Use, Hypersexuality, and Erectile Dysfunction in Service Members and Veterans
  1066. Association between the early maladaptive schemes and extra marital relationship among married people
  1067. Association between the hemodialysis adequacy and sexual dysfunction in chronic renal failure: a preliminary study
  1068. Association of ADHD and hypersexuality and paraphilias.
  1069. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic
  1070. Association of major depression with sexual dysfunction in men
  1071. Association of testosterone with estrogen abolishes the beneficial effects of estrogen treatment by increasing ROS generation in aorta endothelial cells
  1072. Associations Among Body Mass Index and sexual Behavior and sexual Health in Chinese Adults
  1073. Associations among everyday stress, critical life events, and sexual problems
  1074. Associations between affect, context, and sexual desire in depressed young women
  1075. Associations between altered cerebral activity patterns and psychosocial disorders in patients with psychogenic erectile dysfunction: A mediation analysis of …
  1076. Associations between androgens and sexual function in premenopausal women: a cross-sectional study
  1077. Associations between gender role conflict, sexual dysfunctions, and male patients’ wish for physician–patient conversations about sexual health.
  1078. Associations between testosterone secretion and sexual activity in women
  1079. Associations of body mass index and physical activity with sexual dysfunction in breast cancer survivors
  1080. Associations of VEGF gene polymorphisms with erectile dysfunction and related risk factors
  1081. Attachment Insecurities Bias the Functioning of the sexual Behavior System
  1082. Attachment Insecurity and sexual and Relational Experiences in Saudi Arabian Women: The Role of Perceived Partner Responsiveness and sexual Assertiveness
  1083. Attachment styles and male sex addiction
  1084. Attachment styles in heterosexual males with sexual addiction in the United States
  1085. Attachment, sexual assertiveness, and sexual outcomes in women with provoked vestibulodynia and their partners: A mediation model
  1086. Attending to Subjective Effects to Improve Drug Safety
  1087. Attention and emotional responses to sexual stimuli and their relationship to sexual desire
  1088. Attention Bias and Recognition of sexual Images
  1089. Attention Bias for sexual Pictures Revisited
  1090. Attention bias for sexual words in female sexual dysfunction
  1091. Attention Deficit/Hyperactivity Disorder: Are We Fostering Overdiagnosis?
  1092. Attentional and affective processing of sexual stimuli in women with hypoactive sexual desire disorder
  1093. Attentional bias to body-and sexually-relevant stimuli
  1094. Attentional bias toward and distractibility by sexual cues: a meta-analytic integration
  1095. Attentional Processing of Visual sexual Stimuli and the Concordia sexual Image Dataset
  1096. Attitudes about sexual activity among postmenopausal women in different ethnic groups: a cross-sectional study in Jahrom, Iran
  1097. Attitudes toward and frequency of partner interactions among women reporting decreased sexual desire
  1098. Attitudes toward management of decreased sexual desire in premenopausal women: a national survey of nurse practitioners and physician assistants
  1099. Attitudinal survey of women living with low sexual desire
  1100. Attributions for sexual situations in men with and without erectile disorder: Evidence from a sex-specific attributional style measure
  1101. AUA guideline on the pharmacologic management of premature ejaculation
  1102. Auer K, Bachmayr-Heyda A, Aust S, Grunt TW, Pils D
  1103. Authors, Titles, and Subjects
  1104. Autoeroticism, mental health, and organic disturbances in patients with erectile dysfunction
  1105. Automatic and deliberate affective associations with sexual stimuli in women with superficial dyspareunia
  1106. Automatic thoughts during sexual activity, distressing sexual symptoms, and sexual orientation: Findings from a web survey
  1107. Automating Complex Data Analysis: A Disruptive Business Opportunity
  1108. Autonomic imbalance and female sexual arousal disorder: the identification of heart rate variability level as a marker and treatment target
  1109. Average associations between sexual desire, testosterone, and stress in women and men over time
  1110. Avoiding false positives: zones of rarity, the threshold problem, and the DSM clinical significance criterion
  1111. Avoiding the sexual: Visual attention and distraction in dyspareunia
  1112. Azapirone 5-HT1A receptor partial agonist treatment for major depressive disorder: systematic review and meta-analysis
  1113. B. Sc., The University of British Columbia, 1997 MA, The University of British Columbia, 1999
  1114. Back to stir it up: erectile dysfunction in an evolutionary, developmental, and clinical perspective
  1115. BACKGROUND AND ETIOLOGY
  1116. Bacterial vaginosis
  1117. Barriers and bridges to intimacy and mutuality: A critical review of sexual advice found in self-help bestsellers
  1118. Barriers in the bedroom: A feminist application for working with couples
  1119. Barriers to loving: A clinician’s perspective
  1120. Barriers to talking about sexual health issues with physicians
  1121. Basal ganglia lateralization in different types of reward
  1122. baseline and month 12 was statistically
  1123. Basic manual of sexology and sexual pathology
  1124. BASIC SCIENCE: A Prospective Study Examining the Anatomic Distribution of Nerve Density in the Human Vagina
  1125. BASIC SCIENCE: Acute and Repeated Flibanserin Administration in Female Rats Modulates Monoamines Differentially Across Brain Areas: A Microdialysis Study
  1126. BASIC SCIENCE: I. Slow Oscillations in Vaginal Blood Flow: Alterations during sexual Arousal in Rodents and Humans
  1127. BASIC SCIENCE: Initial Characterization of Hydrogen Sulfide Effects in Female sexual Function
  1128. BASIC SCIENCE: The Associations among GNB3 C825T Polymorphism, Erectile Dysfunction, and Related Risk Factors
  1129. Basic sexual therapy for physicians. SIAD in women.
  1130. Bayesian Adaptive Trials for Drug Safety
  1131. Bayesian methods for design and analysis of safety trials
  1132. BDSM, sex, and stress: The impact of stress on sexual activity within BDSM and non-BDSM practitioners
  1133. Beauty and Attractiveness in the Human Voice
  1134. Beauty of humans
  1135. Becoming a sexual being: The ‘elephant in the room’of adolescent brain development
  1136. Becoming a sexual being: The ‘elephant in the room’of adolescent brain development
  1137. Becoming an Onion: The Extra-Human Nature of Genital Difference in the Old English Riddling and Medical Traditions
  1138. Becoming impossible: Asexual narratives of identity, experience, and importance
  1139. Behavior and sexual Attraction
  1140. Behavior and sexual Attraction
  1141. Behavior and symptom change among women treated with placebo for sexual dysfunction
  1142. Behavior and symptom change among women treated with placebo for sexual dysfunction
  1143. Behavior Change After HIV/AIDS Diagnosis of Female sexuality in The Yogyakarta City
  1144. Behavioral addiction: Screening, assessment, and treatment
  1145. Behavioral counseling
  1146. Behavioral interventions for sexual dysfunction in the elderly
  1147. Behavioral neuroendocrinology of reproduction in mammals
  1148. Behavioural correlates of testosterone
  1149. Behavioural therapy and counselling
  1150. Behind common symptoms and psychosocial implications of endometriosis: the role of cognitive and personality factors
  1151. Beliefs and sexual Education Influence the Development of Female sexual Dysfunctions-A Literature Review
  1152. Bench to Bedside
  1153. Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016
  1154. Beneficial effects of testosterone therapy in women measured by the validated Menopause Rating Scale (MRS)
  1155. Beneficial Effects of Tibolone on sexual Dys-function in Women with Premature Ovarian Failure (POF)
  1156. Benefits and Adverses Effects of Testosterone Therapy
  1157. Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding …
  1158. Benefits of female” libido” drug flibanserin are marginal, systematic review finds
  1159. Benign prostatic hyperplasia evaluation, association with sexual dysfunction, treatment, and practice patterns according to physician specialty
  1160. Benign prostatic hyperplasia evaluation, treatment and association with sexual dysfunction: practice patterns according to physician specialty
  1161. Benzyne‐Induced Ring Opening Reactions of DABCO: Synthesis of 1, 4‐Disubstituted Piperazines and Piperidines
  1162. BEST ABSTRACTS FOR ROBERT GREENBLATT PRIZES OC1.
  1163. Best of the 2008 sexual Medicine Society of North America: Highlights From the sexual Medicine Society of North America, October 16–19, 2008, Toronto …
  1164. Betrayal of the body: group approaches to hypo-sexuality for adult female sufferers of childhood sexual abuse
  1165. Between DSM and ICD: Paraphilias and the transformation of sexual norms
  1166. Between the local and the global: Chronicles for understanding the field of sexology in Mexico
  1167. Beyond dysfunction: A new view of women’s sexual problems
  1168. Beyond Gender Identity Disorder Diagnoses Codes: An Examination of Additional Methods to Identify Transgender Individuals in Administrative Databases
  1169. Beyond masculinity: Testosterone, gender/sex, and human social behavior in a comparative context
  1170. Beyond the bedroom: Cognitive, affective, and behavioral responses to partner touch in women with and without sexual problems
  1171. Beyond the disease model of mental disorders
  1172. Beyond the pleistocene: Using phylogeny and constraint to inform the evolutionary psychology of human mating.
  1173. Beyond the Valley of the Genitals: Using eye-tracking to analyze sexual arousal and desire in women and men
  1174. Beyond theoretical orientations: The emergence of a unified scientific framework in professional psychology.
  1175. Beyond tribulus (Tribulus terrestris L.): The effects of phytotherapics on testosterone, sperm and prostate parameters
  1176. Beyond Western paradigms: A culturally grounded approach to psychotherapy with Chaldean Americans.
  1177. Biased agonism at serotonin 5-HT1A receptors: preferential postsynaptic activity for improved therapy of CNS disorders
  1178. Biases for affective versus sexual content in multidimensional scaling analysis: An individual difference perspective
  1179. Bibliotherapy for low sexual desire: Evidence for effectiveness.
  1180. Bibliotherapy for sexual dysfunction
  1181. Bibliotherapy for sexual Dysfunctions: A Systematic Review and Meta-Analysis
  1182. Bibliotherapy in the treatment of sexual dysfunctions: A meta-analysis.
  1183. Bibliotherapy interventions for female low sexual desire: erotic fiction versus self-help
  1184. Bibliotherapy: An effective therapeutic tool for female sexual dysfunction?
  1185. Big enough for an aromatase inhibitor? How adiposity affects male fertility
  1186. Big pharma, women, and the labour of love
  1187. Bill 10 Court Challenge
  1188. Bio-Psycho-Social factors affecting women’s sexual function during pregnancy: A Narrative review
  1189. Bio-sexual Profile of Wives of Males with sexual Dysfunction
  1190. Bioavailability of Compounded Bioidentical Hormone Therapy Preparations
  1191. Biocultural Correlates of Chronic Pelvic Pain in Women
  1192. Bioidentical Hormone Therapy: A Look at Standard of Practice, Attitudes, and Knowledge
  1193. Bioidentical hormone therapy: a review of the evidence
  1194. Bioidentical hormones
  1195. Bioidentical hormones for menopausal therapy
  1196. Bioidentical Hormones in the News
  1197. Bioidentical hormones: an evidence-based review for primary care providers
  1198. Bioidentical testosterone cream: A rare cause of postmenopausal virilisation
  1199. Biointerface Research in Applied Chemistry
  1200. Biologic basis for female orgasm: A retrospective report
  1201. Biologic basis of serotonin reuptake inhibitor antidepressant-associated female sexual dysfunction: A novel signaling perspective
  1202. Biological and psychosocial pathophysiology of female sexual dysfunction during the menopausal transition
  1203. Biological Determinants of sexual desire in Women
  1204. Biological markers of asexuality: Handedness, birth order, and finger length ratios in self-identified asexual men and women
  1205. Biology International 46 (July, 2004)
  1206. Biology of the sexual response.
  1207. Biomarkers, erectile dysfunction, and cardiovascular risk prediction: the latest of an evolving concept
  1208. Biomedicalization: Technoscience, Health, and Illness in the US
  1209. Biopharmaceuticals: New Frontier
  1210. Biopsy Procedures in Patients with Primary Lung Cancer
  1211. Biopsychosocial assessment and treatment of sexual problems in older age
  1212. Biopsychosocial determinants of hypoactive sexual desire in women: a narrative review
  1213. Biopsychosocial determinants of men’s sexual desire: Testing an integrative model
  1214. Biopsychosocial evaluation of sexual dysfunctions
  1215. Biopsychosocial factors in the sexual desire of contraception-using couples and trans persons
  1216. Biopsychosocial models of women’s sexual response: applications to management of ‘desire disorders’
  1217. Biopsychosocial treatment of sexual dysfunctions
  1218. Biosynthesis of DHEAS by the human adrenal cortex and its age‐related decline
  1219. Biphasic effects of anandamide on behavioural responses: emphasis on copulatory behaviour
  1220. Birth Control Pills and Hormonal Contraception Effects on Female sexual desire and Pleasure
  1221. Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms
  1222. Blast Concussion mTBI, Hypopituitarism, and Psychological Health in OIF/OEFVeterans
  1223. Blindspot: An Exploration of Countertransference Reactions and Management of Licensed Counseling Professionals Without sexuality Training Around …
  1224. Block-3 Disorders of Personality, Paraphilic and Substance-Related Disorders
  1225. Blueprints Urology
  1226. BMI and Male Fertility
  1227. Bodies that Matter: Calixthe Beyala’s Female Bodies and Strategies of Hegemonic Subversion
  1228. Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist
  1229. Body composition characteristics predict sexual functioning in obese women with or without PCOS
  1230. Body image and female sexual functioning and behavior: A review
  1231. Body Image and hypoactive sexual desire Disorder Relationship in a Representative Sample of Iranian Women
  1232. Body Image and Psychosexual Functioning in Late Identified Indonesian Treated and Untreated Patients with a Disorders of sex Development
  1233. Body image and sexuality in Indonesian adults with a disorder of sex development (DSD)
  1234. Body image and sexuality in Indonesian adults with disorders of sex development
  1235. Body Image Disturbance and Self-Esteem after Hysterectomy in Egyptian Women.
  1236. Body image in dyadic and solitary sexual desire: The role of encoding style and distracting thoughts
  1237. Body Image Self-Consciousness during Physical Intimacy and sexual Dissatisfaction in Women: The Mediating Role of sexual Self-Esteem
  1238. Body image, self-compassion and sexual distress in patients with mastectomy
  1239. Body imagen, sexual function and dysfunction in men with obstructive sleep apnea syndrome
  1240. Body mass index and sexual dysfunction in males and females in a population study
  1241. Body mass index, urinary incontinence, and female sexual dysfunction: how they affect female postmenopausal health
  1242. Body-identical Hormone Replacement Therapy: Micronised Progesterone is Finally Available in Australia
  1243. Boehringer Ingelheim withdraws libido drug for women
  1244. BONAFIDE CERTIFICATE
  1245. Book review: asexuality and sexual normativity: an anthology edited by Mark Carrigan et al.
  1246. Book Review: Disorders of sexual desire, Vol. II: And Other New Concepts and Techniques in sex Therapy
  1247. Book Review: Principles and Practice of sex Therapy
  1248. Book Review: sexual Dysfunctions: Handbook of sexual Dysfunction
  1249. Boosting Female sexual Response by RECONNECTing the Dots
  1250. Born with a Junk Food Deficiency: How Flaks, Quacks, and Hacks Pimp the Public Health
  1251. Botanical Medicine and Natural Products Used for Erectile Dysfunction
  1252. Botanical therapies in sexual dysfunction
  1253. Both comorbidity burden and low testosterone can explain symptoms and signs of testosterone deficiency in men consulting for sexual dysfunction
  1254. Botulinum toxin type A—a novel treatment for provoked vestibulodynia? Results from a randomized, placebo controlled, double blinded study
  1255. Bowel preparation for colonoscopy may decrease the levels of testosterone in Korean men
  1256. Bowel preparation for colonoscopy may decrease the levels of testosterone in Korean men
  1257. Bowel preparation for colonoscopy may decrease the levels of testosterone in Korean men
  1258. BP101 peptide promotes female sexual receptivity in the rat
  1259. Brain activation patterns in women with acquired hypoactive sexual desire disorder and women with normal sexual function: a cross-sectional pilot study
  1260. Brain activity during episodic retrieval of autobiographical and laboratory events: an fMRI study using a novel photo paradigm
  1261. Brain circuits for mating behavior in cats and brain activations and de-activations during sexual stimulation and ejaculation and orgasm in humans
  1262. Brain effects of melanocortins
  1263. Brain functional imaging studies of sexual desire and arousal in human males.
  1264. Brain imaging of human sexual response: recent developments and future directions
  1265. Brain Morphological Changes With Functional Deficit Associated With sexual Arousal in Postmenopausal Women
  1266. Brain neuronal activation induced by flibanserin treatment in female rats
  1267. Brain potentials related to the human penile erection
  1268. Brain processing of audiovisual sexual stimuli inducing penile erection: a positron emission tomography study
  1269. Brain processing of visual sexual stimuli in healthy men: a functional magnetic resonance imaging study
  1270. Brain processing of visual sexual stimuli in men with hypoactive sexual desire disorder
  1271. Brain processing of visual sexual stimuli in treated and untreated hypogonadal patients
  1272. Brain RegionSpecific Transcriptomic Markers of Serotonin1A Receptor Agonist Action Mediating sexual Rejection and Aggression in Female Marmoset Monkeys
  1273. Brain response to visual sexual stimuli in heterosexual and homosexual males
  1274. Brain responses to erotic and other emotional stimuli in breast cancer survivors with and without distress about low sexual desire: a preliminary fMRI study
  1275. Brain structures involved in the sexual behaviour of Ile de France rams with different sexual preferences and levels of sexual activity
  1276. Brain-Behavioral Systems and Psychological Distress in Women with hypoactive sexual desire Disorder
  1277. Bravissimo-F Tablet: A Scientifically Formulated Potent Female Aphrodisiac
  1278. Bravissimo-F tablet: A scientificallyFormulated Daily Health Supplement for women For Mental, Physical & sexual Health.
  1279. BRAVISSIMO-M Tablets: Scientifically Formulated Male Libido Enhancer Helps to Restore sexual Vitality
  1280. break, and disappointment. Additionally, they
  1281. Breast Cancer and sexuality with Focus in Young Women: From Evidence-Based Data to Women’s Wording to Treatment Perspectives
  1282. Breast Cancer and sexuality: Multi‐modal Treatment Options (CME)
  1283. Breast cancer in young women and its impact on reproductive function
  1284. Breast cancer vaccine prevents and arrests tumor growth in animal study
  1285. Breast cancer, aromatase inhibitor therapy, and sexual functioning: a pilot study of the effects of vaginal testosterone therapy
  1286. Breast Cancer, Aromatase Inhibitors, and sexual Functioning: A Pilot Study on the Effects of Vaginal Testosterone Therapy
  1287. BREMELANOTIDE (continued)
  1288. Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial
  1289. Bremelanotide for female sexual dysfunctions: responder analyses from a phase 2B dose-ranging study
  1290. Bremelanotide for hypoactive sexual desire disorder
  1291. Bremelanotide for hypoactive sexual desire Disorder: Age and Weight Subgroup Efficacy Analyses [1Q]
  1292. Bremelanotide for hypoactive sexual desire disorder: analyses from a phase 2B dose-ranging study
  1293. Bremelanotide for hypoactive sexual desire Disorder: Contraceptive Subgroups Efficacy Analysis [15OP]
  1294. Bremelanotide for the treatment of hypoactive sexual desire disorder: two randomized phase 3 trials
  1295. Bremelanotide Injection (Vyleesi)
  1296. Bremelanotide is safe and well-tolerated in premenopausal women with hypoactive sexual desire disorder (HSDD): safety results from the reconnect studies …
  1297. Bremelanotide Provides Meaningful Treatment Benefits for Premenopausal Women With hypoactive sexual desire Disorder
  1298. Bremelanotide: an overview of preclinical CNS effects on female sexual function
  1299. Bremelanotide: first approval
  1300. Bremelanotide: new drug approved for treating hypoactive sexual desire disorder
  1301. Brenner and Rector’s The Kidney
  1302. Brief but comprehensive psychotherapy: The multimodal way
  1303. Brief psychotherapies
  1304. Brief report: sexual wellbeing in heterosexual, mostly heterosexual, and bisexually attracted men and women
  1305. Bright Light Therapy and Circadian Neuroendocrine Function in Seasonal Afiective Disorder
  1306. Bringing sex Back In: sexual Expression and Relationship Happiness In Married, Cohabiting and Living Apart Together Partnerships In Britain
  1307. Bringing sex research into the 21st century: genetic and epigenetic approaches on female sexual function
  1308. Bringing sexy back: CPD-erectile dysfunction
  1309. British Menopause Society Tools for Clinicians: Testosterone replacement in menopause.
  1310. Broadening your horizons: Self-expanding activities promote desire and satisfaction in established romantic relationships.
  1311. Bullying, Self-Disclosure and sexual Incompatibility as Correlates of Marital Instability among Newly Married Adults in Nigeria
  1312. Bupropion and bupropion analogs as treatments for CNS disorders
  1313. Bupropion and sexual function: a placebo-controlled prospective study on diabetic men with erectile dysfunction
  1314. Bupropion and SSRI-induced side effects
  1315. Bupropion improves sexual functioning in depressed minority women: an open-label switch study
  1316. Bupropion in methadone induced erectile dysfunction
  1317. Bupropion in the depression-related sexual dysfunction: a systematic review
  1318. Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women
  1319. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women
  1320. Bupropion-associated movement disorders: A systematic review
  1321. Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant
  1322. Bupropion: pharmacology and therapeutic applications
  1323. Bupropion.
  1324. Burden of misconception in sexual health care setting: a cross-sectional investigation among the patients attending a psychiatric sex clinic of Bangladesh
  1325. C 7 8AHL sexual pain disorder}~(0. TE” E (o
  1326. C-tactile mediated erotic touch perception relates to sexual desire and performance in a gender-specific way
  1327. Calvarial intraosseous leiomyoma: Another consideration in children with suspected esosinophilic granuloma
  1328. Cambios electroencefalográficos y niveles de testosterona en un modelo animal de estrés puberal: efectos sobre la motivación sexual adulta
  1329. Can a woman with sexual dysfunction take sildenafil citrate?
  1330. Can a woman with sexual dysfunction take sildenafil citrate?
  1331. Can Botox Offer Help Women With Vaginismus? A Systematic Review and Meta-Analysis
  1332. Can methods developed for interpreting group-level patient-reported outcome data be applied to individual patient management?
  1333. Can perinatal SSRI exposure affect sexual behavior later in life? Early Developmental Fluoxetine Exposed Female Rats Observed in a Seminatural Environment
  1334. Can sexual offenders be treated?
  1335. Can we treat anorgasmia in women? The challenge to experiencing pleasure
  1336. Can written information material help to increase treatment motivation in patients with erectile dysfunction? A survey of 1188 men
  1337. Cancer and sexual health
  1338. Cannabinoid receptor antagonism increases female sexual motivation
  1339. Cannabinoids, reproduction, and sexual behavior
  1340. Cannabis and male fertility: A systematic Review
  1341. Cannabis Usage Pre-masturbation in Women: Effects on Orgasm and Pleasure
  1342. Cant a mother sing the blues
  1343. CAPS, 80 cost and physical barriers, 91 IES (15-item self-report scale), 81 PTSD self-report assessments, 13 measures, 80 t
  1344. Capturing the sexual side effects of hormonal contraception
  1345. Carbon dioxide (CO 2) laser ablation of symptomatic vaginal endometriosis: a pilot study
  1346. Carbon dioxide laser treatment for vulvovaginal atrophy in women treated for breast cancer: Preliminary results of the feasibility EPIONE trial
  1347. Cardiometabolic disorders and menopausal hormone therapy
  1348. Cardiometabolic risk and female sexual health: the Princeton III Summary (CME)
  1349. Cardiometabolic risk and female sexuality—Part I. Risk factors and potential pathophysiological underpinnings for female vasculogenic sexual dysfunction syndromes
  1350. Cardioprotection by low-dose of estrogen and testosterone at the physiological ratio on ovariectomized rats during ischemia/reperfusion injury
  1351. Cardiovascular and cancer safety of testosterone in women
  1352. Cardiovascular and sexual health effects of postmenopausal testosterone therapy
  1353. Cardiovascular effects of transdermal testosterone in postmenopausal women
  1354. Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists …
  1355. Cardiovascular issues in male and female sexual dysfunction
  1356. Cardiovascular physiology of androgens and androgen testosterone therapy in postmenopausal women
  1357. Cardiovascular risk and erectile dysfunction
  1358. Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis
  1359. Care of Individuals With
  1360. Care of the Patient with sexual Concerns
  1361. Care of women in menopause: sexual function, dysfunction and therapeutic modalities
  1362. Carpolobia lutea roots restore sexual arousal and performance in paroxetine-induced sexually impaired male rats
  1363. Case 3: Joanne, age 74 Joanne has been on hormone therapy (HT) since her early 50s. About 10 years ago, she tried to stop her HT after reading about the …
  1364. Case for vaginal pain induced by multiple sclerosis
  1365. Case presentation: the object relations approach
  1366. Case report: Clinical, sexual and psychopathological changes after clitoral reconstruction in a Type II female genital mutilation/cutting: A case report
  1367. CASE REPORT: Possible Correlation Between Type 1 Diabetes Mellitus and Female sexual Dysfunction: Case Report and Literature Review
  1368. Catastrophe theory and the human sexual response
  1369. Categorical and multi-axial diagnosis of male erectile disorder
  1370. Categories of female sexual dysfunction.
  1371. Cathleen Morrow, MD
  1372. Causes and indications of hysterectomy in AL-Kadhymia teaching hospital
  1373. Causes and Threatments of sexual desire Discrepancies in Male Couples
  1374. CBT Benefits Adults With ADHD Taking Medication
  1375. CBT Effective in Adolescents with Depression Who Do Not Want Medication
  1376. Celebrating or Mourning Patriarchal Love: The Case of Curious Courtships in Marquez’s Love in the Time of Cholera
  1377. Celibacy in marriage: Female object relations and their adult manifestations
  1378. Cell therapy products in Alzheimer disease
  1379. Cengage Learning
  1380. Central nervous system anatomy and neurochemistry of sexual desire
  1381. Centrally Active Treatment for Premenopausal Women with sexual Interest/Arousal Disorder
  1382. Cerebral white matter deficiencies in pedophilic men
  1383. Certain socio% cultural aspects of prevalence and treatment of vaginismus in Georgia
  1384. Cervix removal at the time of hysterectomy: factors affecting patients’ choice and effect on subsequent sexual function
  1385. Challenges and opportunities in dermal/transdermal delivery
  1386. Challenges in conducting multicenter clinical trials in female sexual dysfunction: baseline differences between study populations
  1387. Challenges in designing psychological treatment studies for sexual dysfunction
  1388. Challenges in sexual medicine
  1389. Challenges in the gynecologic care of premenopausal women with breast cancer
  1390. Challenges in the identification and management of HSDD
  1391. Challenges in the Practice of sexual Medicine in the Time of COVID-19 in the United States
  1392. Challenging Aging The Anti-senescence Effects of Hormesis, Environmental Enrichment and Information Exposure
  1393. Change to either a nonandrogenic or androgenic progestin‐containing oral contraceptive preparation is associated with improved sexual function in women with oral …
  1394. Changes in assertiveness and changes in orgasmic response occurring with sexual therapy for preorgasmic women
  1395. Changes in autonomic nervous system activity are associated with changes in sexual function in women with a history of childhood sexual abuse
  1396. Changes in prenatal testosterone and sexual desire in expectant couples
  1397. Changes in sexual distress, depression and sexual function after clitoral reconstruction in women with female genital mutilation/cutting
  1398. Changes in sexual function after medical or surgical termination of pregnancy
  1399. Changes in sexual function after the midurethral sling procedure for stress urinary incontinence: long-term follow-up
  1400. Changes in sexual function among midlife women:“I’m older… and I’m wiser.”
  1401. Changes in sexual function among women with polycystic ovary syndrome: a pilot study
  1402. Changes in sexual function and comparison of questionnaires following surgery for pelvic organ prolapse
  1403. Changes in sexual function in middle‐aged and older men: Longitudinal data from the Massachusetts Male Aging Study
  1404. Changes in sexual function: hormonal treatment
  1405. Changes in sexual functioning in the bremelanotide RECONNECT study
  1406. Changes in sexual functioning in women after neuromodulation for voiding dysfunction
  1407. Changes in sexuality and quality of couple relationship during the Covid-19 lockdown
  1408. Changes in the Diagnosing of sexual Dysfunctions of Women in ICD-11 Classification
  1409. Changes in the sexual function during pregnancy
  1410. Changes in women’s sexual desire in middle life: the longitudinal study of women in Gothenburg
  1411. Changes of androgens levels in menopausal women
  1412. Changing the political landscape of a nation
  1413. Changing with the times: sex therapy to sexual health
  1414. Chapter draft for a volume on the psychology of love, edited by Robert J. Sternberg and Karin Weis. Please do not quote this draft without the authors’ …
  1415. Chapter Eight Painful Genital sexual Activity
  1416. Chapter Female pelvic floor dysfunctions and evidence-based physical therapy| 7|
  1417. Chapter Seven Women’s Difficulties with Low sexual desire and sexual Avoidance
  1418. Chapter Six When Do We Say A Woman’s sexuality is Dysfunctional?
  1419. CHAPTER TEN “PSYCHICAL IMPOTENCE”: WHAT PSYCHOANALYSIS CAN TELL US ABOUT MEN’S sexual DYSFUNCTIONS MICHAEL D. BERRY
  1420. CHAPTER TEN THE QUEER IDENTITY FOR THE TWENTY-FIRST CENTURY? AN EXPLORATION OF AsexualITY ANNA KUROWICKA
  1421. CHAPTER TWELVE LIMITS OF FLUIDITY: FLOATING SKYSCRAPERS AND A PATHOSOPHY OF desire
  1422. Characteristics and specificities of adolescent sexual offenders
  1423. Characteristics of an Egyptian sample of patients with female sexual dysfunction: a cross-sectional study
  1424. Characteristics of compensated hypogonadism in patients with sexual dysfunction
  1425. Characteristics of couples applying for bibliotherapy via different recruitment strategies: a multivariate comparison
  1426. Characteristics of genital dissatisfaction among a nationally representative sample of US women
  1427. Characteristics of male sexual dysfunction subjects from a sociocultural perspective: Analysis of 18 years
  1428. Characteristics of men undergoing testosterone replacement therapy and adherence to follow-up recommendations in metropolitan multicenter health care system
  1429. Characteristics of women who experience mood and sexual side effects with use of hormonal contraception
  1430. Characterization of hypoactive sexual desire disorder (HSDD) in men
  1431. Characterization of MC3 and the other melancortin receptors (MC) in the hypothalamo-pituitary-gonadal system of the mouse
  1432. Characterization of orgasmic difficulties by women: focus group evaluation
  1433. Characterizing Pelvic-Floor Muscle Function and Morphometry in Survivors of Gynecological Cancer Who Have Dyspareunia: A Comparative Cross-Sectional Study
  1434. Charmaine Borg, Peter J. de Jong &
  1435. Chasing aces: Asexuality, misinformation and the challenges of identity
  1436. Chemical composition and health effects of maca (Lepidium meyenii)
  1437. Chemotherapy-induced versus natural menopause: A comparison of menopausal symptoms and sexual functioning
  1438. Child and adolescent psychiatry for the specialty board review
  1439. Childhood sexual Abuse and sexual Risk-Taking Among Men Who Have sex with Women: The Roles of Alcohol, Mental Health Symptoms, and sex Motives
  1440. Childhood sexual abuse as a predictor of adult female sexual dysfunction: A study of couples seeking sex therapy
  1441. Childhood sexual abuse moderates the association between sexual functioning and sexual distress in women
  1442. Chiropractic Insights
  1443. Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration
  1444. Choosing Love
  1445. chosocial Interventions for Male sexual
  1446. Chronic disease and sexuality: a generic conceptual framework
  1447. Chronic disease, disability, and sexuality
  1448. Chronic fatigue syndromes: the limbic hypothesis
  1449. Chronic flibanserin treatment increases solicitations in the female rat
  1450. Chronic hypopituitarism associated with increased postconcussive symptoms is prevalent after blast-induced mild traumatic brain injury
  1451. Chronic illnesses and disabilities affecting women’s sexuality
  1452. Chronic irisin exposure decreases sexual incentive motivation in female rats
  1453. Chronic pain and depression in low back (spinal) injured patients
  1454. Chronic pain and family: A clinical perspective
  1455. Chronic Pain and sexual Relations
  1456. Chronic pain, opioid therapy, sexual desire, and satisfaction in sexual life: a population-based survey
  1457. Chronic paroxetine treatment does not affect sexual behavior in hormonally sub-primed female rats despite 5-HT
  1458. Chronic paroxetine treatment does not affect sexual behavior in hormonally sub‐primed female rats despite 5‐HT1A receptor desensitization
  1459. Chronic pelvic pain and sexual dysfunction: cause and effect
  1460. Chronic pelvic pain: pathogenesis and validated assessment
  1461. Chronic renal failure and sexual functioning: clinical status versus objectively assessed sexual response.
  1462. Chronic stress influences sexual motivation and causes damage to testicular cells in male rats
  1463. Chronic systemic administration of serotonergic ligands flibanserin and 8-OH-DPAT enhance HPA axis responses to restraint in female marmosets
  1464. Cigarette smoking is significantly linked to sexual dissatisfaction in chinese heroin-dependent patients receiving methadone maintenance treatment
  1465. Cinsellikten tiksinti duyma bozukluğu: Davranışçı tedaviye olumlu ve hızlı yanıt veren bir olgu
  1466. Circuits of desire: Science, Therapy, Trauma, Femininity
  1467. Circuits of sexual desire in hypoactive sexual desire disorder
  1468. Circular and linear modeling of female sexual desire and arousal
  1469. Circulating androgen levels and self-reported sexual function in women
  1470. CITATION
  1471. Citation analysis did not provide a reliable assessment of core outcome set uptake
  1472. Classical conditioning of sexual response in women: A replication study
  1473. Classical Conditioning of sexual Response in Women: A Replication Studyjsm_2453
  1474. Classification and Pathogenesis of Female sexual Dysfunction
  1475. Classification of sexual disorders
  1476. Classification of sexual dysfunctions: towards DSM-V and ICD-11
  1477. Classification, comorbidity, heredity, and risk factors of female sexual dysfunctions
  1478. Classification, disease, and diagnosis
  1479. Classification, etiology, and key issues in female sexual disorders
  1480. Classifying female sexual dysfunction
  1481. Classifying pain: What’s at stake for women with dyspareunia
  1482. Cleveland Clinic Names Two Cancer Advances among Top 10 Medical Innovations for 2016
  1483. Clients in sexually open relationships: Considerations for therapists
  1484. Climacteric
  1485. Climacteric And sexuality [climatério E sexualidade]
  1486. Climacteric Symptoms: Importance and Management
  1487. Clinical and Experimental Evidence for the Pathological Mechanisms Underlying Aspects of sexual Dysfunction: Impact of Adiposity and Chronic Kidney Disease
  1488. Clinical and Instrumental diagnosis of sexual disorders
  1489. Clinical and metabolic evaluation of subjects with erectile dysfunction: a review with a proposal flowchart
  1490. Clinical and research evaluations of sexual dysfunctions
  1491. Clinical and Research Perspective
  1492. Clinical and Social Correlates of sexual Disorders in Bahawalpur
  1493. Clinical and statistical classification of sexual disorders: The case of unintegrated sexuality applied to a clergy sample
  1494. Clinical and therapeutic aspects of Klinefelter’s syndrome: sexual function
  1495. Clinical application of CNS‐acting agents in FSD
  1496. Clinical Assessment of the Male Presenting with sexual Dysfunction
  1497. Clinical Assessment of Tribulus terrestris Extract in the Treatment of Female sexual Dysfunction
  1498. Clinical Case Studies for the Family Nurse Practitioner
  1499. Clinical Cases
  1500. Clinical Cases and Self-Study Review for the Mental Health
  1501. Clinical Cases and Self-Study Review for the Mental Health of Military and Veteran Populations
  1502. Clinical characteristics, health care utilization and costs among men with primary or secondary hypogonadism in a US commercially insured population
  1503. Clinical consult for psychiatric mental health care
  1504. Clinical Consult to Psychiatric Mental Health Management for Nurse Practitioners
  1505. Clinical consult to psychiatric nursing for advanced practice
  1506. Clinical consultation guide on imaging in male infertility and sexual dysfunction
  1507. Clinical correlates of erectile dysfunction and premature ejaculation in men with couple infertility
  1508. Clinical effects of cross-sex hormone therapy in adult trans persons
  1509. Clinical effects of early or surgical menopause
  1510. CLINICAL EVALUATION & DIFFERENTIAL DIAGNOSIS OF ERECTILE DYSFUNCTION (IMPOTENCY)
  1511. Clinical evaluation and management strategy for sexual dysfunction in men and women
  1512. Clinical evaluation of women presenting with low libido and determination of whether androgen therapy might be appropriate
  1513. Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: a meta …
  1514. Clinical Features Associated with Female Genital Mutilation/Cutting: A Pilot Longitudinal Study
  1515. Clinical features of and couple’s attitudes towards premature ejaculation: a multicenter cross-sectional study
  1516. Clinical guidance for the use of trazodone in major depressive disorder and concomitant conditions: pharmacology and clinical practice
  1517. Clinical guide to the diagnosis and treatment of mental disorders
  1518. Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD
  1519. Clinical hypnosis in treating sexual abulia
  1520. Clinical implications of measuring prolactin levels in males of infertile couples
  1521. Clinical interviewing techniques and sexuality questionnaires for male and female cancer patients
  1522. Clinical Investigations in Andrology
  1523. Clinical management of hypoactive sexual desire disorder
  1524. Clinical manual of sexual disorders
  1525. Clinical outcome measurement tools
  1526. Clinical pattern of Dhat Syndrome
  1527. CLINICAL PEARLS 196 MYTHS OF AGING AND sexualITY 197
  1528. Clinical pearls to managing men’s health conditions during the COVID-19 pandemic
  1529. CLINICAL PRACTICE GUIDELINE: Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
  1530. Clinical Practice Guidelines for management of sexual disorders in elderly
  1531. Clinical practice guidelines for management of sexual dysfunction
  1532. Clinical psychology and evolutionary psychology: Toward a dialogue
  1533. CLINICAL PSYCHOLOGY: Psychophysiological Assessment in Premenopausal sexual Arousal Disorder
  1534. Clinical Remission in a Multi-Ethnic Urban Population of Older Adults With Schizophrenia
  1535. Clinical research trials and the treatment of hypoactive sexual desire disorder
  1536. Clinical sexology: an integrated approach between the psychosomatic and the somatopsychic
  1537. CLINICAL STUDIES
  1538. Clinical trial development in female sexual dysfunction
  1539. Clinical trial methodology in premature ejaculation observational, interventional, and treatment preference studies—Part I—Defining and selecting the study …
  1540. Clinical vignette
  1541. Clinically relevant changes in sexual desire, satisfying sexual activity and personal distress as measured by the PFSF, SAL & PDS in postmenopausal women …
  1542. Clinician Resources
  1543. Clinician’s Guide to Psychopharmacology
  1544. Clitoral circulation in postmenopausal women with sexual dysfunction: A pilot randomized study with hormone therapy
  1545. Clitoral frenuloreduction: A new surgical intervention
  1546. Clitoral hemodynamic changes after a topical application of alprostadil
  1547. Clitorally stimulated orgasms are associated with better control of sexual desire, and not associated with depression or anxiety, compared with vaginally stimulated …
  1548. Clitorodynia: a descriptive study of clitoral pain
  1549. Clobazam/oxcarbazepine
  1550. Clomipramine as daily dose in the treatment of patients with premature ejaculation: prospective placebo-controlled study
  1551. CME information: sexual health and religion: a primer for the sexual health clinician (CME)
  1552. CME information: sexuality education in North American medical schools: Current status and future directions (CME)
  1553. CME stands for commercial medical education: and ACCME still won’t address the issue
  1554. CNS Agents Emerge as Frontrunners in FDA-Approved Treatments for Low Libido in Women
  1555. CNS drug development: lessons learned part 3: psychiatric and central nervous system drugs developed over the last decade—implications for the field
  1556. Coaching Women on the Impact of Alcohol Intake on Mental Well-Being: A Systematic Literature Review
  1557. Cocaine and sexual Dysfunction
  1558. Cognitions, emotions, and sexual response: Analysis of the relationship among automatic thoughts, emotional responses, and sexual arousal
  1559. Cognitive analytic therapy for borderline erotomania: Forensic romances and violence in the therapy room
  1560. Cognitive and emotional predictors of female sexual dysfunctions: Preliminary findings
  1561. Cognitive aspects of sexual functioning: Differences between East Asian-Canadian and Euro-Canadian women
  1562. Cognitive aspects of sexual functioning: differences between East Asians and Euro-Caucasians
  1563. Cognitive Behavioral Factors Relevant to Treatment
  1564. Cognitive behavioral therapy as an adjunct treatment for Pakistani men with ED
  1565. Cognitive behavioral therapy for sexual dysfunctions in women
  1566. Cognitive behavioral therapy in sexual dysfunction
  1567. Cognitive factors in women hypoactive sexual desire disorder
  1568. Cognitive hypnotherapy for major depressive disorder
  1569. Cognitive hypnotherapy for treating depression
  1570. Cognitive orientation and sexual dysfunctions in women
  1571. Cognitive processing in women with dyspareunia: What is more salient, the pain or the sex?
  1572. Cognitive processing of sexual cues in asexual individuals and heterosexual women with desire/arousal difficulties
  1573. Cognitive schemas activated in sexual context: a comparative study with homosexual and heterosexual men and women, with and without sexual problems
  1574. Cognitive schemas associated with negative sexual events: A comparison of men and women with and without sexual dysfunction
  1575. Cognitive structures in women with sexual dysfunction: the role of early maladaptive schemas
  1576. Cognitive-behavioral and mindfulness-based therapy for low sexual desire
  1577. Cognitive-behavioral therapy for sexual dysfunction
  1578. Cognitive-behavioral therapy for women with lifelong vaginismus: A randomized waiting-list controlled trial of efficacy.
  1579. Cognitive-behavioral treatment of sexual dysfunctions
  1580. Cognitive‐behavioral bibliotherapy for sexual dysfunctions in heterosexual couples: A randomized waiting‐list controlled clinical trial in the Netherlands
  1581. Coital incontinence: a factor for deteriorated health-related quality of life and sexual function in women with urodynamic stress urinary incontinence
  1582. Collaborative care to improve treatment of co-occurring diabetes mellitus and psychiatric disorders
  1583. College virgins: How men and women perceive their sexual status
  1584. Colorectal cancer patients’ experiences with cancer life and medical care
  1585. Colorectal cancer: aspects of multidisciplinary treatment, metastatic disease and sexual function
  1586. Combination alpha blocker and phosphodiesterase 5 inhibitor versus alpha-blocker monotherapy for lower urinary tract symptoms associated with benign …
  1587. Combination of Testosterone and Vardenafil Increases Female sexual Functioning in Sub‐Primed Rats
  1588. Combination therapy for sexual dysfunction: integrating sex therapy and pharmacotherapy
  1589. Combined conjugated esterified estrogen plus methyltestosterone supplementation and risk of breast cancer in postmenopausal women
  1590. Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women
  1591. Combined oral contraceptives and sexual function in women—a double-blind, randomized, placebo-controlled trial
  1592. Combined oral contraceptives with natural estrogen and sexual function: the optimal method of contraception for women of different ages
  1593. Coming out of the sex therapy closet: Using experiential psychotherapy with sexual problems and concerns
  1594. Coming to an asexual identity: Negotiating identity, negotiating desire
  1595. Coming to understand
  1596. Comment on Janssen et al.(2008)
  1597. Commentary on “Critical Flaws in the FSFI and IIEF”
  1598. Commentary on David Rowland’s “Will medical solutions to sexual problems make sexological care and science obsolete?”
  1599. Commentary on Rowland’s article
  1600. Commentary on Spurgas’s “Interest, arousal, and shifting diagnoses of female sexual dysfunction”
  1601. Commentary to McCarthy’s Bridges to sexual desire
  1602. Commentary: approved hormonal treatments for HSDD: an unmet medical need
  1603. COMMENTARY: Are the Endocrine Society’s Clinical Practice Guidelines on Androgen Therapy in Women Misguided? A Commentary
  1604. Commentary: hypoactive sexual desire in men
  1605. Commentary: Management of hypoactive sexual desire Disorder (HSDD)
  1606. Commentary: The future of erectile dysfunction therapy II-novel pharmacotherapy and innovative technology
  1607. Commentary: The stagnation of sex therapy
  1608. Commentary:“will medical solutions to sexual problems make sexological care and science obsolete?”
  1609. Common Childhood Masturbation, But Different sexual Attitudes in Three Male-at-Birth Adolescents: Possible Implications for sexual Development
  1610. Common complications
  1611. Common mental disorders
  1612. Common sexual Disorders: A Clinical Review
  1613. Common therapeutic strategies in the management of sexual dysfunction and cardiovascular disease
  1614. Communication and sexual desire
  1615. Comorbid LUTS and erectile dysfunction: optimizing their management
  1616. Comparative analysis of copper intrauterine device impact on female sexual dysfunction subtypes
  1617. Comparative effectiveness and impact on health-related quality of life of hysterectomy vs. levonorgestrel intra-uterine system for abnormal uterine bleeding
  1618. Comparative Safety of Sleep Prescriptions and Suicide Attempts in Veterans
  1619. Comparative study of Psychiatric Morbidity among HIV Positive patients and Leprosy patients.
  1620. Compare the effectiveness of PLISSIT and sexual health models on Women’s sexual problems in Tehran, Iran: a randomized controlled trial
  1621. Comparing different thinking styles and marital satisfaction among engineers of urban and nonurban areas
  1622. Comparing male and female sexual arousal, utilizing fMRI: a theoretical perspective
  1623. Comparing Male and Female sexual Function and Dysfunction
  1624. Comparing sildenafil alone vs. sildenafil plus brief couple sex therapy on erectile dysfunction and couples’ sexual and marital quality of life: A pilot study
  1625. Comparing the effects of the second-and third-generation oral contraceptives on sexual functioning
  1626. Comparing the effects of two methods of group education and peer education on sexual dysfunction of menopausal women: A randomized controlled trial
  1627. Comparing the relative amount of testosterone required to restore sexual arousal, motivation, and performance in male rats
  1628. Comparing two books and establishing probably efficacious treatment for low sexual desire.
  1629. Comparison among some effects of sexual dysfunction in female spouses of fertile and infertile couples
  1630. Comparison of 2 methods of vaginal cuff closure at laparoscopic hysterectomy and their effect on female sexual function and vaginal length: a randomized clinical …
  1631. Comparison of anogenital distance and correlation with vulvo-vaginal atrophy: a pilot study on premenopausal and postmenopausal women
  1632. Comparison of biopsychosocial functioning of women of different nationalities in the perimenopausal period
  1633. Comparison of Effect of Anterior Colporrhaphy and Transobturator Tape Surgeries on Urinary Incontinence and sexual Performance in Women
  1634. Comparison of efficacy, safety, and tolerability of on‐demand tadalafil and daily dosed tadalafil for the treatment of erectile dysfunction
  1635. Comparison of Elaeagnus angustifolia extract and sildenafil citrate on female orgasmic disorders: a randomized clinical trial
  1636. Comparison of female sexual function in women who underwent abdominal or vaginal hysterectomy with or without bilateral salpingo-oophorectomy
  1637. Comparison of interactive voice response (IVR) with paper administration of instruments to assess functional status, sexual function, and quality of life in elderly men
  1638. Comparison of marital satisfaction, intimacy and sexual function in female nurses with fixed and changing shiftwork
  1639. Comparison of prevalence of hypoactive sexual desire disorder (HSDD) in women after five different hysterectomy procedures
  1640. Comparison of primipara women’s pre-pregnancy, pregnancy, and postpartum sexual lives
  1641. Comparison of salivary versus serum testosterone levels in postmenopausal women receiving transdermal testosterone supplementation versus placebo
  1642. Comparison of serum level of Brain-Derived Neurotrophic factor and Hypothalamus-Pituitary-Adrenal axis functioning in clinical burnout with controls
  1643. Comparison of sexual dysfunction in women using depo-medroxyprogesterone acetate (DMPA) and cyclofem
  1644. Comparison of sexual dysfunction using the Female sexual Function Index following surgical treatments for uterine fibroids
  1645. Comparison of sexual Dysfunctions among Employed Women and Housewives Attending’s to Tabriz Counseling Crescent Center Iran
  1646. Comparison of the effect of Elaeagnus angustifolia flower capsule and sildenafil citrate tablet female sexual interest/arousal disorder in clinical trial study
  1647. Comparison of the effect of intermittent and continuous aerobic physical training on sexual function of women with polycystic ovary syndrome: randomized controlled …
  1648. Comparison of the Effects of Elaeagnus angustifolia Flower Capsule and Sildenafil Citrate Tablet on Anxiety Resulting From sexual Dysfunction in Women Referring …
  1649. Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol+ drospirenone and tibolone, on sexual function in healthy …
  1650. Comparison of the Effects of the PLISSIT Model Versus the sexual Health Model on Quality of Life Among Women with Breast Cancer
  1651. Comparison of vaginal penetration cognitions and metacognitions between women with genito-pelvic pain and penetration disorder and healthy controls
  1652. Comparisons of depression, marital intimacy, sexual function and quality of life in sexual active or inactive groups of post-menopausal married women
  1653. Compile and standardization of Tehran married women sexual function questionnaire (Tehran-SFQ)
  1654. Complex pelvic floor failure and associated problems
  1655. Complications of opioid therapy
  1656. COMPOSITE ENDPOINTS FOR CLINICAL TRIALS
  1657. COMPOSITE ENDPOINTS FOR CLINICAL TRIALS
  1658. COMPOSITE ENDPOINTS FOR CLINICAL TRIALS
  1659. Compounded bioidentical hormones in endocrinology practice: an Endocrine Society scientific statement
  1660. Comprehensive Assessment of Women’s sexual Arousal Requires Both Objective and Subjective Measurement
  1661. Comprehensive molecular characterization of papillary renal-cell carcinoma
  1662. Comprehensive Review of Psychiatry
  1663. Comprehensive review of the anatomy and physiology of male ejaculation: Premature ejaculation is not a disease
  1664. Comprehensive self-management reduces the negative impact of irritable bowel syndrome symptoms on sexual functioning
  1665. Comprehensive sexual health assessment
  1666. Compulsive sexual Behavior Disorder: Understanding, Assessment, and Treatment
  1667. Compulsory sexuality
  1668. Compulsory sexuality and Amatonormativity in Higher Education: A Photovoice Study with Asexual and Aromantic Students
  1669. Compulsory sexuality and asexual/crip resistance in John Cameron Mitchell’s Shortbus
  1670. Compulsory sexuality and Its Discontents: The Challenge of Asexualities
  1671. Computerized behavioral activation treatment for major depressive disorder and the effects on sexual desire
  1672. Concept Analysis of Female sexual Subjectivity based on Walker and Avant’s Method
  1673. Concept of ʻIhtiraqʼ in Unani Medicine–A correlation with oxidative stress, and future prospects
  1674. Conceptions of Psychopathology
  1675. Conceptions of psychopathology
  1676. Conceptual approach to developing quality measures for transgender patients
  1677. Conceptual bases of sexual health
  1678. Conceptualization of the sexual response models in men: Are there differences between sexually functional and dysfunctional men?
  1679. Conceptualization, History, and Future of the Paraphilias
  1680. Conceptualizing women’s sexual problems
  1681. Concise Review for Clinicians—CME Credit Offered
  1682. Concordance in the perception of couples recovering from primary surgical treatment of prostate cancer
  1683. CONDITIONS NOT RECOMMENDED FOR APPROVAL
  1684. Conditions of servitude: Woman’s peculiar role in the master-slave dialectic in Beauvoir’s The Second sex
  1685. CONFERENCE PROCEEDINGS (In bold are undergraduate research assistants)
  1686. Confirmatory factor analysis of a Spanish version of the sex Fantasy Questionnaire: Assessing gender differences
  1687. Confirmatory factor analysis of the female sexual function index
  1688. Conflicts within the family and within the couple as contextual factors in the determinism of male sexual dysfunction
  1689. Confluent Education in a Counseling Psychology Program
  1690. Confronting the challenges of postmenopausal urogenital health
  1691. Congenital penile curvature presenting as unconsummated marriage. Repair by 16-dot plication with subjectively reported patient and partner satisfaction
  1692. Connect the Dots—November 2019
  1693. Consensus guidelines on male sexual dysfunction
  1694. Consensus Position Statement on the Use of Testosterone in Women
  1695. Consensus statement for non-estrogen-based treatments for menopausal symptoms
  1696. Consensus statement on the use of HRT in postmenopausal women in the management of osteoporosis by SIE, SIOMMMS and SIGO
  1697. Consequences of impaired female sexual functioning: Individual differences and associations with sexual distress
  1698. Consequences of premature ovarian insufficiency on women’s sexual health
  1699. Consequences of rape: injuries, posttraumatic stress and neuroendocrinological changes
  1700. Conservative Christianity, partnership, hormones, and sex in late life
  1701. Consideration of a spiritual role in sex and sex therapy
  1702. Considerations for national public health leadership in advancing sexual health
  1703. Considering asexuality as a sexual orientation and implications for acquired female sexual arousal/interest disorder
  1704. Consistency of three different questionnaires for evaluating sexual function in healthy young women
  1705. Constructing illness: How the public in eight Western nations respond to a clinical description of “schizophrenia”
  1706. Constructing women’s sexual health: A feminist critique of selected topics in college human sexuality textbooks
  1707. Constructions of Asexual Identity in China: Intersections of Class, Gender, Region of Residence, and Asexuality
  1708. Consulting “Dr Google” for sexual dysfunction: a contemporary worldwide trend analysis
  1709. Consumer’s guide to dietary supplements and alternative medicines: servings of hope
  1710. Contemporary Considerations in the Pathophysiology of Low sex Drive in Men
  1711. Contemporary drugs and biologics with special significance
  1712. Contemporary psychiatric-mental health nursing
  1713. Contemporary Review of BPH Medical and Surgical Treatments on sexual Function
  1714. Contemporary sex Therapy: Skills in Managing sexual Problems
  1715. Contemporary treatment of sexual dysfunction: Reexamining the biopsychosocial model
  1716. Contemporary vistas in geriatric sexuality
  1717. Content Analysis of Patient Voices at the FDA’s “Female sexual Dysfunction Patient-Focused Drug Development Public Meeting”
  1718. Content and valence of sexual cognitions and their relationship with sexual functioning in Spanish men and women
  1719. Content validity of the Female sexual Function Index (FSFI) in pre‐and postmenopausal women with hypoactive sexual desire disorder
  1720. Contested psychiatric ontology and feminist critique: ‘Female sexual Dysfunction’ and the Diagnostic and Statistical Manual
  1721. Continued efficacy and safety of flibanserin in premenopausal women with hypoactive sexual desire disorder (HSDD): results from a randomized withdrawal trial
  1722. Continuing medical education and the marketing of fentanyl for breakthrough pain: marketing messages in an industry‐funded CME module on breakthrough pain
  1723. Continuing Medical Education: Key Methodological Issues in sexual Medicine Research (CME)
  1724. Continuing medical education: sexual functioning in transsexuals following hormone therapy and genital surgery: a review (CME)
  1725. Continuing medical education: the use of estrogen therapy in women’s sexual functioning (CME)
  1726. Continuing Medical Education: Urogenital Complaints and Female sexual Dysfunction (Part 1)(CME)
  1727. Continuing Medical Education: Urogenital Complaints and Female sexual Dysfunction (Part 2)(CME)
  1728. Continuous one-flow multi-step synthesis of active pharmaceutical ingredients
  1729. Contraception and sexual health
  1730. Contraception, sex and sexual wellbeing: a reflective account
  1731. Contraceptive effect of ethanolic extract of Dioscorea villosa tuber on reproductive hormones of female wistar rats
  1732. Contraceptive usage patterns in North American medical students
  1733. Contribution of androgen receptor sensitivity to the relation between testosterone and sexual desire: an exploration in male-to-female transsexuals
  1734. Contribution of imaging to our understanding of sexual function and dysfunction
  1735. Contribution of psychosexual approach to assessment and treatment of sexual dysfunction: a working model
  1736. Contributor Biographies
  1737. Contributors to Optimal sexual Experiences
  1738. Controlled studies on women presenting with sexual drive disorder: I. Endocrine status
  1739. Controversial aspects of testosterone in the regulation of sexual function in late‐onset hypogonadism
  1740. Controversies about hypersexual disorder and the DSM-5
  1741. Controversies in sexual Medicine: Clinical and Basic Science Research in sexual Medicine Must Rely, in Part, on Pharmaceutical Funding?
  1742. Controversies in sexual medicine: Is sex just fun? How sexual activity improves health
  1743. Controversies in sexual medicine: Organic vs. psychogenic? The Manichean diagnosis in sexual medicine
  1744. Controversies of women’s sexual arousal and desire
  1745. Controversies regarding transdermal androgen therapy in postmenopausal women
  1746. Convenient and Robust Metal-Free Synthesis of Benzazole-2-Ones Through the Reaction of Aniline Derivatives and Sodium Cyanate in Aqueous Medium
  1747. Conventional and unconventional cardiovascular risk factors in men with erectile dysfunction
  1748. Convergent-divergent validity and correlates of the Day-to-Day Impact of Vaginal Aging domain scales in the MsFLASH vaginal health trial
  1749. Conversations With Women About Female sexual Dysfunction (FSD) and Treatment With Bremelanotide
  1750. Conversion of Benzimidazoles, Imidazothiazoles and Imidazoles into more Potent Central Nervous System Acting Drugs
  1751. Conversion Tables for ICD-10 and DSM-IV
  1752. Coping with pain in intimate situations: Applying the avoidance-endurance model to women with vulvovaginal pain
  1753. Core document on erectile dysfunction: key aspects in the care of a patient with erectile dysfunction
  1754. CORRECTION OF URINARY DISCOMFORT BY M-CHOLINOLYTIC SPASMEX IN WOMEN WITH sexual DYSFUNCTIONS AND HYPERACTIVE URINARY …
  1755. Correlated genetic and non-shared environmental influences account for the co-morbidity between female sexual dysfunctions
  1756. Correlates of circulating androgens in mid-life women: the study of women’s health across the nation
  1757. Correlates of extra-dyadic sex in Czech heterosexual couples: Does sexual behavior of parents matter?
  1758. Correlates of lesbian sexual functioning
  1759. Correlates of men’s sexual interest: a cross-cultural study
  1760. Correlates of placebo response in the treatment of sexual dysfunction in women: a preliminary report
  1761. Correlates of sexual function following vulvar excision
  1762. Correlates of sexual functioning in Italian menopausal women
  1763. Correlates of sexual satisfaction among sexually active postmenopausal women in the Women’s Health Initiative-Observational Study
  1764. Correlates of sexual satisfaction in marriage
  1765. Correlation between ejaculatory and erectile dysfunction
  1766. Correlation between flow-mediated dilation and erectile dysfunction
  1767. Correlation between general health and sexual function in older women in an Iranian setting
  1768. Correlation between insula activation and self-reported quality of orgasm in women
  1769. Correlation of Online Physician Reviews and Overall Patient Satisfaction
  1770. Correlation of oxytocin with male sexual dysfunction: An update
  1771. Correlation of question 15 of the FSDS-DAO with clinician evaluation of female orgasmic disorder
  1772. Correlation of sexual dysfunction with sex hormone and estrogen receptor gene polymorphism in Chinese Han women with epilepsy
  1773. Correlation of sexual knowledge and attitude with sexual function in female nurses
  1774. Correspondence (letter to the editor): Absence of desire
  1775. Corresponding author (Email: bimilo@ hanmail. net)
  1776. Corresponding author (Email: uropark@ gmail. com)
  1777. Corresponding author (Email: wowhana@ ewha. ac. kr)
  1778. Corresponding author: Kwangsung Park. Email: uropark@ gmail. com
  1779. Cortisol, sexual arousal, and affect in response to sexual stimuli
  1780. Cosmetic gynecology in the view of evidence-based medicine and ACOG recommendations: a review
  1781. Cosmetic Medicine
  1782. Cost implications of sexual dysfunction: the female picture
  1783. Cost-Effectiveness Analysis of High-Sensitivity Troponin T Versus Conventional Troponin I Testing for Acute Myocardial Infarction
  1784. Cost–effectiveness of elagolix versus leuprolide acetate for treating moderate-to-severe endometriosis pain in the USA
  1785. Costs of pleasure and the benefits of pain: self-perceived genital sensation, anatomy and sexual dysfunction
  1786. Could diabetes mellitus affect female sexual function: a comparative study
  1787. Counseling and Antibody Testing to Prevent HIV Infection-Reply
  1788. Counseling asexual clients
  1789. Counseling Couples Before, During, and After Pregnancy: sexuality and Intimacy Issues
  1790. Counseling HIV-positive gay men
  1791. Counselling Women in Midlife: A Sociocultural Framework
  1792. Counting Chickens before the Eggs Hatch: On the Valuation of New Drug (Product) Development Portfolios in the Pharmaceutical Sector
  1793. Couple Attachment and sexual desire Discrepancy: A Longitudinal Study of Non-Clinical Married Couples at Mid-Life
  1794. Couple sex therapy versus group therapy for women with genito-pelvic pain
  1795. Couple therapy and the treatment of sexual dysfunction
  1796. Couple therapy for low sexual desire: A systemic approach
  1797. Couple therapy for premature ejaculation
  1798. Couple therapy, family therapy and systemic interventions for adult‐focused problems: The current evidence base
  1799. Couple‐Based Interventions for the Treatment of Depressive and Anxiety Disorders
  1800. Couplepause: a new paradigm in treating sexual dysfunction during menopause and andropause
  1801. Couples and kinky sexuality: The need for a new therapeutic approach
  1802. Couples in collusion: Short-term, assessment-based strategies for helping couples disarm their defenses
  1803. Couples Research & Therapy NEWSLETTER
  1804. Couples Therapy and Counseling
  1805. Couples’ sexual communication and dimensions of sexual function: A meta-analysis
  1806. Couples’ sexuality: Relation to gender role attitudes and division of household labor
  1807. COUPLES’sexual DYSFUNCTION: Vardenafil Improves sexual Function and Treatment Satisfaction in Couples Affected by Erectile Dysfunction (ED): A …
  1808. COUPLES’sexual DYSFUNCTIONS: Female sexual Dysfunction, sexual Distress, and Compatibility with Partner
  1809. COUPLES’sexual DYSFUNCTIONS: The Effects of Treating Male Hypogonadism on Couples’ sexual desire and Function
  1810. COUPLES’sexual DYSFUNCTIONS: Women’s sexual Function Improves When Partners Are Administered Vardenafil for Erectile Dysfunction: A Prospective …
  1811. Covariation of sexual desire and sexual arousal: The effects of anger and anxiety
  1812. COVID-19
  1813. Creating and Validating the DESEA Questionnaire for Men and Women
  1814. Creating the’dis-ease’of high cholesterol: A sociology of diagnosis reception analysis
  1815. Creation and Validation of the Self-esteem/Self-image Female sexuality (SESIFS) Questionnaire
  1816. Crisis and safety: The asexual in sexusociety
  1817. Critical analyses
  1818. Critical flaws in the female sexual function index and the international index of erectile function
  1819. Critical overview of the new consensus-based definitions and classification of female sexual dysfunction
  1820. Critical review of group interventions for sexual dysfunction: Advances in the last decade
  1821. Critiques and challenges to old and recently proposed American psychiatric Association’s website DSM 5 diagnostic criteria for sexual dysfunctions
  1822. Cross Sectional Study of Age Profile of Alleged Accused and Victims of sexual Offence
  1823. Cross-cultural adaptation of the female sexual function index
  1824. Cross-Cultural Analysis of sexual Response and Relationship Satisfaction in Women With and Without Orgasmic Difficulty During Partnered sex
  1825. Cross-cultural psychotherapy
  1826. CSA survivors: What heals and what hurts in a couple relationship
  1827. CSBD in Women
  1828. Cues resulting in desire for sexual activity in women
  1829. Cultivating healthy skepticism towards help-seeking advertisements: Dispelling the illusion of unique invulnerability
  1830. Cultural and organizational aspects of application of the Americans with Disabilities Act to persons with psychiatric disabilities
  1831. Cultural attitudes and female sexual desire
  1832. Cultural Considerations in the Treatment of sexual Dysfunction
  1833. Cultural factors and sexual dysfunction in clinical practice
  1834. Culturally sensitive sex therapy
  1835. Culture and sexuality: cognitive–emotional determinants of sexual dissatisfaction among Iranian and New Zealand women
  1836. Curation and bioinformatic analysis of strabismus genes supports functional heterogeneity and proposes candidate genes with connections to RASopathies
  1837. Curing sexual desire with the Lust Enhancing Pill for Women: Where Medicine Meets Normality
  1838. Current and future pharmacotherapies of premature ejaculation
  1839. Current approaches to the evaluation of sexual desire disorders
  1840. Current challenges in recognizing and treating eating disorders.
  1841. Current diagnosis and management of erectile dysfunction
  1842. Current Literature Review
  1843. Current literature review
  1844. Current Literature Review
  1845. Current Literature Review
  1846. CURRENT MANAGEMENT OPTIONS FOR WOMEN WITH HSDD (hypoactive sexual desire DISORDER)
  1847. Current management strategies of the postmenopausal patient with sexual health problems
  1848. Current perspectives on the clinical assessment and diagnosis of female sexual dysfunction and clinical studies of potential therapies: A statement of concern
  1849. Current Practice in Hysterectomy for Benign Reasons and Its Effect on sexual Function
  1850. Current Research Journal of Social Sciences
  1851. Current research on how infertility affects the sexuality of men and women
  1852. Current research on sexual response and sexual functioning among lesbian women
  1853. Current Resources for Evidence-Based Practice, November/December 2016
  1854. Current status and future directions in couple therapy
  1855. Current therapies for premature ejaculation
  1856. Current therapies for premature ejaculation
  1857. Current Treatment Modalities for the Genitourinary Syndrome of Menopause
  1858. Current updates on salpingectomy for the prevention of ovarian cancer and its practice patterns worldwide
  1859. Curriculum Vitae Alessandra H. Rellini, Ph. D Associate Professor in Clinical Psychology The University of Vermont-UVM arellini@ uvm. edu-(802) 419-0820
  1860. CURRICULUM VITAE JOHN M. THORP, JR., MD.
  1861. Currituck County
  1862. Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use
  1863. Cutoff score of the sexual interest and desire inventory-female for diagnosis of hypoactive sexual desire disorder
  1864. Cutting-Edge Work
  1865. Cyclodextrin-based drug delivery systems
  1866. Daily affect and female sexual function
  1867. Daily diary study of adult men’s and women’s event-level sexual motivations and sexual behaviour
  1868. Daily hassles in the family-work system and life satisfaction: the moderating effect of sexual satisfaction
  1869. Dancing with Science, Ideology, and Technique: Treating sexual desire Disorders: A Clinical Casebook Edited by Sandra R. Leiblum New York, NY: Guilford, 2010 …
  1870. Dangerous Bedfellows, Industry and Medicine: Life Savers Or Disease Makers
  1871. Danilo Antonio Baltieri
  1872. Dapoxetine
  1873. Darwin’s legacy: An evolutionary view of women’s reproductive and sexual functioning
  1874. Darwinian psychiatry
  1875. Data based medicine and clinical judgement
  1876. David B. Vodušek
  1877. DAY 4 25TH JANUARY 2020 ABSTRACTS
  1878. Declining consumption of added sugars and sugar-sweetened beverages in Australia: a challenge for obesity prevention
  1879. Declining gonadal function in elderly men
  1880. Decreased sexual desire Screener
  1881. Decreased sexual desire Screener©
  1882. Decreased sexual motivation and heightened anxiety in male Long-Evans rats are correlated with the memory for a traumatic event
  1883. Defining Asexuality Into (Or Out Of) Its Radical Potential
  1884. Defining normal
  1885. Defining premature ejaculation for experimental and clinical investigations
  1886. Defining the Challenge: Epidemiology of Mental Disorders in British Columbia: Estimating the Prevalence of Mental Disorders in Adults
  1887. Definition and classification of female sexual disorders.
  1888. Definition and diagnosis of sexual problems
  1889. Definition and diagnosis of sexuality in the XXI century
  1890. Definition and Epidemiology
  1891. Definition, etiology, and treatment of absent/low desire in women.
  1892. DEFINITIONS AND HISTORY
  1893. Definitions of sexual dysfunctions in women and men: a consensus statement from the Fourth International Consultation on sexual Medicine 2015
  1894. Definitions of women’s sexual d ysf u nct i on recons id ered: advocating expansion and revision
  1895. Definitions of women’s sexual dysfunction reconsidered: advocating expansion and revision
  1896. Degarelix: An Antagonist to GnRH—Theoretical and Treatment Considerations in Paraphilia
  1897. Dehydroepiandrosterone and cortisol as markers of HPA axis dysregulation in women with low sexual desire
  1898. Dehydroepiandrosterone for women in the peri‐or postmenopausal phase
  1899. Dehydroepiandrosterone potentiates the effect of vitamin D on thyroid autoimmunity in euthyroid women with autoimmune thyroiditis: A pilot study
  1900. Dehydroepiandrosterone replacement therapy—panacea, snake oil, or a bit of both?
  1901. Dehydroepiandrosterone use in postmenopausal women: an androgenic option for managing sexual pain caused by vulvovaginal atrophy
  1902. Delayed ejaculation
  1903. Delayed ejaculation and alexithymia: what is the relationship?
  1904. Delayed ejaculation and alexithymia: what is the relationship?[version 2; referees: 2 approved]
  1905. Delayed ejaculation and orgasm
  1906. Delayed orgasm and anorgasmia
  1907. Demographic and psychological factors related to sexual desire among heterosexual women in a relationship
  1908. Demographics, cancer-related factors, and sexual function in rectal cancer patients in taiwan: preliminary findings
  1909. Demystifying love: Plain talk for the mental health professional
  1910. Demystifying Steroids
  1911. Dendritic arbor of neurons in the hypothalamic ventromedial nucleus in female prairie voles (Microtus ochrogaster)
  1912. Department of Dynamic and Clinical Psychology Doctorate course in Dynamic and Clinical Psychology XXX Cycle
  1913. Departures from linearity in the relationship between measures of muscular strength and physical performance of the lower extremities: the Women’s Health and Aging …
  1914. Depiction of Mental Illness in Film and Association with Financial and Critical Success
  1915. Deployment and its Effects on sexual Functioning and Relationships of United States Military Members
  1916. Depressed mood and sexual functioning
  1917. DEPRESSION AMONG WOMEN WITH hypoactive sexual desire: ORGASM CONSISTENCY TRAINING ANALYSIS AND EFFECT ON TREATMENT OUTCOME …
  1918. Depression and antidepressant-associated erectile dysfunction
  1919. Depression and female sexual dysfunction
  1920. Depression and sexual dysfunction
  1921. Depression and sexual Function: pocketbook
  1922. Depression and sexual functioning in minority women: current status and future directions
  1923. Depression as an outcome or cause of sexual dysfunctions: A review study
  1924. Depression in premenopausal women with HSDD: baseline findings from the HSDD Registry for Women
  1925. Depression mood stabilisation: novel concepts and clinical management
  1926. Depression, antidepressants, and sexual functioning
  1927. Depression, sexual Functioning and the Life Satisfaction of Pakistani Women with and without Polycystic Ovary Syndrome
  1928. Depression, sexual Functioning, & Relationship with Primary Care Providers among Female Veterans: A Pilot Study
  1929. Depression, sexuality and fibromyalgia syndrome: clinical findings and correlation to hematological parameters
  1930. Depression: the ambivalence of diagnosis
  1931. Depressive disorders and the menopause transition
  1932. Depressive symptoms and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus: the Dogo Study
  1933. Depressive symptoms are not associated with long-term integrated testosterone concentrations in hair
  1934. DESCRIPTION OF THE DISORDER AND CLINICAL PICTURE
  1935. DESCRIPTION OF THE DISORDERS
  1936. Descriptive Study of Some Egyptian Females Having sexual Dysfunction and Attending Al-Azhar University Hospitals: Results of a Clinical Study with the Aid of …
  1937. Design, Preparation And in vitro Characterization of a biodegradable injectable form of testosterone
  1938. Designing drugs for the treatment of female sexual dysfunction
  1939. desire AND AROUSAL DISORDERS IN WOMEN: AN UPDATE ON ASSESSMENT AND EVIDENCE-BASED TREATMENTS
  1940. desire emerges from excitement: A psychophysiological perspective on sexual motivation
  1941. desire lost, desire feared, desire never named
  1942. desire Thinking and Metacognition Associated with Dysregulated sexuality
  1943. desire-Phase Problems and the Search for Explanations
  1944. Desk reference to the diagnostic criteria from DSM-5®
  1945. Detection, identification and quantification by 1H NMR of adulterants in 150 herbal dietary supplements marketed for improving sexual performance
  1946. Determinants of female sexual function in breastfeeding women
  1947. Determinants of sexual desire problems in women: Testing a cognitive-emotional model
  1948. Determinants of sexual dysfunction and interventions for patients with obstructive sleep apnoea: a systematic review
  1949. Determinants of women’s sexual dissatisfaction: Assessing a cognitive-emotional model
  1950. Determination of flibanserin and tadalafil in supplements for women sexual desire enhancement using high-performance liquid chromatography with tandem mass …
  1951. Determination of flibanserin in the presence of confirmed degradation products by a third derivative emission spectrofluorometric method: Application to …
  1952. Determination of menopausal status in women: the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study
  1953. Determine the rule of gender in relation between sexual desire and quality of life in patients with major depression
  1954. Determining a Bayesian predictive power stopping rule for futility in a non-inferiority trial with binary outcomes
  1955. Determining the correlation between sexual satisfaction and loneliness levels in patients with hemodialysis in a Muslim community
  1956. Determining the effects of androgen therapy on sexual well-being: a complex challenge
  1957. Determining the Role of Occupational Therapists for Improving Interventions Related to sexual Health for Women Ages 45–64 who have a Chronic Medical Condition
  1958. Detrimental effects of testosterone addition to estrogen therapy involve cytochrome P-450-induced 20-HETE synthesis in aorta of Ovariectomized …
  1959. DeŪnition and classiŪcation of erectile dysfunction: Report of the Nomenclature Committee of the International Society of Impotence Research
  1960. Developing a biased unmatched bivalent ligand (BUmBL) design strategy to target the GPCR homodimer allosteric signaling (cAMP over β-arrestin 2 recruitment) …
  1961. Developing Cognitive Bias Modification Scenarios for Women with sexual Interest Arousal Disorder and Comparing Effectiveness with Mindfulness Therapy
  1962. Developing guidelines for adapting questionnaires into the same language in another culture
  1963. Developing Serotonergic Antidepressants Acting on More Than the Serotonin Transporter
  1964. Developing treatments for female sexual dysfunction
  1965. Development and Characterization of a Rat Model of Female sexual Dysfunction
  1966. Development and evaluation of a curriculum targeting emotional components of women’s sexual health
  1967. Development and feasibility of a group-based therapeutic yoga program for women with chronic pelvic pain
  1968. Development and Greenness Evaluation of Spectrofluorometric Methods for Flibanserin Determination in Dosage Form and Human Urine Samples
  1969. Development and Implementation of the sexual and Vaginal Health After Cancer (SVHC) Care Pathway in a Rural Oncology Clinic
  1970. Development and Psychometric Evaluation of a Scale to Assess
  1971. Development and Psychometric Evaluation of a Scale to Assess sexual Difficulties in Gay Men
  1972. Development and Psychometric Performance of the Self-Efficacy to Communicate About sex and Intimacy (SECSI) Scale in Women Treated for Cancer
  1973. Development and psychometric properties of the Female sexual desire Questionnaire (FSDQ)
  1974. Development and Validation of a Measure of Responsive sexual desire
  1975. Development and validation of a new screening tool for hypoactive sexual desire disorder: The Brief Profile of Female sexual Function© (B-PFSF©)
  1976. Development and validation of Chinese version of female sexual function index in a Chinese population—a pilot study
  1977. Development and validation of liquid chromatography–electrospray–tandem mass spectrometry method for determination of flibanserin in human plasma: Application …
  1978. Development and validation of the Attitudes Towards Asexuals (ATA) scale
  1979. Development and validation of the Korean version of the Female sexual Function Index-5 (FSFI-5)
  1980. Development and validation of the Polish version of the Female sexual Function Index in the Polish population of females
  1981. Development and Validation of the Polish Version of the Female sexual Function Index in the Polish Population of Femalesjsm_12012
  1982. Development and validation of the pretending orgasm reasons measure
  1983. Development and validation of the Self-Esteem And Relationship (SEAR) questionnaire in erectile dysfunction
  1984. Development and validation of Turkish version of the female sexual distress scale-revised
  1985. Development and Validation of Turkish Version of The Female sexual Distress Scale-Revised.
  1986. Development of a Self-Report Instrument for Use in the Clinical Setting that Describes Symptoms related to Urogenital Atrophy in Women with Breast Cancer
  1987. Development of a sexual dysfunction scale for women with inflammatory bowel disease
  1988. Development of a sexual function questionnaire for clinical trials of female sexual dysfunction
  1989. Development of an evidence-based classification system for uterine fibroids
  1990. Development of hMC1R Selective Small Agonists for Sunless Tanning and Prevention of Genotoxicity of UV in Melanocytes
  1991. Development of novel frog‐skin peptide scaffolds with selectivity towards melanocortin receptor subtypes
  1992. Development of the ‘Perceived sexual Distress Scale-Hindi’for measuring sexual distress following spinal cord injury
  1993. Development of the Occupational Performance Inventory of sexuality and Intimacy (OPISI): Phase One
  1994. Development of the psychopathology instrument for mentally retarded adults—sexuality scale (PIMRA-S)
  1995. Development of the sexual Arousal and desire Inventory (SADI) for the assessment of the psychological and subjective experience of sexual arousal and desire
  1996. Development of the sexual Five-Facet Mindfulness Questionnaire (FFMQ-S): Validation among a community sample of French-speaking women
  1997. Development of the WHO-INTEGRATE evidence-to-decision framework: an overview of systematic reviews of decision criteria for health decision-making
  1998. Development, implementation, and evaluation of a multidisciplinary oncology sexual health clinic in a Canadian cancer care setting
  1999. Development, validity and reliability of sexual health measures for spinal cord injured patients in iran
  2000. Developmental fluoxetine exposure facilitates sexual behavior in female offspring
  2001. Developments and new vistas in the field of melanocortins
  2002. Developments in sexology and sex Therapy
  2003. Deviant Men, Prostitution, and the Internet: A Qualitative analysis of Men who killed Prostitutes whom they met online.
  2004. Devices and methods to measure female sexual arousal
  2005. DHEA for postmenopausal women: a review of the evidence
  2006. DHEA metabolism to the neurosteroid androsterone: a possible mechanism of DHEA’s antidepressant action
  2007. DHEA supplementation in Menopause
  2008. DHEA therapy in postmenopausal women: the need to move forward beyond the lack of evidence
  2009. Diabetes and Female sexual Dysfunction
  2010. Diabetes and female sexual dysfunction: moving beyond” benign neglect”
  2011. Diabetes and female sexual function: A critical review
  2012. Diabetes and sexual Disorders
  2013. Diabetes and sexual dysfunction: current perspectives
  2014. Diabetes and sexual dysfunction: current perspectives
  2015. Diabetes and sexuality
  2016. Diabetes and the endocrine pancreas II
  2017. Diabetes mellitus and female sexuality: a review of 25 years’ research
  2018. Diabetes mellitus and sexual dysfunction
  2019. Diabetes, sexual dysfunction and therapeutic exercise: a 20 year review
  2020. Diabetic autonomic neuropathy
  2021. Diabetic autonomic neuropathy resulting in sexual dysfunction
  2022. DIABETIC PANDEMONIUM: A REVIEW
  2023. Diagnoses are not diseases
  2024. Diagnosing desire: Biopolitics and Femininity Into the Twenty-first Century
  2025. Diagnosing sexual dysfunction in men and women: sexual history taking and the role of symptom scales and questionnaires
  2026. Diagnosis and Assessment of Female sexual Dysfunction (s)
  2027. Diagnosis and classification
  2028. Diagnosis and clinical features of major neuropsychiatric disorders in HIV infection
  2029. Diagnosis and management of female Orgasmic disorder
  2030. Diagnosis and management of female sexual arousal disorder
  2031. Diagnosis and management of macrosomia
  2032. Diagnosis and management of premature ovarian failure
  2033. Diagnosis and management of sexual pain disorders: dyspareunia
  2034. Diagnosis and treatment of erectile dysfunction
  2035. Diagnosis and treatment of female sexual dysfunction
  2036. Diagnosis and treatment of hypoactive sexual desire disorder
  2037. Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes
  2038. Diagnosis and treatment of testosterone deficiency: recommendations from the Fourth International Consultation for sexual Medicine (ICSM 2015)
  2039. Diagnosis and treatment of urinary and sexual dysfunction in hereditary TTR amyloidosis
  2040. DIAGNOSIS AND TREATMENT OF WOMEN WITH hypoactive sexual desire DISORDER AND DEPRESSION/ANXIETY
  2041. Diagnosis of acute vertigo
  2042. diagnosis of female
  2043. Diagnosis of female arousal disorder
  2044. Diagnosis of female hypoactive sexual desire disorder using the p300 EEG auditory/visual method
  2045. Diagnosis of Female sexual Dysfunction
  2046. Diagnosis of Female sexual Dysfunction
  2047. Diagnosis of sexual dysfunction: relationships between DSM-III (R) and the GRISS
  2048. Diagnosis of sexual Dysfunctions in Psychiatric Population: Lights and Shadows of DSM-5 Taxonomy of sexual Disorders
  2049. Diagnosis, epidemiology, and course of sexual disorders.
  2050. Diagnosis: A symptom-based approach in internal medicine
  2051. Diagnosis: truths and tales
  2052. Diagnostic and statistical manual of mental disorders
  2053. Diagnostic and statistical manual of mental disorders (DSM-5®)
  2054. Diagnostic and Statistical Manual of Mental Disorders and the Buddhist Jathaka Stories
  2055. Diagnostic and treatment strategies for erectile dysfunction: the ‘Process of Care’model
  2056. Diagnostic controversy: female sexual dysfunction
  2057. Diagnostic Evaluation of the Female Patient
  2058. Diagnostic Systems and Their Use
  2059. Did parents have it right all along? Parents, risk, and living kidney donation: Revisiting the arguments for and against parental living donation of kidneys
  2060. Diet and Female sexual Health
  2061. Dietary supplements for female sexual dysfunction
  2062. Difference or dysfunction?: Deconstructing desire in the DSM-5 diagnosis of Female sexual Interest/Arousal Disorder
  2063. Differences between sexually functional and dysfunctional women in childhood experiences and individual and relationship domains
  2064. Differences in automatic thoughts presented during sexual activity between sexually functional and dysfunctional men and women
  2065. Differences in female attitudes toward sex across three generations
  2066. Differences in orgasm frequency among gay, lesbian, bisexual, and heterosexual men and women in a US national sample
  2067. Differences in Personality Beliefs of Emerging Adults in Two Distinct Online Asexual Communities
  2068. Differences in sexual desire between women with clinical versus biochemical signs of hyperandrogenism in polycystic ovarian syndrome
  2069. Differences in sexual guilt and desire in East Asian and Euro-Canadian men
  2070. DIFFERENCES IN SOME DIABETIC INDICATORS AMONG PATIENTS WITH sexual DYSFUNCTION
  2071. Differences in the sexual Function and sexual Healthcare Needs of Pregnant Women Who Underwent in Vitro Fertilization and Women Who Conceived …
  2072. Different characteristics of the Female sexual Function Index in a sample of sexually active and inactive women
  2073. Different profile of endothelial cell apoptosis in patients with Klinefelter’s syndrome
  2074. Different testosterone levels are associated with ejaculatory dysfunction
  2075. Different ways to get there: Evidence of a variable female sexual response cycle
  2076. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in …
  2077. Differential effects of intranasal oxytocin on sexual experiences and partner interactions in couples
  2078. Differential effects of sympathetic activation on sexual arousal in sexually dysfunctional and functional women.
  2079. Differential effects of testosterone and estradiol on clitoral function: an experimental study in rats
  2080. Differentiating components of sexual well-being in women: Are sexual satisfaction and sexual distress independent constructs?
  2081. Differentiation, negative attributions and sexual desire in committed relationships
  2082. Difficult Cases in Primary Care: Women’s Health
  2083. Difficulties in achieving vs maintaining erection: organic, psychogenic and relational determinants
  2084. Difficulty in Vaginal Intercourse and its Correlates: A Survey Study among Chinese Women in Hong Kong.
  2085. Diffuse alveolar haemorrhage with ANCA associated vasculitis: review of literature
  2086. Diffusion-tensor MR imaging and fiber tractography: a new method of describing aberrant fiber connections in developmental CNS anomalies
  2087. Digging in my secret garden: Disinhibitory effects of the” Hidden Observer” on reported sexual fantasies.
  2088. Dilators, Q-tips, and Extortion: How to Train a Woman for Intercourse in the “Post-Feminist” Era
  2089. Dilemmas encountered by the sexual and Gender Identity Disorders Work Group for DSM-5: an interview with Kenneth J. Zucker
  2090. Dimensionality and transcultural specificity of the sexual Attraction Questionnaire (SAQ)
  2091. Dimensions of sexual health
  2092. Diminished functional connectivity on the road to child sexual abuse in pedophilia
  2093. Diminished sexual activity, interest, and feelings of attractiveness among HIV-infected women in two eras of the AIDS epidemic
  2094. direct to consumer telemedicine: is healthcare From home Best?
  2095. DIRECTED MASTURBATION: 26 A TREATMENT OF FEMALE ORGASMIC DISORDER
  2096. Directed masturbation: A treatment of female orgasmic disorder
  2097. Directions in Marriage and
  2098. DIS News
  2099. Discovery of novel isoliquiritigenin analogue ISL-17 as a potential anti-gastric cancer agent
  2100. Discovery series: Human sexuality
  2101. Discrepant attentional biases toward sexual stimuli
  2102. Discussion of Premature Ejaculation
  2103. Disease-branding and drug-mongering: Could pharmaceutical industry promotional practices result in tort liability
  2104. Disentangling desire and arousal: a classificatory conundrum
  2105. Disgust and sexual arousal in young adult men and women
  2106. Disgust and sexual Arousal in Young Adult Men and Women Andrea Grauvogl 16, Peter de Jong 2, Madelon Peters, Silvia Evers 3, Mark van Overveld 4 & …
  2107. Disgust sensitivity, sexual trauma history, and female sexual functioning
  2108. Disgust versus lust: Exploring the interactions of disgust and fear with sexual arousal in women
  2109. Disorders in sexual desire and sexual arousal in women, a 2010 state of the art
  2110. Disorders of Ejaculation and Male Orgasm
  2111. Disorders of Female Orgasm
  2112. Disorders of Female sexual Arousal
  2113. Disorders of male sexual desire
  2114. Disorders of orgasm and ejaculation in men
  2115. Disorders of orgasm in women: A literature review of etiology and current treatments
  2116. Disorders of reproduction
  2117. Disorders of sex development in Indonesia: The course of psychological development in late identified patients
  2118. Disorders of sexual desire and arousal.
  2119. Disorders of sexual desire and subjective arousal in women.
  2120. Disorders of the male sexual response cycle
  2121. Disorders related to sexuality and gender identity in the ICD-11: Revising the ICD-10 classification based on…
  2122. Disorders related to sexuality and gender identity in the ICD‐11: revising the ICD‐10 classification based on current scientific evidence, best clinical practices, and …
  2123. Disposition of urinary and serum steroid metabolites in response to testosterone administration in healthy women
  2124. Dissatisfaction with male sexual performance and female sexual dysfunction in women with type 1 diabetes
  2125. Distinctive Acne Entities
  2126. Distinguishing premature ejaculation from other sexual function disorders
  2127. Distress about sex: A national survey of women in heterosexual relationships
  2128. Distress reduction in female sexual dysfunctions: a dose-ranging study of subcutaneous bremelanotide
  2129. Distress, sexual dysfunctions, and DSM: dialogue at cross purposes?
  2130. Distressing sexual difficulties in heterosexual and non-heterosexual Croatian men: assessing the role of minority stress
  2131. Distressing sexual function at midlife: unmet needs, practical diagnoses, and available treatments
  2132. Distressing sexual problems in United States women revisited: prevalence after accounting for depression
  2133. Distribution and codistribution of TAC-2 and ERα in neurons of the adult female murine brain
  2134. Diverse Women’s sexualities: A Contemporary View
  2135. Diversity in family life
  2136. Divinely Attuned: Using Brain Science, Psychology, and Spiritual Practice to Maximize Spirituality, Improve Intimacy, and Make Good Rela
  2137. Divorce in the Christian society and a prescriptive model to rekindle the marriage bond
  2138. Do Clinicians Conceptualize DSM‐IV Disorders Hierarchically?
  2139. Do dehydroepiandrosterone, progesterone, and testosterone influence women’s depression and anxiety levels? Evidence from hair-based hormonal measures of …
  2140. Do drugs have a role in turning indifference into passion?
  2141. Do gynecologists talk about sexual dysfunction with their patients?
  2142. Do men and women with asexual identities show low category specificity in their patterns of sexual attraction and attention to male and female swimsuit …
  2143. Do patients lie? An open interview vs. a blind questionnaire on sexuality
  2144. Do psychosocial factors moderate the relation between testosterone and female sexual desire? The role of interoception, alexithymia, defense mechanisms, and …
  2145. Do stressful life events impact women’s sexual desire?
  2146. Do women with endometriosis have to worry about sex?
  2147. Do women’s orgasms function as a masculinity achievement for men?
  2148. Do You Feel in Control? sexual desire, sexual Passion Expression, and Associations with Perceived Compulsivity to Pornography and Pornography Use Frequency
  2149. Doctor in My Bedroom: Physicians’ lack of sexual health education, its effects on patient welfare and the development of a new paradigm
  2150. Doctors and drug companies: Is the dangerous liaison drawing to an end?
  2151. Documentation of the impact of spinal cord injury on female sexual function: the female spinal sexual function classification
  2152. Does endometriosis affect sexual activity and satisfaction of the man partner? A comparison of partners from women diagnosed with endometriosis and controls
  2153. Does flibanserin have a future
  2154. Does HIV matter when you are poor and how?: the impact of HIV/AIDS on the psychological adjustment of South African mothers in the era of HAART
  2155. Does hypertension and its pharmacotherapy affect the quality of sexual function in women?
  2156. Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and overactive bladder syndrome? An Australian …
  2157. Does Loneliness Following Empty Nest Impair sexual Function and Satisfaction of Middle-Aged Iranian Women?
  2158. Does Marriage Really Improve sexual Satisfaction? Evidence from the Pairfam Dataset
  2159. Does monogamy harm women? Deconstructing monogamy with a feminist lens
  2160. Does oral contraceptive-induced reduction in free testosterone adversely affect the sexuality or mood of women?
  2161. Does physical intimate partner violence affect sexual health? A systematic review
  2162. Does repeated testing impact concordance between genital and self-reported sexual arousal in women?
  2163. Does severe maternal morbidity affect female sexual activity and function? Evidence from a Brazilian cohort study
  2164. Does sex really matter? Examining the connections between spouses’ nonsexual behaviors, sexual frequency, sexual satisfaction, and marital satisfaction
  2165. Does Studying Circumstances of the Woman Affect Her sexual Life?
  2166. Does subjective tinnitus cause sexual disturbance?
  2167. Does surgical menopause affect sexual performance differently from natural menopause?
  2168. Does the Female sexual Distress Scale‐Revised cover the feelings of women with HSDD?
  2169. Does transdermal testosterone increase the risk of developing breast cancer? A systematic review
  2170. Does type 1 diabetes modify sexuality and mood of women and men?
  2171. Does Type of Menopause Affect the sex Lives of Women?
  2172. Does vaginal anti-incontinence surgery affect sexual satisfaction? A comparison of TVT and Burch-colposuspension
  2173. Does vaginal size impact sexual activity and function?
  2174. Does varicocelectomy improve gonadal function in men with hypogonadism and infertility? Analysis of a prospective study
  2175. Domestic violence: a worldwide exploration
  2176. Dopamine and norepinephrine responses to film-induced sexual arousal in sexually functional and sexually dysfunctional women
  2177. Dopamine receptor genes are associated with age at first sexual intercourse
  2178. DOROTHY M. GRIFFITHS, PAUL FEDOROFF
  2179. Dose-finding study of Lorexys for hypoactive sexual desire disorder in premenopausal women
  2180. DOSING AND USE
  2181. Double blind trial of yohimbine hydrochloride in the treatment of erection inadequacy: an update
  2182. Dove Press
  2183. Dr. Mohamed Abbas Eid
  2184. Dramatizing Doubt in Hamlet1
  2185. Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development
  2186. Drug for low sexual desire carries significant harms, FDA advisers find
  2187. Drug maker urges group to lobby FDA on testosterone for women
  2188. Drug Repurposing Patent Applications January–March 2019
  2189. Drug treatments for women’s sexual disorders
  2190. Drug Utilization of Intrinsa [superscript]®[/superscript](Testosterone Patch) in England
  2191. Drug Utilization of Intrinsa®(Testosterone Patch) in England
  2192. Drug-associated spontaneous orgasm: A case report and systematic review of literature
  2193. Drug-Induced Acne
  2194. Drug-induced acne
  2195. Drug-induced sexual dysfunction in men and women
  2196. Drugs and sexual health
  2197. Drugs for the treatment of menopausal symptoms
  2198. Drugs in early clinical development for the treatment of female sexual dysfunction
  2199. Drugs that affect sexual function
  2200. DSM-5 and beyond: A critical feminist engagement with psychodiagnosis
  2201. DSM-5 Changes in Diagnostic Criteria of sexual Dysfunctions. Reprod Sys sexual Disorders 2: 122. doi: 10.4172/2161-038X. 1000122 Page 2 of 3 Reprod Sys …
  2202. DSM-5 CRITERIA AND TERMINOLOGY
  2203. DSM-5 CRITERIA AND TERMINOLOGY
  2204. DSM-5 handbook of differential diagnosis
  2205. DSM-5 Insanely Simplified: Unlocking the Spectrums within DSM-5 and ICD-10
  2206. DSM-5 learning companion for counselors
  2207. DSM-5: call for commentaries on gender dysphoria, sexual dysfunctions, and paraphilic disorders
  2208. DSM-III-R: Professional Implications and Revisions for Mental Health Counselors.
  2209. DSM-IV training guide
  2210. DSM-IV-TR and the Paraphilias: An Argument for Removal
  2211. DSM-IV-TR in Action: DSM-5 E-Chapter Update
  2212. Dual Special Issue: Surface Electromyography and Rehabilitation, and Surface Electromyography and Pelvic Floor Muscle Disorders
  2213. Dupilumab Approved to Treat Chronic Rhinosinusitis with Nasal Polyposis
  2214. Duration of hypertension and antihypertensive agents in correlation with the phases of female sexual response cycle
  2215. Dyadic adjustment and sexual function in postmenopausal women
  2216. Dyadic adjustment in couples with hypoactive sexual desire
  2217. Dyadic adjustment, sexuality and psychological distress in older couples
  2218. Dyadic and solitary sexual desire in patients with fibromyalgia: a controlled study
  2219. Dyadic configurations of sexual problems among older US adults: A national study
  2220. Dynamics and Geometry of the Human sexual Response
  2221. Dysfunction of sexual and Accessory sex Organs
  2222. dysfunction reconsidered: advocating expansion and revision
  2223. dysfunctional self-concepts, as well as on presenting focal problems (Beck & Freeman, 1989; Ellis, 1985; Freeman, 1987). Reviews of principles and techniques for …
  2224. Dysfunctional sex Beliefs as an Inhibitor of Female Intercourse Experience
  2225. Dysfunctional sexual beliefs as vulnerability factors for sexual dysfunction
  2226. Dysfunctional sexual beliefs: a comparative study of heterosexual men and women, gay men, and lesbian women with and without sexual problems
  2227. Dyspareunia among women subjected to normal vaginal delivery with episiotomy
  2228. Dyspareunia and DSM: A gynecologist’s opinion
  2229. Dyspareunia in a teenager reveals a rare occurrence: retroperitoneal cervical leiomyoma of the left pararectal space
  2230. Dyspareunia in gynaecological practice
  2231. Dyspareunia in the context of psychopathology, personality traits, and coping resources: results from a prospective longitudinal cohort study from age 30 to 50
  2232. Dyspareunia is associated with decreased frequency of intercourse in the menopausal transition
  2233. Dyspareunia is the only valid sexual dysfunction and certainly the only important one
  2234. Dyspareunia: a difficult symptom in gynaecological practice
  2235. Dyspareunia: a difficult symptom in gynaecological practice
  2236. Dyspareunia: a pain disorder or sexual dysfunction?
  2237. Dyspareunia: Another argument for removal
  2238. e toxpred: A machine learning-based approach to estimate the toxicity of drug candidates
  2239. Earliest time to onset of action leading to successful intercourse with vardenafil determined in an at‐home setting: a randomized, double‐blind, placebo‐controlled trial
  2240. Early menarche and high parity contribute to better sexual-quality of life in perimenopausal women
  2241. Early‐stage cervical carcinoma, radical hysterectomy, and sexual function: A longitudinal study
  2242. Early, average adulthood, old age and education psychosexual
  2243. Eastern approaches for enhancing women’s sexuality: Mindfulness, acupuncture, and yoga (CME)
  2244. Eating, sleeping and sexual function disorders in women with polycystic ovary syndrome (PCOS): A systematic review and meta‐analysis
  2245. EAU Guidelines on
  2246. EAU guidelines on chronic pelvic pain
  2247. Ebbs and Flows of desire: A Qualitative Exploration of Contextual Factors Affecting sexual desire in Bisexual, Lesbian, and Straight Women
  2248. ED PHARMACOTHERAPY: Comparing Vardenafil and Sildenafil in the Treatment of Men with Erectile Dysfunction and Risk Factors for Cardiovascular Disease: A …
  2249. ED PHARMACOTHERAPY: Efficacy and Safety of Flexible‐Dose Vardenafil in Men with Type 1 Diabetes and Erectile Dysfunction
  2250. ED PHARMACOTHERAPY: Efficacy and Safety of Mirodenafil, A New Oral Phosphodiesterase Type 5 Inhibitor, for Treatment of Erectile Dysfunction
  2251. ED PHARMACOTHERAPY: Flexible‐Dose Vardenafil in a Community‐Based Population of Men Affected by Erectile Dysfunction: A 12‐Week Open‐Label, Multicenter …
  2252. ED-71: a promising new candidate for the treatment of osteoporosis?
  2253. ED: Efficacy and Safety of Daily Tadalafil in Men with Erectile Dysfunction Previously Unresponsive to On‐demand Tadalafil
  2254. eDiary and Female sexual Distress Scale© in Evaluating Distress in hypoactive sexual desire Disorder (HSDD)
  2255. Edible halophytes of the Mediterranean basin: Potential candidates for novel food products
  2256. Editorial (Thematic Issue: Frontier View on Drug Discoveries for Different Diseases-Part I)
  2257. editorial boards of Emotion, Personality and Social Psychology Bul-letin, and Social and Personality Psychology Compass. Lisa Feldman Barrett, PhD, is …
  2258. Editorial Comment on “Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to …
  2259. Editorial comment on” Psychology treatment trials for hypoactive sexual desire disorder: A sexual medicine critique and perspective”.
  2260. Editorial comments on” The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.”
  2261. EDUCATION
  2262. Education among Iranian Women with Breast Cancer: A Randomized Clinical Trial
  2263. Education based on theory of planned behavior over sexual function of women with breast cancer in Iran
  2264. Education Committee Mission Statement
  2265. Education in sexual medicine: proceedings from the international consultation in sexual medicine, 2009
  2266. EDUCATION: sexual Counseling for Women in the Context of Physical Diseases—A Teaching Model for Physicians
  2267. Educational objectives for a junior psychiatry clerkship
  2268. Effect of 1-year, low-dose DHEA therapy on climacteric symptoms and female sexuality
  2269. Effect of a change in housing conditions on body weight, behavior and brain neurotransmitters in male C57BL/6J mice
  2270. Effect of a multi-ingredient based food supplement on sexual function in women with low sexual desire
  2271. Effect of a single dose of levodopa on sexual response in men and women
  2272. Effect of acupuncture of different acupoints on electrical activities of hypothalamic sexual arousal stimulation-related neurons at different stages of oestrous cycle in …
  2273. Effect of androgens combined with hormone therapy on quality of life in post-menopausal women with sexual dysfunction
  2274. Effect of ArginMax on sexual functioning and quality of life among female cancer survivors: results of the WFU CCOP Research Base Protocol 97106
  2275. Effect of auriculotherapy on pain and sexual function of primary dysmenorrhea female patients
  2276. Effect of breast augmentation mammoplasty on self-esteem and sexuality: a quantitative analysis
  2277. Effect of Bremelanotide on Ambulatory Blood Pressure When Administered for Up to 16 Consecutive Days [14B]
  2278. Effect of Brexpiprazole on Prolactin and sexual Functioning: An Analysis of Short-and Long-Term Study Data in Major Depressive Disorder
  2279. Effect of bupropion on sexual dysfunction
  2280. Effect of Damiana extract on the electric activity of a female brain. A case report
  2281. Effect of depression and antidepressants on sexual dysfunction in men with diabetes: a national population-based cohort study
  2282. Effect of diabetes mellitus on female sexual function and risk factors
  2283. Effect of diabetes mellitus on sexual arousal and intercourse
  2284. Effect of educational program to encourage safe sexual behaviors among addicted men refered to substance abuse treatment centers in Hamadan, Western Iran …
  2285. Effect of Evidence-Based Nursing intervention on Quality of sexual Function among Vaginal introitus laxity Women
  2286. Effect of Flibanserin on sexual Functioning: An Analysis of Female sexual Function Index Domains [24H]
  2287. Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with hypoactive sexual desire Disorder: A Post Hoc Analysis
  2288. Effect of Genetic Polymorphism on the Response to PDE5 Inhibitors in Patients With Erectile Dysfunction: A Systematic Review and a Critical Appraisal
  2289. Effect of hormone replacement therapy on clitoral artery blood flow in healthy postmenopausal women
  2290. Effect of hyperprolactinemia in male patients consulting for sexual dysfunction
  2291. Effect of hyperprolactinemia in male patients consulting for sexual dysfunction
  2292. Effect of infertility on sexual function: a cross-sectional study
  2293. Effect of infertility on the sexual function of couples: state of the art
  2294. Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study
  2295. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women
  2296. Effect of intravaginal prasterone on sexual dysfunction in postmenopausal women with vulvovaginal atrophy
  2297. Effect of laparoscopic hysterectomy on sexual function and quality of life: 12-month follow-up results
  2298. Effect of Lepidium meyenii (MACA) on sexual desire and its absent relationship with serum testosterone levels in adult healthy men
  2299. Effect of levitra on sustenance of erection (EROS): an open-label, prospective, multicenter, single-arm study to investigate erection duration measured by …
  2300. Effect of long-term intranasal oxytocin on sexual dysfunction in premenopausal and postmenopausal women: a randomized trial
  2301. Effect of long‐term testosterone administration on the endometrium of female‐to‐male (FtM) transsexuals
  2302. Effect of Melissa officinalis (lemon balm) on sexual dysfunction in women: A double-blind, randomized, placebo-controlled study
  2303. Effect of metabolic syndrome on fertility of male type 2 diabetic mice
  2304. Effect of midurethral sling surgery on vaginal sensation
  2305. Effect of normative masculinity on males’ dysfunctional sexual beliefs, sexual attitudes, and perceptions of sexual functioning
  2306. Effect of oral hormone therapy on oxidative stress produced by hot flashes in postmenopausal women
  2307. Effect of Pre-marital sexual Counseling on Self-efficacy and sexual Function of Iranian Newlywed Women
  2308. Effect of premature menopause on sexuality
  2309. Effect of radiotherapy for rectal cancer on female sexual function: a prospective cohort study
  2310. Effect of radiotherapy for rectal cancer on ovarian androgen production
  2311. Effect of sex education, based on the theory of planned behavior, on the sexual function of the woman attending Mashhad health centers
  2312. Effect of sex hormones on brain connectivity related to sexual function in perimenopausal women: a resting-state fMRI functional connectivity study
  2313. Effect of sexual diary keeping and self-evaluation on female sexual function and depression: a pilot study
  2314. Effect of sexual Dysfunction and Its Treatment on Quality of Life of Affected Men
  2315. Effect of sexual Educational Package on Knowledge and Female sexual Function for Pregnant Women
  2316. Effect of sexual function on health-related quality of life mediated by depressive symptoms in cardiac rehabilitation. findings of the SPARK project in 493 patients
  2317. Effect of Shift Working on Depression Prevalence and sexual Life of Female Nurses: A Correlational Study in Turkey
  2318. Effect of sildenafil citrate on women affected by sexual dysfunction referred to health clinics
  2319. Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder
  2320. Effect of single-session, cryogen-cooled monopolar radiofrequency therapy on sexual function in women with vaginal laxity: the VIVEVE I trial
  2321. Effect of single-treatment, surface-cooled radiofrequency therapy on vaginal laxity and female sexual function: the VIVEVE I randomized controlled trial
  2322. Effect of testosterone administration on sexual behavior and mood in men with erectile dysfunction
  2323. Effect of testosterone on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro
  2324. Effect of the 5‐HT2A/2C receptor agonist DOI on female rat sexual behavior
  2325. Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in …
  2326. Effect of thyroid hormone derangements on sexual function in men and women
  2327. Effect of two brain serotonin depletors on the sexual behavior of male rats.
  2328. Effect of vaginal electrical stimulation on female sexual functions: a randomized study
  2329. Effect of Vitex agnus-castus plant on sexual function in women of reproductive age
  2330. Effect size in efficacy trials of women with decreased sexual desire
  2331. Effective factors on sexual dysfunction in women with diabetes: a systematic review
  2332. Effective Factors on sexual Quality of Life in Iranian Women: A Path Model
  2333. Effective Manual Therapy Intervention for
  2334. Effective treatment of erectile dysfunction with vardenafil
  2335. Effectiveness cognitive therapy based on mindfulnesson the sexual and familial function of sexless women
  2336. Effectiveness of a low dose testosterone undecanoate to improve sexual function in postmenopausal women
  2337. Effectiveness of a Multi-Dimensional Group Counseling Program Based on the GATHER Approach on the Quality of Life in Surgically Menopausal Women
  2338. Effectiveness of a PLISSIT model intervention in patients with type 2 diabetes mellitus in primary care: design of a cluster-randomised controlled trial
  2339. Effectiveness of a sex education program on sexual function in postmenopausal women with sexual dysfunction: A randomized trial
  2340. Effectiveness of Behavioral Activation Treatment in Reduction of Anxiety and Depression of Premenopausal Women
  2341. Effectiveness of Behavioral Activation Treatment in Reduction of Anxiety and Depression of Premenopausal Women
  2342. Effectiveness of behavioral activation treatment on marital intimacy and sexual satisfaction of women during premenopause
  2343. Effectiveness of botulinum neurotoxin on treatment of vaginismus and overall sexual functioning
  2344. Effectiveness of Healthy sexual Behavior in the sexual Dysfunction of Addicted Women
  2345. Effectiveness of hyaluronate-based pessaries in the treatment of vulvovaginal atrophy in postmenopausal women
  2346. Effectiveness of Korean Medicine Therapy for Parkinson’s Disease Management: National Health Insurance Service-National Sample Cohort (NHIS-NSC)
  2347. Effectiveness of Self Instructional Module on Coping Strategies of Tri-Dimensional Problems of Premenopausal Women–A Community Based Study
  2348. Effectiveness of sexual skills education on sexual attitude and knowledge in married women
  2349. Effectiveness of sexual Skills Training with an Eclectic Approach for Improving sexual Function in Iranian Women
  2350. Effectiveness of structured teaching programme on alternative remedies for menopausal symptoms among women between the age group of 45–55 years in a …
  2351. Effectiveness of treatments of sexual disorders
  2352. Effects and Management of Pelvic Radiation on Female Reproductive System: sexual Dysfunction, Fertility Effects, and Premature Menopause
  2353. Effects of 17 α-methyltestosterone on transcriptome, gonadal histology and sex steroid hormones in rare minnow Gobiocypris rarus
  2354. Effects of 50 and 100 mg desvenlafaxine versus placebo on sexual function in patients with major depressive disorder: A meta-analysis
  2355. Effects of a Combination of Foeniculum vulgare, Melissa officinalis Extract, and Nigella saliva Powder on Healthy Menopausal Women with sexual …
  2356. Effects of a food product (based on Daucus carota) and education based on traditional Persian medicine on female sexual dysfunction: a randomized clinical …
  2357. Effects of a Proprietary Freeze-Dried Water Extract of
  2358. Effects of a proprietary freeze-dried water extract of Eurycoma longifolia (Physta) and Polygonum minus on sexual performance and well-being in men: A …
  2359. Effects of a transdermal testosterone metered-dose nanoemulsion in peri-and postmenopausal women: a novel protocol for treating low libido
  2360. Effects of Adenosine Monophosphate Used in Combination with L‐Arginine on Female Rabbit Corpus Cavernosum Tissue
  2361. Effects of adjunctive aripiprazole on sexual functioning in patients with major depressive disorder and an inadequate response to standard antidepressant …
  2362. Effects of alcohol administered with flibanserin in healthy premenopausal women: a randomized, double-blind, single-dose crossover study
  2363. Effects of androgens on bone in men and women
  2364. Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial
  2365. Effects of bacterial vaginosis and its treatment on sexual functions: A cross-sectional questionnaire study
  2366. Effects of cannabinoids on female sexual function
  2367. Effects of CBT and sex thearpy on psychosexual factors among patients with premature ejaculation
  2368. Effects of chronic cigarette and marijuana smoking on reproductive health
  2369. Effects of cognitive-behavioral therapy on sexual function in women with vaginismus disorder
  2370. Effects of dehydroepiandrosterone (DHEA) supplementation on sexual function in premenopausal infertile women
  2371. Effects of dehydroepiandrosterone supplementation on cognitive function and quality of life: the DHEA and Well‐Ness (DAWN) Trial
  2372. Effects of depression, anxiety, stress, and partner relationship satisfaction on sexual dysfunction in women in the postpartum period
  2373. Effects of depressive symptoms and experimentally adopted schemas on sexual arousal and affect in sexually healthy women
  2374. Effects of different progestins in oral contraceptives on sexual function and well-being of women
  2375. Effects of Educational Program on Marital Satisfaction in Postmenopausal Women with sexual Dysfunction in Tehran; a Randomized, Controlled Trial
  2376. Effects of experimentally adopted sexual schemas on vaginal response and subjective sexual arousal: A comparison between women with sexual arousal disorder …
  2377. Effects of expressive writing on sexual dysfunction, depression, and PTSD in women with a history of childhood sexual abuse: Results from a randomized clinical trial
  2378. Effects of female genital cutting on the sexual function of Egyptian women. A cross‐sectional study
  2379. Effects of female genital mutilation/cutting on the sexual function of Sudanese women: a cross-sectional study
  2380. Effects of flibanserin on appetitive and consummatory aspects of sexual behavior in ovariectomized female rats primed with estrogen and progesterone
  2381. Effects of flibanserin on the pharmacokinetics of a combined ethinylestradiol/levonorgestrel oral contraceptive in healthy premenopausal women: A …
  2382. Effects of hormone replacement therapy on sexual psychophysiology and behavior in postmenopause
  2383. Effects of hormone therapy on blood pressure
  2384. Effects of hormone treatment on sexual functioning in postmenopausal women
  2385. Effects of hyperthyroidism, hypothyroidism, and thyroid autoimmunity on female sexual function
  2386. Effects of hypoactive sexual desire disorder in women
  2387. Effects of hypothyroidism and subclinical hypothyroidism on sexual function: a meta-analysis of studies using the female sexual function index
  2388. Effects of hysterectomy on sexual function
  2389. Effects of individual differences on the efficacy of different distracters during visual sexual stimulation in women
  2390. Effects of intra-nasally administered testosterone on sexual proceptive behavior in female capuchin monkeys (Cebus apella)
  2391. Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals
  2392. Effects of Korean red ginseng on sexual arousal in menopausal women: placebo-controlled, double-blind crossover clinical study
  2393. Effects of long-term high dose testosterone administration on vaginal epithelium structure and estrogen receptor-α and-β expression of young women
  2394. Effects of methylphenidate and MDMA on appraisal of erotic stimuli and intimate relationships
  2395. Effects of mindfulness-based therapies for female sexual dysfunction: A meta-analytic review
  2396. Effects of neonatal domoic acid treatment and social isolation rearing on measures of attentional processing in rats: An investigation of the “two-hit” hypothesis …
  2397. Effects of oral vs transdermal estrogen therapy on sexual function in early postmenopause: ancillary study of the Kronos Early Estrogen Prevention Study (KEEPS)
  2398. Effects of Oral vs Transdermal Estrogen Therapy on sexual Function in Early Postmenopause: Results from the Kronos Early Estrogen Prevention Study …
  2399. Effects of ovariectomy and dehydroepiandrosterone (DHEA) on vaginal wall thickness and innervation
  2400. Effects of percutaneous tibial nerve stimulation therapy on chronic pelvic pain
  2401. Effects of physical and depressive symptoms on the sexual life of Turkish women in the climacteric period
  2402. Effects of Physiologic Testosterone Replacement on Quality of Life, Self-Esteem, and Mood in Women with Primary Ovarian Insufficiency
  2403. Effects of Pornography Use and Demographic Parameters on sexual Response during Masturbation and Partnered sex in Women
  2404. Effects of predisposing factors on the success and treatment period in vaginismus
  2405. Effects of pregnancy on female sexual function and body image: A prospective study
  2406. Effects of reproductive history on symptoms of menopause: a brief report
  2407. Effects of sacral neuromodulation on female sexual function
  2408. Effects of sex education and Kegel exercises on the sexual function of postmenopausal women: a randomized clinical trial
  2409. Effects of sex hormones in combined oral contraceptives and cyclofem on female sexual dysfunction score: A study on Iranian Females
  2410. Effects of sex hormones in oral contraceptives on the female sexual function score: a study in German female medical students
  2411. EFFECTS OF SMOKING CESSATION ON sexual HEALTH IN MEN
  2412. Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight
  2413. Effects of testosterone and estrogen replacement on memory function
  2414. Effects of testosterone on female rat sexual behavior
  2415. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study
  2416. Effects of testosterone therapy for women: a systematic review and meta-analysis protocol
  2417. Effects of testosterone therapy on cardiovascular risk markers in androgen-deficient women with hypopituitarism
  2418. Effects of testosterone undecanoate administered alone or in combination with letrozole or dutasteride in female to male transsexuals
  2419. Effects of the addition of methyltestosterone to combined hormone therapy with estrogens and progestogens on sexual energy and on orgasm in postmenopausal …
  2420. Effects of Therapeutic-Supportive Interventions on sexual Satisfaction and Function in Women with Breast Cancer: A Systematic Review
  2421. effects of tibolone versus low dose e
  2422. Effects of timing of flibanserin administration relative to alcohol intake in healthy premenopausal women: A randomized, double-blind, crossover study
  2423. Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study
  2424. Effects of transobturator midurethral sling surgery on sexual functions: one-year follow-up
  2425. Effects of urinary incontinence subtypes on women’s sexual function and quality of life
  2426. Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy post-menopausal women with vaginal symptoms …
  2427. Effects of yoga on sexual function in women with metabolic syndrome: a randomized controlled trial
  2428. Effects on the quality of life of a new oral contraceptive containing 30 mcg EE and 3 mg drospirenone (Yasmin)
  2429. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled …
  2430. Efficacy and safety of alfuzosin 10 mg once daily in the treatment of symptomatic benign prostatic hyperplasia
  2431. Efficacy and safety of alprostadil cream for the treatment of female sexual arousal disorder: A double‐blind, placebo‐controlled study in Chinese population
  2432. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Improving sexual Function in Women: a double-‐blind, randomized, placebo …
  2433. Efficacy and safety of Ashwagandha (Withania somnifera) root extract in improving sexual function in women: a pilot study
  2434. Efficacy and safety of bupropion hydrochloride extended-release versus escitalopram oxalate in Chinese patients with major depressive disorder: results from a …
  2435. Efficacy and safety of daily intake of apomorphine SL in men affected by erectile dysfunction and mild hyperprolactinemia: a prospective, open-label, pilot study
  2436. Efficacy and safety of flexible-dose oral sildenafil citrate (Viagra®) in the treatment of erectile dysfunction in Brazilian and Mexican men
  2437. Efficacy and safety of flibanserin for the treatment of hypoactive sexual desire disorder in women: a systematic review and meta-analysis
  2438. Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial
  2439. Efficacy and safety of flibanserin in women with hypoactive sexual desire disorder: a systematic review and meta-analysis
  2440. Efficacy and safety of flibanserin” new female Viagra®?”: Literature review
  2441. Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally
  2442. Efficacy and safety of MED2005, a topical glyceryl trinitrate formulation, in the treatment of erectile dysfunction: a randomized crossover study
  2443. Efficacy and safety of mirodenafil in men taking antihypertensive medications
  2444. Efficacy and safety of on demand clomipramine for the treatment of premature ejaculation: a multicenter, randomized, double-blind, phase III clinical trial
  2445. Efficacy and safety of on-demand use of 2 treatments designed for different etiologies of female sexual interest/arousal disorder: 3 randomized clinical trials
  2446. Efficacy and safety of oral sildenafil citrate (Viagra®) in the treatment of male erectile dysfunction in Colombia, Ecuador, and Venezuela: a double-blind, multicenter …
  2447. Efficacy and safety of oral SK3530 for the treatment of erectile dysfunction in Korean men: a multicenter, randomized, double‐blind, placebo‐controlled, fixed dose …
  2448. Efficacy and safety of red ginseng on women’s health related QOL and sexual function
  2449. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder
  2450. Efficacy and safety of sildenafil in estrogenized women with sexual dysfunction associated with female sexual arousal disorder
  2451. Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women
  2452. Efficacy and safety of testosterone patches for the treatment of low sexual desire in surgically menopausal women
  2453. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis
  2454. Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury
  2455. Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: the depression-related improvement with vardenafil for erectile response …
  2456. Efficacy of acupuncture treatment of sexual dysfunction secondary to antidepressants
  2457. Efficacy of an exercise intervention for sexual side effects of antidepressant medications in women
  2458. Efficacy of Ashwagandha (Withania somnifera Dunal. Linn.) in the management of psychogenic erectile dysfunction
  2459. Efficacy of bibliotherapy as a treatment for low sexual desire in women
  2460. Efficacy of Bremelanotide Across hypoactive sexual desire Disorder Duration Subgroups [15M]
  2461. Efficacy of bremelanotide among women completing the core phase of the RECONNECT studies
  2462. Efficacy of bremelanotide for HSDD in women: RECONNECT open-label extension phase results [8Q]
  2463. Efficacy of Cognitive Behavioral Therapy on Catastrophic thoughts on Women with primary Vaginismus: A Single-Case trial
  2464. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial
  2465. Efficacy of hormone therapy with and without methyltestosterone augmentation of venlafaxine in the treatment of postmenopausal depression: a double-blind …
  2466. Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast …
  2467. Efficacy of metacognitive therapy for hypoactive sexual desire disorder among Iranian couples
  2468. Efficacy of oral estrogen plus testosterone gel to improve sexual function in postmenopausal women
  2469. Efficacy of pharmacological and non-pharmacological interventions on low sexual interest/arousal of peri-and post-menopausal women: a meta-analysis
  2470. Efficacy of Physical Therapy in the Management of Reproductive Disorders
  2471. Efficacy of psychological interventions for sexual dysfunction: a systematic review and meta-analysis
  2472. Efficacy of psychosocial interventions in men and women with sexual dysfunctions—a systematic review of controlled clinical trials
  2473. Efficacy of psychosocial interventions in men and women with sexual dysfunctions—a systematic review of controlled clinical trials
  2474. Efficacy of sildenafil citrate in the treatment of female sexual dysfunction
  2475. Efficacy of testosterone combined with a PDE5 inhibitor and testosterone combined with a serotonin 1A receptor agonist in women with SSRI-induced sexual …
  2476. Efficacy of Tribulus terrestris for the treatment of hypoactive sexual desire disorder in postmenopausal women: a randomized, double-blinded, placebo-controlled trial
  2477. Efficacy of Tribulus Terrestris for the treatment of premenopausal women with hypoactive sexual desire disorder: a randomized double-blinded, placebo-controlled …
  2478. Efficacy of type‐5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: A systematic review
  2479. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on sexual function in postmenopausal women: a randomized controlled trial
  2480. Efficacy, tolerability and safety of a new medical device, Monurelle Biogel® vaginal gel, in the treatment of vaginal dryness: a randomized clinical trial in women of …
  2481. Eighth International Thyroid Congress Sydney, Australia; February 4-8, 1980
  2482. Ejaculatory abstinence influences intravaginal ejaculatory latency time: results from a prospective randomized trial
  2483. Ejaculatory disorders
  2484. Ejaculatory disorders: epidemiology and current approaches to definition, classification and subtyping
  2485. Ejaculatory dysfunction
  2486. Ejaculatory Dysfunction
  2487. Ejaculatory Dysfunction and Vasodynamics
  2488. Ejaculatory Dysfunction and Vasodynamics
  2489. Ejaculatory dysfunction as a cause of infertility
  2490. Electrical stimulation in sexual dysfunction
  2491. Electroencephalographic activity during sexual behavior: a novel approach to the analysis of drug effects on arousal and motivation relevant for sexual dysfunctions
  2492. Electroencephalographic changes and testosterone levels in a pubertal stress animal model: effects on adult sexual motivation
  2493. Electrophysiological actions of the dopamine agonist apomorphine in the paraventricular nucleus during penile erection
  2494. Elevated serum testosterone, hirsutism, and virilism associated with combined androgen-estrogen hormone replacement therapy.
  2495. Elucidating Unconscious Drivers in Clandestine sexual Practices: Means and Methods for Ego-Syntonic Dynamic sexual Consent
  2496. Elucidating women’s (hetero) sexual desire: Definitional challenges and content expansion
  2497. Email: MFS96@ aol. com
  2498. EMAS position statement: managing the menopause in women with a past history of endometriosis
  2499. EMAS position statement: managing women with premature ovarian failure
  2500. Embracing Our Differences to Help Our Patients
  2501. Emerging concepts in erectile preservation following radical prostatectomy: a guide for clinicians
  2502. Emerging drugs for major depressive disorder
  2503. Emerging drugs for major depressive disorder: an update
  2504. Emerging medication for the treatment of male hypogonadism
  2505. Emerging medication for the treatment of male hypogonadism
  2506. Emerging role of testosterone in menopause
  2507. Emerging therapies for female sexual dysfunction
  2508. Emotion regulation in couples affected by female sexual interest/arousal disorder
  2509. Emotional Aspects of Gynecology
  2510. Emotional attention for erotic stimuli: Cognitive and brain mechanisms
  2511. Emotional Disturbances in Diabetes Mellitus
  2512. Emotional dysregulation: Concurrent relation to sexual problems among trauma-exposed adult cigarette smokers
  2513. Emotional functioning in Huntington’s disease patients and its relation to caregiver experience
  2514. Emotional intimacy, sexual desire, and sexual satisfaction among partnered heterosexual men
  2515. Emotional states of love moderate the association between catecholamines and female sexual responses in the laboratory
  2516. Emotional States of Love Moderate the Association Between Catecholamines and Female sexual Responses in the Laboratoryjsm_2799
  2517. Emotionally Focused Couples Therapy: A Review of the Literature.
  2518. Emotions during sexual activity: Differences between sexually functional and dysfunctional men and women
  2519. Empirically Supported
  2520. Empirically supported couple and family interventions for marital distress and adult mental health problems.
  2521. Empirically supported incentive model of sexual response ignored
  2522. Empirically supported psychological interventions: Controversies and evidence
  2523. Empirically supported treatments or type I errors? Problems with the analysis of data from group-administered treatments.
  2524. EMPOWER (Empowerment and Protection Women Right) Community as Individual Approach Method to Rebuild Women’s Mentality from sexual Violence’s …
  2525. Empowering PAs to ask their female patients about sexual health
  2526. Empowering the woman: a comprehensive model of sexual anti-ageing
  2527. Encompassing sexual medicine within psychiatry: pros and cons
  2528. Endo-Depression; Definition and Suggestion’s Background.
  2529. Endocannabinoid influence on partner preference in female rats
  2530. Endocannabinoids interact with the dopaminergic system to increase sexual motivation: lessons from the sexual satiety phenomenon
  2531. Endocrine and psychological aspects of sexual dysfunction in Klinefelter patients
  2532. Endocrine aspects of female sexual dysfunction
  2533. Endocrine aspects of male sexual dysfunctions
  2534. Endocrine aspects of women’s sexual function
  2535. Endocrine care of transgender adults
  2536. Endocrine causes of erectile dysfunction
  2537. Endocrine control of ejaculation
  2538. Endocrine Disorders
  2539. Endocrine evaluation of erectile dysfunction
  2540. Endocrine Psychiatry in Historical Perspective
  2541. Endocrinologic control of men’s sexual desire and arousal/erection
  2542. Endocrinological investigation of men with erectile dysfunction
  2543. Endocrinology of human female sexuality, mating, and reproductive behavior
  2544. Endocrinology of women sexual health
  2545. ENDOCRINOLOGY: a comparison of NCEP-ATPIII and IDF metabolic syndrome definitions with relation to metabolic syndrome-associated sexual dysfunction
  2546. Endocrinology: Androtest©: a structured interview for the screening of hypogonadism in patients with sexual dysfunction
  2547. ENDOCRINOLOGY: NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction
  2548. Endocrinology: Transdermal Testosterone Gel prn application for hypoactive sexual desire disorder in premenopausal women: A controlled pilot study of the effects on …
  2549. ENDOCRINOLOGY: Vaginal Application of Testosterone: A Study on Pharmacokinetics and the sexual Response in Healthy Volunteers
  2550. Endogenous estrogen and androgen levels are not independent predictors of lipid levels in postmenopausal women
  2551. Endogenous sex hormone levels and coronary heart disease risk in postmenopausal women: A meta-analysis of prospective studies
  2552. Endogenous testosterone levels and cardiovascular risk: meta-analysis of observational studies
  2553. Endometrial hyperplasia, estrogen therapy, and the prevention of endometrial cancer
  2554. Endometriosis and women’s sexual functioning: a systematic review of the available evidence
  2555. Endometriosis doubles the risk of sexual dysfunction: a cross-sectional study in a large amount of patients
  2556. Endorsement of models describing sexual response of men and women with a sexual partner: An online survey in a population sample of Danish adults ages 20–65 …
  2557. Endothelial function analysis can predict which patients will have arterial insufficiency on penile duplex ultrasound
  2558. Endothelin I activates the NAADP signaling complex on myometrial smooth muscle cell
  2559. Endurance exercise training and male sexual libido
  2560. Enhanced patient activation in cancer care transitions: protocol for a randomized controlled trial of a tailored electronic health intervention for men with …
  2561. Enhanced transdermal bioavailability of testosterone propionate via surfactant-modified ethosomes
  2562. Enhancing care of the survivor of gynecologic cancer: managing the menopause and radiation toxicity
  2563. Enhancing sexual desire and intimacy via the metaphor of a problem child: Utilizing structural-strategic family therapy
  2564. Enhancing sexuality: A problem-solving approach therapist guide
  2565. Environmental exposure to di-2-ethylhexyl phthalate is associated with low interest in sexual activity in premenopausal women
  2566. Environmental Factors within the Assessment Process. PUB DATE 1996-00-00
  2567. Environmental Mismatches and Mating Effectiveness
  2568. Enzymatic Synthesis of Anabolic Steroid Glycosides by Glucosyltransferase from Terribacillus sp. PAMC 23288
  2569. Enzyme inhibitory activities of plant extracts under the Philippine’s drug discovery program
  2570. Epidemiology
  2571. Epidemiology and neurobiology of female sexual dysfunction
  2572. Epidemiology and pathophysiology of male sexual dysfunction
  2573. Epidemiology of delayed ejaculation
  2574. Epidemiology of female sexual dysfunction
  2575. Epidemiology of male sexual dysfunction
  2576. Epidemiology of Male sexual Dysfunction in Asian and European Regions: A Systematic Review
  2577. Epidemiology of sexual disorders in general medical practice: an Italian survey
  2578. Epidemiology of sexual dysfunction in Iran: A systematic review and meta-analysis
  2579. Epidemiology of sexual dysfunction in the male population
  2580. Epidemiology of sexual dysfunction: the role of psychosocial factors
  2581. Epidemiology of the symptoms of menopause–an intercontinental review
  2582. Epidemiology: Correlates of sexually related personal distress in women with low sexual desire
  2583. EPIDEMIOLOGY: sexual desire in a Nationally Representative Danish Population
  2584. EPIDEMIOLOGY: The HSDD Registry for Women: A Novel Patient Registry for Women with Generalized Acquired hypoactive sexual desire Disorder
  2585. epidemiology: the prevalence of sexual dysfunction and potential risk factors that may impair sexual function in Malaysian women
  2586. Epidemiology: What can prevalence studies tell us about female sexual difficulty and dysfunction?
  2587. Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology
  2588. Epilepsy and sexual dysfunction
  2589. Epilogue: Cautiously optimistic for the future of a transdisciplinary sexual medicine
  2590. Epilogue: Challenges in Research Methods and Future Directions on sexual and Gender Minority Mental Health Research
  2591. Epistemic injustice and psychiatric classification
  2592. Erectile Dysfunction
  2593. Erectile dysfunction
  2594. Erectile dysfunction
  2595. Erectile dysfunction
  2596. Erectile Dysfunction
  2597. Erectile dysfunction among HIV patients undergoing highly active antiretroviral therapy: dyslipidemia as a main risk factor
  2598. Erectile dysfunction among men with diabetes is strongly associated with premature ejaculation and reduced libido
  2599. Erectile Dysfunction and Anejaculation in the Neurologic Patient
  2600. Erectile dysfunction and associated risk factors among young Mexican adults: The importance of partner availability
  2601. Erectile dysfunction and cardiovascular risk: a review of current findings
  2602. Erectile dysfunction and central obesity: an Italian perspective
  2603. Erectile dysfunction and comorbid diseases, androgen deficiency, and diminished libido in men
  2604. Erectile dysfunction and premature ejaculation in homosexual and heterosexual men: a systematic review and meta-analysis of comparative studies
  2605. Erectile dysfunction can have a devastating effect on a relationship. Safe and effective treatment is available
  2606. Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment
  2607. Erectile dysfunction in men with chronic medical illness
  2608. Erectile dysfunction in the 21st century: whom we can treat, whom we cannot treat and patient education
  2609. Erectile dysfunction is common among men with acromegaly and is associated with morbidities related to the disease
  2610. Erectile Dysfunction, An Issue of Urologic Clinics-E-Book
  2611. Erectile dysfunction, depression, and pharmacological treatments: biologic interactions
  2612. Erectile dysfunction: a review and herbs used for its treatment
  2613. ERECTILE DYSFUNCTION: The Associations Among eNOS G894T Gene Polymorphism, Erectile Dysfunction, and Benign Prostate Hyperplasia‐Related Lower …
  2614. Erectile dysfunction: why drug therapy isn’t always enough
  2615. Erectile failure in the aged: evaluation and treatment
  2616. Erectile response with vardenafil in sildenafil nonresponders: A multicentre, double‐blind, 12‐week, flexible‐dose, placebo‐controlled erectile dysfunction …
  2617. Erection
  2618. ERECTION HARDNESS SCORE AND PERCEIVED FAMILY FUNCTIONING OF MEN WITH ERECTILE DYSFUNCTION IN EKU BAPTIST HOSPITAL, DELTA STATE
  2619. Erotica viewing effects on intimate relationships and self/partner evaluations
  2620. ERPs reveal disengagement processes related to condom use embarrassment in intention-behavior inconsistent young adults
  2621. Errata by Fabre et al. in Gepirone‐ER Treatment of hypoactive sexual desire Disorder Associated with Depression in Women
  2622. ERRATAjsm_1535 3225
  2623. ERRATUMjsm_1759 856
  2624. ESHRE Guideline: management of women with premature ovarian insufficiency
  2625. Essential assessment skills for couple and family therapists
  2626. Essential concepts for healthy living update
  2627. Essential Evidence Topics January 2015 North Dakota Academy of Family Physicians Big Sky, Montana
  2628. Essential Oils & Healthy Menopause: History and Research Secrets
  2629. Essentials of female sexual dysfunction from a sex therapy perspective
  2630. Essentials of psychiatric diagnosis: Responding to the challenge of DSM-5
  2631. Essentials of psychiatric nursing
  2632. Establishing a cohort of transgender men and gender nonconforming individuals to understand the molecular impact of testosterone on breast physiology
  2633. Establishing consensus on residency education in women’s health
  2634. Estetrol review: profile and potential clinical applications
  2635. Estimating the Prevalence of sexual Dysfunction Using the New ICD-11 Guidelines.
  2636. Estimating the prevalence of sexual function problems: The impact of morbidity criteria
  2637. Estradiol modulates Kiss1 neuronal response to ghrelin
  2638. Estradiol Regulation of Kiss1 Neurons
  2639. Estradiol Sensitization of sexual Behaviors in the Ovariectomized Rat: Mechanisms and Applications
  2640. Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.
  2641. Estrogen and transdiagnostics: a systematic review
  2642. Estrogen implants: embodiments of deeper problems in the marketing of drugs
  2643. Estrogen replacement therapy for the treatment of postmenopausal genitourinary tract dysfunction
  2644. Estrogen-androgen for hormone replacement. A review.
  2645. Estrogens, androgens, and the hormonal modulation of female primate sexual motivation in rhesus monkeys
  2646. Ethical aspects of sexual medicine. Internet, vibrators, and other sex aids: toys or therapeutic instruments?
  2647. Ethical Decision Making in Geriatric Medicine
  2648. Ethical dilemmas: Abstracts of papers from 15th anniversary meeting of society for sex therapy and research, New York, March 18–20, 1988
  2649. Ethics and sex therapy: A neglected dimension.
  2650. Ethno-survey of traditional use of plants as aphrodisiacs in Kashmir Himalaya, India
  2651. Ethnobotanical study of medicinal plants used in the treatment of sexual dysfunctions in traditional medicine in Kampemba-Lubumbashi, DR Congo
  2652. Ethnobotanical Survey of Medicinal Plants Used For the Management of Male sexual Dysfunction and Infertility in Tana River County, Kenya
  2653. Etiological factors in female hypoactive sexual desire disorder
  2654. Etiological Perspectives of ABDL Behavior from Members of an Online ABDL Community
  2655. Etiology and management of sexual dysfunction
  2656. Etiology and Management of sexual Dysfunction
  2657. Etiology and Risk Factors of Erectile Dysfunction
  2658. Etiology of female sexual dysfunction
  2659. Etonogestrel contraceptive implant-associated secondary anorgasmia
  2660. European association of urology guidelines for sexual and reproductive health 2020: what is new?
  2661. European Society for sexual Medicine position statement “Assessment and hormonal management in adolescent and adult trans people, with attention for sexual …
  2662. Evaluate models of high-frequency sexual behaviors already
  2663. Evaluating a couple-based intervention addressing sexual concerns for breast cancer survivors: study protocol for a randomized controlled trial
  2664. Evaluating benefits and harms of screening
  2665. Evaluating benefits and harms of screening-the streetlight effect?
  2666. Evaluating changes in sexual functioning in depressed patients: sensitivity to change of the CSFQ
  2667. Evaluating Consumer Health Information: What Fails to Harm Us Makes Us Smarter
  2668. Evaluating erectile dysfunction: Don’t forget hypofunctional thyroid
  2669. Evaluating medications for women
  2670. Evaluating sexual dysfunction in women
  2671. Evaluating the quality of websites offering information on female hypoactive sexual desire disorder
  2672. Evaluating the relationship between women’s sexual desire and satisfaction from a biopsychosocial perspective
  2673. Evaluating the sexual experience in men: validation of the sexual experience questionnaire
  2674. Evaluation and management of female sexual dysfunction
  2675. Evaluation and management of hypoactive sexual desire disorder
  2676. Evaluation and treatment of female sexual disorders
  2677. Evaluation and treatment of orgasmic dysfunction
  2678. Evaluation and Treatment of sexual Disorders Due to Medical Conditions
  2679. Evaluation and treatment of substance/medication-induced sexual dysfunction
  2680. Evaluation of a cognitive behavior therapy program for people with sexual dysfunction
  2681. Evaluation of a sexual health approach to prevent HIV among low income, urban, primarily African American women: results of a randomized controlled trial
  2682. Evaluation of agomelatine for the treatment of sleep problems in adults with autism spectrum disorder and co-morbid intellectual disability
  2683. Evaluation of changes in sexual response and factors influencing sexuality during pregnancy among Nigerian women in Jos, Nigeria
  2684. Evaluation of clinical effects of microsurgical subinguinal varicocelectomy with and without testicular delivery
  2685. Evaluation of different electrophysiological studies in the detection of urinary and sexual dysfunction in diabetic women
  2686. Evaluation of Erectile Disorder
  2687. Evaluation of female orgasmic disorder
  2688. evaluation of female sexual function after vaginal surgery with the FSFi (Female sexual Function index): our experience
  2689. Evaluation of female sexual function in persons with type 2 diabetes mellitus seen in a tertiary hospital in Southeast Nigeria with emphasis on its frequency and …
  2690. Evaluation of female sexual interest/arousal disorder
  2691. Evaluation of Flibanserin Safety: Comparison with Other Serotonergic Medications
  2692. Evaluation of flibanserin: science and advocacy at the FDA
  2693. Evaluation of male fertility-enhancing activities of water seed extract of hunteria umbellata in wistar rats
  2694. Evaluation of Male hypoactive sexual desire Disorder
  2695. Evaluation of Male sexual Dysfunction
  2696. Evaluation of Obesity Influence in the sexual Function of Postmenopausal Women: A Cross-Sectional Study
  2697. Evaluation of Phosphodiesterase-5 Inhibitory Potential of Biofield Energy Treated DMEM by Determining cGMP Level in Human Endothelial Cell Line
  2698. Evaluation of premature ejaculation
  2699. Evaluation of prevalence of sexual dysfunctions and its related factors in women
  2700. Evaluation of prevalence of sexual dysfunctions and its related factors in women.
  2701. Evaluation of quality of life and sexual satisfaction in women suffering from chronic pelvic pain with or without endometriosis
  2702. Evaluation of results from a single session psychotherapeutic intervention in population affected by the Colombian internal armed conflict, 2009
  2703. Evaluation of safety for flibanserin
  2704. Evaluation of sexual dysfunction and its associated risk factors in the male partners of the infertile couples using International Index of Erectile Function
  2705. Evaluation of sexual dysfunction in LUTS/BPH patients.
  2706. Evaluation of sexual dysfunction in men with spinal cord injury using the male sexual quotient
  2707. Evaluation of sexual function and quality of life in Iranian women with tubal ligation: a historical cohort study
  2708. Evaluation of sexual Function in Breast Cancer Survivors Using Female sexual Function Index: A Systematic
  2709. Evaluation of sexual function in postmenopause women with metabolic syndrome
  2710. Evaluation of sexual function in women with deep infiltrating endometriosis
  2711. Evaluation of sexual function in women with labia minora hypertrophy: a preliminary study
  2712. Evaluation of spermatogenic, aphrodisiac and anti-oxidant activity of classical siddha drug Thathu Viruthi Chooranam in rodents
  2713. Evaluation of student pharmacists’ ability and confidence using drug information resources to analyze drug–drug interactions
  2714. Evaluation of Testosterone Hormone Level in Healthy Obese Subjects in Khartoum State
  2715. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder
  2716. Evaluation of the effect of carrot seed (Daucus Carota) in women of fertile age with hypoactive sexual desire disorder: A randomized double-blind clinical trial
  2717. Evaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction—a prospective, randomized, double-blind, placebo-controlled clinical trial
  2718. Evaluation of the female sexual dysfunction in a sample of iranian infertile women
  2719. Evaluation of the female sexual function after vaginal surgery using the FSFI (Female sexual Function Index)
  2720. Evaluation of the female sexual function index in a population based sample from Finland
  2721. Evaluation of the female with sexual dysfunction
  2722. Evaluation of the Hamburg model of couple therapy in the treatment of low sexual desire and vaginismus. A prospective group comparison
  2723. Evaluation of the mistakes in self-diagnosis of sexual dysfunctions in 11,000 male outpatients: a real-life study in an andrology clinic
  2724. Evaluation of the patient with erectile dysfunction
  2725. Evaluation of the quality of life and sexual functioning of women using a 30-μg ethinyloestradiol and 3-mg drospirenone combined oral contraceptive
  2726. Evaluation of the Safety and Efficacy of Hybrid Fractional 2940 nm and 1470 nm Lasers for Treatment of Vaginal Tissue: Pilot Study
  2727. Evaluation of the sexual desire Relationship Distress Scale (SDRDS) in women with hypoactive sexual desire disorder
  2728. Evaluation of the sildenafil effect on female sexual dysfunction
  2729. Evaluation of young men with organic erectile dysfunction
  2730. Evaluation Systems of Female sexual Function
  2731. Evening the score on sex drugs: feminist movement or marketing masquerade?
  2732. Event monitoring in the UK
  2733. Everything you always wanted to know about sex and Neurology: neurological disability and sexuality
  2734. Evidence & ethics: Once more into the fray
  2735. Evidence and health policy: using and regulating systematic reviews
  2736. Evidence and opinion: finding the proper balance
  2737. Evidence Based Review of Hysterectomy and sexuality
  2738. Evidence based review of medicines for sexual dysfunction in females: A report commissioned by the New Zealand
  2739. Evidence for centrally initiated genital vasocongestive engorgement in the female rat: Findings from a new model of female sexual arousal response
  2740. Evidence for the efficacy and effectiveness of systemic family therapy
  2741. Evidence for the possible occurrence of Grave’s disease in a blue-eyed black lemur (Eulemur flavifrons)
  2742. Evidence that relationship quality, social support, and SSRI use do not account for the shared underlying relationships among symptoms of depression, anxiety, and …
  2743. Evidence-based practice for nurse practitioner students: a competency-based teaching framework
  2744. Evidence-Based Practice Summary Benefits and Harms of Flibanserin and Testosterone for the Treatment of Low Libido in Menopausal Women
  2745. Evidence-Based Practice Summary Hormone therapy for menopausal women with low libido
  2746. Evidence-Based Practice Summary Prevalence of low libido in US menopausal women and women who have been treated for cancer
  2747. Evidence-based reproductive toxicity of propylthiouracil-induced hypothyroidism in sexually experienced male rats.
  2748. Evidence-based treatments for low sexual desire in women
  2749. Evolution of flow-oriented design strategies in the continuous preparation of pharmaceuticals
  2750. EVOLUTION OF sexual HEALTH IN PARKINSON
  2751. Evolutionary Perspectives on hypoactive sexual desire Disorder in Women
  2752. Evolving techniques to evaluate ejaculatory function
  2753. Evşen NAZİK1
  2754. Ex‐centric textualities and rehearsed narratives at a gender identity clinic in Brazil: Challenging discursive colonization
  2755. Examination of the effect of COVID‐19 on sexual dysfunction in women
  2756. EXAMINATION OF THE SIMILARITIES AND DISSIMILARITIES BETWEEN HYPERsexualITY AND PROBLEMATIC PORNOGRAPHY USE
  2757. Examining Clinician Attitudes on sexual Health Assessment After an Educational Intervention
  2758. Examining relationship quality across three types of relationship agreements
  2759. Examining the Relationship Between Antecedents of sexuality and Women’s Reported Level of sexual Satisfaction During the First Five Years of Marriage
  2760. Examining the Relationships between Men’s and Women’s Motives for Pretending Orgasm and Levels of sexual desire, and Relationship and sexual Satisfaction
  2761. Examining the sexual function and related attitudes among aged women: A cross-sectional study
  2762. Executive summary of the consensus statement on assistance to women with HIV infection in the health care sector
  2763. Exercise improves sexual function in women taking antidepressants: results from a randomized crossover trial
  2764. Exercise Predictors of Self-Reported sexual Performance among Healthy Adults
  2765. Existential Group Therapy: Therapy Illustrations
  2766. Existing and future educational needs in graduate and postgraduate education
  2767. Exit Survey of Women with HSDD Treated With Bremelanotide Demonstrated Meaningful Treatment Benefits [28G]
  2768. Exo-clinical trials of nutritional supplements for sexual dysfunction: Precedents, Principles, and protocols
  2769. Exotic dance: An exploratory study of disordered eating, substance abuse, and disembodiment
  2770. Expanding Access to sexual and Reproductive Health Care in Alternative Primary Care Settings
  2771. Expanding the analysis of psychosocial factors of sexual desire in men
  2772. Expansion of the concept of mental disorder in the DSM-5
  2773. Experience, meaning, and identity in sexuality: A psychosocial theory of sexual stability and change
  2774. Experiences of Menopause on sexual Intimacy and Coping Strategies Used among Karen Married Women
  2775. Experimental models for the study of female and male sexual function
  2776. Experimental models in sexual medicine: eight best practices
  2777. Expert commentary B: Asexuality: Dysfunction or variation?
  2778. Expert opinion on existing and developing drugs to treat female sexual dysfunction
  2779. Expert Reviews Ovarian conservation vs removal at the time of benign hysterectomy
  2780. Experts debate—should DSM-V raise the bar for female sexual dysfunction diagnosis?
  2781. Experts Publish sexual Dysfunction Guidelines
  2782. Explorations of a sex Therapy Question in Feminism: Feminist Interventions in sex Therapy
  2783. EXPLORATORY RESEARCH PROJECT-PN-II-ID-PCE-2011-3-0784
  2784. Exploring a biopsychosocial model of women’s sexual problems
  2785. Exploring erotic plasticity as an individual difference variable: Theory and measurement
  2786. Exploring factors in the relationship balance assessment
  2787. Exploring Female sexuality
  2788. Exploring hypersexual behavior in men with Parkinson’s disease: is it compulsive sexual behavior?
  2789. Exploring men’s perceptions of a community-based men’s shed programme in England
  2790. Exploring psychotherapists’ perceptions of the impact of childhood sexual abuse on adult intimate relationships.
  2791. Exploring reasons why men and women refrain from sex despite desire
  2792. Exploring sexual behaviors and health communication among older women
  2793. Exploring sexual dysfunction in the menopausal woman
  2794. Exploring sexuality attitudes and knowledge in nursing: An education program
  2795. Exploring the continuum: medical information to effective clinical practice*. Paper II. Towards aetiology‐centred clinical practice
  2796. Exploring the functions of chemical substances in individuals’ sexual behaviour
  2797. Exploring the relationship between sexual function, sense of coherence, and well-being in a sample of Iranian breast cancer survivors
  2798. Exploring the role of sexual avoidance in male sexual dysfunction
  2799. Exposing orgasm in the brain: a critical eye
  2800. Exposure to an anabolic steroid changes female mice’s sexual responses according to sex partner
  2801. Exposure to methylphenidate during peri-adolescence affects endocrine functioning and sexual behavior in female Long–Evans rats
  2802. Exposure to sexualized media content and selective attention for sexual cues: An experimental study
  2803. Expression and distribution of phosphodiesterase isoenzymes in the human seminal vesicles
  2804. Expressions of female sexuality
  2805. Extended duration of efficacy of vardenafil when taken 8 hours before intercourse: a randomized, double-blind, placebo-controlled study
  2806. Extended-release bupropion: an antidepressant with a broad spectrum of therapeutic activity?
  2807. Extending the prediction of infidelity using a five-factor model
  2808. Extending therapeutic use of psychostimulants: focus on serotonin-1A receptor
  2809. EXTENT OF FEMALE PARTNER sexual FUNCTION IMPROVEMENT IN FEMALE PARTNERS OF MEN WITH PEYRONIE’S DISEASE WHO RECEIVED …
  2810. Extinction of aversive classically conditioned human sexual response
  2811. Extra-Thyroidal Factors Impacting Thyroid Hormone Homeostasis
  2812. Extraction and microencapsulation of khat: effects on sexual motivation and estradiol level in female rats
  2813. Extradyadic behaviors and gender: How do they relate with sexual desire, relationship quality, and attractiveness
  2814. Extragenital Adolescent Endometriosis
  2815. Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women
  2816. EYE DYNAMICS IN PATIENTS WITH FEMALE
  2817. EYE DYNAMICS IN PATIENTS WITH FEMALE
  2818. EYE DYNAMICS IN PATIENTS WITH FEMALE
  2819. Eye of the beholder? Sociocultural factors in the body image and sexual well-being of heterosexual women
  2820. Eyes Wide Shut: Erasing Women’s Experiences from the Clinic to the Courtroom
  2821. F52. 0 sexual dysfunction.
  2822. Facilitated early cortical processing of nude human bodies
  2823. Facilitating sexual health: Intimacy enhancement techniques for sexual dysfunction
  2824. Facilitation of proceptivity/sexual motivation in female rats by a serotonin 2A/2C (5-HT2A/2C) receptors agonist
  2825. Facilitation of sexual behavior in ovariectomized rats by estradiol and testosterone: a preclinical model of androgen effects on female sexual desire
  2826. Facilitators and barriers in sexual history taking
  2827. Facing the complexities of women’s sexual desire
  2828. Factor structure and normative data of the Greene Climacteric Scale among postmenopausal Portuguese women
  2829. Factor Structure, Reliability, and Validity of the Malay version of the sexual desire Inventory-2 (SDI-2-BM) in a Sample of Lower Urinary Tract Symptoms (LUTS) and …
  2830. Factors affecting sexual function and body image of early-stage breast cancer survivors in Poland: a short-term observation
  2831. Factors affecting sexuality in older Australian women: sexual interest, sexual arousal, relationships and sexual
  2832. Factors affecting sexuality in older Australian women: sexual interest, sexual arousal, relationships and sexual distress in older Australian women
  2833. Factors associated with common sexual concerns in women: New findings from the Canadian Contraception Study
  2834. Factors associated with low sexual desire in 45-year-old men: Findings from the German Male sex-Study
  2835. Factors associated with marital satisfaction and stability of married men and women
  2836. Factors associated with mortality after widowhood.
  2837. Factors associated with sexual arousal, sexual sensation seeking and sexual satisfaction among female African American adolescents
  2838. Factors associated with sexual dysfunction in men with HIV infection
  2839. Factors associated with sexual dysfunction in Taiwanese females with rheumatoid arthritis
  2840. Factors associated with sexual function in Iranian women with type 2 diabetes mellitus: partner relationship as the most important predictor
  2841. Factors associated with sexual health and well being in older adulthood
  2842. Factors associated with specific diagnostic and statistical manual of mental disorders, sexual dysfunctions in breast cancer survivors: a study of patients and their …
  2843. Factors associated with specific DSM-IV sexual dysfunctions among breast cancer survivors: A study of patients and their partners
  2844. Factors associated with the age of natural menopause and menopausal symptoms in Chinese women
  2845. Factors impacting women’s sexual desire: Examining long-term relationships in emerging adulthood.
  2846. Factors influencing stress, anxiety, and depression among Iranian pregnant women: the role of sexual distress and genital self-image
  2847. Factors Influencing Transition to Shisheh (Methamphetamine) among Young People Who Use Drugs in Tehran: A Qualitative Study
  2848. Factors related to coital frequency of women in their thirties
  2849. Factors shaping women’s sexual satisfaction: a comparison of medical and social models
  2850. Factors that affect libido
  2851. Factors that Influence Individual Differences in Female sexual Response in a College-Aged Population
  2852. Factors that influence sexual arousal in men: A focus group study
  2853. Faculty of Health Sciences & Technology
  2854. FACULTY OF HEALTH SCIENCES SCHOOL OF MEDICINE
  2855. Fallowfield’s sexual Activity Questionnaire in women with without and at risk of cancer
  2856. False bodies, true selves: Moving beyond appearance-focused identity struggles and returning to the true self
  2857. Familiarizing Students with the Empirically Supported Treatment Approaches for Psychophysiological Disorders and Chronic Pain.
  2858. Families, mental illness, and suicide
  2859. Family Counseling and Psychotherapy
  2860. Family History for Cardio-Metabolic Diseases: A Predictor of Major Adverse Cardiovascular Events in Men With Erectile Dysfunction
  2861. Family Involved Psychosocial Treatments for Adult Mental Health Conditions: A Review of the Evidence
  2862. Family sex communication and the sexual desire, attitudes, and behavior of late adolescents
  2863. Fast and slow sexual strategies are not opposites: Implications for personality and psychopathology
  2864. Fatigue and cognition-hormonal perspectives
  2865. Fatigue is associated with high prevalence and severity of physical and emotional symptoms in patients on chronic hemodialysis
  2866. FDA advisers to assess drug for low sexual desire in women
  2867. FDA approval of flibanserin—treating hypoactive sexual desire disorder
  2868. FDA Approvals of Brand-Name Prescription Drugs in 2015
  2869. FDA approves female sexual dysfunction drug
  2870. FDA Approves Flibanserin to Treat Female hypoactive sexual desire Disorder: A Billion Dollar Market?
  2871. FDA approves ultra-orphan drug on a 4-patient trial
  2872. FDA committee recommends approval for” female Viagra”
  2873. FDA Decisions on Measures of hypoactive sexual desire Disorder in Women: A History, With Grounds to Consider Clinical Judgment
  2874. FDA lacks desire for flibanserin–but does hypoactive sexual desire disorder even exist?
  2875. FDA new drug approvals in Q2 2019.
  2876. FDA Panel Backs New Emergency Contraceptive
  2877. FDA panel rejects testosterone patch for women on safety grounds
  2878. Fear avoidance and self-efficacy in relation to pain and sexual impairment in women with provoked vestibulodynia
  2879. Fear-based reasons for not engaging in sexual activity during pregnancy: associations with sexual and relationship well-being
  2880. Feasibility and preliminary effectiveness of a novel cognitive–behavioral couple therapy for provoked vestibulodynia: a pilot study
  2881. Feasibility of a brief online psychoeducational intervention for women with sexual interest/arousal disorder
  2882. Feasibility of interactive voice response methods in health behavior research with immigrant Latinos
  2883. Feasibility of transvaginal natural orifice transluminal endoscopic surgery–assisted living donor nephrectomy: is kidney vaginal delivery the approach of the future?
  2884. feasible?
  2885. Features of psychological status in women with functional ovarian cysts
  2886. Fecal incontinence, sexual complaints, and anorectal function after third-degree obstetric anal sphincter injury (OASI): 5-year follow-up
  2887. Feed Group
  2888. Feelings under dynamic description: The asexual spectrum and new ways of being.
  2889. Female adolescents, sexual empowerment and desire: A missing discourse of gender inequity
  2890. Female androgen deficiency
  2891. Female androgen deficiency syndrome—an unproven hypothesis
  2892. Female coital orgasm and male attractiveness
  2893. Female copulatory orgasm and male partner’s attractiveness to his partner and other women
  2894. Female cosmetic genital reconstruction: a review of current trends, treatments, and techniques
  2895. Female hypoactive sexual desire disorder
  2896. Female hypoactive sexual desire disorder
  2897. Female hypoactive sexual desire Disorder
  2898. Female hypoactive sexual desire disorder due to androgen deficiency: clinical and psychometric issues
  2899. Female hypoactive sexual desire disorder psychological treatment
  2900. Female hypoactive sexual desire Disorder: A Practical Guide to Causes, Clinical Diagnosis, and Treatment
  2901. Female hypoactive sexual desire disorder: History and current status
  2902. Female hypoactive sexual disorder: Case studies of physiologic androgen replacement
  2903. Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management
  2904. Female low sexual desire and sexually transmitted infections
  2905. Female orgasm and overall sexual function and habits: a descriptive study of a cohort of US women
  2906. Female orgasmic disorder
  2907. Female Orgasmic Disorder
  2908. Female orgasmic disorder
  2909. Female Orgasmic Disorder
  2910. Female rat sexual behavior is unaffected by perinatal fluoxetine exposure
  2911. Female reproductive behavior
  2912. Female sexual
  2913. Female sexual arousal disorder (FSAD)
  2914. Female sexual Arousal Disorder: A holistic approach
  2915. Female sexual arousal disorders
  2916. Female sexual arousal disorders
  2917. Female sexual behavior in mice is controlled by kisspeptin neurons
  2918. Female sexual desire disorders–prevalence, classification and treatment possibilities
  2919. Female sexual desire disorders: subtypes, classification, personality factors and new directions for treatment
  2920. Female sexual desire Questionnaire
  2921. Female sexual desire—beyond testosterone
  2922. Female sexual desire, response, and behavior
  2923. Female sexual desire, subjectivity, and the problem of negative sexual objectification
  2924. Female sexual desire: what helps, what hinders, and what women want
  2925. Female sexual disorders
  2926. Female sexual disorders nowadays
  2927. Female sexual disorders: assessment, diagnosis, and treatment
  2928. Female sexual disorders: assessment, diagnosis, and treatment
  2929. Female sexual disorders: Psychiatric aspects
  2930. Female sexual disorders: Treatment options in the pipeline
  2931. Female sexual distress in infertile Turkish women
  2932. Female sexual distress in infertile Turkish women İnfertil türk kadınlarda cinsel sıkıntı
  2933. Female sexual Distress Scale—Revised
  2934. Female sexual dysfunction
  2935. Female sexual dysfunction
  2936. Female sexual dysfunction
  2937. Female sexual dysfunction
  2938. Female sexual dysfunction
  2939. Female sexual dysfunction
  2940. Female sexual dysfunction
  2941. Female sexual dysfunction
  2942. Female sexual dysfunction
  2943. Female sexual Dysfunction
  2944. Female sexual dysfunction
  2945. Female sexual dysfunction
  2946. Female sexual dysfunction
  2947. Female sexual dysfunction
  2948. Female sexual dysfunction
  2949. Female sexual dysfunction
  2950. Female sexual dysfunction
  2951. Female sexual dysfunction
  2952. Female sexual dysfunction
  2953. FEMALE sexual DYSFUNCTION
  2954. Female sexual dysfunction
  2955. Female sexual Dysfunction
  2956. Female sexual dysfunction
  2957. Female sexual Dysfunction
  2958. Female sexual Dysfunction
  2959. Female sexual Dysfunction (FSD)
  2960. Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL)
  2961. Female sexual dysfunction a theoretical consideration of the nature of the sexual response and etiological factors
  2962. Female sexual dysfunction after ileal pouch–anal anastomosis
  2963. Female sexual dysfunction among married women in the Gaza Strip: an internet-based survey
  2964. Female sexual dysfunction among menopausal women
  2965. Female sexual dysfunction among Muslim women: increasing awareness to improve overall evaluation and treatment
  2966. Female sexual dysfunction among the wives of opioid-dependent males in Iran
  2967. Female sexual dysfunction among women attending the family planning clinic at Aminu Kano Teaching Hospital: A cross-sectional survey
  2968. Female sexual dysfunction amongst rural postmenopausal women
  2969. Female sexual dysfunction and adolescents
  2970. Female sexual Dysfunction and Cancer
  2971. Female sexual dysfunction and hormonal status in multiple sclerosis patients
  2972. FEMALE sexual DYSFUNCTION AND HORMONAL STATUS IN SPINAL CORD INJURED (SCI) PATIENTS
  2973. Female sexual dysfunction and infertility
  2974. Female sexual dysfunction and its associated risk factors: an epidemiological study in the north-east of Iran
  2975. Female sexual dysfunction and its relationship with marital satisfaction in Indian women
  2976. Female sexual dysfunction and postmenopausal androgen therapy
  2977. Female sexual dysfunction and premature menopause with focus on women’s wording
  2978. Female sexual Dysfunction and Schizophrenia: A Clinical Review
  2979. Female sexual dysfunction and the placebo effect: a meta-analysis
  2980. Female sexual Dysfunction and the Placebo Effect: A Meta-analysis
  2981. Female sexual dysfunction and use of hormone therapy in postmenopausal women
  2982. Female sexual Dysfunction as a Warning Sign of Chronic Disease Development
  2983. Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention
  2984. Female sexual Dysfunction during Reproductive Age: Types and Associated Risk Factors
  2985. Female sexual dysfunction following vaginal surgery: a review
  2986. Female sexual dysfunction following vaginal surgery: myth or reality?
  2987. Female sexual dysfunction in a population-based study in Iran: prevalence and associated risk factors
  2988. Female sexual Dysfunction in Alcohol and Drug Abuse
  2989. Female sexual dysfunction in essential hypertension: a common problem being uncovered
  2990. Female sexual dysfunction in female genital mutilation
  2991. Female sexual dysfunction in Iran: study of prevalence and risk factors
  2992. Female sexual dysfunction in Lower Egypt
  2993. Female sexual dysfunction in married medical students
  2994. Female sexual dysfunction in obstetrics and gynecology
  2995. Female sexual dysfunction in patients with endometriosis: Indian scenario
  2996. Female sexual dysfunction in patients with psoriasis and vitiligo: an Egyptian pilot study
  2997. Female sexual dysfunction in postmenopausal women
  2998. Female sexual dysfunction in type 2 diabetes: a case control study
  2999. Female sexual Dysfunction in women with Multiple Sclerosis
  3000. Female sexual Dysfunction in Women with Pelvic Pain
  3001. Female sexual dysfunction in women with thyroid disorders
  3002. Female sexual dysfunction management after pubovaginal/midurethral sling surgery
  3003. Female sexual dysfunction—from diagnosis to treatment
  3004. Female sexual dysfunction—medical and psychological treatments, committee 14
  3005. Female sexual dysfunction, feminist sexology, and the psychiatry of the normal
  3006. Female sexual dysfunction, voiding symptoms and depression: common findings in partners of men with erectile dysfunction
  3007. Female sexual dysfunction: a call to arms for collaboration to understand the sexological elephant
  3008. Female sexual dysfunction: A case study of disease mongering and activist resistance
  3009. Female sexual dysfunction: A comparative study in drug naive 1st episode of depression in a general hospital of South Asia
  3010. Female sexual dysfunction: a focus on flibanserin
  3011. Female sexual dysfunction: a primary care perspective
  3012. Female sexual dysfunction: A review
  3013. Female sexual dysfunction: a systematic overview of classification, pathophysiology, diagnosis and treatment
  3014. Female sexual dysfunction: a systematic review of outcomes across various treatment modalities
  3015. Female sexual dysfunction: anatomy, physiology, evaluation and treatment options
  3016. Female sexual Dysfunction: Assessment and Treatment.
  3017. Female sexual dysfunction: barriers to treatment
  3018. Female sexual Dysfunction: Classification and Definitions
  3019. Female sexual dysfunction: classification, pathophysiology, and management
  3020. Female sexual Dysfunction: clinical approach
  3021. Female sexual dysfunction: Definition, classification, and debates
  3022. Female sexual dysfunction: definitions, causes, and treatment
  3023. Female sexual dysfunction: Diagnosis and treatment in 2002; When sexual dysfunction occurs in women, several diagnostic and therapeutic strategies can help …
  3024. Female sexual dysfunction: Don’t assume it’sa side effect
  3025. Female sexual dysfunction: Drug treatment options
  3026. Female sexual Dysfunction: Epidemiology, Physiology, Evaluation, and Treatment
  3027. Female sexual dysfunction: focus on low desire
  3028. Female sexual dysfunction: Focus on low desire
  3029. Female sexual Dysfunction: Identifying the Problem
  3030. Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options
  3031. Female sexual Dysfunction: Indian Scenario
  3032. Female sexual dysfunction: is it a treatable disease?
  3033. Female sexual dysfunction: Knowledge development and practice implications
  3034. Female sexual Dysfunction: Natural and Complementary Treatments
  3035. Female sexual dysfunction: new developments
  3036. Female sexual dysfunction: new perspectives on anatomy, physiology, evaluation and treatment
  3037. Female sexual dysfunction: pharmacologic and therapeutic interventions
  3038. Female sexual dysfunction: physiology, epidemiology, classification, evaluation and treatment
  3039. Female sexual dysfunction: principles of diagnosis and therapy
  3040. Female sexual dysfunction: reality or disease-mongering?
  3041. Female sexual dysfunction: review of the disorder and evidence for available treatment alternatives
  3042. Female sexual Dysfunction: Screening, Diagnosis and Treatment
  3043. Female sexual dysfunction: State of the art
  3044. Female sexual Dysfunction: The Effectiveness of Psychological and Medical Treatments
  3045. Female sexual dysfunction: the important points to remember
  3046. Female sexual dysfunction: therapeutic options and experimental challenges
  3047. Female sexual dysfunction: what Arab gynecologists think and know
  3048. Female sexual dysfunction: what we know, what we suspect, and enduring enigmas
  3049. Female sexual dysfunction: what’s new?
  3050. FEMALE sexual DYSFUNCTION…
  3051. Female sexual dysfunctionand digital era: To listen to voice of a female
  3052. Female sexual Dysfunctions
  3053. Female sexual Dysfunctions
  3054. Female sexual Dysfunctions and Urogynecological Disorders
  3055. Female sexual dysfunctions: definitions and classification
  3056. Female sexual dysfunctions: prevalence and related factors in a sample of young university women–a cross-sectional study
  3057. Female sexual dysfuntion and gynaecological practice: Report of six cases
  3058. Female sexual Dysfuntion: Effective Treatment Strategies for All Ages
  3059. Female sexual Function after Vaginal Delivery with Episiotomy and Cesarean Section
  3060. Female sexual function and dysfunction
  3061. Female sexual Function and Dysfunction
  3062. Female sexual Function and Dysfunction
  3063. Female sexual function and dysfunction in the reproductive years: the influence of endogenous and exogenous sex hormones
  3064. Female sexual function and dysfunction: a cross-national prevalence study in Slovenia
  3065. Female sexual function and dysfunction: can the Cinderella of medicine turn into a princess?
  3066. Female sexual function and fertility after ileal pouch-anal anastomosis
  3067. Female sexual function and its associations with number of children, pregnancy, and relationship satisfaction
  3068. Female sexual function and the pelvic floor
  3069. Female sexual function and urinary incontinence in nulliparous athletes: An exploratory study
  3070. Female sexual function at midlife and beyond
  3071. Female sexual function during pregnancy and after childbirth
  3072. Female sexual function evaluation of the tension-free vaginal tape (TVT) and transobturator suburethral tape (TOT) incontinence surgery: results of a prospective study
  3073. Female sexual function following mid-urethral slings for the treatment of stress urinary incontinence
  3074. Female sexual Function in Childhood, Adolescent, and Young Adult Cancer Survivors
  3075. Female sexual function in users of combined oral and traditional contraceptive methods
  3076. Female sexual Function Index short version: a MsFLASH item response analysis
  3077. Female sexual Function Index-FSFI
  3078. Female sexual function, dysfunction, and pregnancy: implications for practice
  3079. Female sexual Function: The Role of Animal Models in Assessing Female sexual Dysfunction
  3080. Female sexual functioning and pregnancy
  3081. Female sexual healing and longevity
  3082. Female sexual Health
  3083. Female sexual health consensus clinical guidelines
  3084. Female sexual health predicts male and female partner satisfaction following IPP placement
  3085. Female sexual health: Barriers to optimal outcomes and a roadmap for improved patient–clinician communications
  3086. Female sexual Interest and Arousal Disorder: How We Can Help When Our Patient’s Libido Hits the Brakes
  3087. Female sexual interest/arousal disorder: a diagnosis out of thin air
  3088. Female sexual Issues in Clinical Practice
  3089. Female sexual Orgasmic Dysfunction and Genital Sensation Deficiency
  3090. Female sexual pain disorders and cognitive behavioral therapy
  3091. Female sexual Problems and the Gynecologist
  3092. Female sexual problems I: Loss of desirewhat about the fun?
  3093. Female sexual response: the role of drugs in the management of sexual dysfunction
  3094. Female sexual satisfaction and pharmaceutical intervention: A critical review of the drug intervention studies in female sexual dysfunction
  3095. Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients
  3096. Female sexual wellness, relationship mutuality, and femininity ideology
  3097. Female sexuality
  3098. Female sexuality and Androgens
  3099. Female sexuality and common sexual dysfunctions: evaluation and management in a primary care setting
  3100. Female sexuality and sexual dysfunction: Are we stuck on the learning curve?
  3101. Female sexuality at reproductive age as an indicator of satisfaction with life–descriptive cross-sectional survey
  3102. Female sexuality during pregnancy and postpartum: a study of 80 Tunisian women
  3103. FEMALE sexualITY IN AYURVEDA
  3104. Female sexuality in multiple sclerosis: the multidimensional nature of the problem and the intervention
  3105. Female sexuality: A State of Mind
  3106. Female sexuality.
  3107. Female Viagra’and the intersection of medicine, gender, and desire: reinforcing misconceptions of female sexuality in the sexopharmaceutical era
  3108. Feminism, psychology, and the gendering of neoliberal subjectivity: From critique to disruption
  3109. Feminist Psychology and the “Body Problem” sexuality, Physical Appearance, and Women’s Physical and Mental Health
  3110. Feminist sex Therapy in the Age of Viagramm
  3111. Ferri’s clinical advisor 2018 E-Book: 5 Books in 1
  3112. Fertility and sexuality in the spinal cord injury patient
  3113. Fertility, Belief, and sexuality
  3114. Fezf1 is a novel regulator of female sex behavior in mice
  3115. Field Testing of ICD-11 Proposals for Female sexual Dysfunctions in India: Cognitive Interviews with Patients
  3116. Finasteride and erectile dysfunction in patients with benign prostatic hyperplasia or male androgenetic alopecia
  3117. Finding her voice: First class female sexuality
  3118. Finding strength in diversity with The Journal of sexual Medicine as the common bond
  3119. Finnish women and men who self-report no sexual attraction in the past 12 months: Prevalence, relationship status, and sexual behavior history
  3120. Fireworks exploded in my mouth: affective responses before, during, and after the very first kiss
  3121. First pharmacological therapy for hypoactive sexual desire disorder in premenopausal women: Flibanserin
  3122. First published in The Journal of Clinical Endocrinology & Metabolism, Vol. 91, issue 10, pages
  3123. Fish Oils and Bleeding—Where Is the Evidence?
  3124. Fisiopatologia del trastorno del deseo sexual en el climaterio
  3125. Five Questions About the Relational and Bodily Experiences Theory: A Consideration of the Theoretical Framework, the Major Constructs, and Intended Application of …
  3126. Flaccid penile acceleration as a marker of cardiovascular risk in men without classical risk factors
  3127. Flash count diary: Menopause and the vindication of natural life
  3128. Fleeing the Apollonian Marriage Bed: Daphne and the Discourse of desire
  3129. Flibanserin
  3130. Flibanserin
  3131. Flibanserin (Addyi): the first FDA-approved treatment for female sexual interest/arousal disorder in premenopausal women
  3132. FLIBANSERIN (continued)
  3133. Flibanserin and 8‐OH‐DPAT implicate serotonin in association between female marmoset monkey sexual behavior and changes in pair‐bond quality
  3134. Flibanserin and female sexual desire
  3135. Flibanserin and its discontents
  3136. Flibanserin approval: facts or feelings?
  3137. Flibanserin as pharmacological therapy of inhibited sexual desire in women
  3138. Flibanserin efficacy and safety in premenopausal women with generalized acquired hypoactive sexual desire disorder
  3139. Flibanserin for female sexual dysfunction.
  3140. Flibanserin for hypoactive sexual desire disorder in premenopausal women
  3141. Flibanserin for hypoactive sexual desire disorder in premenopausal women
  3142. Flibanserin for hypoactive sexual desire disorder: an open-label safety study
  3143. Flibanserin for hypoactive sexual desire disorder: place in therapy
  3144. Flibanserin for low sexual desire in women: A molecule from bench to bed?
  3145. Flibanserin for postmenopausal women—are they really that different?
  3146. Flibanserin for premenopausal hypoactive sexual desire disorder: pooled analysis of clinical trials
  3147. Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women
  3148. Flibanserin for treating hypoactive sexual desire disorder
  3149. Flibanserin for treating low sexual desire in women
  3150. Flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the PLUMERIA study
  3151. Flibanserin ineffective for hypoactive sexual desire disorder in women
  3152. Flibanserin Tablets (Addyi)
  3153. Flibanserin Therapy and CYP2C19 Genotype
  3154. Flibanserin toxicity in a toddler following ingestion
  3155. Flibanserin treatment increases appetitive sexual motivation in the female rat
  3156. Flibanserin Versus Vardenafil in the Treatment of Female sexual Dysfunction, Randomized Controlled Clinical Trial
  3157. Flibanserin‐Stimulated Partner Grooming Reflects Brain Metabolism Changes in Female Marmosets
  3158. Flibanserin–the female Viagra?
  3159. Flibanserin, a drug intended for treatment of hypoactive sexual desire disorder in pre-menopausal women, affects spontaneous motor activity and brain …
  3160. Flibanserin: A controversial drug for female hypoactive sexual desire disorder
  3161. FLIBANSERIN: A Happy Ending Solution to hypoactive sexual desire Disorder
  3162. Flibanserin: A Miracle Drug in Management of hypoactive sexual desire Disorder in Female.
  3163. Flibanserin: a novel, nonhormonal agent for the treatment of hypoactive sexual desire disorder in premenopausal women
  3164. Flibanserin: a potential treatment for hypoactive sexual desire Disorder in premenopausal women
  3165. Flibanserin: Approval of a controversial drug for a controversial disorder
  3166. Flibanserin: first global approval
  3167. Flibanserin: from bench to bedside
  3168. Flibanserin: initial evidence of efficacy on sexual dysfunction, in patients with major depressive disorder
  3169. Flibanserin: more than just a” Pink Viagra”
  3170. Flibanserin: The first drug approved for the treatment of hypoactive sexual desire disorder in pre-menopausal women
  3171. Flibanserin: The First Pharmacologic Therapy for Women with hypoactive sexual desire Disorder
  3172. Flow-oriented synthetic design in the continuous preparation of the aryl piperazine drug flibanserin
  3173. Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial
  3174. Fluoxetine-induced changes in tactile sensation and sexual functioning among clinically depressed women
  3175. Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients
  3176. Fluparoxan in male erectile disorder: a case report
  3177. Focus on early years to create fairer society and reduce health inequality, Marmot review says
  3178. Focus on sexual health
  3179. Focus on the Impact of Gynecological Surgery on Female sexual Function
  3180. Focus on Women’s Mental Health
  3181. Focusing “hot” or focusing “cool”: Attentional mechanisms in sexual arousal in men and women
  3182. Folk Medicines
  3183. Follicle-stimulating hormone promotes the transformation of cholesterol to estrogen in mouse adipose tissue
  3184. Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes?
  3185. Food with influence in the sexual and reproductive health
  3186. Forbidden fruit in the golden years: Elderly sexuality
  3187. FORBIDDEN FRUIT IN THE GOLDEN YEARS: GERIATRIC sexualITY
  3188. Forecasting the critical role of intermittent therapies for the control of bone resorption
  3189. Forensic and medico-legal aspects of sexual crimes and unusual sexual practices
  3190. Forensic psychology of spousal violence
  3191. Formulations and use of androgens in women
  3192. Foundations of professional psychology: The end of theoretical orientations and the emergence of the biopsychosocial approach
  3193. Four solid forms of flibanserin: Insight into the crystal structures, properties, stability, and solid-state transition
  3194. Fractional CO2 laser versus promestriene and lubricant in genitourinary syndrome of menopause: a randomized clinical trial
  3195. Framing disease: The example of female hypoactive sexual desire disorder
  3196. Freedom to’and ‘freedom from’: A new vision for sex-positive politics
  3197. freedoM to” and “freedoM FroM
  3198. Freedom, invisibility, and community: A qualitative study of self-identification with asexuality
  3199. Frequency and predictors of sexual dysfunctions among male Nigerians with diabetes mellitus (A Preliminary report)
  3200. Frequency and timing of coital orgasm in women desirous of becoming pregnant
  3201. Frequency Distribution of Female sexual Dysfunction in Patients with Lower Urinary Tract Symptoms Referred to University Hospitals and a Private Urology …
  3202. Frequency of sexual activity and cardiovascular risk in subjects with erectile dysfunction: Cross‐sectional and longitudinal analyses
  3203. FREQUENCY OF sexual DYSFUNCTION IN FEMALES SUFFERING FROM MAJOR DEPRESSIVE DISORDER.
  3204. Frequency of sexual Dysfunctions and Behaviors Among Women Attending Health Care Centers in West of Tehran
  3205. Frequency of sexual dysfunctions in type 2 diabetic males
  3206. Fresh from the biotech pipeline—2015
  3207. Freud’s handicap
  3208. FRI-09 THE CREATION OF THE NEOVAGINA: A HISTORY OF VAGINAL RECONSTRUCTION
  3209. FRI-10 PIONEERING ANATOMICAL RESEARCH ON FEMALE PELVIS AND VESICO-VAGINAL FISTULAS AT THE UNIVERSITY OF PADUA (15TH-18TH CENTURY)
  3210. FRI-11 TO STIMULATE OR NOT TO STIMULATE: MEDICAL MASTURBATION, FEMALE FRIGIDITY AND CONTEMPORARY UNDERSTANDINGS OF FEMALE …
  3211. Frigid transgressions: Unveiling the queer potentialities of asexuality
  3212. Frigidity: An intellectual history
  3213. From diagnosis to treatment: The office management of premature ejaculation
  3214. From effects of psychotropic medication to mechanisms of sexual functioning: a clinically oriented review
  3215. From Female sexuality and Hysteria to Feminine Psychology: the Gender of Insanity in Literature
  3216. From Impotence to Erectile Dysfunction: Reflections on 50 Years in Male sexual Medicine
  3217. From morality to mental health: Virtue and vice in a therapeutic culture
  3218. From Primary Hypergonadotropic Amenorrhea to “POI”: Aetiology and Therapy
  3219. From sexual desire discrepancies to desirable sex: Creating the optimal connection
  3220. From sexual desire Discrepancies to Desirable sex: Creating the Optimal Connection From sexual desire Discrepancies to Desirable sex: Creating the …
  3221. From talk to action: mapping the diagnostic process in psychiatry
  3222. From the Editor on Women’s Health: Potential detrimental health effects during pregnancy and menopause
  3223. From the journals, July—August 2005
  3224. FROM THE MARGINS TO THE BASEMENT
  3225. From whence comes HSDD?
  3226. Frontier View on Drug Discoveries for Different Diseases-Part II
  3227. Frontier View on Drug Discoveries for Different Diseases-Volume 3
  3228. Frontiers in Aging Science Volume 1 Challenging Aging The Anti-senescence Effects of Hormesis, Environmental
  3229. Frontiers in Gynecological
  3230. Frontiers in gynecological endocrinology: Volume 1: from symptoms to therapies
  3231. FSD PHARMACOTHERAPY: Tibolone and Transdermal E2/NETA for the Treatment of Female sexual Dysfunction in Naturally Menopausal Women: Results of a …
  3232. Functional and dysfunctional sexual behavior: a synthesis of neuroscience and comparative psychology
  3233. Functional brain correlates of heterosexual paedophilia
  3234. Functional Foods and Women’s High Cholesterol
  3235. Functional neuroanatomy of human cortex cerebri in relation to wanting sex and having it
  3236. Functional neuroanatomy of sexual arousal
  3237. Functional neuroimaging studies of sexual arousal and orgasm in healthy men and women: a review and meta-analysis
  3238. Functional sexuality, sexual difficulties, and sexual dysfunctions
  3239. Functional significance of the rapid regulation of brain estrogen action: where do the estrogens come from?
  3240. Functional specialization within rostral prefrontal cortex (area 10): a meta-analysis
  3241. Functioning During a Pandemic
  3242. Fundamentals of Theory and Practice Revisited: sex Therapy: Historical Evolution, Current Practice. Part I
  3243. FUNDING AND CONFLICTS OF INTEREST: None
  3244. Further examination of measurement properties of Spanish version of the sexual desire Inventory with undergraduates and adolescent students
  3245. Further validation of the Female sexual Function Index: Specificity and associations with clinical interview data
  3246. Furthering our understanding of asexuality: an investigation into biological markers of asexuality, and the development of the asexuality identification scale
  3247. Future Developments and Research
  3248. Future Directions in sexual Medicine
  3249. Future of male infertility research and treatment
  3250. Future predictions on the fate of PAS children: What hath alienators wrought
  3251. Future sexual medicine physiological treatment targets
  3252. Future targets for female sexual dysfunction
  3253. Gaining political will for actions to achieve health equity: lessons from Australia for advocates
  3254. Gay Men, Drinking, and Alcoholism
  3255. Gender and Asexuality in Academic Sources
  3256. Gender and Mental Health
  3257. Gender and mental health: a review of two textbooks of psychiatry
  3258. Gender and sexuality
  3259. Gender and sexuality
  3260. Gender and sexuality diversity (GSD): Respecting difference
  3261. Gender bias and sex distribution of mental disorders in the DSM-IV-TR
  3262. Gender commonalities and differences in the neural processing of visual sexual stimuli
  3263. Gender difference of androgen actions on skeletal muscle transcriptome
  3264. Gender differences and similarities in sexual desire
  3265. Gender differences and the medicalization of sexuality in the creation of sexual dysfunctions diagnosis
  3266. Gender differences in beliefs about the causes of male and female sexual desire
  3267. Gender differences in desire discrepancy as a predictor of sexual and relationship satisfaction in a college sample of heterosexual romantic relationships
  3268. GENDER DIFFERENCES IN EXPLANATIONS FOR INFIDELITY OF LATVIAN RESIDENTS
  3269. Gender differences in factors associated with hypoactive sexual desire
  3270. Gender differences in HIV-related psychological distress in heterosexual couples
  3271. Gender Differences in HIV-Related Psychological Distress in Heterosexual Couples
  3272. Gender differences in implicit processing of sexual stimuli
  3273. Gender differences in psychiatric disorders with a focus on estrogen
  3274. Gender differences in sexual attitudes and behaviors: A review of meta-analytic results and large datasets
  3275. Gender differences in sexual desire: The effects of anger and anxiety
  3276. Gender differences in sexual dysfunctions among individuals with obesity
  3277. Gender Differences in sexual Health Impairment in Hidradenitis Suppurativa: A Systematic Review
  3278. Gender differences in sexual motivation
  3279. Gender Differences in Social Relationships and Social Support of School Children
  3280. Gender differences in the cardiovascular effect of sex hormones
  3281. Gender differences in the cardiovascular effects of sex hormones
  3282. Gender differences in the diagnosis of mental disorders: Conclusions and controversies of the DSM–IV.
  3283. Gender differences in the relationship of sexual functioning with implicit and explicit sex liking and sex wanting: A community sample study
  3284. Gender discrepancy in asexual identity: The effect of hegemonic gender norms on asexual identification
  3285. GENDER IDENTITY DISORDER
  3286. Gender in Contemporary US Culture. Asexuality in Representation and Reception.
  3287. Gender Incongruence
  3288. Gender Incongruence 28
  3289. Gender issues and sexual desire: the role of emotional and relationship variables
  3290. Gender role and women’s health: Effects of feminine gender role stress and femininity on somatic symptoms and sexual functioning
  3291. Gender-based violence and mental disorders in female college students
  3292. Gender-specific medicine and ageing: the endocrine impact: second world congress, Rome, Italy, March 8-11, 2007
  3293. Gender‐specificity of solitary and dyadic sexual desire among gynephilic and androphilic women and men
  3294. Gender, sexuality, and intimate relationships
  3295. Gendered populations and trauma beyond Oedipus: reply to Angel’s commentary
  3296. Genders and sexualities in History
  3297. Gene polymorphism at serotonin 5-HT1A receptors: moving towards personalized medicine for psychosis and mood deficits
  3298. General and sex profile of women with partner affected by premature ejaculation: results of a large observational, non‐interventional, cross‐sectional, epidemiological …
  3299. General management of female sexual dysfunction for urologists
  3300. General practitioners’ knowledge, attitudes, beliefs, and practices in the management of sexual dysfunction—results of the Portuguese sexOS study
  3301. General practitioners’ procedures for sexual history taking and treating sexual dysfunction in primary care
  3302. Generalized Restriction: Understanding Anorexia Nervosa in an Interpersonal Context
  3303. Genetic and environmental risk factors for sexual distress and its association with female sexual dysfunction
  3304. Genetic polymorphisms of monoamine oxidase (MAO) B and serotonin transporter receptor (5-HTTR) influence variability in neurobehavioral symptoms by n-hexane …
  3305. Genetics and erectile dysfunction: leveraging early foundations for new discoveries
  3306. Genital and subjective measurement of the time course effects of an acute dose of testosterone vs. placebo in postmenopausal women
  3307. Genital and subjective sexual arousal in women: effects of menopause, sympathetic nervous system activation, and arousal disorder
  3308. Genital responsiveness in healthy women with and without sexual arousal disorder
  3309. Genital sensory detection thresholds and patient satisfaction with vaginoplasty in male-to-female transgender women
  3310. Genital vascular responsiveness and sexual feelings in midlife women: Psychophysiologic, brain, and genital imaging studies
  3311. Genito pelvic vaginal laxity: classification, etiology, symptomatology, and treatment considerations
  3312. Genito Urinary Syndrome of Menopause (GSM) or Vulvo-vaginal Atrophy (VVA) an Unspoken Sorrow
  3313. Genito-pelvic pain through a dyadic lens: Moving toward an interpersonal emotion regulation model of women’s sexual dysfunction
  3314. Genito-sensory analysis in women with arousal and orgasmic dysfunction
  3315. Genitourinary and sexual adverse effects of psychotropic medication
  3316. Genitourinary changes with aging
  3317. Genitourinary Syndrome of Menopause and Female sexual Dysfunction
  3318. Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: a double-blind, randomized, placebo-controlled cross-over trial
  3319. Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women
  3320. Gepirone‐ER treatment of low sexual desire associated with depression in women as measured by the Derogatis Inventory of sexual Function (DISF) fantasy …
  3321. Gerald R. Weeks and Nancy Gambescia
  3322. Geriatric Gynecology
  3323. Geriatric gynecology
  3324. Geriatric psychiatry
  3325. Geriatric Psychiatry: A Companion to the American Pyschiatric Publishing Textbook of Geriatric Psychiatry
  3326. Geriatric sexuality
  3327. Geriatric sexuality
  3328. Geriatric sexuality
  3329. Germaine Greer’s On Rape Revisited: Clarifying the Long-standing Relationship Between Rape and Heterosexual Pleasure in Greer’s Work.
  3330. Gery C. Karantzas and Patricia Noller
  3331. Gettin’It On Vs. Givin’It Up: The Association Between sexual Goals, Interdependence and sexual desire in Long-Term Relationships
  3332. Getting it on versus getting it over with: sexual motivation, desire, and satisfaction in intimate bonds
  3333. Getting the Word Out: Sharing the Benefits of Vaginally Applied Testosterone Cream in the Perimenopausal Years
  3334. Giacomo Tirabassi, Angelo Gioia, Lara Giovannini, Marco Boscaro, Giovanni Corona, Angelo Carpi, Mario Maggi &
  3335. Giuseppe Scimeca, Antonio Bruno, Gianluca Pandolfo, Umberto Micò, Vincenzo M. Romeo, Elisabetta Abenavoli, Adriano Schimmenti, et al.
  3336. Giving in to arousal or staying stuck in disgust? Disgust-based mechanisms in sex and sexual dysfunction
  3337. Global and specific attachment patterns in romantic relationships: distinct and interactional functions.
  3338. Global consensus position statement on the use of testosterone therapy for women
  3339. Global consensus statement on testosterone therapy for women: an Australian perspective
  3340. Global consensus statement on testosterone therapy in women
  3341. Glücksmedizin
  3342. Glutamate afferents from the medial prefrontal cortex mediate nucleus accumbens activation by female sexual behavior
  3343. Glutamate in Male and Female sexual Behavior: Receptors, Transporters, and Steroid Independence
  3344. Going Wild: Law and Literature and sex
  3345. Goldilocks and menopause
  3346. Gonadal dysfunction in chronic kidney disease
  3347. Gonadal hormones and cognitive aging: a midlife perspective
  3348. Gonadal Steroid-Independent sexual Behavior in Female and Male B6D2F1 Gonadectomized Mice
  3349. Gonadal Suppressive and Cross‐sex Hormone Therapy for Gender Dysphoria in Adolescents and Adults
  3350. Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech
  3351. GORDON CONWELL THEOLOGICAL SEMINARY-CHARLOTTE MASTERS OF ARTS IN COUNSELING PROGRAM CO 719 HUMAN sexualITY SPRING …
  3352. Green fingers or pink viagra? female sexual dysfunction and medicalisation in contemporary medical discourse
  3353. Group counseling curriculum for women with female interest/arousal disorder
  3354. Group Counseling: The Efficacy of Group Work.
  3355. Group mindfulness-based therapy significantly improves sexual desire in women
  3356. Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft)
  3357. Guidelines: Making the Diagnosis and Managing the Partner
  3358. Guilt about first intercourse: An antecedent of sexual dissatisfaction among college women
  3359. Guilt and lack of orgasm during sexual intercourse: Myth versus reality among college women
  3360. Gut Microbes are Linked to sexual desire, Differences in Gut Microbes and Fecal Metabolomes of Women with vs Without HSDD
  3361. Gynaecological aspects of the treatment and follow-up of transsexual men and women
  3362. GYNAECOLOGICAL PROBLEMS IN THE AGEING WOMAN: A REVIEW
  3363. Gynecologic problems in women with autoimmune diseases
  3364. Gynecologic radiation oncology patients report unmet needs regarding sexual health communication with providers
  3365. Gynecologic Surgical Outcomes Through the Patient’s Eyes: Are Physicians Looking in the Same Direction?
  3366. Gynecological associated disorders and management
  3367. Gynecological Cancers
  3368. Gynecological Issues for Cancer Survivors
  3369. Gynecomastia in subjects with sexual dysfunction
  3370. Handbook of forensic psychology: Resource for mental health and legal professionals
  3371. Handbook of Male Infertility & Andrology
  3372. Handbook of sexual and gender identity disorders
  3373. Handbook of sexual Dysfunction
  3374. Hard science’: Gendered constructions of sexual dysfunction in theViagra Age’
  3375. Has flibanserin revolutionized the treatment of hypoactive sexual desire disorder or is there still room for more effective therapeutics?
  3376. Has testosterone passed the test in premenopausal women with low libido? A systematic review
  3377. Has training in human sexuality changed over the past twenty years? A survey of clinical psychology, counseling psychology, and doctor of social work …
  3378. Having ‘The Talk’
  3379. Having an Orgasm with the Power of the Mind
  3380. Having your cake and eating it, too: Factors impacting perception of life satisfaction during outside partnerships
  3381. Healing and functional outcomes after obstetric anal sphincter injury in HIV positive vs HIV negative patients
  3382. Healing the Wounded Heart: The Heartache of sexual Abuse and the Hope of Transformation
  3383. Healing the wounded self: Combining hypnotherapy with ego state therapy
  3384. Health and Ageing in Older Adults: A gender-specific and life-course perspective
  3385. Health and behavior: A multidisciplinary perspective
  3386. Health care clinicians in sexual health medicine: focus on erectile dysfunction
  3387. HEALTH CARE OF THE OLDER ADULT: AN AUSTRALIAN AND NEW ZEALAND PERSPECTIVE
  3388. Health care providers have used the Diagnostic and Statistical Manual of Mental Disorders (DSM) to support communication of essential characteristics of mental …
  3389. Health needs assessment
  3390. Health seeking practices of infertile women
  3391. Health-Related Quality of Life and Adjustment in Patients with Hepatocellular Carcinoma
  3392. Health-related quality of life in patients with hepatocellular carcinoma: a systematic review
  3393. Health-related quality of life, definitions and determinants.
  3394. Health‐Related Characteristics and Unmet Needs of Men with Erectile Dysfunction: A Survey in Five E uropean Countries
  3395. Health‐related quality of life by human immunodeficiency virus status in a cross‐sectional survey of gay and bisexual prostate cancer survivors
  3396. Health, body image, gender, and migration status: their relationship to sexuality in old age
  3397. Health, Disease, and the Basic Aims
  3398. Health, disease, and the basic aims of medicine
  3399. Healthcare costs and quality of life outcomes following gender affirming surgery in trans men: a review
  3400. Healthcare resource utilization and expenditures of women diagnosed with hypoactive sexual desire disorder
  3401. Healthcare utilization in women diagnosed with hypoactive sexual desire disorder: Interim baseline results from the HSDD Registry for Women
  3402. Healthy Aging & Functional Capacity
  3403. Heart Disease and Erectile Dysfunction
  3404. Heart rate variability biofeedback increases sexual arousal among women with female sexual arousal disorder: Results from a randomized-controlled trial
  3405. Heatwave-related Mortality in Australia: Who’s impacted the most?
  3406. Help-seeking behavior of women with self-reported distressing sexual problems
  3407. Help-seeking behaviors for female sexual dysfunction: a cross sectional study from Iran
  3408. Help-seeking for sexual difficulties and the potential role of interactive digital interventions: Findings from the third British National Survey of sexual Attitudes and …
  3409. Helping people with sexual problems: a practical approach for clinicians
  3410. Herbal dietary supplements for erectile dysfunction: a systematic review and meta-analysis
  3411. Herbal medicine for low sexual desire in menopausal women: A clinical review
  3412. Herbal medicine for sports: a review
  3413. Herbal Medicine in Andrology
  3414. Herbal prescription for managing menopausal disorders: A practice survey in Korean medicine doctors
  3415. Herbal remedies for hypoactive sexual desire based on Persian medicine
  3416. Herbal slimming products and natural sexual enhancers
  3417. Het mannelijk seksueel functioneren na een besnijdenis
  3418. Heterosexual men’s sexual desire: Supported by, or deviating from, traditional masculinity norms and sexual scripts?
  3419. Heterosexual women’s causal attributions regarding impairment in sexual function: Factor structure and associations with well-being
  3420. Heterosexuality
  3421. HEY, DOC CAN I TALK TO YOU ABOUT sex?
  3422. Hidden disorder/hidden desire
  3423. High levels of testicular interleukin-1 could be involved in the impairment of male fertility of IL-1 receptor antagonist knock-out mice or mice with systemic infection …
  3424. High prevalence of chronic pituitary and target-organ hormone abnormalities after blast-related mild traumatic brain injury
  3425. High prevalence of sexual dysfunction in women with rheumatic diseases: a not recognized health domain
  3426. High rates of sexual behavior in the general population: Correlates and predictors
  3427. High triglycerides predicts arteriogenic erectile dysfunction and major adverse cardiovascular events in subjects with sexual dysfunction
  3428. High-density lipoprotein cholesterol-raising strategies
  3429. High-dose ascorbic acid increases intercourse frequency and improves mood: a randomized controlled clinical trial
  3430. High-yield brain and behavior
  3431. Higher testosterone levels are associated with unfaithful behavior in men
  3432. highlightS froM thE Edition
  3433. HiGHliGHtS fRom tHE Edition> interview with dr. Jackson by Editor-in-Chief> inflatable penile prosthesis implantation
  3434. HISTO-ANATOMICAL AND PRELIMINARY TLC INVESTIGATIONS ON TRIBULUS TERRESTRIS L.(ZYGOPHYLLACEAE) SPECIES
  3435. Historical and international context of nosology of female sexual disorders
  3436. Historical Links Between Psychiatry and sexual Medicine
  3437. Historical revolutions in sex therapy: A critical examination of men’s sexual dysfunctions and their treatment
  3438. Historical, scientific, clinical and feminist criticisms of “the human sexual response cycle” model
  3439. History and Discovery
  3440. History of the International Society for the Study of Women’s sexual Health (ISSWSH)
  3441. History of the treatment of female sexual dysfunction (s)
  3442. History Taking and Physical Examination
  3443. HIV and Testosterone in Men
  3444. HIV infection and women’s sexual functioning
  3445. HIV-1 status is independently associated with decreased erectile function among middle-aged MSM in the era of combination antiretroviral therapy
  3446. HIV-associated female sexual dysfunction–clinical experience and literature review
  3447. Holding onto womanhood: A qualitative study of heterosexual women with sexual desire loss
  3448. Hormonal and surgical treatment options for transgender women and transfeminine spectrum persons
  3449. Hormonal aspects of sexual dysfunction: the therapeutic use of exogenous androgens in men and women
  3450. Hormonal association and sexual dysfunction in patients with impaired fasting glucose: a cross-sectional and longitudinal study
  3451. Hormonal causes of male sexual dysfunctions and their management (hyperprolactinemia, thyroid disorders, GH disorders, and DHEA)
  3452. Hormonal changes and sexual dysfunction
  3453. Hormonal changes associated with physical activity and exercise training
  3454. Hormonal changes in menopause and implications on sexual health
  3455. Hormonal consequences, replacement therapy, and lost workdays after cervical cancer treatment
  3456. Hormonal contraception and female sexuality: position statements from the European Society of sexual Medicine (ESSM)
  3457. Hormonal contraception and sexual desire: a critical review
  3458. Hormonal contraceptives, female sexual dysfunction, and managing strategies: a review
  3459. Hormonal correlates and causes of sexual desire: A review
  3460. Hormonal determinants of the severity of andropausal and depressive symptoms in middle-aged and elderly men with prediabetes
  3461. Hormonal Evaluation and Therapy of Erectile Dysfunction
  3462. Hormonal predictors of sexual motivation in natural menstrual cycles
  3463. Hormonal profile of menopausal women receiving androgen replacement therapy: a meta-analysis
  3464. Hormonal therapy after menopause
  3465. Hormonal Therapy for Male sexual Dysfunction
  3466. HORMONAL THERAPY IN THE POSTMENOPAUSAL WOMAN WITH sexual DYSFUNCTION Claudia Panzer MD
  3467. Hormonal therapy is associated with better self-esteem, mood, and quality of life in transsexuals
  3468. Hormonal treatment effect on sexual distress in transgender persons: 2-year follow-up data
  3469. Hormonal, metabolic, and endometrial safety of testosterone vaginal cream versus estrogens for the treatment of vulvovaginal atrophy in postmenopausal women: a …
  3470. Hormone Levels and sexual Functioning After Risk-Reducing Salpingo-Oophorectomy
  3471. Hormone management of trans women
  3472. Hormone receptors and sexuality in the human female
  3473. Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective study
  3474. Hormone replacement therapy and sexuality
  3475. Hormone Replacement Therapy in Female sexual Dysfunction.
  3476. Hormone Replacement Therapy in Premature Ovarian Insufficiency
  3477. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause
  3478. Hormone replacement therapy in young women with surgical primary ovarian insufficiency
  3479. Hormone replacement therapy: update and practical prescribing
  3480. Hormone Therapies and Menopause: Where Do We Stand in the Post-WHI Era?
  3481. Hormone Therapy
  3482. Hormone Therapy (I): Estrogens, Progestogens, and Androgens
  3483. Hormone Therapy in Menopause
  3484. Hormone therapy in transgender adults is safe with provider supervision; a review of hormone therapy sequelae for transgender individuals
  3485. Hormone Therapy Use After Premature Surgical Menopause Based on Prescription Records: A Population-Based Study
  3486. Hormone Therapy, Mental Health, and Quality of Life Among Transgender People: A Systematic Review
  3487. Hormones and human partnering
  3488. Hormones and human sexuality
  3489. Hormones and sex Behavior
  3490. Hormones and sex Behavior
  3491. Hormones and sexual function.
  3492. Hormones and sexual functioning in menopausal transition
  3493. Hormones and sexuality during transition to menopause
  3494. Hormones and sexuality: current complexities and future directions
  3495. Hormones and sexuality: effect of estrogen and progestogen.
  3496. Hormones are the Masterkey in Chemical co-ordination system of body.
  3497. Hormones, metabolism, aging and men’s health
  3498. Hormones, the brain, and me.
  3499. How and why thoughts change: Foundations of cognitive psychotherapy
  3500. How Can Experiential Psychotherapy Help Transform
  3501. How can the objectified know their objectification?
  3502. How changes in depression and anxiety symptoms correspond to variations in female sexual response in a nonclinical sample of young women: a daily diary study
  3503. How did erectile dysfunction become “natural”? A review of the critical social scientific literature on medical treatment for male sexual dysfunction
  3504. How do men and women define sexual desire and sexual arousal?
  3505. How do SSRIs cause sexual dysfunction
  3506. How do women survivors of childhood sexual abuse experience’good sex‘later in life? A mixed-methods investigation
  3507. How does childhood trauma impact women’s sexual desire? Role of depression, stress, and cortisol
  3508. How does lower urinary tract dysfunction affect sexual function in men and women? ICI‐RS 2015—Part 1
  3509. How does paying attention improve sexual functioning in women? A review of mechanisms
  3510. How drug companies manipulate prescribing behavior
  3511. How hot are they? Neural correlates of genital arousal: an infrared thermographic and functional magnetic resonance imaging study of sexual arousal in men and …
  3512. How hot is he? A psychophysiological and psychosocial examination of the arousal patterns of sexually functional and dysfunctional men
  3513. How is asexuality different from hypoactive sexual desire disorder?
  3514. How Japanese culture affects the sexual functions of normal females
  3515. How Lesbian Relationships Are Similar to and Different from Heterosexual Relationships: Lived Experience of Lesbian Women Who Were Previously Married to …
  3516. How predictable is the erectile function of patients with epilepsy?
  3517. How sexual is sexual desire? desire and Testosterone in Women
  3518. How Similar is “Similar”? A Deeper Dive into Bucher Versus Bayesian Network Meta-Analysis
  3519. How the emotional motor system controls the pelvic organs
  3520. How the Female Orgasm Was Turned into a Trademark
  3521. How the prevalence rates of male sexual dysfunction vary using different criteria
  3522. How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer
  3523. How to improve complex drug development? A critical review of FDA advisory meetings
  3524. How to purchase viagra, Generic viagra when
  3525. How to Take a sexual History
  3526. How: Genotyping techniques and study designs
  3527. HP-07-003 First sexual intercourse among high school students in Slovenia
  3528. HRT for women with premature ovarian insufficiency: a comprehensive review
  3529. HSDD and asexuality: A question of instruments
  3530. HSDD, Flibanserin, and Eye Dynamics: A Double-Blind Randomized Placebo-Controlled Clinical Trial [24I]
  3531. HSDD: Circuits of sexual desire/Inhibition| Psychiatrist. com
  3532. http://heanoti. com/index. php/hn
  3533. Human asexuality: What do we know about a lack of sexual attraction?
  3534. Human Reproductive Health in Relation to Thyroid Alterations
  3535. Human sex differences in sexual psychology and behavior
  3536. Human sex-response cycles
  3537. Human sexual Anatomy and Physiology
  3538. Human sexual desire Disorder: Do We Have a Problem?.
  3539. Human sexual development is subject to critical period learning: Implications for sexual addiction, sexual therapy, and for child rearing
  3540. Human sexual development is subject to critical-period learning: Paradigm-shifting implications for sexual therapy and for child-rearing
  3541. Human sexual response
  3542. Human sexual response
  3543. Human sexuality
  3544. Human sexuality and ageing
  3545. Human sexuality of children and adolescents: A comprehensive training guide for social work professionals
  3546. Human sexuality today
  3547. Humor preferences among angered males and females: Associations with humor content and sexual desire
  3548. Huntington’s Disease
  3549. Huntington’s disease and ALS-the ethical challenges for families and professionals facing genetic disease
  3550. Hurlbert Index of sexual Assertiveness: A study of psychometric properties in a Spanish sample
  3551. Hurlbert index of sexual compatibility
  3552. Husbands who use sexual dissatisfaction to balance the scales of power in their dual-career marriages
  3553. Hyperactive sexual desire in Klinefelter Syndrome: Treatment with sertraline
  3554. Hyperprolactin as cause of hypoactive sexual desire in men
  3555. Hyperprolactinemia and sexual disorders in men.
  3556. Hypersexual desire in males: An operational definition and clinical implications for males with paraphilias and paraphilia-related disorders
  3557. Hypersexual desire in males: are males with paraphilias different from males with paraphilia-related disorders?
  3558. Hypersexual disorder: A proposed diagnosis for DSM-V
  3559. Hypersexual disorder: Just more muddled thinking
  3560. Hypersexual disorder: Searching for clarity
  3561. Hypersexuality and high sexual desire: Exploring the structure of problematic sexuality
  3562. Hypersexuality during use of levodopa
  3563. Hypersexuality following anterior communicating artery aneurysm rupture
  3564. Hypersexuality: clinical aspects
  3565. Hypersexuality: the controversial mismatch of the psychiatric diagnosis
  3566. Hypertension and sexual dysfunction: time to act
  3567. Hypertension and stroke
  3568. Hyperthyroidism and erectile dysfunction: a population-based case—control study
  3569. Hyperthyroidism: a risk factor for female sexual dysfunction
  3570. Hypnosis in the treatment of an adjustment disorder
  3571. Hypnosis in the treatment of sexual desire disorders
  3572. Hypnotic Interventions in the treatment of sexual dysfunctions
  3573. Hypnotic Relaxation Therapy and sexual Function in PostmenopausalWomen: Results of a Randomized Clinical Trial
  3574. Hypo Active sexual desire
  3575. hypoactive market desire disorder
  3576. hypoactive sexual desire
  3577. hypoactive sexual desire
  3578. hypoactive sexual desire
  3579. hypoactive sexual desire
  3580. hypoactive sexual desire (HSD) disorder: a psychiatric condition with a biological “dark side”
  3581. hypoactive sexual desire among depressed female patients treated with selective serotonin reuptake inhibitors: a comparison between escitalopram and fluoxetine
  3582. hypoactive sexual desire and testosterone deficiency in men
  3583. hypoactive sexual desire disorder
  3584. hypoactive sexual desire disorder
  3585. hypoactive sexual desire disorder
  3586. hypoactive sexual desire disorder
  3587. hypoactive sexual desire Disorder
  3588. hypoactive sexual desire Disorder
  3589. hypoactive sexual desire disorder (HSDD) is not “female erectile dysfunction (ED)”: challenges with the characterization of HSDD in women based on a systematic …
  3590. hypoactive sexual desire Disorder (HSDD) is not “The Female Erectile Dysfunction (ED)”: Challenges with the Characterization of HSDD in Women
  3591. hypoactive sexual desire Disorder and current pharmacotherapeutic options in women
  3592. hypoactive sexual desire disorder and depression: A treatment outcome study.
  3593. hypoactive sexual desire disorder caused by antiepileptic drugs
  3594. hypoactive sexual desire disorder in a population-based study of Brazilian women: associated factors classified according to their importance
  3595. hypoactive sexual desire disorder in men: clinical approach in sexual medicine
  3596. hypoactive sexual desire disorder in menopausal women: a survey of Western European women
  3597. hypoactive sexual desire disorder in postmenopausal women
  3598. hypoactive sexual desire disorder in postmenopausal women: quality of life and health burden
  3599. hypoactive sexual desire disorder in postmenopausal women: US results from the Women’s International Study of Health and sexuality (WISHeS)
  3600. hypoactive sexual desire disorder in premenopausal women: case studies
  3601. hypoactive sexual desire disorder in surgical menopause
  3602. hypoactive sexual desire disorder in women from the perspective of Persian medicine
  3603. hypoactive sexual desire Disorder in women: An Evolving Understanding
  3604. hypoactive sexual desire disorder in women: treatment options beyond testosterone and approaches to communicating with patients on sexual health
  3605. hypoactive sexual desire disorder, HSDD
  3606. hypoactive sexual desire disorder, sexual distress and quality of life between women with surgical menopause and women with natural menopause
  3607. hypoactive sexual desire disorder: A biopsychosocial perspective
  3608. hypoactive sexual desire disorder: a review of epidemiology, biopsychology, diagnosis, and treatment
  3609. hypoactive sexual desire disorder: An overview.
  3610. hypoactive sexual desire disorder: an underestimated condition in men
  3611. hypoactive sexual desire disorder: can it be treated by drugs?
  3612. hypoactive sexual desire disorder: can we treat it with drugs?
  3613. hypoactive sexual desire disorder: How do you identify it and treat it?
  3614. hypoactive sexual desire disorder: International Society for the Study of Women’s sexual Health (ISSWSH) expert consensus panel review
  3615. hypoactive sexual desire Disorder: Inventing a Disease to
  3616. hypoactive sexual desire disorder: inventing a disease to sell low libido
  3617. hypoactive sexual desire disorder: Prevalence and comorbidity in 906 subjects
  3618. hypoactive sexual desire disorder: separating fact from fiction
  3619. hypoactive sexual desire Disorder: Understanding the Impact on Midlife Women
  3620. hypoactive sexual desire DISORDERS IN FEMALE PATIENTS AFTER KIDNEY TRANSPLANTATION
  3621. hypoactive sexual desire dysfunction in community-dwelling older women
  3622. hypoactive sexual desire in a couple with unresolved loyalty conflicts
  3623. hypoactive sexual desire in a Couple With Unresolved Loyalty Conflicts: Discussion
  3624. hypoactive sexual desire in heterosexual women: A feminist analysis
  3625. hypoactive sexual desire in men
  3626. hypoactive sexual desire in Men
  3627. hypoactive sexual desire IN MENOPAUSAL WOMEN IN EUROPE
  3628. hypoactive sexual desire in transsexual women: prevalence and association with testosterone levels
  3629. hypoactive sexual desire in women
  3630. hypoactive sexual desire: A cognitive model
  3631. hypoactive sexual dysfunction in a young woman
  3632. Hypogonadism and erectile dysfunction: the role for testosterone therapy
  3633. Hypogonadism and metabolic syndrome
  3634. Hypogonadism associated with long-term opioid therapy: A systematic review
  3635. Hypogonadism in human immunodeficiency virus-positive men
  3636. Hypogonadism in Male sexual Dysfunction
  3637. Hypopituitarism
  3638. Hypothalamic Melanocortin 4 Receptors Regulate sexual Behavior in Mice
  3639. Hysterectomy and concurrent oophorectomy for endometrial cancer: which women benefit?
  3640. Hysterectomy and sexual function
  3641. Hysterectomy outcomes: Evaluating the quality of life factors in sexual functioning, physical and emotional health, and partner-satisfaction levels
  3642. Hysterical traits are not from the uterus but from the testis: A study in men with sexual dysfunction
  3643. I Have a Partner
  3644. I–THEORETICAL-METHODOLOGICAL PREPARATION STUDY OF sexual DYSFUNCTIONS
  3645. Iatrogenic and post-traumatic female sexual disorders
  3646. IBA, 260 PCMH screening opportunities for, 254box18. 2 during pregnancy, 358
  3647. Ideal female sexual function
  3648. Ideal partner preferences among adolescents
  3649. Identification of sexual disorders in clinical settings using a brief assessment tool and training program
  3650. Identification of the Gender-Specific Health Needs of Women Following Lung Transplantation
  3651. Identifying and treating sexual dysfunction in postmenopausal women: the role of estrogen
  3652. Identifying HSDD in the family medicine setting
  3653. Identifying objective markers of sexual arousal: Using eye-tracking, pupillometry, and heart rate variability
  3654. Identifying the disruptions in the sexual response cycles of women with sexual Interest/Arousal Disorder
  3655. Identifying what matters to hysterectomy patients: Postsurgery perceptions, beliefs, and experiences
  3656. Ignorance is not bliss: if we don’t understand hypoactive sexual desire disorder, how can flibanserin treat it? Commentary
  3657. II. Antidepressants and sexual behavior: Acute fluoxetine, but not ketamine, disrupts paced mating behavior in sexually experienced female rats
  3658. II. Slow oscillations in vaginal blood flow: Regulation of vaginal blood flow patterns in rat by central and autonomic mechanisms
  3659. III–sexual PROBLEMS EXPERIENCE IN EVERYDAY LIFE
  3660. IJHG review
  3661. Illustrating the circuits of sexual desire
  3662. Imagery, fantasy, and female sexual arousal
  3663. Imaging Data From Phase III Study Support Parathyroid as Bone Builder
  3664. Imbalance in the blood concentrations of selected steroids in pre-pubertal gilts depending on the time of exposure to low doses of zearalenone
  3665. Immature defense mechanisms are associated with lesser vaginal orgasm consistency and greater alcohol consumption before sex
  3666. Immediate processing of erotic stimuli in paedophilia and controls: a case control study
  3667. Immunomodulators and immunosuppressants for patients with relapsing-remitting multiple sclerosis: a network meta-analysis
  3668. Impact of an integrated mindfulness and cognitive behavioural treatment for provoked vestibulodynia (IMPROVED): A qualitative study
  3669. Impact of androgen deprivation therapy on sexual function
  3670. Impact of androgen deprivation therapy on sexual function: a response
  3671. Impact of antidepressant drugs on sexual function and satisfaction
  3672. Impact of apical prolapse surgical correction on the quality of life of women
  3673. Impact of breast hypertrophy on musculoskeletal pain, sexual function and physical activity
  3674. Impact of breast hypertrophy on musculoskeletal pain, sexual function and physical activity.
  3675. Impact of chemotherapy and hormone therapy on female sexual health
  3676. Impact of contraceptive type on sexual desire of women and of men partnered to contraceptive users
  3677. Impact of diabetes mellitus on the sexuality of Peruvian postmenopausal
  3678. Impact of estrogens in males and androgens in females
  3679. Impact of gender on sexual problems and perceptions among urban Malay elderly in Malaysia
  3680. Impact of gynecological surgery on female sexual function
  3681. Impact of health education on preventive therapy with integrated monitoring of Tuberculosis cases
  3682. Impact of hormones on female sexual function and dysfunction
  3683. Impact of hysterectomy or levonorgestrel-releasing intrauterine system on ovarian function, bone, and sexual functioning in menorrhagic patients
  3684. Impact of Incontinence on Female sexual Function
  3685. Impact of Infertility on the sexuality of Couples: an Overview
  3686. Impact of iron supplementation on sexual dysfunction of women with iron deficiency anemia in short term: a preliminary study
  3687. Impact of male partner responses on sexual function in women with vulvodynia and their partners: A dyadic daily experience study.
  3688. IMPACT OF MEDICAL STUDENT WELL-BEING WORKSHOP ON THE MEDICAL STUDENTS’STRESS LEVEL: A PRELIMINARY STUDY
  3689. Impact of Nursing Intervention on Female sexual Problems and Its effect on Husband Satisfaction
  3690. Impact of Obesity on Female sexual Dysfunction: A Remiss
  3691. Impact of opioid therapy on gonadal hormones: focus on buprenorphine
  3692. Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction.
  3693. Impact of Overactive Bladder Syndrome on Female sexual Function
  3694. Impact of physical resistance training on the sexual function of women with polycystic ovary syndrome
  3695. Impact of retirement on depression, a systematic review
  3696. IMPACT OF SELF-CARE GUIDELINES ON FUNCTIONING AND WELL-BEING OF POSTMENOPAUSAL WOMEN WITH AGING VAGINAL SYMPTOMS
  3697. Impact of sexual dysfunction on quality of life among anxiety disorder patients
  3698. Impact of the changing hormonal milieu on psychological functioning
  3699. Impact of the metabolic syndrome on erectile dysfunction
  3700. Impact of the mode of delivery on female sexual function after childbirth
  3701. Impact of thyroid disease on testicular function
  3702. Impact of Trauma on Marital Life
  3703. Impact of treatment induced premature menopause on quality of life following hematopoietic cell transplantation
  3704. Impact of urinary incontinence on female sexual health in women during midlife
  3705. Impact of varicocelectomy on gonadal and erectile functions in men with hypogonadism and infertility
  3706. Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy
  3707. Impacts of medical treatments for lower urinary tract symptoms suggestive to benign prostatic hyperplasia on male sexual functions
  3708. Impaired lipid profile is a risk factor for the development of sexual dysfunction in women
  3709. Impaired masturbation‐induced erections: A new cardiovascular risk factor for male subjects with sexual dysfunction
  3710. Impaired sexual and reproductive outcomes in women with classical forms of congenital adrenal hyperplasia
  3711. Impaired sexual function
  3712. Impairment of couple relationship in male patients with sexual dysfunction is associated with overt hypogonadism
  3713. Implementation of a Bibliotherapy in the treatment of sexual dysfunction. Research review
  3714. Implementing a successful clinical development program for female sexual dysfunctions (aka how to navigate a regulatory minefield)
  3715. Implication of Cigarette Smoking and Cessation on sexual Function in Men and Women
  3716. Implications of diminished ovarian reserve (DOR) extend well beyond reproductive concerns
  3717. Implications of off-label use: An example from the final results of an observational cohort study on Intrinsa®(testosterone patch)
  3718. Implicit and explicit associations with erotic stimuli in sexually functional and dysfunctional men
  3719. Implicit and explicit associations with erotic stimuli in women with and without sexual problems
  3720. Implicit and explicit attitudes toward sex and romance in asexuals
  3721. Implicit and explicit cognitive sexual processes in survivors of childhood sexual abuse
  3722. Implicit and explicit sexual attitudes: How are they related to sexual desire and sexual satisfaction in men and women?
  3723. Implicit Measures in Clinical sex Research: A Critical Evaluation
  3724. Imploding the Diagnostic Statistical Manual
  3725. Importance of gynecological assessment for the treatment of vaginismus as a predictive value
  3726. Impotence and aging: clinical and hormonal factors
  3727. Improved bleeding profile and tolerability of tibolone versus transdermal E2/NETA treatment in postmenopausal women with female sexual dysfunction
  3728. Improved spontaneous erectile function in men with mild‐to‐moderate arteriogenic erectile dysfunction treated with a nightly dose of sildenafil for one year: A …
  3729. Improvement in duration of erection following phosphodiesterase type 5 inhibitor therapy with vardenafil in men with erectile dysfunction: the ENDURANCE study
  3730. Improvement in sexual functioning in patients with type 2 diabetes and depression treated with bupropion
  3731. Improvement in sexual quality of life of the female partner following vardenafil treatment of men with erectile dysfunction: A randomized, double‐blind, placebo …
  3732. Improvement of the quality of the DSM‐IV diagnostic definitions through computerized algorithms using macros in SPSS and SAS language
  3733. Improvements in confidence, sexual relationship and satisfaction measures: results of a randomized trial of tadalafil 5 mg taken once daily
  3734. Improving female sexual health: A quantitative evaluation of an educational intervention for medical and mental health professionals. Helping clinicians take …
  3735. Improving Marital Satisfaction: An Enrichment Program for Couples in the Huntington, New York Seventh-day Adventist Church
  3736. Improving Mind-Body Connection and sexual Response while Strengthening the Pelvic Floor Muscles
  3737. Improving quality of life after breast cancer: dealing with symptoms
  3738. Improving sexual Function in People With Chronic Kidney Disease: A Narrative Review of an Unmet Need in Nephrology Research
  3739. Improving sexual satisfaction in persons with spinal cord injuries: collective wisdom
  3740. Improving the gender-affirmation process for transgender and gender-nonconforming individuals: associations among time since transition began, body satisfaction …
  3741. Improving the management of testosterone deficiency
  3742. Improving the quality of sexuality education programs: emerging evidence from research, relevant challenges for sexology
  3743. Improving the sexual quality of life of couples affected by erectile dysfunction: A double‐blind, randomized, placebo‐controlled trial of vardenafil
  3744. Impulse Control Disorders and Criminal Responsibility: A Neuroscientific Insanity Defense
  3745. Impulsivity and the Experience of desire in the Choice of Erotic Stimuli
  3746. IMS updated recommendations on postmenopausal hormone therapy
  3747. in Aging Adults
  3748. In Focus
  3749. In grateful appreciation of Dr. Margery Gass for her dedication and service to NAMS on her retirement
  3750. In Memoriam: Harold I. Lief, MD
  3751. In premenopausal women with low sexual desire, is flibanserin (Addyi®) an effective and safe treatment?
  3752. In pursuit of ‘good’sex: Self-determination and the sexual experience
  3753. In pursuit of “good” sex: Self-determination and the intimate experience
  3754. In recent years, there has been a veritable explosion in therapeutic approaches, self-help books, and groups aimed at the treatment of “sexual addiction.” In this chap …
  3755. in Relationships
  3756. In search for animal models of female sexual dysfunction
  3757. In search of desire: The role of intimacy, celebrated otherness, and object-of-desire affirmation in sexual desire in women
  3758. In sickness and in health: The effects of hysterectomy on women’s partners and intimate relationships
  3759. In the article appearing in volume 13, pages 770-779, of Menopause, entitled BTestosterone patch for the treatment of hypoactive sexual desire disorder in naturally …
  3760. In the mind and bed of the beholder?: individual and situational differences in the experience of sexual interactions
  3761. IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NORTH DAKOTA SOUTHWESTERN DIVISION
  3762. In their own words: a qualitative content analysis of women’s and men’s preferences for women’s genitals
  3763. In vitro effects of intravenous propofol infusion on cytokine gene expression in rats
  3764. In vitro wound healing potential of the triterpene lupeol isolated from the steam bark of bowdichia virgilioides Kunth
  3765. Inappropriate sexual Behaviors in Dementia
  3766. Incidence and Knowledge of hypoactive sexual desire Disorder and Its Treatment: A Survey [6Q]
  3767. Incidence and prevalence of sexual dysfunction in women and men: a consensus statement from the Fourth International Consultation on sexual Medicine 2015
  3768. Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature
  3769. Incidence and Risk Factors for sexual Dysfunction in Male Patients with Psychotic Disorders
  3770. Incidence of arousal and orgasmic disorders in women with female genital mutilation/cutting
  3771. Incidence of postpartum mood disorders depending on selected risk factors–a logistic regression model
  3772. Incidence of sexual dysfunction: a prospective survey in Ghanaian females
  3773. Including sexual Function in Patient Evaluation in the Rehabilitation Setting
  3774. Incognito libido: Introducing the sexual false self scale
  3775. Incompetence schemas and sexual functioning in heterosexual and lesbian women: the mediator role of automatic thoughts and affective states during sexual activity
  3776. Incorporating mindfulness and chat groups into an online cognitive behavioral therapy for mixed female sexual problems
  3777. Incorporating mindfulness into an internet-based intervention for female sexual dysfunctions
  3778. Incorporating pelvic floor exercises in complete decongestive therapy for females with lower extremity lymphedema, with and without genital involvement, to improve …
  3779. Incorporating sexual medicine into clinical practice
  3780. Incorporating women: A theory of female sexuality informed by psychoanalysis and biological science
  3781. Increasing orgasm and decreasing dyspareunia by a manual physical therapy technique
  3782. Increasing women’s sexual desire: the comparative effectiveness of estrogens and androgens
  3783. Index of sexual Satisfaction (ISS): a study on the reliability and validity
  3784. Individual and dyadic barriers to a pharmacotherapeutic treatment of hypoactive sexual desire disorders: results and implications from a small-scale study with …
  3785. Individual and relationship factors associated with the self-identified inability to experience orgasm in a community sample of heterosexual men from three European …
  3786. Individual differences in women’s salivary testosterone and estradiol following sexual activity in a nonlaboratory setting
  3787. Individual prolactin reactivity modulates response of nucleus accumbens to erotic stimuli during acute cannabis intoxication: an fMRI pilot study
  3788. Indo-American
  3789. Infectious Disease
  3790. Infertility and sexual Dysfunction (SD) in the Couple
  3791. Infertility and sexual dysfunctions: a systematic literature review
  3792. Infertility-related distress and female sexual function during assisted reproduction
  3793. Infidelity and its associated factors: A systematic review
  3794. Infidelity: A practitioner’s guide to working with couples in crisis
  3795. Inflammatory Bowel Diseases and sexual Health: More Studies Are Needed
  3796. Inflatable Penile Prosthesis Washout
  3797. Influence of dyslipidemia on the quality of sexual life in women in the menacme using a combined oral contraceptive
  3798. Influence of genotype and hyperandrogenism on sexual function in women with congenital adrenal hyperplasia
  3799. Influence of methyltestosterone postmenopausal therapy on plasma lipids, inflammatory factors, glucose metabolism and visceral fat: a randomized study
  3800. Influence of self perceived vulvar appearance on female sexual function
  3801. Influence of self‐perceived incontinence severity on quality of life and sexual function in women with urinary incontinence
  3802. Influence of sildenafil on genital engorgement in women with female sexual arousal disorder
  3803. Influence of Unilateral Cryptorchidism on Libido, Haematology and Serum Reproductive Hormones, Total Protein, Lipid Profile and Oxidative Stress in West …
  3804. Influence of weight reduction by sibutramine on female sexual function
  3805. Influence of X-chromosome dosage on masculine behaviors
  3806. Influences of different hysterectomy techniques on patients’ postoperative sexual function and quality of life
  3807. Influences of economic, social and cultural marginalization on the association between alcohol use and sexual risk among formerly incarcerated Latino men
  3808. Influences of situational factors and alcohol expectancies on sexual desire and arousal among heavy-episodic drinking women: Acute alcohol intoxication and …
  3809. Influencias de las cogniciones en el placer sexual femenino.
  3810. INFOPOEMS
  3811. Infusional therapies, continuous dopaminergic stimulation, and nonmotor symptoms
  3812. Inhaled Fluticasone-Salmeterol Better Than Fluticasone Alone for Moderate to Severe Asthma
  3813. Inhibited arousal in women
  3814. Inhibited sexual desire
  3815. Inhibited sexual desire and sexual avoidance
  3816. Inhibited sexual desire in women
  3817. Inhibition of serotonin synthesis: A novel therapeutic paradigm
  3818. Inhibitors of 5 [alpha]-reductase-related side effects in patients seeking medical care for sexual dysfunction
  3819. Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction
  3820. Initiating new sexual behaviours in heterosexual relationships
  3821. Injectable Botulinum Toxin for Pelvic Pain: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines
  3822. Innovations, reviews and proposals on the DSM-5: The case of sexual dysfunctions, gender dysphoria and paraphilic disorders
  3823. Insight of Women’s sexual Function and Intimate Relationships AfterTermination of Pregnancy: A Review on Recent Findings and FuturePerspectives
  3824. Insights into flibanserin oxidative stress degradation pathway: in silico–in vitro toxicity assessment of its degradates
  3825. Insomnia and sexual dysfunction associated with severe worsening of the quality of life in sexually active hysterectomized women
  3826. Instruments for Screening, Diagnosis, and Management of Patients with Generalized Acquired hypoactive sexual desire Disorder
  3827. Instruments to measure sexual dysfunction in community and psychiatric populations
  3828. Insulin resistance and hypogonadism
  3829. Integrated and gender-affirming transgender clinical care and research
  3830. Integrating couple therapy into work with sexual dysfunctions
  3831. Integrating psychotherapy and pharmacotherapy in the treatment of premature ejaculation
  3832. Integrating Psychotherapy and Psychopharmacology
  3833. Integrating Psychotherapy and Psychopharmacology in sexual Disorders
  3834. Integrating sex therapy and couple therapy in the treatment of hypoactive sexual desire disorder: An attachment-based approach
  3835. Integrating sex Therapy and Couple Therapy.
  3836. Integrating sex therapy interventions with couple therapy
  3837. Integrating sexual partners into pharmacological sex therapy
  3838. Integration of medical and psychologic diagnosis and treatment
  3839. Integration of sex and sexuality into counseling programs
  3840. Integrative Therapy in a Woman with Secondary Low sex desire
  3841. Integrative therapy in a woman with secondary low sex desire.
  3842. Integrative Treatment of Female sexual Dysfunction
  3843. Intended or unintended consequences? The likely implications of raising the bar for sexual dysfunction diagnosis in the proposed DSM‐V revisions: 1. For women with …
  3844. Intended or unintended consequences? The likely implications of raising the bar for sexual dysfunction diagnosis in the proposed DSM‐V revisions: 2. For women with …
  3845. Intensified antituberculosis therapy in adults with tuberculous meningitis
  3846. Inter-relationships between sexual abuse, female sexual function and childbirth
  3847. Interacting Factors Between Physical Health, Mental Health, and a Long Quality Life
  3848. Interactions between human sexual arousal and sexual desire: A challenge for social neuroscience
  3849. Interactions between inflammation and female sexual desire and arousal function
  3850. Interactions of catecholamines and progesterone receptors in the medial amygdala enhance female sexual motivation
  3851. Interactions of Sleep and Female sexual Function: a Review
  3852. Intercourse frequency among men presenting to a sexual health clinic: does age matter?
  3853. Interest, arousal, and shifting diagnoses of female sexual dysfunction, or: How women learn about desire
  3854. Intermittent Treatment with the Psychodynamic Psychiatrist: A Patient-Centered Approach
  3855. INTERNAL MEDICINE. Comparison of Prevalence and Female sexual Dysfunction between Diabetic and Non-Diabetic in Kelantan.
  3856. International handbook of psychiatry: a concise guide for medical students, residents, and medical practitioners
  3857. International Journal of Africa Nursing Sciences
  3858. International Journal of Clinical and Health Psychology
  3859. International Journal of Gynaecology Research
  3860. INTERNATIONAL JOURNAL OF PAIN MANAGEMENT
  3861. International Society for sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation
  3862. International Society for the Study of Women’s sexual Health (ISSWSH) Review of Epidemiology and Pathophysiology, and a Consensus Nomenclature and Process …
  3863. Internet and sexuality in Morocco, from cyber habits to psychopathology
  3864. Internet Based Cognitive Behavioral Therapy for sexual Dysfunctions After Breast Cancer
  3865. Internet-based brief sex therapy for heterosexual men with sexual dysfunctions: a randomized controlled pilot trial
  3866. Internet-based cognitive behavioral therapy for DSM-IV sexual dysfunctions in breast cancer survivors: Predictors of treatment response
  3867. Internet-based cognitive behavioral therapy for sexual dysfunctions in women treated for breast cancer: design of a multicenter, randomized controlled trial
  3868. Internet-based cognitive behavioral therapy realizes long-term improvement in the sexual functioning and body image of breast cancer survivors
  3869. Internet‐Based sex Therapy
  3870. Interoception and awareness of physiological sexual arousal in women with sexual arousal concerns
  3871. Interoceptive awareness moderates the relationship between perceived and physiological genital arousal in women
  3872. Interoceptive awareness, alexithymia, and sexual function
  3873. Interpersonal dependency in child abuse perpetrators and victims: A meta-analytic review
  3874. Interpretation of the sexual Functioning Questionnaire in the presence of vulvar pain
  3875. Interprofessional health education and its impact on integral healthcare
  3876. Interrelationship between Androgen Levels, Ageing, and Cognitive Functions
  3877. Intervention: androgens
  3878. Interventions for couples
  3879. Interventions for psychosexual dysfunction in women treated for gynaecological malignancy
  3880. Interventions for sexual dysfunction following treatments for cancer
  3881. Interventions for sexual dysfunction following treatments for cancer in women
  3882. Interventions to address sexual problems in people with cancer: American Society of Clinical Oncology clinical practice guideline adaptation of Cancer Care …
  3883. Interventions to treat erectile dysfunction and premature ejaculation: an overview of systematic reviews
  3884. Interview with Brian S. Alper of DynaMed
  3885. Intestinal Stoma: sexual Dysfunction and Intimacy for Ostomates
  3886. Intimacy and sex therapy
  3887. Intimacy disorders and sexual panic states
  3888. Intimacy in the midst of caregiving: Examining relationship and sexual satisfaction of parents raising children with special needs
  3889. Intimacy, libido, depressive symptoms and marital satisfaction in postpartum couples
  3890. Intimacy, sexual desire and differentiation in couplehood: A theoretical and methodological review
  3891. Intimacy, sexuality, and Fertility Issues Associated With Cancer Treatment
  3892. Intimate partner abuse among women diagnosed with depression
  3893. Intimate partner relationship distress in the DSM‐5
  3894. Intimate stimuli result in fronto-parietal activation changes in anorexia nervosa
  3895. Intimate tablets: digital advocacy and post-feminist pharmaceuticals
  3896. Intimately connected: The importance of partner responsiveness for experiencing sexual desire.
  3897. Intracrinology: The New Science of sex Steroid Physiology in Women
  3898. Intranasal apomorphine. Nastech Pharmaceutical
  3899. Intranasal niosomal in situ gel as a promising approach for enhancing flibanserin bioavailability and brain delivery: In vitro optimization and ex vivo/in vivo evaluation
  3900. Intrapsychic and interpersonal factors related to hypoactive sexual desire
  3901. Intravaginal DHEA for the treatment of vulvovaginal atrophy, intracrinology at work
  3902. Intravaginal energy-based devices and sexual health of female cancer survivors: a systematic review and meta-analysis
  3903. Intravaginal testosterone improves sexual satisfaction and vaginal symptoms associated with aromatase inhibitors
  3904. Intrinsa fails to impress FDA advisory panel
  3905. Intrinsa: An Inquiry into Female sexual Dysfunction and Testosterone
  3906. Intrinsa: testosterone patch for low sexual desire in women
  3907. Intrinsic and extrinsic religiosity and sexual compulsivity with Christian males: understanding concepts and correlations based on race, age and socioeconomic status …
  3908. Intrinsic links among sex, emotion, and reproduction
  3909. Introducing asexuality, unthinking sex
  3910. Introducing sexual dysfunction in mental care
  3911. Introduction and overview: Clinical perspectives on and treatment for sexual desire disorders.
  3912. Introduction and Pharmacodynamics
  3913. Introduction to sexual medicine
  3914. Introduction to special issue on surgical menopause
  3915. Introduction to the special section on contemporary issues in human sexuality: Research and practice.
  3916. Introduction: 2013 Symonds Prize Essay
  3917. Introduction: A Long History of a Pseudoscientific Object
  3918. Introduction: Clinician’s handbook of evidence-based practice guidelines: The role of practice guidelines in systematic quality improvement
  3919. Introduction: New developments in the area of sexual dysfunction (s)
  3920. Introduction: sexual health matters!
  3921. Introduction: the need of sexual medicine in contemporary psychiatry and the need of psychiatry in the growing field of sexual medicine
  3922. Intrusive partners-elusive mates: The pursuer-distancer dynamic in couples
  3923. Inventories for male and female sexual dysfunctions
  3924. Investigating Neuromodulation as a Treatment for Female sexual Dysfunction
  3925. Investigation of ejaculatory disorder by silodosin in the treatment of prostatic hyperplasia
  3926. Investigation of factors affecting sexual disorders in women with breast cancer
  3927. Investigation of Host Factors Required for Lymphocytic Choriomeningitis Virus Entry
  3928. Investigation of the effect of Elaeagnus angustifolia flower capsule on sexual satisfaction and levels of androgenic hormones in 18-40 year old married women …
  3929. Investigation of three Tanacetum L. taxa from Turkey on the proliferation of human prostate cancer cells and expression of detoxification enzyme activities
  3930. Investigation on psychological symptoms improves ANDROTEST accuracy in predicting hypogonadism in subjects with sexual dysfunction
  3931. Investigational noncardiovascular uses of phosphodiesterase-5 inhibitors
  3932. Investigational therapies in the treatment of obesity
  3933. Investigations in sexual Medicine for Women and Men with sexual Health Problems
  3934. Involvement of 5-HT1A and 5-HT2A receptors but not α2-adrenoceptors in the acute electrophysiological effects of cariprazine in the rat brain in vivo
  3935. Iranian Couples Conceptualization of the Role of sexual Socialization in Their sexual desire: A Qualitative Study
  3936. Irreducible volar subluxation of the metacarpophalangeal joint of the thumb
  3937. Is “Dilator Use” More Effective Than “Finger Use” in Exposure Therapy in Vaginismus Treatment?
  3938. Is 100mg Flibanserin Effective in Increasing the Number of sexually Satisfying Events (SSE) in Women with hypoactive sexual desire Disorder (HSDD)?
  3939. Is beautiful always good? Implicit benefits of facial attractiveness
  3940. Is cognitive processing affected in adults with hypospadias?: P300 study
  3941. Is committed desire intentional? A qualitative exploration of sexual desire and differentiation of self in couples
  3942. Is dehydroepiandrosterone a hormone?
  3943. Is dialysis adequacy a useful predictor for sexual function in males and females with end-stage renal disease?
  3944. Is dyspareunia unrelated to early sexual abuse?
  3945. Is early exposure to pornography a risk factor for sexual compulsivity? Findings from an online survey among young heterosexual adults
  3946. Is female sexual dysfunction related to personality and coping? An exploratory study
  3947. Is female sexual function related to the male partners’ erectile function?
  3948. Is Flibanserin a Safe and Effective Treatment to Increase sexual desire in Premenopausal Women with hypoactive sexual desire Disorder?
  3949. Is flibanserin meaningfully superior to placebo?
  3950. Is Healthcare Hazardous to Life? An American Transcendentalist Perspective
  3951. Is hypersexuality dimensional? Evidence for the DSM-5 from general population and clinical samples
  3952. Is it good to be giving in the bedroom? A prosocial perspective on sexual health and well-being in romantic relationships
  3953. Is it sufficent to be a sex therapist to deal efficiently with couples who have sexual problems?
  3954. Is it time to move on from” hypoactive sexual desire disorder?”
  3955. Is menopause a disorder?
  3956. Is mild erectile dysfunction associated with severe psychological symptoms in Chinese patients with moderate-to-severe chronic prostatitis/chronic pelvic pain …
  3957. Is multiple sclerosis only a neurological problem? Evaluation of sexual dysfunctions in a group of multiple sclerosis patients
  3958. Is obesity a further cardiovascular risk factor in patients with erectile dysfunction?
  3959. Is one question enough to detect female sexual dysfunctions? A diagnostic accuracy study in 6,194 women
  3960. Is polycystic ovary syndrome associated with risk of female sexual dysfunction? A systematic review and meta-analysis
  3961. Is pornography use associated with sexual difficulties and dysfunctions among younger heterosexual men?
  3962. Is psychosexual therapy a reliable alternative to bupropion extended-release to promote the sexual function in infertile women? An RCT
  3963. Is responsive sexual desire for partnered sex problematic among men? Insights from a two-country study
  3964. Is Shifting to a Progestin Worthwhile When Estrogen—Progestins Are Inefficacious for Endometriosis-Associated Pain?
  3965. is still important in the elderly
  3966. Is successful lithium augmentation limited to serotonergic antidepressants?(letter). Bschor, Apr, 240 Lack of pharmacologic interaction
  3967. Is testosterone a food for the brain?
  3968. Is Testosterone an Effective Hormonal Therapy for Women With Antidepressant-Resistant Major Depression?
  3969. Is testosterone involved in low female sexual desire?
  3970. Is testosterone or estradiol the hormone of desire? A novel study of the effects of testosterone treatment and aromatase inhibition in postmenopausal women
  3971. Is Testosterone the Hormone of desire? For Some Women, Some of the Time
  3972. Is the coital imperative really imperative? An exploratory study of the experience of individuals in heterosexual relationships who have been unable to have …
  3973. Is the Female sexual Function Affected by the Vaginal Wall Prolapse?
  3974. Is the functional ‘normal’? Aging, sexuality and the bio-marking of successful living
  3975. Is the hype around the reproductive health claims of maca (Lepidium meyenii Walp.) justified?
  3976. Is the metabolic syndrome a risk factor for female sexual dysfunction in sexually active women?
  3977. Is the sexual satisfaction of postmenopausal women enhanced by physical exercise and pelvic floor muscle training?
  3978. Is there a correlation between androgens and sexual desire in women?
  3979. Is there a gender difference in strength of sex drive? Theoretical views, conceptual distinctions, and a review of relevant evidence
  3980. Is there a link between social phobia and sexual problems?
  3981. Is there a role for testosterone therapy in postmenopausal women?
  3982. Is there a role for testosterone therapy in premenopausal women?
  3983. Is There a Space to Improve the Treatment of Erectile Dysfunction in the Next Years?
  3984. Is There a Space to Improve the Treatment of Erectile Dysfunction in the Next Years? Opinion: No. Ten reasons that there will be no new pharmacologic …
  3985. Is There an Association Between Vitamin D Deficiency and Erectile Dysfunction? A Systematic Review and Meta-Analysis
  3986. Is This Really a Disease?
  3987. Is Tribulus Terrestris Effective at Increasing sexual desire in Adult Women Suffering from hypoactive sexual desire Disorder?
  3988. Is vulvovaginal atrophy due to a lack of both estrogens and androgens?
  3989. Isolation and structural elucidation of flibanserin as an adulterant in a health supplement used for female sexual performance enhancement
  3990. Issues for DSM-V: sexual dysfunction, disorder, or variation along normal distribution: Toward rethinking DSM criteria of sexual dysfunctions
  3991. Issues in Differential Diagnosis of Sesxual Dysfunction: Mental and Physical Dysorders
  3992. Issues in the laboratory study of human sexual response: A synthesis for the nontechnical sexologist
  3993. Issues in Women’s Health
  3994. Issues of Isolation and Intimacy
  3995. Issues regarding sexuality
  3996. Issues relating to quality of life in postmenopausal women and their measurement
  3997. ISSWSH special report on the US Food and Drug Administration draft guidance on low sexual desire and arousal: a new hope or old habits die hard?
  3998. It takes two: sexual communication patterns and the sexual and relational adjustment of couples coping with provoked vestibulodynia
  3999. It’s not just about sex: Asexual identity and intimate relationship practices
  4000. It’s not the size of the boat or the motion of the ocean: The role of self-objectification, appearance anxiety, and depression in female sexual functioning
  4001. IU GERIATRICS e-news for JULY 2004
  4002. JAMA Internal Medicine
  4003. Janet Froeschle Hicks
  4004. Jann Adams (3) Department of Psychology, Morehouse College, Atlanta, Georgia 30314 K. Angeleque Akin-Little (369) Department of Educational and School …
  4005. Javaad Zargooshi, Elham Rahmanian, Hiva Motaee
  4006. JAYPEE BROTHERS
  4007. Jennifer S. Coelho
  4008. Job-related strain and sexual health difficulties among heterosexual men from three European countries: The role of culture and emotional support
  4009. John P. Wincze Amy K. Bach
  4010. JOURNAL OF MANAGED
  4011. Journal of Pharmaceutical Tehnology Research and Management
  4012. Journal: Encyclopedia of sexuality and Gender, 2019, p. 1-8
  4013. Joyce In and Out of Character: The Syntheses, Oppositions, and Archetypes of” A Painful Case”
  4014. Juan Arias,’19
  4015. Judy Chicago, feminist artist and educator
  4016. Just ask! Talking to patients about sexual function
  4017. K a ren A. Hanson
  4018. Kaplan’s Triphasic Model
  4019. Karl Strecker, Michael Adamaszek, Sven Ohm, Florian Wegner, Jürgen Beck &
  4020. Karolinska Psychodynamic Profile for sexual Disorders: KAPP-SD. A proposal for a psychodynamic rating scale for sexual disorders
  4021. Kathy M. Sanders
  4022. Kava for the Treatment of Generalized Anxiety
  4023. Keeping the spark alive: Being motivated to meet a partner’s sexual needs sustains sexual desire in long-term romantic relationships
  4024. Kellner’s Symptom Questionnaire, a highly sensitive patient-reported outcome measure: systematic review of clinimetric properties
  4025. Kidney Disease
  4026. Kidney-pancreas transplantation is associated with near-normal sexual function in uremic type 1 diabetic patients
  4027. Kids Now Plus FY2009 Annual Report
  4028. Klinefelter’s syndrome: a clinical and therapeutical update
  4029. Knowledge gaps in urologic care of female spinal cord injury patients
  4030. Knowledge of dyfuntion among students at the university of Witwatersrand
  4031. Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived Cells
  4032. Kundaini Awakening, the Physical and Psychological Aspects
  4033. L. Vignozzi, N. Malavolta, P. Villa, G. Mangili, S. Migliaccio & S. Lello
  4034. La seduction: How the French play the game of life
  4035. La terapia cognitivo-comportamentale nelle disfunzioni sessuali.
  4036. Labia Minora Surgery in the Adolescent Population: A Cross-Sectional Satisfaction Study
  4037. Labial paraffinoma in menopause women
  4038. Lack of ‘responsive’sexual desire in women: implications for clinical practice
  4039. Lack of increase in sexual drive and function after dopaminergic stimulation in women
  4040. Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women
  4041. Lack of sexual privacy affects psychological and marital domains of male sexual dysfunction
  4042. Lakeman MME Laan E
  4043. Laparoscopic supracervical hysterectomy with transcervical morcellation: our experience
  4044. Laparoscopic versus vaginal cuff closure in laparoscopic hysterectomy: does it affect female sexuality?
  4045. Largest Study of its Kind Reveals Low sexual desire is Most Common Female sexual Problem
  4046. Laser Doppler Imaging as a Measure of Female sexual Arousal: Further Validation and Methodological Considerations
  4047. Laser Doppler imaging: A new measure of genital blood flow in female sexual arousal
  4048. Laser Vaginal Tightening (LVT)–evaluation of a novel noninvasive laser treatment for vaginal relaxation syndrome
  4049. Late effects and long-term follow-up
  4050. Late positive potential to explicit sexual images associated with the number of sexual intercourse partners
  4051. Late-life psychiatric diagnosis in DSM-IV
  4052. Late‐Life sexuality
  4053. Late‐stage clinical development in lower urogenital targets: sexual dysfunction
  4054. Late‐Stage Isotopic Carbon Labeling of Pharmaceutically Relevant Cyclic Ureas Directly from CO2
  4055. Latent structures of female sexual functioning
  4056. Latent structures of male sexual functioning
  4057. Lateral episiotomy versus no episiotomy to reduce obstetric anal sphincter injury in vacuum-assisted delivery in nulliparous women: study protocol on a …
  4058. Latin American and Latina/Latino Issues in sexual Health
  4059. Latina adolescent sexual desire
  4060. Lauren Streicher and James A. Simon
  4061. Laxity of the vaginal introitus after childbirth: nonsurgical outpatient procedure for vaginal tissue restoration and improved sexual satisfaction using low-energy …
  4062. Learned but Not Chosen: A Reward Competition Feedback Model for the Origins of sexual Preferences and Orientations
  4063. Learning DSM-5® by Case Example
  4064. Learning from lab-rat love
  4065. Learning to be a Girl: Gender, Risks and Legal Drugs Amongst Spanish Teenagers
  4066. Leaving a lot to be desired? sex therapy and the discourses of heterosex
  4067. Legal abortion
  4068. Legitimate Medicine in the Age of Consumerism
  4069. LEI (Lack of tEstosterone Impact) survey in a clinical sample with surgical menopause
  4070. Lesbian sexuality post-Stonewall to post-modernism: Putting the “lesbian bed death” concept to bed
  4071. Lesbian, gay, bisexual, trans, intersex, and queer psychology: An introduction
  4072. Lesbians and female sexual dysfunction—
  4073. Lessons from great lovers
  4074. Let us integrate sexual health—do psychiatrists integrate sexual health in patient management?
  4075. Let’s talk about chemsex and pleasure: the missing link in chemsex services
  4076. Let’s talk about sex
  4077. Let’s talk about sex-and drugs
  4078. Let’s talk about sex: a critical narrative analysis of heterosexual couples’ accounts of low sexual desire
  4079. Let’s talk about sex: A survey of patients’ preferences when addressing sexual health concerns in a family medicine residency program office
  4080. Let’s Talk About sex: Constructing a Scale Measuring Comfort with sexual Topics
  4081. Let’s talk about sexuality and relationships
  4082. Letters Copyright ª by t he American College of Obstetricians
  4083. Letters to the FDA critical of the flibanserin application by Boehringer-Ingelheim for a wide variety of reasons from a wide variety of interested persons Mostly …
  4084. Leukocytospermia in late adolescents: possible clinical interpretations
  4085. Level of bother and treatment-seeking predictors among male and female in-patients with sexual problems: a hospital-based study
  4086. Lexicon of psychiatric and mental health terms
  4087. LGBTA: Asexuality Becomes a Movement
  4088. LGBTQ Cultural Humility for the Urology Healthcare Provider
  4089. LGBTQ cultures: What health care professionals need to know about sexual and gender diversity
  4090. LGGL GGLGGGL GLGLGLG GLL GGGGL ADOLESCENTS
  4091. lI Didnit Hurt You, but if I Did I Had a Good Reason! m
  4092. Libido and sexual function in the menopause
  4093. Libido in Limbo: sexuality and the mature woman
  4094. Life after infertility treatment: a long-term investigation of marital and sexual function.
  4095. Life quality and physical activity frequency in older adults from community groups, Chillán commune, Chile
  4096. Lifestyle and Over‐the‐Counter Drugs
  4097. Lifestyle choices can augment female sexual well-being
  4098. Lifestyle Drugs in Old Age–A Mini-Review
  4099. Lifestyle modifications alone or combined with hormonal contraceptives improve sexual dysfunction in women with polycystic ovary syndrome
  4100. Lifestyles and sexuality in men and women: the gender perspective in sexual medicine
  4101. Light therapy as a treatment for sexual dysfunctions
  4102. Light therapy as a treatment for sexual dysfunctions–beyond a pilot study
  4103. Limited usefulness of meta-analysis for informing patient care
  4104. Linguistic changes in expressive writing predict psychological outcomes in women with history of childhood sexual abuse and adult sexual dysfunction.
  4105. Listening to placebo in clinical trials for female sexual dysfunction
  4106. Listening to those with lived experience
  4107. Listmania!
  4108. LITERATURE ARE ORGANIZED UNDER THE FOLLOWING
  4109. Literature review: a critical update
  4110. Living with dyspareunia: A qualitative study
  4111. Localization of the Androgen‐Synthesizing Enzymes, Androgen Receptor, and sex Steroids in the Vagina: Possible Implications for the Treatment of Postmenopausal …
  4112. London & South East Medicines Information Service
  4113. Long term effect of vaginal delivery and cesarean section on female sexual function in primipara mothers
  4114. Long-term assessment of the physical, mental, and sexual health among transsexual women
  4115. Long-term consequences of medical therapy for benign prostatic hyperplasia
  4116. Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial
  4117. Long-term effects of hysterectomy: a focus on the aging patient
  4118. Long-term experience of vaginal vault prolapse prevention at hysterectomy time by modified McCall culdoplasty or Shull suspension: Clinical, sexual and quality of life …
  4119. Long-Term Favorable Effects of Physical Exercise on Burdensome Symptoms in the OptiTrain Breast Cancer Randomized Controlled Trial
  4120. Long-term health consequences of premature or early menopause and considerations for management
  4121. Long-term preventive care in depression: the use of bupropion in patients intolerant of other antidepressants.
  4122. Long-term safety and efficacy of bremelanotide for hypoactive sexual desire disorder
  4123. Long-term sexual function in survivors of vulvar cancer: a cross-sectional study
  4124. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in …
  4125. Long‐term treatment of erectile dysfunction with a phosphodiesterase‐5 inhibitor and dose optimization based on nocturnal penile tumescence
  4126. Longitudinal changes in sexual problems related to cancer treatment in Korean breast cancer survivors: a prospective cohort study
  4127. Longitudinal changes over three years in sex steroid hormone levels in women aged 70 years and over
  4128. Longitudinal modeling of dyadic data
  4129. Losing My Dad
  4130. Loss of desire–what about the fun?((Female sexual problems, part 1)(ABC of sexual Health)
  4131. Loss of libido in Parkinson’s disease
  4132. Loss of libido in postmenopausal women
  4133. Loss of sexual desire in the postmenopausal woman
  4134. Love Drugs: The Chemical Future of Relationships
  4135. Love in the time of COVID-19: sexual function and quality of life analysis during the social distancing measures in a group of Italian reproductive-age women
  4136. Love protects lover’s life
  4137. Love, sex and Oxytocin
  4138. Love. com: Young People with Intellectual Disabilities and the Usage of the Internet
  4139. Low desire, trauma and femininity in the DSM-5: a case for sequelae
  4140. Low Libido
  4141. Low prebiopsy state irritability scores at the clinical onset of invasive breast carcinoma
  4142. Low prolactin is associated with sexual dysfunction and psychological or metabolic disturbances in middle-aged and elderly men: the European Male Aging Study …
  4143. Low Rates of Insomnia Associated With Flibanserin in Premenopausal Women With hypoactive sexual desire Disorder [21Q]
  4144. Low sexual desire
  4145. Low sexual desire Disorder
  4146. Low sexual desire Disorder
  4147. Low sexual desire in heterosexual committed couples: An education intervention
  4148. Low sexual desire in midlife and older women: personality factors, psychosocial development, present sexuality
  4149. LOW sexual desire IN WOMEN
  4150. Low sexual desire in women: amongst the confusion, could distress hold the key?
  4151. Low sexual desire in women: The effects of marital therapy
  4152. Low sexual desire in women: The role of reproductive hormones
  4153. Low sexual desire—is it all in her head? Pathophysiology, diagnosis, and treatment of hypoactive sexual desire disorder
  4154. Low sexual function and its associated risk factors in pre-and postmenopausal women without clinically significant depression
  4155. Low stress hormones linked to low sexual desire
  4156. Low testosterone levels and metabolic syndrome in aging male
  4157. Low-dose testosterone augmentation for antidepressant-resistant major depressive disorder in women: an 8-week randomized placebo-controlled study
  4158. Low-dose transdermal testosterone augmentation therapy improves depression severity in women
  4159. Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study
  4160. Lower urinary tract symptoms and sexual dysfunction in women
  4161. Lower urinary tract symptoms in women and quality of life
  4162. Lumping, Splitting, and treating: therapies are needed for women with overlapping sexual dysfunctions
  4163. Lust for life
  4164. Lust: What we know about human sexual desire
  4165. Lust? Love? Status? Young adults’ motives for engaging in casual sex
  4166. M edical S erie S
  4167. Main Article Content
  4168. Maintaining our sexual desires despite difficulties: A workshop for couples experiencing sexual dysfunction
  4169. Maintaining physiologic testosterone levels during combined oral contraceptives by adding dehydroepiandrosterone: II. Effects on sexual function. A phase II …
  4170. Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects
  4171. Maintaining postreproductive health: a care pathway from the European Menopause and Andropause Society (EMAS)
  4172. Maintaining sexual desire in intimate relationships: The importance of approach goals.
  4173. Maintaining sexual desire in long-term relationships: A systematic review and conceptual model
  4174. Maintaining sexual health throughout gynecologic cancer survivorship: A comprehensive review and clinical guide
  4175. Maintaining sexuality in menopause
  4176. Maintenance in Couple and Family Therapy
  4177. Major changes are proposed for definitions of female sexual dysfunction
  4178. Making Distinctions
  4179. Making Marriage Work: Avoiding the Pitfalls and Achieving Success
  4180. Making sense in and of the asexual community: Navigating relationships and identities in a context of resistance
  4181. Making the case for sexual pain: Let’s not throw out the baby with the bath water
  4182. Making us crazy
  4183. Maladaptive defense mechanisms are associated with decoupling of testosterone from sexual desire in women of reproductive age
  4184. Male and female sexual dysfunction
  4185. Male and female sexual dysfunction in diabetic subjects: Focus on new antihyperglycemic drugs
  4186. Male and Female sexual Dysfunction in Pediatric Cancer Survivors
  4187. Male and female sexual function after surgical repair of female organ prolapse
  4188. Male erectile disorder
  4189. Male hypoactive sexual desire disorder
  4190. Male hypoactive sexual desire disorder
  4191. Male hypoactive sexual desire disorder: A conceptual model and case study
  4192. Male infertility
  4193. Male infertility in reproductive medicine: diagnosis and management
  4194. Male infertility: A major problem worldwide and its management in Ayurveda.
  4195. Male infertility: an obstacle to sexuality?
  4196. Male partners of women with provoked vestibulodynia: Attributions for pain and their implications for dyadic adjustment, sexual satisfaction, and psychological distress
  4197. Male rats that differ in novelty exploration demonstrate distinct patterns of sexual behavior.
  4198. Male reproductive physiology as a sexually selected handicap? Erectile dysfunction is correlated with general health and health prognosis and may have evolved as a …
  4199. Male sexual and Reproductive Health
  4200. Male sexual arousal elicited by film and fantasy matched in content
  4201. Male sexual desire disorder
  4202. Male sexual desire: an overview of biological, psychological, sexual, relational, and cultural factors influencing desire
  4203. Male sexual disorders
  4204. Male sexual disorders: options for psychotherapeutic treatment
  4205. Male sexual dysfunction
  4206. Male sexual dysfunction
  4207. Male sexual dysfunction
  4208. Male sexual dysfunction
  4209. Male sexual dysfunction and chronic kidney disease
  4210. Male sexual Dysfunction in Psychiatric Illnesses
  4211. MALE sexual DYSFUNCTION, DEPRESSION, AND PHARMACOLOGICAL TREATMENTS: BIOLOGIC INTERACTIONS
  4212. Male sexual dysfunction, leptin, pituitary and gonadal hormones in nigerian males with metabolic syndrome and type 2 diabetes mellitus
  4213. Male sexual dysfunction: continuing medical education
  4214. MALE sexual DYSFUNCTION: CURRENT TREATMENT APPROACHES
  4215. Male sexual dysfunctions
  4216. Male sexual Dysfunctions
  4217. Male sexual Dysfunctions 11
  4218. Male sexual dysfunctions and homosexuality
  4219. Male sexual Function
  4220. Male sexual Function and Dysfunction
  4221. Male sexual function and its disorders: physiology, pathophysiology, clinical investigation, and treatment
  4222. Male sexual Quality Of Life Is Maintained Satisfactorily Throughout Life In The Amazon Rainforest
  4223. Male sexuality
  4224. Male sexuality
  4225. Male sexuality
  4226. Male sexuality and cardiovascular risk. A cohort study in patients with erectile dysfunction
  4227. Male-Affirmative Couple sex Therapy
  4228. Male-Sensitive Couples Counseling
  4229. Male–female differences in the effects of cannabinoids on sexual behavior and gonadal hormone function
  4230. Malignant transformation of tubal precursors into serous ovarian cancer
  4231. Malleable (semi-rigid) penile prosthesis (MPP)
  4232. Mammy, Sapphire, and Jezebel: Historical images of Black women and their implications for psychotherapy.
  4233. Man and His Penis- A Relationship Under Threat?
  4234. Management and rehabilitation of neurologic patients with sexual dysfunction
  4235. Management of common disorders in psychosexual medicine
  4236. Management of common problems in obstetrics and gynecology
  4237. MANAGEMENT OF ENDOCRINE DISEASE: Female sexual dysfunction for the endocrinologist
  4238. Management of female sexual dysfunction
  4239. Management of female sexual problems: perceived barriers, practice patterns, and confidence among primary care physicians and gynecologists
  4240. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American …
  4241. Management of hypoactive sexual desire disorder
  4242. Management of hypoactive sexual desire disorder
  4243. Management of hypoactive sexual desire disorder (HSDD)
  4244. Management of hypoactive sexual desire disorder in transgender women: a guide for clinicians
  4245. MANAGEMENT OF hypoactive sexual desire DISORDER IN WOMEN: AWARENESS AND TREATMENTS
  4246. Management of hypoactive sexual desire disorder in women: current and emerging therapies
  4247. Management of hypopituitarism
  4248. Management of idiopathic chronic pelvic pain
  4249. Management of Klinefelter syndrome during transition
  4250. Management of perimenopause disorders: hormonal treatment
  4251. Management of premature ejaculation: a clinical guideline from the Italian Society of Andrology and sexual Medicine (SIAMS)
  4252. Management of premature ejaculation: an update
  4253. Management of premature ovarian failure
  4254. Management of premenstrual syndrome
  4255. Management of psychosexual problems in primary care
  4256. Management of sexual dysfunction in breast cancer survivors: a systematic review
  4257. Management of sexual Dysfunction in Men and Women
  4258. Management of sexual dysfunction in men and women: an interdisciplinary approach
  4259. Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus Panel
  4260. Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy
  4261. Management of sexual problems in cancer patients and survivors
  4262. Management of treatment-related sexual complications in cancer care: evidence for erectile function recovery and penile rehabilitation after radical prostatectomy in …
  4263. Management of urologic and sexual dysfunction in Parkinson disease
  4264. Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review
  4265. Management strategies for antidepressant-related sexual dysfunction: a clinical approach
  4266. Management Strategies for Antipsychotic-Related sexual Dysfunction: A Clinical Approach
  4267. Management Strategies for sexual Health After Breast Cancer Diagnosis
  4268. Management strategies for the ovaries at the time of hysterectomy for benign disease
  4269. Management strategies in SSRI-associated sexual dysfunction in women at midlife
  4270. Management strategies of sexual dysfunctions
  4271. Managing common problems in the menopause
  4272. Managing disability in progressive multiple sclerosis
  4273. Managing female sexual dysfunction
  4274. Managing Female sexual Dysfunction in the 21 st Century
  4275. Managing hypoactive sexual desire in women
  4276. Managing Infertility Due to Endocrine Causes
  4277. Managing low sexual desire in women
  4278. Managing menopause abstract and summary statement
  4279. Managing premature ovarian insufficiency
  4280. Managing short-term menopausal symptoms (Section 8)
  4281. Managing the hypoactive sexual desire Disorder in Women
  4282. Managing the Risks of Medicines: An Examination of FDA’s Application of Criteria for Requiring a REMS
  4283. Managing Urological Disorders in Multiple Sclerosis Patients: A Review of Available and Emerging Therapies
  4284. Managing women with sexual dysfunction: difficulties experienced by Malaysian family physicians
  4285. Managing Women’s Health Issues Across a Lifespan
  4286. Managing women’s health issues across a lifespan: NPWH 2017-2018 regional meetings
  4287. Managing Women’s Hyperandrogenism
  4288. Mandatory Vaccination or Termination of Employment
  4289. Manual for clinical psychology trainees
  4290. Manualized treatment programs for FSD: Research challenges and recommendations
  4291. Mapping in Structural Family Therapy
  4292. Marcel D. Waldinger January 17, 1955–May 1, 2019
  4293. Margaret McCartney: Flibanserin for low sexual desire is not feminism
  4294. Marginalisierung in der Marginalität?: Ein Blick auf digitale Räume anhand sprachlicher Konstruktionen von randständigen Positionen im Kontext von Asexualität
  4295. Margolin, Gayla
  4296. Marital adjustment of educated working and educated non working women as a factor of communication style with their spouses
  4297. Marital and sexual aspects of old age
  4298. Marital and sexual functioning and dysfunctioning, depression and anxiety
  4299. marital burnout
  4300. Marital problems.
  4301. Marital Satisfaction and Satisfaction With Life: Mediating Role of sexual Satisfaction in Married Women
  4302. Marital satisfaction in menopausal women with and without sexual dysfunction
  4303. Marital satisfaction, sexual problems, and the possible difficulties on sex therapy in traditional Islamic culture
  4304. Marital Schism in Couples
  4305. Marital style and its effects on sexual desire and functioning
  4306. Marital/family developmental theory as a context for understanding and treating inhibited sexual desire
  4307. Marjan Khajehei, Maryanne Doherty &
  4308. Mark Kim Malan Ph. D., MPH, Walter R. Schumm Ph. D., Jennifer Ripley Ph. D. & Brian D. Zamboni Ph. D.
  4309. Marketing messages in continuing medical education (CME) modules on binge-eating disorder (BED)
  4310. Marking territory—now and for the future
  4311. Markman, Howard
  4312. Markus Wiegel John P. Wincze David H. Barlow
  4313. Marriage and Family Therapist Workshop: Enhancing Marriage and Family Therapists’ Comfort and Ability to Discuss sexuality with Baby Boomers
  4314. Marriage and family therapy with people from China
  4315. Marriage and motherhood are associated with lower testosterone concentrations in women
  4316. Married women’s and men’s experiences regarding the concept of sexual desire: A qualitative research
  4317. Marta Caretto, Andrea Giannini, Eleonora Russo
  4318. Marta Meana Yitzchak M. Binik Lea Thaler
  4319. Mass Spectrometry-Based Rapid Quantitative Bioanalysis of Flibanserin: Pharmacokinetic and Brain Tissue Distribution Study in Female Rats
  4320. Master Conflict Therapy: A New Model for Practicing Couples and sex Therapy
  4321. Master’s Level Training in Couple and Family Therapy
  4322. Masters, William
  4323. Masturbation and pornography use among coupled heterosexual men with decreased sexual desire: How many roles of masturbation?
  4324. Match (Brain). Com: A Review of the Neurochemical Foundations for the Behaviors
  4325. Mate choice could be random in female rats (Rattus norvegicus)
  4326. Maternal overweight and sexual function in pregnancy
  4327. Maturana, Humberto
  4328. Mature sexual Intimacy: Making Menopause a Turning Point not an Ending
  4329. Maxillofacial Signs and Symptoms of Parkinson’s Disease and Their
  4330. Maximizing the post-approval safety of flibanserin: a role for regulators, clinicians, and patients
  4331. MCG Medicine [Fall 2013]
  4332. McMaster Family Therapy
  4333. MCQs for the New MRCPsych Paper A with Answers Explained
  4334. MDR1 in paroxetine-induced sexual dysfunction
  4335. Meaningful Treatment Benefit from the Patient’s Perspective
  4336. Meanings of sexuality among heterosexual women: a metasynthesis
  4337. Measurement of metabolic monitoring in youth and adult Medicaid recipients prescribed antipsychotics
  4338. Measurement of sexual Functioning After Spinal Cord Injury: Preferred Instruments: Report of the National Institute on Disability and Rehabilitation Research Spinal …
  4339. Measurement of testosterone in human sexuality research: Methodological considerations
  4340. Measuring Iranian women’s sexual behaviors: Expert opinion
  4341. Measuring multiple aspects of the sexual self-concept: The Multidimensional sexual Self-Concept Questionnaire
  4342. Measuring sexual health: preliminary development of a sexual health inventory
  4343. Measuring sexual quality of life: Ten recommendations for health psychologists.
  4344. Measuring social invisibility and erasure: Development of the Asexual Microaggressions Scale
  4345. Measuring Women’s Satisfaction with Treatment for sexual Dysfunction: Development and Initial Validation of the Women’s Inventory of Treatment Satisfaction (WITS …
  4346. Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder
  4347. Mechanisms that underlie cultural disparities in women’s sexual desire: the role of sex guilt and its treatment
  4348. Medical and Surgical Causes of Male sexual Dysfunction
  4349. Medical applications of Infrared thermography: A narrative review
  4350. Medical conditions and sexual dysfunction in post-menopausal women
  4351. Medical entanglements: Rethinking feminist debates about healthcare
  4352. Medical family therapy
  4353. Medical history, physical examination, and laboratory tests for the evaluation of dyspareunia
  4354. Medical implications of erectile dysfunction
  4355. Medical Management of Age-Related Hormonal Changes That Affect sexual Function
  4356. Medical management of libido disturbances in treated hypertensive patients: differences between men and women
  4357. Medical marketing in the United States, 1997-2016
  4358. Medical nihilism: by Jacob Stegenga, Oxford, Oxford University Press, 2018, 256 pp.,£ 31.99 (hardback), ISBN: 9780198747048
  4359. Medical student debts could rise to more than£ 70 000 under Browne proposals, BMA says
  4360. Medical students’ sexuality–beliefs and attitudes
  4361. Medical students’ sexuality–development and fulfilment of sexual needs
  4362. Medical therapy for female sexual dysfunction
  4363. Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily
  4364. Medical treatment or surgery for colorectal endometriosis? Results of a shared decision-making approach
  4365. Medical treatments for sexual problems in women
  4366. MEDICAL VOCABULARY
  4367. Medicalization (psychiatricization) of distress
  4368. Medicalization of sexuality
  4369. Medicalization of women’s sexual problems: A different story?
  4370. Medication Use and sexual Function: A Population-Based Study in Middle Aged Women
  4371. Medications and sexual function and dysfunction
  4372. Medications and sexual function.
  4373. Medications with the potential to enhance sexual responsivity in women
  4374. Medicinal plants as alternative treatments for female sexual dysfunction: utopian vision or possible treatment in climacteric women?
  4375. Medicinal plants/herbal supplements as female aphrodisiacs: Does any evidence exist to support their inclusion or potential in the treatment of FSD?
  4376. Medroxyprogesterone acetate, nocturnal penile tumescence, laboratory arousal, and sexual acting out in a male with schizophrenia
  4377. MEETING OF THE sexual MEDICINE SOCIETY OF NORTH AMERICA, MIAMI BEACH, USA, NOVEMBER 20–23, 2014
  4378. Meeting sexual Dysfunction Again for the First Time
  4379. Meeting sexual health requirements in menopause
  4380. Melanocortin receptor agonists in the treatment of male and female sexual dysfunctions: results from basic research and clinical studies
  4381. Melanocortin-4 receptor (MC4R) agonists for the treatment of obesity
  4382. Melanotan Tanning Injection: A Rare Cause of Priapism
  4383. Memories of you: On women’s sexual desire
  4384. men who ausal facto subsequent
  4385. Men with hypoactive sexual desire disorder: The role of interpersonal dependency and assertiveness
  4386. Men with sexual problems and their partners: Findings from the International Survey of Relationships
  4387. Men, intimacy, and eroticism
  4388. Men, s and Women, s sexual health and dysfunction among students population.
  4389. Men’s aging and sexual disorders: An update on diagnosis and treatment
  4390. Men’s health and aging: The 5th world congress on the aging male
  4391. Men’s health: sexual dysfunction, physical, and psychological health—is there a link?
  4392. Men’s preferences for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia: a discrete choice experiment
  4393. Men’s sexual health and the metabolic syndrome
  4394. Men’s sexual Issues After Breast Cancer in Their Wives
  4395. Men’s sexual issues after breast cancer in their wives: a qualitative study
  4396. Men’s sexual response to female partner’s intranasal oxytocin administration for hypoactive sexual desire disorder: an open prospective cohort study
  4397. Men’s sexual response to female partner’s intranasal oxytocin administration for hypoactive sexual desire disorder: an open prospective cohort study
  4398. Menopausal Hormone Therapy to Prevent Chronic Conditions
  4399. Menopausal Hormone Therapy: a Comprehensive Review
  4400. Menopausal hormone treatments and risk of cardiovascular diseases: modern view
  4401. Menopausal Remediation and Quality of Life (QoL) Improvement: Insights and Perspectives
  4402. Menopausal sexual Interest Questionnaire (MSIQ): a unidimensional scale for the assessment of sexual interest in postmenopausal women
  4403. Menopausal status in breast cancer patients with past chemotherapy determines long-term hypoactive sexual desire disorder
  4404. Menopausal symptoms
  4405. Menopausal transition: between physiology and psychology
  4406. Menopause and aging
  4407. Menopause and aging, quality of life and sexuality: International Menopause Society Expert Workshop 1–4 December 2006, Pisa, Italy
  4408. Menopause and care of the mature woman
  4409. Menopause and Obesity: A Risk Factor for sexual Dysfunction?
  4410. MENOPAUSE AND sexual ACTIVITY
  4411. Menopause and sexual desire: the role of testosterone
  4412. Menopause and sexuality
  4413. Menopause and sexuality: key issues in premature menopause and beyond
  4414. Menopause and sexuality: prevalence of symptoms and impact on quality of life
  4415. Menopause and the postmenopausal women
  4416. Menopause and Women’s sexuality
  4417. Menopause as a Manifestation of Aging
  4418. Menopause for the MRCOG and Beyond
  4419. Menopause hormone therapy: latest developments and clinical practice
  4420. Menopause Maze
  4421. Menopause negatively impacts sexual lives of middle-aged Iranian women: a cross-sectional study
  4422. Menopause pharmacology
  4423. Menopause symptom management in women with dyslipidemias: An EMAS clinical guide
  4424. Menopause, hormones and sex: The role of the doctor
  4425. Menopause, libido and the Internet
  4426. Menopause: A Contextualized Experience Across Social Structures
  4427. Menopause: evidence-based practice
  4428. Menopause: the best chapter of our lives
  4429. Menopause: The Concepts and the Biological Background
  4430. Menopause. A problem that is not out of date. Specialist comment and updated data from the National Consensus on the Management of Patients in …
  4431. Menstrual cycle phase modulates cognitive control over male but not female stimuli
  4432. Menstrual cycle‐related changes in circulating androgens in healthy women with self‐reported normal sexual function
  4433. Mental disorder and social deviance
  4434. Mental health after unintentional injury in a pediatric managed-medicaid population
  4435. Mental Health and Mental Disorders: An Encyclopedia of Conditions, Treatments, and Well-Being [3 volumes]: An Encyclopedia of Conditions, Treatments …
  4436. Mental health and sexual medicine: an update
  4437. Mental health around and after the menopause
  4438. Mental Health as a Basic Human Right and the Interference of Commercialized Science
  4439. Mental Health Disorders and Case
  4440. Mental Health over the Life Span
  4441. Mental health professionals’ pathologization of compulsive sexual behavior: Does clients’ gender and sexual orientation matter?
  4442. Mental illness is NOT “an illness like any other”
  4443. Mental Research Institute
  4444. Mental well-being in polyamorous and monogamous relationship
  4445. Mentally Disordered Offenders: What Research Says
  4446. Merging of marketing and medical science: female sexual dysfunction
  4447. Mesosystems in Family Systems Theory
  4448. Meta-analysis in Couple and Family Therapy
  4449. Meta-analysis of Clinical Trials
  4450. Meta-analysis of the long-term efficacy and tolerance of tadalafil daily compared with tadalafil on-demand in treating men with erectile dysfunction
  4451. Meta-analytic evidence for neural dysactivity underlying sexual dysfunction
  4452. Metabolic and cardiovascular outcomes of fatherhood: Results from a cohort of study in subjects with sexual dysfunction
  4453. Metabolic syndrome and sexual (dys) function
  4454. Metabolic syndrome and sexual dysfunction
  4455. Metabolic syndrome and sexual function in postmenopausal women
  4456. Metabolic syndrome and urologic diseases
  4457. Metabolic syndrome: The vicious cycle
  4458. Metacognition and persecutory delusions: Tests of a metacognitive model in a clinical population and comparisons with non‐patients
  4459. Metaframeworks: Transcending the Models of Family Therapy
  4460. Metal‐Free Oxidative C–H Amidation of N,N′‐Diarylureas with PhI(OAc)2: Synthesis of Benzimidazol‐2‐one Derivatives
  4461. Methodological Challenges in Studying Testosterone Therapies for hypoactive sexual desire Disorder in Women
  4462. Methodological issues for psychological evaluation across the lifespan of individuals with a difference/disorder of sex development
  4463. Methodology and challenges to recruitment to a randomized, double-blind, placebo-controlled trial of oral DHEA in postmenopausal women
  4464. Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic review
  4465. Methods for the design of vasomotor symptom trials: the MsFLASH network
  4466. Methods for the Sequential Parallel Comparison Design
  4467. Methods to determine the minimum important difference for a sexual event diary used by postmenopausal women with hypoactive sexual desire disorder
  4468. Methods used in cross-cultural comparisons of psychological symptoms and their determinants
  4469. Mexican beliefs and attitudes toward menopause and menopausal-related symptoms
  4470. Mgraduate
  4471. Michelle Aiello,’17
  4472. Michelle Kenyon, John Murray, Barry Quinn
  4473. Microablative fractional CO2 laser for the genitourinary syndrome of menopause: up to 12-month results
  4474. Microfat and Nanofat Grafting in Genital Rejuvenation
  4475. Micropolitics and Poetics in Couple and Family Therapy
  4476. Middle-aged female sexual dysfunction and multimorbidity: a population-based study
  4477. Middlesex University Research Repository
  4478. Midlife and beyond: female hormonal status/menopause and its effects on sexual health
  4479. Midlife women’s attributions for their sexual response changes
  4480. Milan systemic family therapy
  4481. Military sexual trauma and sexual health in women veterans: a systematic review
  4482. Millennials Experience of Romantic Relationships during the period of Emerging Adulthood in Relation to Attachment Style.
  4483. Mind-Body-Spirit Model for the Medical Management of Female sexual Well-Being
  4484. Mindful sex
  4485. Mindfulness and cognitive behavior therapy for provoked vestibulodynia: Mediators of treatment outcome and long-term effects.
  4486. Mindfulness in sexual and relationship therapy
  4487. Mindfulness skills are associated with female orgasm?
  4488. Mindfulness-Based Cognitive Therapy for sexuality (MBCT-S) improves sexual functioning and intimacy among older women with epilepsy: A multicenter …
  4489. Mindfulness-based group therapy for women with provoked vestibulodynia
  4490. Mindfulness-Based Interventions in the Treatment of Female sexual Dysfunction: A Systematic Review
  4491. Mindfulness-Based Interventions in the Treatment of Female sexual Dysfunction: A Systematic Review
  4492. Mindfulness-Based Interventions in the Treatment of Female sexual Dysfunction: A Systematic Review/Kadinda Cinsel Islev Bozuklugunun Tedavisinde Bilincli …
  4493. Mindfulness-based sex therapy improves genital-subjective arousal concordance in women with sexual desire/arousal difficulties
  4494. Mindfulness-based therapies for sexual dysfunction: a review of potential theory-based mechanisms of change
  4495. Mindfulness, cognitive distraction, and sexual well-being in women
  4496. Minimally invasive gynecologic procedures
  4497. Minority stress and sexual problems among African-American gay and bisexual men
  4498. Minority stress, protective factors, and sexual functioning of women in a same-sex relationship.
  4499. miR-137 affects vaginal lubrication in female sexual dysfunction by targeting aquaporin-2
  4500. Miracle Question in Couple and Family Therapy
  4501. Mirroring in Couple and Family Therapy
  4502. Mismeasures of asexual desires
  4503. Missed opportunities in the patient-focused drug development public meeting and scientific workshop on female sexual dysfunction held at the FDA, October 2014
  4504. Mitra Rashidian, Ph. D., LMFT, ACS
  4505. MMP-1, MMP-8, mmp-13 inhibitory activities of methanolic extracts of cultivated Achilleamillefolium, Achilleafilipendulina, Menthapiperita and Salvia officinalis and …
  4506. Mode of Delivery and Number of Children Effect on sexual Function
  4507. Model construction of sexual satisfaction in patients with a colostomy
  4508. Modeling and interactions analysis of the novel antagonist agent flibanserin with 5-hydroxytryptamine 2A (5-HT2A) serotonin receptor as a HSDD treatment in …
  4509. Modeling and simulation of sexual activity daily diary data of patients with female sexual arousal disorder treated with sildenafil citrate (Viagra®)
  4510. Modeling human sexual motivation in rodents: some caveats
  4511. Modern approaches to the problem of genital prolapse by vaginal access use of syntheticmaterials in urogynecology
  4512. Modulation of late positive potentials by sexual images in problem users and controls inconsistent with “porn addiction”
  4513. Molecular and Preclinical Pharmacology of Androgen Receptor Ligands
  4514. Molecular basis of androgen action on human sexual desire
  4515. Mona and her coauthors exhort sex therapists to increase their level of “disability-related cultural competence” because “people with disabilities have become the …
  4516. Monitoring Differences in Vaginal Hemodynamic and Temperature Response for sexual A rousal by Different Anesthetic Agents Using an Optical Probe
  4517. Monophasic estrogen-progestogen therapy and sexuality in postmenopausal women
  4518. Monurelle Biogel® vaginal gel in the treatment of vaginal dryness in postmenopausal women
  4519. Mood disorders
  4520. Moral dysfunction: Theoretical model and potential neurosurgical treatments
  4521. More New Medication Approvals
  4522. More than 10 years diabetes mellitus related female sexual function
  4523. More than just bad sex: sexual dysfunction and distress in patients with endometriosis
  4524. Moroccan women with a history of child sexual abuse and its long-term repercussions: A population-based epidemiological study
  4525. Most Couples have Matched sexual Appetites
  4526. Mothers have lower testosterone than non-mothers: Evidence from the Philippines
  4527. Motivated behaviors and levels of 3α, 5α-THP in the midbrain are attenuated by knocking down expression of pregnane xenobiotic receptor in the midbrain ventral …
  4528. Motivational and neural systems of religion
  4529. Motivational drive in non-copulating and socially Monogamous Mammals
  4530. Motor preparation and sexual action: a psychophysiological perspective on sexual motivation
  4531. Moving toward or away from sexuality
  4532. mp–/fz7d9
  4533. MP-11.02: Evaluation of Semen Parameters, Sperm Chromosomal Abnormalities and Reproductive Endocrine Profile in Patients with Chronic Hepatitis C
  4534. MP-11.03: Midodrine for the Treatment of Organic Anejaculation but Not Spinal Cord Injury: A Prospective Randomized Placebo-Controlled Double-Blind Clinical …
  4535. MP-11.04: Reversal of SSRI-Induced Female sexual Dysfunction by Adjunctive Bupropion in Menstruating Women: A Double Blind, Placebo-Controlled and …
  4536. MP43-05 EFFECT OF BUPROPION AND TADALAFIL COMBINATION THERAPY IN FEMALE RAT hypoactive sexual desire DISORDER MODEL
  4537. MP43-06 MECHANISM OF SONIC HEDGEHOG INDUCED CAVERNOUS NERVE REGENERATION.
  4538. MP78-15 POST-SSRI sexual DYSFUNCTION (PSSD): TEN YEAR RETROSPECTIVE CHART REVIEW
  4539. MP78-16 PROBABILITY OF SHUNTING FOR ISCHEMIC PRIAPISM BASED ON ETIOLOGY: ROLE FOR PATIENT EDUCATION
  4540. MP78-17 RISK FACTORS FOR REOCCURRENCE OF PRIAPISM AFTER INITIAL PRIAPISM TREATMENT
  4541. MRCOG Part 2: 200-plus EMQs, MCQs and SBAs: Self-assessment in Obstetrics and Gynaecology: Prepare for the MRCOG
  4542. MRI Brief Family Therapy
  4543. MsFLASH network vaginal health trial: absence of evidence is NOT evidence of absence
  4544. Much more than prescribing a pill-Assessment and treatment of erectile dysfunction by the general practitioner
  4545. Mucosal delivery of nitric oxide
  4546. Multiaxial presentation of the ICD-10 for use in adult psychiatry
  4547. Multiaxial problem-oriented system for sexual dysfunctions: An alternative to DSM-III
  4548. Multicenter study on the prevalence of sexual symptoms in male hypo-and hyperthyroid patients
  4549. Multidimensional family therapy
  4550. Multifunctional drugs: a novel concept for psychopharmacology
  4551. Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder
  4552. Multilevel analyses of on-demand medication data, with an application to the treatment of Female sexual Interest/Arousal Disorder
  4553. Multimodal vaginal toning for bladder symptoms and quality of life in stress urinary incontinence
  4554. Multiple minority identities and mental health: Social and research implications of diversity within and between groups
  4555. Multiple-phase sexual dysfunction
  4556. Multisystemic Therapy
  4557. My name is Donald Hilton Jr., MD I am over the age of eighteen years. I have never been convicted of a felony or crime of moral turpitude, and I am fully …
  4558. My patient, my stalker empathy as a dual-edged sword: a cautionary tale
  4559. Myofibroblasts and mechanotransduction: Do forces in the tunica albuginea contribute to Peyronie’s disease?
  4560. Myths About sexual Health
  4561. N30 Experience of living with intestinal failure: a systematic review of qualitative studies
  4562. Naloxone, but not flupenthixol, disrupts the development of conditioned ejaculatory preference in the male rat.
  4563. Narrating juvenile mental disorders in Calixthe Beyala’s selected novels
  4564. Narrative literature review: sexual dysfunction in the patient on hemodialysis.
  4565. Narratives of desire in mid-age women with and without arousal difficulties
  4566. Natesto®. What Else? New Trends in Drug Naming
  4567. National differences in patient–clinician communication regarding hypoactive sexual desire disorder
  4568. Natural aphrodisiacs—a review of selected sexual enhancers
  4569. Natural orifice transluminal endoscopic surgery in urology: The Chinese experience
  4570. Natural Pregnancy Seeking in Subfertile Women with Endometriosis
  4571. Natural premature ovarian insufficiency and early menopause: a snapshot of hormonal management in a real-life setting in Italy
  4572. Natural remedies for impotence in medieval Persia
  4573. Natural selection, childrearing, and the ethics of marriage (and divorce): Building a case for the neuroenhancement of human relationships
  4574. Nature, Prevalence, Risk Factors and Explanatory Models of Female sexual Dysfunction in the Community.
  4575. Negative Body Attitudes and sexual Difficulties in Gay Men: The Mediating Role of Body Self-Consciousness during Physical Intimacy.
  4576. Negative identity
  4577. Negative metacognitive beliefs predict sexual distress over and above pain in women with endometriosis
  4578. Negative regulation of glucose metabolism in human myotubes by supraphysiological doses of 17β-estradiol or testosterone
  4579. Neglected subjects in sex research: A survey of sexologists
  4580. Negotiating sexual agency: Postmenopausal women’s meaning and experience of sexual desire
  4581. Negotiating the boundaries of intimacy: The personal lives of asexual people
  4582. Nejčastější problémy sexuality žen fertilního věku.
  4583. Neonatal testicular suppression with a GnRH agonist in rhesus monkeys: effects on adult endocrine function and behavior
  4584. Neovagina Formation with the Use of Bowel
  4585. Nerve and seminal sparing radical cystectomy with orthotopic urinary diversion for select patients with superficial bladder cancer: an innovative surgical approach
  4586. Neural activations of the acquisition of conditioned sexual arousal: effects of contingency awareness and sex
  4587. Neural Activations of the Acquisition of Conditioned sexual Arousal: Effects of Contingency Awareness and sexjsm_1405
  4588. Neural and Endocrine Factors Contribute to the Comorbidity of Urinary and sexual Dysfunctions
  4589. Neural bases of hypoactive sexual desire disorder in women: An event‐related fMRI study
  4590. Neural correlates of antidepressant-related sexual dysfunction: a placebo-controlled fMRI study on healthy males under subchronic paroxetine and bupropion
  4591. Neural correlates of sexual orientation in heterosexual, bisexual, and homosexual women
  4592. Neural representation of subjective sexual arousal in men and women
  4593. Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson’s disease
  4594. Neural responses to sexual stimuli in heterosexual and homosexual men and women: Men’s responses are more specific
  4595. Neural substrates of sexual arousal are not sex dependent
  4596. Neural substrates of sexual arousal in heterosexual males: event-related fMRI investigation
  4597. Neuro-urology
  4598. Neuroanatomical correlates of penile erection evoked by photographic stimuli in human males
  4599. Neuroanatomical evidence for a role of central melanocortin-4 receptors and oxytocin in the efferent control of the rodent clitoris and vagina
  4600. Neuroanatomy and function of human sexual behavior: A neglected or unknown issue?
  4601. Neurobehavioral impact of menopause on mood
  4602. Neurobiological Effects of Dhea in Females with Special Reference to sexual Function: Findings from In-vivo and Human Studies
  4603. Neurobiological foundations underlying normal and disturbed sexuality
  4604. Neurobiological signature of intimacy in anorexia nervosa
  4605. Neurobiology of DHEA and effects on sexuality, mood and cognition
  4606. Neurobiology of male sexual dysfunctions in psychiatric disorders: the cases of depression, anxiety, mania and schizophrenia
  4607. Neurobiology of sexual desire
  4608. Neurochemical aspects of the sexual response cycle
  4609. Neuroendocrine Modulation of sexual desire
  4610. Neuroendocrine regulation of feminine sexual behavior: lessons from rodent models and thoughts about humans
  4611. Neuroendocrine response to film-induced sexual arousal in men and women
  4612. Neuroenhancement of love and marriage: The chemicals between us
  4613. Neuroimaging and sexual behavior: identification of regional and functional differences
  4614. Neuroimaging of female sexual desire and hypoactive sexual desire disorder
  4615. Neuroimaging of love in the twenty-first century.
  4616. Neuroimaging techniques as a new tool to study the neural correlates involved in human male sexual arousal
  4617. Neurologic factors in female sexual function and dysfunction
  4618. Neuromodulation and female sexual function: does treatment for refractory voiding symptoms have an added benefit?
  4619. Neuronal activity in the hypothalamic paraventricular nucleus varies across the estrous cycle in anesthetized female rats: Effects of dopamine receptor agonism
  4620. Neuropathy and sexual dysfunction of diabetic females in southern west Virginia
  4621. Neuropeptide signalling systems–an underexplored target for venom drug discovery
  4622. Neuropeptides and central control of sexual behaviour from the past to the present: a review
  4623. Neuropeptides and male sexual behavior
  4624. NEUROPSYCHIATRIC ASPECTS OF sexual DYSFUNCTION NKANGINEME IKE
  4625. Neuropsychiatric burden in Huntington’s disease
  4626. Neuropsychiatric morbidity in early HIV disease: implications for military occupational function
  4627. Neuropsychiatric Perspectives on Community Mental Health
  4628. Neuropsychiatry of Huntington’s disease
  4629. Neuropsychiatry of Huntington’s disease and other basal ganglia disorders
  4630. Neuropsychological and neuropsychiatric aspects of Huntington’s disease
  4631. Neuropsychological Profile of Various Neurological and Psychiatric Conditions
  4632. Neuropsychology, neuroscience, volitional impairment and sexually violent predators: A review of the literature and the law and their application to civil commitment …
  4633. Neuropsychophysiological correlates of emotional processing
  4634. Neuroreductionism about sex and love
  4635. Neuroreductionism about sex and love
  4636. Neuroscience of salutary close relationships.
  4637. Neurosexology: European Federation of Neurological Societies Task Force on Neurosexology
  4638. Neurosteroids in clinical practice: implications for women’s health
  4639. Neurovascular preservation in orthotopic cystectomy: impact on female sexual function
  4640. Neutral endopeptidase inhibition: could it have a role in the treatment of female sexual arousal disorder?
  4641. New Approach to Management of Erectile Dysfunction in 2017
  4642. New approach to patients with premature ejaculation: Do social cognition and attachment profiles play a role in premature ejaculation?
  4643. New Approaches for the Therapy of Treatment Refractory Depression
  4644. New attitudes to sexuality in the menopause: clinical evaluation and diagnosis
  4645. New Challenges for sexual Medicine
  4646. New clinical and research perspectives on the sexual pain disorders
  4647. New concepts in the understanding of female sexual dysfunction
  4648. New developments in the treatment of hypoactive sexual desire disorder–a focus on Flibanserin
  4649. New diagnoses for old diseases: dangers and distractions
  4650. New directions in sex therapy: Innovations and alternatives
  4651. New directions in the psychology of human sexuality: research and theory
  4652. NEW DRUG APPROVALS
  4653. New drug approvals for 2019: Synthesis and clinical applications
  4654. New Drug for sexual desire Disorder
  4655. New Drugs 2015
  4656. New Drugs 2020, part 2
  4657. New drugs approved in 2019
  4658. New electroencephalogram (EEG) neuroimaging methods of analyzing brain activity applicable to the study of human sexual response
  4659. New frontiers in men’s sexual health: Understanding erectile dysfunction and the revolutionary new treatments
  4660. New medical device containing verbascoside, carrageenan and glycerophosphoinositol for the treatment of dyspareunia in reproductive age women: A prospective …
  4661. New Medications for Neuropsychiatric Disorders
  4662. New oral agents for erectile dysfunction: what is changing in our practice
  4663. New orientations: Asexuality and its implications for theory and practice
  4664. New paradigms in GPCR drug discovery
  4665. New preparations and reactions of salt stabilized organozinc reagents for the functionalization of aromatics, heteroaromatics, and allylic compounds
  4666. New products and regimens (since 2003)
  4667. New therapeutic agents marketed in 2015: Part 2
  4668. New therapeutic agents marketed in 2019: Part 2
  4669. New Treatments for Female sexual Dysfunction: Are they Safe and Effective for Older Post-Menopausal Women?
  4670. New Treatments for Women’s sexual and Genital Health
  4671. New tricks for an old dog: A repurposing approach of apomorphine
  4672. Newer Sulfonylureas Not Associated with Increased Mortality, MIs, or Strokes
  4673. News on the treatment of women with hypoactive sexual desire Disorder (HSDD)
  4674. News-Screen Menopause
  4675. Next‐day residual effects of flibanserin on simulated driving performance in premenopausal women
  4676. Nicht-paraphile hypersexuelle Störungen (sexsucht)
  4677. Niedobór androgenów u kobiet Androgen deficiency in women
  4678. Nieuwe ontwikkelingen in de behandeling van de complicaties van HIV-infectie: 4. HIV-infectie en AIDS bij vrouwen
  4679. Nieves Moyano, E. Sandra Byers & Juan
  4680. Night sweats, sleep disturbance, and depression associated with diminished libido in late menopausal transition and early postmenopause: baseline data from the …
  4681. Nine When Do We Say a Woman’s sexuality Is Dysfunctional?
  4682. Nineteenth-century Attitudes to Female sexuality
  4683. No hope for a ‘female Viagra’
  4684. No means yes? Perpetuating myths in the sexological construction of women’s desire
  4685. No romantic feelings–asexuality in Japan: Ren’aikanjou nai? Nihon ni okeru asekushariti
  4686. No. 279-Female sexual Health Consensus Clinical Guidelines
  4687. No. 279-Female sexual Health Consensus Clinical Guidelines
  4688. No. 366-Gynaecologic management of hereditary breast and ovarian cancer
  4689. Nocturnal penile tumescence in the evaluation of erectile disorders: A critical review
  4690. Noel N. Kim, PhD The Institute for sexual Medicine, San Diego, California James A. Simon, MD IntimMedicine Specialists
  4691. Nomegestrol acetate/17beta-estradiol does not negatively alter the vascular resistance of clitoral arteries: a prospective, exploratory study
  4692. Non-estrogen-based treatments for menopausal symptoms: Writing Group for the British Menopause Society Council
  4693. Non-estrogen-based treatments for menopausal symptoms.
  4694. Non-invasive Urine Markers of Interstitial Cystitis
  4695. Non-pharmacological interventions for treating sexual dysfunction in postpartum women: a systematic review protocol
  4696. Non-pharmacological interventions to promote sexual function in women with Type 2 diabetes
  4697. Non-pharmacological treatment of sexual problems–A review of research literature 1970–2008
  4698. Non-Pharmological Management of sexual Dysfunction in Females
  4699. Non-specialist psychosocial support interventions for women living with HIV: A systematic review
  4700. Nonbiological predictors of sexual desire in women with female sexual interest and arousal disorder
  4701. NONOPPORTUNISTIC INFECTIONS
  4702. Nonparaphilic hypersexual behavior: An evidence-based approach to treatment
  4703. Nonpharmacological treatment of postmenopausal symptoms
  4704. Nonresponse to phosphodiesterase 5 inhibitors in erectile dysfunction. Part 1: related factors
  4705. Nonsteroidal selective androgen receptor modulators enhance female sexual motivation
  4706. Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study
  4707. Normal sexual response in women
  4708. NORMAL sexualITY, sexual AND RELATIONSHIP DYSFUNCTION, AND sexual ASSAULT
  4709. Normal syndrome:[Conditions which were once considered normal are becoming medicalised to justify treatment.]
  4710. Normalisation versus medicalisation of sexual disturbances during menopause: A qualitative research in the Italian context
  4711. Normative hypogonadism and depression: does ‘andropause’exist?
  4712. Normative values for Glazer Protocol in the evaluation of pelvic floor muscle bioelectrical activity
  4713. Nose-to-brain peptide delivery–The potential of nanotechnology
  4714. Nosology and Epidemiology of Arousal Disorders in Women
  4715. Nosology and Epidemiology of Female Orgasm Disorder
  4716. Nosology and epidemiology of hypoactive sexual desire disorder
  4717. Nosology of the sexual Dysfunctions: Are They Appropriate to Older Adults?
  4718. Not all progestins are created equally: considering unique progestins individually in psychobehavioral research
  4719. Not Sick: Liberal, Trans, and Crip Feminist Critiques of Medicalization
  4720. Not Tonight, Dear’: The Elusive Female Libido
  4721. Not too big, not too small: a goldilocks approach to sample size selection
  4722. Novel approaches to female sexual dysfunction
  4723. Novel Bivalent 5-HT2A Receptor Antagonists Exhibit High Affinity and Potency in Vitro and Efficacy in Vivo
  4724. Novel drug approvals in 2015 and thus far in 2016
  4725. Novel emerging therapies for erectile dysfunction
  4726. Novel xanthones from Securidaca longepedunculata with activity against erectile dysfunction
  4727. Now That You’re Out: The Challenges and Joys of Living as a Gay Man: The Challenges and Joys of Living as a Gay Man
  4728. Nuclear medicine imaging technique in the erectile dysfunction evaluation: a mini-review
  4729. Nuclear medicine procedures for the evaluation of male sexual organs: a brief review
  4730. Nurses Honored for Excellence in Education and Practice
  4731. Nursing consultation concerning sexuality: an instrument for women’s nursing healthcare at the level of primary healthcare
  4732. NVA Research Update E-Newsletter
  4733. O-Shot®
  4734. Obesity and associated reproductive conditions in women
  4735. Obesity and psychosexual disorders
  4736. Obesity and sexual dysfunction, male and female
  4737. Obesity, mental health, and sexual dysfunction: A critical review
  4738. Objective assessment of sexual arousal in women with a history of hysterectomy
  4739. Objectivity as neutrality, nondisabled ignorance, and strong objectivity in biomedical ethics
  4740. Objects Are Incompetent: Exploring the Impact of Reduced Agency on Men’s Experience of Self-objectification
  4741. Obstacles of sexual satisfaction in couples: a qualitative study
  4742. Obstetric and gynecologic care for individuals who are LGBT
  4743. Obstetrician–Gynecologist Copyright ª by t he American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. Unauthorized …
  4744. Obstetrics & Gynaecology: An evidence-based text for MRCOG
  4745. OBSTETRICS AND GYNAECOLOGY
  4746. Obstructive sleep apnoea and sexual function in men
  4747. October 28–Suicidality
  4748. of article
  4749. of Neurogenic Bowel
  4750. Of rats and women: Preclinical insights into the nature of female sexual desire
  4751. of sex Research, 28, 479. 489. Reprinted with permission.* Indicates the hyperfeminine choice.
  4752. of women and cancer
  4753. Off-Label Prescribing and Polypharmacy: Minimizing the Risks
  4754. Off-label targeted cancer drugs fail in first randomized trial
  4755. Off-label’drug use in sexual medicine treatment
  4756. OFFICES
  4757. Old and new tools to study human brain physiology: Current state, future directions and implications for metabolic regulation
  4758. Older adult report of change in depressive symptoms as a treatment decision tool
  4759. Older adult sexuality: measuring healthcare provider knowledge, attitudes, and behaviors
  4760. Older adults and sexual health: A review of current literature
  4761. OLDER WOMEN AND sexual HEALTH
  4762. Older women’s sexual desire problems: Biopsychosocial factors impacting them and barriers to their clinical assessment
  4763. Olfactory Exposure to β-Caryophyllene Increases Testosterone Levels in Women’s Saliva
  4764. On ‘good sex‘and other dangerous ideas: Women narrate their joyous and happy sexual encounters
  4765. On conditions of Swedish women’s sexual well-being: An epidemiological approach
  4766. On not knowing what we don’t know to knowing what we don’t know: obstructive sleep apnea in the transgender community
  4767. on some (so-called) paradoxes of quantum physics
  4768. On the proposed sexual and gender identity diagnoses for DSM-5: History and controversies.
  4769. On the role of individual differences in female odor and ultrasonic vocalizations for male’s choice of partner
  4770. On the theory and therapy of mental disorders: An introduction to logotherapy and existential analysis
  4771. On treatment, punishment, and the civil commitment of sex offenders
  4772. Oncologic and functional outcomes after robot-assisted radical hysterectomy for cervical cancer
  4773. Oncology Section EDGE Task Force on Cancer: A systematic review of patient-reported measures for sexual dysfunction
  4774. One session of autogenic training increases acute subjective sexual arousal in premenopausal women reporting sexual arousal problems
  4775. Online couples mindfulness-based intervention for young breast cancer survivors and their partners: A randomized-control trial
  4776. Online health information seeking behavior of middle aged and older people
  4777. Online Pelvic Floor Group Education Program for Women With Persistent Genital Arousal Disorder/Genito-Pelvic Dysesthesia: Descriptive Feasibility Study
  4778. Online sexual behaviors and parenting style of the father
  4779. Onsite pharmacist program in medical homes declared a success: Payer tracking $2.1 million in savings for first six months
  4780. Oophorectomy in premenopausal women: health-related quality of life and sexual functioning
  4781. Oophorectomy: the debate between ovarian conservation and elective oophorectomy
  4782. Open‐label extension study of flibanserin in women with hypoactive sexual desire disorder
  4783. Opinion paper: on the diagnosis/classification of sexual arousal concerns in women
  4784. OPINION PIECE
  4785. Opinion: No. Ten reasons that there will be no new pharmacologic therapies for erectile dysfunctionin the foreseeable future
  4786. Opioid substitution with methadone and buprenorphine: sexual dysfunction as a side effect of therapy
  4787. Opioid Therapy Complications
  4788. Opioid-induced endocrinopathy
  4789. Opioid-induced hypogonadism: why and how to treat it
  4790. Opioids increase sexual dysfunction in patients with non-cancer pain
  4791. Opportunities for intervention in HSDD
  4792. Optimisation by Design of Experiment of Benzimidazol-2-one synthesis under flow conditions
  4793. Optimized Gas Chromatography-Mass Spectrometric Method to Profile Esterified Fatty Acids in Fish Roe and Fish Oil
  4794. Optimized Nanostructured Lipid Carriers Integrated into In Situ Nasal Gel for Enhancing Brain Delivery of Flibanserin
  4795. Optimizing quality of life through sex steroids by their effects on neurotransmitters
  4796. Options for hormone therapy in women who have had a hysterectomy
  4797. Options for Management of Serotonin Reuptake Inhibitor-Induced sexual Dysfunction
  4798. OR27-05 sexual desire Changes in Transgender Individuals upon Initiation of Hormone Treatment; Results from the Longitudinal ENIGI Study
  4799. Oral contraception and female sexual dysfunction in reproductive women
  4800. Oral contraceptive and sexuality
  4801. Oral prescription therapy for erectile dysfunction
  4802. Oral Testofen, L-Citrulline, Resveratrol, and Caffeine Supplement Drink Improves sexual Function in Men with Phosphodiesterase 5 Inhibitors: Randomized …
  4803. Orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin, and quercetin in the prevention of postcoital recurrent urinary tract infections …
  4804. Orchiectomy as bridge or alternative to vaginoplasty
  4805. Organic, relational and psychological factors in erectile dysfunction in men with diabetes mellitus
  4806. Orgasm consistency training in the treatment of women reporting hypoactive sexual desire: An outcome comparison of women-only groups and couples-only groups
  4807. Orgasm disorders in women
  4808. Orgasm-a psychophysiology-based approach to hormonal and non-hormonal medical strategies to manage orgasmic disorders in women
  4809. Orgasmic disorders in women
  4810. Orgasmic disorders subset of sexual dysfunction in women and improve it
  4811. Orgasmic Dysfunction: Prevalence and Risk Factors from a Cohort of Young Females in M exico
  4812. Orientations and deviations: sexuality in anti-discrimination law
  4813. Original Paper Child Rape in Nigeria, Implications on the Education of the Child
  4814. ORIGINAL RESEARCH A Descriptive Analysis of sexual Problems in Long-Term Heterosexual Relationships
  4815. ORIGINAL RESEARCH–EDUCATION: Frequency and Focus of sexual History Taking in Male Patients—A Pilot Study Conducted among Swiss General Practitioners …
  4816. ORIGINAL RESEARCH–ENDOCRINOLOGY: Hypoprolactinemia: A New Clinical Syndrome in Patients with sexual Dysfunction
  4817. ORIGINAL RESEARCH–EPIDEMIOLOGY: Selective Serotonin Reuptake Inhibitor-Induced sexual Dysfunction
  4818. ORIGINAL RESEARCH–INTERsex AND GENDER IDENTITY DISORDERS: Male Gender Identity in an XX Individual with Congenital Adrenal Hyperplasia
  4819. ORIGINAL RESEARCH–MEN’S sexual HEALTH: Self-Reported sexual Difficulties and Their Association with Depression and Other Factors among Gay Men …
  4820. ORIGINAL RESEARCH–PAIN: Misremembering Pain: Memory Bias for Pain Words in Women Reporting sexual Pain
  4821. Our sexuality
  4822. Outcome measurement in female sexual dysfunction clinical trials
  4823. OUTCOMES ASSESSMENT: A Methodology Study to Develop and Validate a Screener for hypoactive sexual desire Disorder in Postmenopausal Women
  4824. OUTCOMES ASSESSMENT: Assessing sexual Function in Well Women: Validity and Reliability of the Monash Women’s Health Program Female sexual Satisfaction …
  4825. OUTCOMES ASSESSMENT: Developing and Validating a Taiwan Version of the Female sexual Function Index for Pregnant Women
  4826. Outcomes assessment: Development and validation of a 6-item version of the Female sexual Function Index (FSFI) as a diagnostic tool for female sexual dysfunction
  4827. outcomes assessment: development and validation of a five‐factor sexual satisfaction and distress scale for women: the sexual satisfaction scale for women (SSS‐W)
  4828. Outcomes assessment: The sexual Arousal and desire Inventory (SADI): A multidimensional scale to assess subjective sexual arousal and desire
  4829. Outcomes associated with hypogonadism in women with chronic kidney disease
  4830. OUTCOMES RESEARCH: The Sensitivity of Event Logs, Self‐Administered Questionnaires and Photoplethysmography to Detect Treatment‐Induced Changes in …
  4831. Ovarian cancer: avoiding compromising quality of life during intense chemotherapy sessions
  4832. Ovarian conservation vs removal at the time of benign hysterectomy
  4833. Ovarian function and menopause
  4834. Overactive bladder syndrome treatment with ospemifene in menopausal patients with vulvovaginal atrophy: improvement of sexuality?
  4835. Overcharged: Why Americans Pay Too Much for Health Care
  4836. OVERCOMING STIGMA AND BARRIERS
  4837. Overestimation of heat tolerance calls for health promotion to limit occupational heat risk
  4838. Overview of androgen deficiency and therapy in women
  4839. Overview of patient-centered outcome measures available in the patient-reported outcome and quality of life instruments database (PROQOLID) for use in …
  4840. Overview of sex Therapy
  4841. Overview of sexual dysfunction in women: Epidemiology, risk factors, and evaluation
  4842. Ovulation induction in women with polycysticovary syndrome
  4843. Oxytocin plasma levels in orgasmic and anorgasmic women
  4844. Oxytocin’s Effects on Well-Being and Social Interactions
  4845. P-01-059 The prevalence of sexual dysfunction in men in a state of socio-economic transition (Republic of Moldova)
  4846. P-01-061 Male sexual dysfunctions with no organic correlates
  4847. P-03-028 Importance of testosterone stabilization in patients with anxiety/depression and hypogonadism
  4848. P-03-052 A case of SRY-positive XX men
  4849. P-1_ Pharmacokinetics and bioavailability of new ciprofloxacin derivative (CNV 97101) in rat: repercussion of precipitation in stomach.
  4850. P0004-sexual dysfunction in veterans with PTSD
  4851. Pain Characteristics, Psychosocial, and sexual Wellbeing of Women Diagnosed with Provoked Vestibulodynia and a History of sexual Abuse
  4852. Pain in abdomen and shoulder
  4853. Pain or sex?: Choosing the best option
  4854. Pain tolerance and thresholds in women with dyspareunia: Do pain and sex primes have differential effects?
  4855. PAIN: sexual Dysfunction in Patients with Chronic Hand Eczema in the Turkish Population
  4856. Painful sex (dyspareunia): a difficult symptom in gynecological practice
  4857. Palliative Care
  4858. Panic disorder and female sexual dysfunction: Biological and psychological factors and treatment considerations
  4859. Panic Disorder Correlates With the Risk for sexual Dysfunction
  4860. Paradigm change and female sexual dysfunctions: An analysis of sexology journals.
  4861. Paradigms for Preclinical Investigations of Female sexual Function and Dysfunction (HSDD and FSAD)
  4862. Paraphilia-related disorders
  4863. Paraphilias among gay men in Puerto Rico
  4864. Parental Communications and Young Women’s Struggle for sexual Agency
  4865. Paroxetine-induced reduction of sexual incentive motivation in female rats is not modified by 5-HT 1B or 5-HT 2C antagonists
  4866. Part 2 MRCOG: 500 EMQs and SBAs
  4867. Partner preferences: What characteristics do men and women desire in their short-term sexual and long-term romantic partners?
  4868. Partner Responses to Low desire: Associations With sexual, Relational, and Psychological Well-Being Among Couples Coping With Female sexual Interest/Arousal …
  4869. Partner status moderates the relationships between sexual problems and self-efficacy for managing sexual problems and psychosocial quality-of-life for …
  4870. Partners experience consequences, too: A comparison of the sexual, relational, and psychological adjustment of women with sexual interest/arousal disorder and their …
  4871. Partners’ similarity in differentiation of self is associated with higher sexual desire: A quantitative dyadic study
  4872. Partnership issues and sexuality
  4873. Passing When Asexual: Methods for Appearing Straight
  4874. Passion and sexuality in Committed Relationships
  4875. Past, Present, Future.
  4876. Patches: established and emerging transdermal treatments in psychiatry
  4877. Pathophysiology and Medical Management of Female Genital Arousal Disorder
  4878. Pathophysiology and medical management of female orgasm disorder
  4879. Pathophysiology and medical management of hypoactive sexual desire disorder
  4880. Pathophysiology of acquired premature ejaculation
  4881. PATHOPHYSIOLOGY: Clinical Biologic Pathophysiologies of Women’s sexual Dysfunction
  4882. Pathways to care through an inner-city mental health service
  4883. Patient Engagement
  4884. Patient Highlights
  4885. Patient interest in the Lowdown on Down There: attendance at a vulvovaginal and sexual health workshop post-cancer treatment
  4886. Patient Management Exercise for Sleep, sex , And Eating Disorders
  4887. Patient perspective: Being diagnosed with the Menopause
  4888. Patient preferences for discussing sexual health with physicians
  4889. Patient scenario: A 53-year-old woman with hypoactive sexual desire disorder
  4890. Patient speaking for patients
  4891. Patient-centered outcomes and treatment preferences regarding sexual problems: a qualitative study among midlife women
  4892. Patient-centric design for peptide delivery: Trends in routes of administration and advancement in drug delivery technologies
  4893. Patient-reported impact of after-hours house-call services on the utilization of emergency department services in Australia
  4894. Patient-Reported Outcomes and Clinical Trials
  4895. Patient-Reported Outcomes and Pelvic Organ Prolapse
  4896. Patient-Reported Outcomes in sexual Medicine
  4897. Patient-reported quality-of-life and sexual-function outcomes after laparoscopic supracervical hysterectomy (LSH) versus total laparoscopic hysterectomy (TLH): a …
  4898. Patient’s knowledge of causes effects and complications of diabetes mellitus in Illorin, KwaraState, Nigeria
  4899. Patients often fail to bring it up, and physicians may be reluctant to discuss it, but ignoring sexual dysfunction can disrupt a woman’s most intimate relationships.
  4900. Patients Taking Misoprostol Misunderstood: How to Manage Patients with Miscarriages
  4901. Patients’ conceptions of terms related to sexual interest, desire, and arousal
  4902. pattern and determinants of sexual dysfunction among adults with type 2 diabetes attending the general out patient clinic of ahmadu bello university teaching …
  4903. Pattern of psychosexual disorders among male patient attending dermatology OPD in a tertiary care center-a descriptive study
  4904. Patterns and predictors of sexual activity among women in the Hormone Therapy trials of the Women’s Health Initiative
  4905. Patterns and their correlates of seeking treatment for erectile dysfunction in type 2 diabetic patients
  4906. Patterns of asexuality in China: sexual activity, sexual and romantic attraction, and sexual desire
  4907. Patterns of intimacy and sexual expression in interaction with addictions
  4908. Patterns of sexual behavior and psychological processes in asexual persons: a systematic review
  4909. PD36-05 PREVALENCE AND CHARACTERIZATION OF DYSPAREUNIA IN A GENERAL UROLOGY CLINIC POPULATION
  4910. PD36-06 TWO-ARM, PROSPECTIVE, OPEN-LABEL, PILOT STUDY OF FLIBANSERIN VERSUS FLIBANSERIN AND sex THERAPY IN WOMEN WITH HSDD
  4911. PD36-07 SAFETY AND EFFICACY OF CO2 FRACTIONAL LASER THERAPY IN WOMEN WITH VESTIBULAR PAIN
  4912. PD44-08 EFFECTS OF FRACTIONAL MICROABLATIVE CO2 LASER THERAPY ON sexual FUNCTION IN POSTMENOPAUSAL WOMEN AND WOMEN WITH A …
  4913. PD44-09 EFFECT OF FLIBANSERIN ON sexual FUNCTIONING: AN ANALYSIS OF FEMALE sexual FUNCTION INDEX DOMAINS
  4914. PD44-10 THEMATIC ANALYSIS OF REFLECTIONS OF WOMEN SUCCESSFULLY TREATED WITH FLIBANSERIN AT A SINGLE CENTER
  4915. PD44-11 SURVEY OF sexual FUNCTION AND PORNOGRAPHY IN FEMALES
  4916. PD44-12 FEMALE sexual DYSFUNCTION TREATMENT: A META-ANALYSIS OF THE PLACEBO EFFECT ACROSS RANDOMIZED CONTROLLED TRIALS
  4917. PD45-01 CHANGE OF CATEGORIES OF THE INTERNATIONAL PROSTATE SYMPTOM SCORE (IPSS) IN HYPOGONADAL PATIENTS WITH AND WITHOUT …
  4918. PD54-01 SAFETY OF FLIBANSERIN IN WOMEN WITH hypoactive sexual desire DISORDER TAKING ANTIDEPRESSANT MEDICATIONS
  4919. PD54-02 LOW RATES OF INSOMNIA ASSOCIATED WITH FLIBANSERIN IN PREMENOPAUSAL WOMEN WITH hypoactive sexual desire DISORDER
  4920. PDE-5 and NOS II mRNA expression in menopausal women: a molecular biology study
  4921. PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes
  4922. PDE-5 inhibitors’ implications in women: Are they of help?
  4923. PDE5 inhibitors beyond erectile dysfunction
  4924. Peddling mental disorder: The crisis in modern psychiatry
  4925. Pedophilic brain potential responses to adult erotic stimuli
  4926. Peggy J. Kleinplatz
  4927. Pelvic floor disorders and sexuality in women with ovarian cancer: A systematic review
  4928. Pelvic floor dysfunction 6 years post vaginal versus cesarean delivery
  4929. Pelvic floor dysfunction 6 years post-anal sphincter tear at the time of vaginal delivery
  4930. Pelvic floor dysfunction and its effect on quality of sexual life
  4931. Pelvic floor dysfunction in midlife women
  4932. Pelvic floor dysfunction in morbidly obese women: pilot study
  4933. Pelvic floor muscle parameters affect sexual function after 8 weeks of transcutaneous electrical stimulation in women with stress urinary incontinence
  4934. Pelvic floor symptoms after gynaecological surgery
  4935. Pelvic muscle strengthening: Impact on sexual functioning in the menopausal woman
  4936. Pelvic nerve plexus trauma at radical hysterectomy and simple hysterectomy: the nerve content of the uterine supporting ligaments
  4937. Pelvic Organ Prolapse
  4938. Pelvic Organ Prolapse
  4939. Pelvic Radiation in Women
  4940. Pelvic radiotherapy and sexual function in women
  4941. Penile Prosthesis Implant for Severe Erectile Dysfunction
  4942. Penile Prosthesis Implant in Neurological Patients
  4943. Penile-scrotal flap vaginoplasty versus inverted penile skin flap expanded with spatulated urethra: A multidisciplinary single-centre analysis
  4944. Peptide Therapeutics 2.0
  4945. Peptides in chemical space
  4946. Perceived ejaculate volume reduction in patients with erectile dysfunction: psychobiologic correlates
  4947. Perceived facilitators and barriers to initmate relationships of persons ages 65 and older
  4948. Perceived partner responsiveness moderates the associations between sexual talk and sexual and relationship well-being in individuals in long-term relationships
  4949. Perceived prevalence and definitions of sexual dysfunction as predictors of sexual function and satisfaction
  4950. Perceived reduced sleep-related erections in subjects with erectile dysfunction: psychobiological correlates
  4951. Perceived stress, spirituality, resourcefulness and sexuality in patients with rectal cancer undergoing cancer treatment
  4952. Perception and practices of masturbation by male medical students, Tanta University, Egypt
  4953. Perception of men’s beauty and attractiveness by women with low sexual desire
  4954. Perceptions about the sexuality of women with fibromyalgia syndrome: a phenomenological study
  4955. Perceptions of and attitudes toward estrogen therapy among surgically menopausal women in Taiwan
  4956. Perceptions of control and improved psychological, physical, and social functioning in postmenopausal women
  4957. Perceptions of female sexual health and sexual dysfunction in a cohort of urban professional women in Abuja, Nigeria
  4958. Perceptions of sexual boredom in a community sample
  4959. Performance stylistics
  4960. Performance stylistics: Deleuze and Guattari, poetry and (corpus) linguistics
  4961. Performing asexuality through narratives of sexual identity
  4962. Performing Asexy: Asexual Identity and Neo-Burlesque in Mississippi, Texas, and Florida
  4963. Perils of Prolonged Ovarian Suppression and Hypoestrogenism in the Treatment of Breast Cancer: Is the Risk of Treatment Worse than the Risk of Recurrence?
  4964. Perimenopause
  4965. Perimenopause and sexual functioning: Implications for therapists
  4966. Perioperative outcome and female sexual function after laparoscopic transvaginal NOTES-assisted nephrectomy
  4967. Peripheral female genital arousal as assessed by thermography following topical genital application of alprostadil vs placebo arousal gel: a proof-of-principle …
  4968. Peripheral polyneuropathy and female sexual dysfunction—familial amyloidotic polyneuropathy as an example besides diabetes mellitus
  4969. Permanent hypogonadism after traumatic brain injury: a case report
  4970. Persistent genital arousal disorder in women: case reports of association with anti-depressant usage and withdrawal
  4971. Persistent Genital Arousal Disorder—Fact or Fiction?
  4972. Persistent sexual arousal disorder through out luteal phase support with intravaginal progesterone after IVF cycle: a case report
  4973. Persistent sexual arousal syndrome: A case report and review of the literature
  4974. Persistent sexual dysfunction with finasteride 1 mg taken for hair loss
  4975. Personal factors that contribute to or impair women’s ability to achieve orgasm
  4976. Personal history
  4977. PERSONAL PERSPECTIVE
  4978. Personalising osteoporosis treatment for patients at high risk of fracture
  4979. Personality and relationship factors associated with dyspareunia among women
  4980. Personality and sexual Dysfunctions
  4981. Personality Characteristics and Cognitive Distortions of Female sex Offenders as Assessed by the MMPI-2 RF and the MSI-2
  4982. Personality Structure and Proneness for sexual Excitation/Inhibition Among Young Polish Adult Women
  4983. Personality Traits of Postmenopausal Women with sexual Dysfunction
  4984. Personalized Pharmacotherapy for Women With sexual Interest/Arousal Disorder
  4985. Perversion’s Calling Card
  4986. Peyronie’s disease and the female sexual partner: a Comparison of the male and female experience
  4987. Pharmaceutical intimacy: Managing female sexuality through Addyi
  4988. PHARMACIA
  4989. Pharmacodynamics of Serotonin. Emphasis on 5HT-3 Antagonists and SSRI Medication (II)
  4990. Pharmacogenetics of testosterone replacement therapy
  4991. Pharmacogenomics and sexuality: a vision
  4992. Pharmacokinetics and pharmacodynamics of LGD-3303 [9-chloro-2-ethyl-1-methyl-3-(2, 2, 2-trifluoroethyl)-3H-pyrrolo-[3, 2-f] quinolin-7 (6H)-one], an orally available …
  4993. Pharmacokinetics of a prototype formulation of sublingual testosterone and a buspirone tablet, versus an advanced combination tablet of testosterone and …
  4994. Pharmacokinetics of a testosterone gel in healthy postmenopausal women
  4995. Pharmacokinetics of a transdermal testosterone cream in healthy postmenopausal women
  4996. Pharmacokinetics of three doses of sublingual testosterone in healthy premenopausal women
  4997. Pharmacologic management of sexual dysfunction: benefits and limitations
  4998. Pharmacologic therapy for female sexual dysfunction
  4999. Pharmacologic treatment options for hypoactive sexual desire disorder
  5000. Pharmacologic treatment strategies for sexual dysfunction in patients with epilepsy and depression
  5001. Pharmacological advances in the management of sexual dysfunction
  5002. Pharmacological and non-pharmacological therapeutic strategies for improvement of state-trait anxiety: a randomized controlled trial among iranian infertile …
  5003. Pharmacological and Surgical Management
  5004. Pharmacological effects on nocturnal penile tumescence (NPT)
  5005. Pharmacological Neuromodulation in Autism Spectrum Disorders
  5006. Pharmacological therapy for female sexual dysfunction
  5007. Pharmacological treatment of female sexual dysfunction: a critical analysis of the placebo and nocebo effects
  5008. Pharmacological treatment of lower urinary tract symptoms in benign prostatic hyperplasia: consequences on sexual function and possible endocrine effects
  5009. Pharmacological treatment of premature ejaculation
  5010. Pharmacological treatment strategies for patients with monogenic obesity
  5011. Pharmacologically induced hypogonadism and sexual function in healthy young women and men
  5012. Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
  5013. Pharmacology for nurses: a pathophysiologic approach/Michael
  5014. Pharmacology of hormone replacement therapy in menopause
  5015. Pharmacology of serotonin and female sexual behavior
  5016. Pharmacology of sexual Function
  5017. Pharmacosexology: Psychiatric Side Effects of Drugs for the Treatment of sexual Dysfunction
  5018. Pharmacotherapy and psychotherapy for sexual dysfunctions.
  5019. pharmacotherapy for Female sexual dysfunction: explorative analyses of a randomized controlled trial
  5020. Pharmacotherapy for sexual dysfunction in women
  5021. Pharmacotherapy for women’s sexual dysfunction
  5022. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
  5023. Pharmacotherapy of female hypoactive sexual desire disorder
  5024. Pharmacotherapy of male sexual dysfunction: From serendipidity to rational approach to treatment
  5025. PHARMACOTHERAPY OF sexual DISORDERS
  5026. Pharmacotherapy of sexual dysfunction in special populations
  5027. Pharmacotherapy of sexual Dysfunctions
  5028. Pharmacotherapy of sexual dysfunctions: Current status
  5029. Pharmacy in the News
  5030. Pharmaological study of the effects of certain aphrodisiac agents in male rats
  5031. Phase I randomized placebo-controlled, double-blind study of the safety and tolerability of bremelanotide coadministered with ethanol in healthy male and …
  5032. Phase II study of dehydroepiandrosterone in androgen receptor‐positive metastatic breast cancer
  5033. Phases of female sexual response cycle among M alaysian women with Infertility: A factor analysis study
  5034. Phenomenological Investigation of Experience of Women with Dependent Husbands
  5035. Phosphodiesterase 5 inhibitors and nitrergic transmission—from zaprinast to sildenafil
  5036. Phosphodiesterase 5 inhibitors in the treatment of erectile dysfunction
  5037. Phosphodiesterase inhibitors in female sexual dysfunction
  5038. Phosphodiesterase type 5 (PDE5) inhibitors in erectile dysfunction: the proper drug for the proper patient
  5039. Phosphodiesterase type 5 inhibitors and female sexual response: faulty protocols or paradigms?
  5040. Phosphodiesterase type 5 inhibitors for treating erectile dysfunction and lower urinary tract symptoms secondary to benign prostatic hyperplasia: a …
  5041. PHP31 The Economic Impact of Switches of Prescription Drugs to the Over-the-Counter Status (Rx-to-OTC): A Systematic Literature Review
  5042. PHP36 Perceptions of Policy Makers and Science Advice Body Staff on Science Advice in Health in Europe
  5043. Physical Activity and sexual Health in Men
  5044. PHYSICAL ACTIVITY AND sexual HEALTH IN MEN.
  5045. Physical Activity, Fitness, and sexual Dysfunction
  5046. Physical Diagnosis and Testing
  5047. Physical function in patients following surgery for colorectal cancer
  5048. Physical therapy in sexually dysfunctional women: a systematic review
  5049. Physical, complementary, and alternative medicine in the treatment of pelvic floor disorders
  5050. PHYSICALLY ACTIVE FEMALE COLLEGE STUDENTS HAVE A BETTER sexual HEALTH.
  5051. Physician attitudes regarding hypoactive sexual desire disorder in a primary care clinic: A pilot study
  5052. Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications
  5053. Physicians’ attitudes towards androgen replacement therapy for male and female sexual dysfunction
  5054. Physicians’ Moral Dilemmas in the Age of Viagra
  5055. Physiologic and pathophysiologic alterations of the neuroendocrine components of the reproductive axis
  5056. Physiologic applications of the new female sexual response classification system
  5057. Physiologic aspects of sexual function and dysfunction
  5058. Physiologic measures of sexual function in women: a review
  5059. Physiological and subjective sexual arousal in self-identified asexual women
  5060. Physiological assessment of male sexual function
  5061. Physiological effects of androgens in women
  5062. Physiological stress responses predict sexual functioning and satisfaction differently in women who have and have not been sexually abused in childhood.
  5063. Physiology and pathophysiology of female sexual function
  5064. Physiology and Pharmacology of the Prostate
  5065. Physiology of erection and causes of erectile dysfunction
  5066. Physiology of Female Genital sexual Arousal
  5067. Physiology of female sexual function and dysfunction
  5068. Physiology of female sexual function and pathophysiology of female sexual dysfunction
  5069. Physiology of female sexual function: animal models
  5070. Physiology of Libido
  5071. Physiology of women’s sexual function: basic knowledge and new findings
  5072. Phytochemical study, adulticidal and larvicidal activity of extracts from Buddleja polystachya against Aedesaegypti
  5073. Phytotherapy of Male hypoactive sexual desire of Psychogenic Origin
  5074. Pictorial cues and sexual desire: an experimental approach
  5075. PIH13 HEALTH CARE UTILIZATION AND COSTS FOR THE TREATMENT OF hypoactive sexual desire DISORDER
  5076. PIH21 DRIVERS OF HEALTH CARE COSTS IN WOMEN WITH hypoactive sexual desire DISORDER (HSDD)
  5077. PIH3 RISK OF WEIGHT GAIN WITH THE USE OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRI) AND ATYPICAL ANTIPSYCHOTICS (SGA) …
  5078. PIH31 A STUDY OF THE EFFECT OF MEDICAID COVERAGE ON CHILDREN’S HEALTH
  5079. PIH51 A PILOT STUDY ASSESSING THE IMPACT OF ADVANCED PHARMACISTS-DELIVERED PATIENT-CENTERED CARE ON HEALTH OUTCOMES FOR …
  5080. PIH52 DEMENTIA-RELATED PSYCHOSIS: REAL-WORLD PATIENT CHARACTERISTICS AND HEALTHCARE UTILIZATION FROM A LARGE US …
  5081. PIH53 PATTERNS AND PREDICTORS OF OFF-LABEL ANTIPSYCHOTIC USE AMONG OLDER ADULTS WITH DEMENTIA IN AMBULATORY CARE …
  5082. PIH54 UNMET NEEDS IN THE DIAGNOSIS AND MANAGEMENT OF WOMEN WITH hypoactive sexual desire DISORDER IN THE REAL WORLD
  5083. PIH55 NATIONAL PATTERNS OF EMERGENCY DEPARTMENT USE FOR WOMEN WITH ENDOMETRIOSIS, 2006-2015
  5084. PIH8 DOES TRIAL PARTICIPATION IMPACT ON THE PSYCHOMETRIC PROPERTIES OF SELF-REPORT DEPRESSION IN POSTNATAL WOMEN?
  5085. PIH9 TRENDS IN IUD INSERTIONS AND RELATED MEDICAL EXPENDITURE IN THE UNITED STATES: THE POPULATION WITH EMPLOYERSPONSORED …
  5086. Pilates for better sex: changes in sexual functioning in healthy Turkish women after Pilates exercise
  5087. Pilot Randomized Control Trial of a Brief Multidisciplinary Consultation Intervention for Treating sexual Dysfunction in MS
  5088. Pilot study of a brief cognitive behavioral versus mindfulness-based intervention for women with sexual distress and a history of childhood sexual abuse
  5089. Pink pills and economic man
  5090. Pinpointing brainstem mechanisms responsible for autonomic dysfunction in Rett syndrome: therapeutic perspectives for 5-HT1A agonists
  5091. Pituitary-gonadal function during sleep in men with hypoactive sexual desire and in normal controls.
  5092. Placebo response in the treatment of women’s sexual dysfunctions: A review and commentary
  5093. Placebo-controlled study on efficacy and safety of daily apomorphine SL intake in premenopausal women affected by hypoactive sexual desire disorder and sexual …
  5094. Placing symptoms in context: the role of contextual criteria in reducing false positives in Diagnostic and Statistical Manual of Mental Disorders diagnoses
  5095. Plant-derivatives and herbs used for the promotion of sexual health and the treatment of sexual problems
  5096. Plant-Derived Supplements for sexual Health and Problems, Part 2: Further Evidence for Specific Herbal Effects
  5097. Plant-Derived Supplements for sexual Health and Problems: Part 1—Trends over the Past Decade
  5098. Plasma MHPG response to yohimbine treatment in women with hypoactive sexual
  5099. Plasma oxytocin level and sexual dysfunction in depressed women treated by either fluoxetine or citalopram: A pilot clinical trial
  5100. Pleasure-centered educational program: A comprehensive approach to pleasure-oriented sexuality education in domestic violence shelters
  5101. PMH3 DEPRESSION: ETHNIC DIFFERENCES IN PREVALENCE, DIAGNOSIS, AND SYMPTOMS
  5102. PNM-10 hypoactive Female sexual desire-The Influence of a Stable Relationship
  5103. PNM-12 Double-blind Randomized Study on the Effect of Non-Hormonal Gel Application to the Genital Area of Women in the Menacme with sexual Dysfunction
  5104. PNM-13 The Role of Buopropion in the Treatment of Female sexual Dysfunctions: Literature Review
  5105. PNM-29 Qualitative Analysis of Four Mental Ilness sexual Stigma Questionnaire Domains
  5106. PODIUM SESSIONS ABSTRACTS
  5107. Policing Pleasure: A Sociolegal Framework for Understanding the Social Control of desire
  5108. Policy Number: C2270-A
  5109. Polish translation and validation of the pelvic organ prolapse/urinary incontinence sexual questionnaire, IUGA-revised (PISQ-IR)
  5110. Political and Religious Perspectives on Managing the Risks and Benefits of Women’s Medicines
  5111. Politics of the womb: The perils of IVF, surrogacy and modified babies
  5112. Polycystic Ovary Syndrome (PCOS) and sexual Dysfunctions
  5113. Polymorphisms in the dopamine D4 receptor gene (DRD4) contribute to individual differences in human sexual behavior: desire, arousal and sexual function
  5114. Polypharmacology of dopamine receptor ligands
  5115. Poor response to alprostadil ICI test is associated with arteriogenic erectile dysfunction and higher risk of major adverse cardiovascular events
  5116. Popular psychology: an encyclopedia
  5117. Population pharmacokinetic/pharmacodynamic model for the sedative effects of flibanserin in healthy volunteers
  5118. Pornography Use and sexual Health among Same-sex and Mixed-sex Couples: An Event-Level Dyadic Analysis
  5119. Portuguese version of Cues for sexual desire Scale: The influence of relationship duration
  5120. Positive and negative affect during sexual activity: differences between homosexual and heterosexual men and women, with and without sexual problems
  5121. Positive and negative sexual cognitions: Similarities and differences between men and women from southern Spain
  5122. Positive Emotions and sexual desire among Healthy Women.
  5123. Positive psychology and the illness ideology: Toward a positive clinical psychology
  5124. Positive Representations of Asexuality in Contemporary Young Adult
  5125. Positron emission tomography assessment of 8-OH-DPAT-mediated changes in an index of cerebral glucose metabolism in female marmosets
  5126. Possible Benefits versus Potential Risks of Testosterone Replacement Therapy in Elderly Men as Evidenced by Laboratory Parameters and Evaluation of …
  5127. Post injury chronic low back pain and depression: Comparative study between early and late post-injury sufferers shows significant difference.
  5128. Post menopausal quality of life and associated factors-A
  5129. Post partum sexuality
  5130. Post-finasteride syndrome: a surmountable challenge for clinicians
  5131. POST-GRADUATE COURSES
  5132. Post-SSRI sexual Dysfunction: Exploration of the sexual Domains and Symptoms
  5133. Postcoital dysphoria: Prevalence and correlates among males
  5134. Poster 135B ‘Pink Pill’: Does It Add To Non-Pharmacological Treatment Of hypoactive sexual desire Disorder?
  5135. Poster Abstracts Table of Contents
  5136. Posterior Pituitary Hormones
  5137. Postmenopausal breast cancer, androgens, and aromatase inhibitors
  5138. Postmenopausal Endocrinology, An Issue of Endocrinology and Metabolism Clinics of North America
  5139. Postmenopausal estrogen therapy: which route to take?
  5140. Postmenopausal Hormone Therapy and the Risk for Uterine Cancer
  5141. Postmenopausal Hyperandrogenism: Evaluation and Treatment Strategies
  5142. Postmenopausal syndrome
  5143. Postmenopausal women sexuality
  5144. Postnatal depression and postpartum sexual dysfunction: an association
  5145. Postoperative quality of life and sexual function in premenopausal women undergoing laparoscopic myomectomy for symptomatic fibroids: a prospective …
  5146. Postoperative Telephone-Based Questionnaire on Quality of Life after Robotic-Assisted Laparoscopic Hysterectomy versus Conventional Total Laparoscopic …
  5147. Postpartum adverse effects and sexual satisfaction following cesarean delivery in Beijing
  5148. Postpartum female sexual function
  5149. Postpartum sexual Dysfunction: A literature review of risk factors and role of mode of delivery
  5150. Postpartum sexual function; conflict in marriage stability: a systematic review
  5151. Postpartum sexual functioning and its predicting factors among Iranian women
  5152. Posttraumatic stress disorder and comorbid sexual dysfunctions
  5153. Posttraumatic stress disorder and its effects on men’s sexual and reproductive health
  5154. Postural instability, the absence of sexual intercourse in the past month, and loss of libido are predictors of sexual dysfunction in Parkinson’s disease
  5155. Potential benefits of pregnancy on endometriosis symptoms
  5156. Potential Financial Bias From Speakers at US Food and Drug Administration’s Bone, Reproductive, and Urologic Drugs Advisory Committee Meetings
  5157. Potential future options in the pharmacotherapy of female sexual dysfunction
  5158. Potential risks of SARS-Cov-2 infection on reproductive health
  5159. Potential role for the PDE5 inhibitor sildenafil in the treatment of female sexual dysfunction
  5160. Potential role of androgens in the treatment of hypoactive sexual desire in women
  5161. Potential testosterone therapy for hypogonadal sexual dysfunction in women
  5162. Pr MYLAN-VARDENAFIL
  5163. Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer
  5164. Practical Gynecology: A Guide for the Primary Care Physician
  5165. Practical Gynecology: A Guide for the Primary Care Physician
  5166. Practicing Evidence-Based Psychiatry
  5167. Practitioner’s guide to evidence-based psychotherapy
  5168. Preclinical abuse potential assessment of flibanserin: effects on intracranial self-stimulation in female and male rats
  5169. Preclinical effects of melanocortins in male sexual dysfunction
  5170. Preclinical models of sexual desire: conceptual and behavioral analyses
  5171. Preclinical research and animal models in sexual medicine
  5172. Predictability of intranasal pharmacokinetics in man using pre-clinical pharmacokinetic data with a dopamine 3 receptor agonist, PF-219061
  5173. Predicting couple satisfaction: The role of differentiation of self, sexual desire and intimacy in heterosexual individuals
  5174. Predicting Emotional Divorce Based on Components of sexual Dysfunctional Beliefs in Married Women
  5175. Predicting low testosterone in aging men: a systematic review
  5176. Predicting older heterosexual women’s sexual desire and sexual activity: a logistic regression analysis
  5177. Predicting sexual dysfunction based on sexual self-esteem and intimacy with spouse among female college students with and without sexual dysfunction disorder
  5178. Predicting sexual Problems in Men and Women: The Relevance of sexual Excitation and sexual Inhibition Inventory
  5179. Predicting the sexual satisfaction and the marital commitment based on religiosity and marital intimacy of married university Students of University of Tehran
  5180. Predicting the signs of sexual desire/arousal in women with their attachment and differentiation styles mediated by marital conflicts
  5181. Prediction of
  5182. Prediction of quality of life based on sexual attitude and knowledge, and personality traits in married women
  5183. Prediction of sexual anxiety of women on the brink of marriage according to knowledge and sexual attitude
  5184. Predictors and correlates of sexual avoidance among partnered older adults among Norway, Denmark, Belgium, and Portugal
  5185. Predictors and moderators of sexually related distress in women with persistent genital arousal disorder
  5186. Predictors of attrition from an expressive writing intervention for sexual abuse survivors
  5187. Predictors of female sexual dysfunction: a systematic review and qualitative analysis through gender inequality paradigms
  5188. Predictors of genital pain in young women
  5189. Predictors of hysterectomy among married women 15–49 years in India
  5190. Predictors of Intention to Use Health Literacy Strategies Among Physicians in Grenada
  5191. Predictors of men’s sexual desire: The role of psychological, cognitive-emotional, relational, and medical factors
  5192. Predictors of relationship satisfaction, sexual satisfaction and sexual frequency in female couples.
  5193. Predictors of response to erectile dysfunction treatment at 12 months: Results from the exceed database
  5194. Predictors of sexual assertiveness: The role of sexual desire, arousal, attitudes, and partner abuse
  5195. Predictors of sexual desire disorders in women
  5196. Predictors of sexual distress in women with desire and arousal difficulties: Distinguishing between personal, partner, and interpersonal distress
  5197. Predictors of sexual dysfunction in veterans with post-traumatic stress disorder
  5198. Predictors of sexual functioning among ethnically diverse college-age women
  5199. Predictors of sexual health in women after a breast cancer diagnosis
  5200. Predictors of task‐persistent and fear‐avoiding behaviors in women with sexual pain disorders
  5201. Predictors of women’s sexual desire: The role of psychopathology, cognitive-emotional determinants, relationship dimensions, and medical factors
  5202. Pregnancy outcomes following repeat myomectomy
  5203. Pregnancy, childbirth, and sexual function: perceptions and facts
  5204. Preliminary clinical experience with androgen administration for pre-and postmenopausal women with hypoactive sexual desire
  5205. Preliminary data on sexual dysfunction in depressed patients
  5206. Preliminary evidence that acute and chronic daily psychological stress affect sexual arousal in sexually functional women
  5207. Preliminary validation of the sexual distress scale-short form: Applications to women, men, and prostate cancer survivors
  5208. Premature and delayed ejaculation: two ends of a single continuum influenced by hormonal milieu
  5209. Premature ejaculation
  5210. Premature ejaculation and its management
  5211. Premature Ejaculation Management
  5212. PREMATURE EJACULATION MANAGEMENT
  5213. Premature Ejaculation Re-Visited: Definition and Contemporary Management Approaches
  5214. Premature ejaculation results in female sexual distress: standardization and validation of a new diagnostic tool for sexual distress
  5215. Premature ejaculation: a psychophysiological review
  5216. Premature ejaculation: An integrative, intersystems approach for couples
  5217. Premature ejaculation: an update on definition and pathophysiology
  5218. Premature ejaculation: definition and prevalence
  5219. Premature Ejaculation: From Physiology to Treatment
  5220. Premature ejaculation: old story, new insights
  5221. Premature ejaculation: old story, new insights
  5222. Premature ejaculation: Theory, evaluation and therapeutic treatment
  5223. Premature Ejaculation: Treatment of the Difficult Case and Advanced Counseling Techniques and When to Refer
  5224. Premature menopause
  5225. Premature Menopause and sexual Outcomes
  5226. Premature menopause and women’s sexuality
  5227. Premature menopause: a comprehensive understanding of psychosocial aspects
  5228. Premature ovarian failure
  5229. Premature ovarian failure: immunological aspects and therapeutic strategies
  5230. Premature ovarian insufficiency
  5231. Premature ovarian insufficiency and autoimmune diseases
  5232. Premature ovarian insufficiency: A hormonal treatment approach
  5233. Premature ovarian insufficiency: an international menopause society white paper
  5234. Premature ovarian insufficiency: the context of long-term effects
  5235. Premenstrual Syndrome and Female sexual Function
  5236. Preoedipal factors in relation to psychogenic inhibited sexual desire
  5237. Preoperative sexual function in women with rectal cancer
  5238. Preparedness of doctoral clinical psychology program faculty to integrate topics of human sexuality into academic training
  5239. Preparing for the arrival of “pink Viagra”: strengthening Canadian direct-to-consumer information regulations
  5240. Prescription Medications that Affect sexual Function
  5241. Presented at Gender and Power in the New Europe, the 5th European Feminist Research Conference, August 20-24, 2003, Lund University, Sweden
  5242. Prevalence and associated factors of sexual dysfunction in malaysian menopausal women
  5243. Prevalence and association of somatic symptoms in patients with Major Depressive Disorder
  5244. Prevalence and characteristics of female sexual dysfunction in a sample of women from Upper Egypt
  5245. Prevalence and characteristics of sexual functioning among sexually experienced middle to late adolescents
  5246. Prevalence and characteristics of vibrator use by women in the United States: Results from a nationally representative study
  5247. Prevalence and clustering of menopausal symptoms in older women by hysterectomy and oophorectomy status
  5248. Prevalence and comorbidity of sexual dysfunctions in a Portuguese clinical sample
  5249. Prevalence and conditions associated with chronic pelvic pain in women from São Luís, Brazil
  5250. Prevalence and correlates of depression in treatment-seeking women with vulvodynia
  5251. Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies
  5252. Prevalence and correlates of sexual activity and function in women: results from the Boston Area Community Health (BACH) Survey
  5253. Prevalence and correlates of sexual dysfunction among young adult married women in rural China: a population-based study
  5254. Prevalence and correlates of sexual morbidity in long-term breast cancer survivors
  5255. Prevalence and evaluation of sexual health problems—HSDD in Europe
  5256. Prevalence and pattern of sexual dysfunction in married females receiving antidepressants: An exploratory study
  5257. Prevalence and predictors of concomitant low sexual desire/interest and new‐onset erectile dysfunction–a picture from the everyday clinical practice
  5258. Prevalence and predictors of female sexual dysfunction: a protocol for a systematic review
  5259. Prevalence and predictors of low sexual desire, sexually related personal distress, and hypoactive sexual desire dysfunction in a community-based sample of midlife …
  5260. Prevalence and risk factors for female sexual dysfunction in Turkish women
  5261. Prevalence and risk factors for female sexual dysfunction in women attending a medical clinic in south India
  5262. Prevalence and risk factors for low sexual function in women: a study of 1,009 women in an outpatient clinic of a university hospital in Istanbul
  5263. Prevalence and risk factors for sexual problems and distress in Chinese unmarried young women: An observational study
  5264. Prevalence and risk factors of erectile dysfunction in men of infertile couples: A cross-sectional study from an in vitro fertility center in the northern Vietnam
  5265. Prevalence and risk factors of relationship dissatisfaction in women during the first year after childbirth: implications for family and relationship counseling
  5266. Prevalence and risk factors of sexual dysfunction in men and women
  5267. Prevalence and risk factors of sexual dysfunction in postpartum Australian women
  5268. Prevalence and risk factors of sexual problems and sexual distress in a sample of women suffering from chronic widespread pain
  5269. Prevalence and sociocultural predictors of sexual dysfunction among Chinese men who have sex with men in Hong Kong
  5270. Prevalence and sociodemographic predictors of sexual problems in Portugal: a population-based study with women aged 18 to 79 years
  5271. Prevalence of and recent developments in female sexual dysfunction
  5272. Prevalence of and risk factors for genito-pelvic pain/penetration disorder: a Population-Based Study of Iranian Women
  5273. Prevalence of endocrine and metabolic disorders in subjects with erectile dysfunction: a comparative study
  5274. Prevalence of erectile disorder among men with diabetes mellitus: comprehensive review, methodological critique, and suggestions for future research
  5275. Prevalence of erectile dysfunction: need for treatment?
  5276. PREVALENCE OF FEMALE sexual DYSFUNCTION (FSD) AT A GYNAECOLOGICAL SET
  5277. Prevalence of female sexual dysfunction among Indian fertile females
  5278. Prevalence of female sexual dysfunction among premenopausal women: a systematic review and meta-analysis of observational studies
  5279. Prevalence of Female sexual Dysfunction and Associated Demographic Factors in Turkey: A Meta-Analysis and Meta-Regression Study
  5280. Prevalence of female sexual dysfunction in Brazil: A systematic review
  5281. Prevalence of female sexual dysfunction in urban chinese women based on cutoff scores of the Chinese version of the female sexual function index: a preliminary …
  5282. Prevalence of female sexual function difficulties and sexual pain assessed by the female sexual function index: A systematic review
  5283. Prevalence of female sexual problems in Portugal: a community-based study
  5284. Prevalence of hypoactive sexual desire Disorder Among sexually Active Postmenopausal Women With Metabolic Syndrome at a Public Hospital Clinic in …
  5285. Prevalence of hypoactive sexual desire disorder in postmenopausal women: results from the WISHeS Trial
  5286. Prevalence of hypothyroid disease: A cross sectional study at a higher rate among young male and female population of Balochistan, Pakistan
  5287. Prevalence of low sexual desire among women in Britain: associated factors
  5288. Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women
  5289. Prevalence of Low sexual desire With Associated Distress Across the Adult Life Span: An Australian Cross-Sectional Study
  5290. PREVALENCE OF MALE sexual DYSFUNCTION AND ITS CORRELATION AT ANDROLOGY CLINICS IN EGYPT
  5291. Prevalence of physical activity and its associated factors among breast cancer patients in Peninsular Malaysia: A multi-centre cross-sectional study
  5292. Prevalence of psychiatric disorders in a mandatory screening program for infection with human immunodeficiency virus: A pilot study
  5293. PREVALENCE OF PSYCHOsexual DYSFUNCTIONS AMONG HEMODIALYSIS MALE PATIENTS
  5294. Prevalence of sexual dysfunction after risk-reducing salpingo-oophorectomy
  5295. Prevalence of sexual dysfunction among females in a university community in Enugu, Nigeria
  5296. Prevalence of sexual dysfunction among general population of Iran: A systematic review
  5297. Prevalence of sexual dysfunction among postmenopausal women with and without metabolic syndrome
  5298. Prevalence of sexual dysfunction among prenatal women attending the Greater Accra Regional Hospital, Ghana
  5299. Prevalence of sexual dysfunction and impact of contraception in female German medical students
  5300. Prevalence of sexual dysfunction and related factors among diabetes mellitus patients in Southwest Ethiopia
  5301. Prevalence of sexual dysfunction and related factors among married couples in Qazvin
  5302. Prevalence of sexual dysfunction and urinary incontinence and associated risk factors in Turkish women
  5303. Prevalence of sexual dysfunction in a group of Obsessive-Compulsive Disorder (OCD) patients in Iran
  5304. Prevalence of sexual dysfunction in infertile versus fertile couples
  5305. Prevalence of sexual dysfunctions among women with multiple sclerosis
  5306. Prevalence of sexual dysfunctions and correlated conditions in a sample of Brazilian women—results of the Brazilian study on sexual behavior (BSSB)
  5307. Prevalence of sexual dysfunctions in transgender persons: results from the ENIGI follow-up study
  5308. Prevalence of sexual Dysfunctions: A Systemic Approach
  5309. Prevalence of sexual dysfunctions: results from a decade of research
  5310. Prevalence of sexual problems in Portugal: Results of a population-based study using a stratified sample of men aged 18 to 70 years
  5311. Prevalence of sexual Side Effects of Antidepressants
  5312. Prevalence of sexual symptoms in relation to menopause in women in Asia: A systematic review
  5313. Prevalence of women’s sexual desire problems: what criteria do we use?
  5314. Prevalence rates of sexual difficulties and associated distress in heterosexual men and women: Results from an Internet survey in Flanders
  5315. Prevalence survey of sexual dysfunction among women in the reproductive age group referred to the Islamic Azad university hospital during 2011-2012
  5316. Prevalence, risk factors, and predictors of female sexual dysfunction in a primary care setting: a survey finding
  5317. Prevalencia del desorden de deseo sexual hipoactivo en mujeres colombianas y factores asociados
  5318. Prevalencia y caracterización de las disfunciones sexuales en mujeres, en 12 ciudades colombianas, 2009-2016
  5319. Prevention and management of postprostatectomy sexual dysfunctions part 2: recovery and preservation of erectile function, sexual desire, and orgasmic function
  5320. Prevention strategies
  5321. Priapus is happier with Venus than with Bacchus
  5322. Primary Care Physicians’ Knowledge of, Attitudes Towards, and Practices in sexual Healthcare for Patients of Middle and Old Age in Trinidad & Tobago
  5323. PRIMARY CARE USE OF TESTOSTERONE THERAPY TO BENEFIT WOMEN EXPERIENCING DISTRESS RELATED TO DECREASED sexual desire …
  5324. Primary Dysmenorrhea and Painful sex: Canaries in the Coal Mine?
  5325. Primary ovarian insufficiency
  5326. Primipara Mothers who delivered vaginally or by cesarean section, is there an impact on the sexual function?
  5327. Primipara Undergoing Episiotomy had Lower Postpartum sexual Function
  5328. Principles and practice of sex therapy
  5329. Principles of management of premature and surgical menopause in women with initial reproductive health problems
  5330. Principles of Marital Therapies and Behavior Therapy of sexual Dysfunction
  5331. Principles of Therapy in sexual Medicine
  5332. Priorities for endometriosis research: a proposed focus on deep dyspareunia
  5333. Priorities in Parkinson’s disease research
  5334. Problematic endorsement of models describing sexual response of men and women with a sexual partner
  5335. Problematic sexual excesses
  5336. Problems in sexual functioning among male OEF/OIF veterans seeking treatment for posttraumatic stress
  5337. Problems of Orgasm in the Female
  5338. Problems of sexual desire and arousal in women
  5339. Problems of sexual desire in Men
  5340. Problems of sexual function in menopausal women
  5341. Problems with psychiatry, and problems with thinking about psychiatry
  5342. Problems with sexuality after sexual assault
  5343. Processes and outcomes in couples and family therapy.
  5344. Producing facts: Empirical asexuality and the scientific study of sex
  5345. Product Update
  5346. Professional Issues
  5347. Profile of female patients at a sexology ambulatory in the brazilian public health system
  5348. Profile of Female sexual Function: a patient-based, international, psychometric instrument for the assessment of hypoactive sexual desire in oophorectomized women
  5349. Profile of the relationship between psychological factors and hypoactive sexual desire in men and women
  5350. Progress in female sexual dysfunction
  5351. Progression of the erectile dysfunction in the population and the possibilities of its regression with bioregeneration
  5352. Prolactin
  5353. Prolactin levels independently predict major cardiovascular events in patients with erectile dysfunction
  5354. Prolactin levels independently predict major cardiovascular events in patients with erectile dysfunction
  5355. Prolactinemia in adolescent males surviving malignancies in childhood: impaired dating activity
  5356. Prolactinoma: A rare, important and treatable cause of male infertility
  5357. Proliferation of granulosa cells in small follicles after FSH treatment in the Macaca mulatta
  5358. Prolonged effects of intra-nasally administered testosterone on proceptive behavior in female capuchin monkeys (Cebus apella)
  5359. Promoting sexual Health and Wellbeing among Elderly Nursing Home Residents
  5360. Promoting the sexual health of the older couple
  5361. Propensity to sexual Response among Adults with Obsessive-Compulsive Disorder
  5362. Prophylactic McCall culdoplasty by a vaginal approach during mini-laparoscopic hysterectomy
  5363. Prophylactic oophorectomy at the time of hysterectomy for benign disease: current practice and need for guidelines.
  5364. Prophylactic oophorectomy in premenopausal women and long-term health
  5365. Proportion of sexual Dysfunction among Drug Free Patients Suffering from Anxiety Disorders.
  5366. Proposal to Introduce Adjustment Disorder With Disturbed sexual Functioning Into the Revised Classifications of DSM and ICD
  5367. Propping up pharma’s (natural) neoliberal phallic man: Pharmaceutical representations of the ideal sexuopharmaceutical user
  5368. Prospective study of psychiatric morbidity in HIV-seropositive women without AIDS
  5369. Prospective study of sexual function and analysis of risk factors after rectal cancer surgery
  5370. Prostate Cancer and Psychological Rehabilitation: An exploratory scoping review
  5371. Protecting sexual diversity: Rethinking the use of neurotechnological interventions to alter sexuality
  5372. Protein Therapeutic: Production, Application, and Future Scenario
  5373. Protein-Protein Interactions with Serotonin G Protein Coupled Receptors: Novel Targets for Neurotherapeutics Drug Discovery
  5374. Protocol for a cluster randomised trial of a communication skills intervention for physicians to facilitate survivorship transition in patients with lymphoma
  5375. Protocol of a randomized controlled trial of an online support group for sexual distress due to gynecologic cancer
  5376. Providing sexual health services for men
  5377. Provoked vestibulodynia and the health care implications of comorbid pain conditions
  5378. Provoked vestibulodynia: psychological predictors of topical and cognitive-behavioral treatment outcome
  5379. PS-01-005 Psychological characteristics of Italian gender dysphoric adolescents: a case control study
  5380. PS-01-009 The relationship between attachment, personality and sexual satisfaction
  5381. PS-01-010 Pornography consumption among Slovakian women: A representative study
  5382. PS-05-003 Which are the male factors associated with Female sexual Dysfunction (FSD)?
  5383. PS-2-2 Correlation of Pelvic Floor Muscle Strength With Female sexual Dysfunction and sexual Distress
  5384. PS-8-7 Role of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios in Peyronie´ s Disease
  5385. Psicologia e Psichiatria nelle Cause Matrimoniali Canoniche by Gianfranesco Zuanazzi
  5386. Psych
  5387. Psychaesthenic syndrome: a review on its implication in female sexual arousal
  5388. Psychiatric characteristics of consecutively evaluated outpatient renal transplant candidates and comparisons with consultation-liaison inpatients
  5389. Psychiatric Co-Morbidity in People with HIV/AIDS: A Cross Sectional Study
  5390. Psychiatric Comorbidities and sexual Health
  5391. Psychiatric comorbidity and compulsive/impulsive traits in compulsive sexual behavior
  5392. Psychiatric Comorbidity in Diagnosis
  5393. Psychiatric comorbidity in heterosexual couples with sexual dysfunction assessed with the composite international diagnostic interview
  5394. Psychiatric consultation for women undergoing rehabilitation for upper-extremity lymphedema following breast cancer treatment
  5395. Psychiatric Disorders
  5396. Psychiatric disorders and sexual dysfunction
  5397. Psychiatric disorders and sexual dysfunction
  5398. Psychiatric disorders in female psychosexual disorders—a nationwide, cohort study in Taiwan
  5399. Psychiatric Morbidity and Explanatory Models in patients attending the Andrology Clinic in a Tertiary Care Hospital
  5400. Psychiatric Morbidity and sexual Dysfunction in Infertile Women.
  5401. Psychiatric Morbidity in Hypothyroid Patients
  5402. Psychiatric nursing: assessment, care plans, and medications
  5403. Psychiatric symptoms in patients with Cushing’s syndrome: prevalence, diagnosis and management
  5404. Psychiatric-mental health nursing: An interpersonal approach
  5405. Psychiatrists and Clinical sexuality
  5406. Psychiatry
  5407. Psychiatry PR N
  5408. Psychiatry PRN
  5409. Psychiatry Specialty Board Review for the DSM-IV
  5410. Psycho-biological correlates of hypoactive sexual desire in patients with erectile dysfunction
  5411. Psycho-endocrinological aspects in aging males and transsexual persons
  5412. Psycho-Physiological Combined Therapy on the sexual desire
  5413. Psycho‐biological correlates of free‐floating anxiety symptoms in male patients with sexual dysfunctions
  5414. Psychoactive drug exposure during breastfeeding: a critical need for preclinical behavioral testing
  5415. Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction
  5416. Psychobiological correlates of delayed ejaculation in male patients with sexual dysfunctions
  5417. Psychobiological correlates of extramarital affairs and differences between stable and occasional infidelity among men with sexual dysfunctions
  5418. Psychobiological correlates of smoking in patients with erectile dysfunction
  5419. Psychobiological correlates of vaginismus: an exploratory analysis
  5420. Psychobiological correlates of women’s sexual interest as perceived by patients with erectile dysfunction
  5421. Psychobiological factors of sexual functioning in aging women–findings from the women 40+ healthy aging study
  5422. Psychobiology of love and sexual relationships in elderly: Issues in management
  5423. Psychobiology of sexuality
  5424. Psychodynamic Issues Raised by sexual Medications: A Prescriber’s Perspective
  5425. Psychoeducation and the Internet
  5426. Psychoeducational group increases vaginal dilation for younger women and reduces sexual fears for women of all ages with gynecological carcinoma treated with …
  5427. Psychoeducational Group Therapy for sexual function and marital satisfaction in Iranian couples with sexual dysfunction disorder
  5428. Psychoeducational support group for gay men who reside in West Hollywood: A 10-week group curriculum
  5429. Psychoemotional state in HIV infected male patients at early and late stages of HIV disease
  5430. Psychogenic erectile dysfunction
  5431. Psychogenic erectile dysfunction: classification and management
  5432. Psychogenic erectile dysfunction: comparative study of three therapeutic approaches
  5433. Psychologic and interpersonal aspects and their management
  5434. Psychologic treatments for female sexual dysfunction: Are they effective and do we need them?
  5435. Psychological Adjustment
  5436. Psychological adjustment of women with HIV/AIDS: Racial and ethnic comparisons
  5437. Psychological and Behavioral Treatment of Female Orgasmic Disorder
  5438. Psychological and interpersonal dimensions of sexual function and dysfunction
  5439. Psychological and interpersonal dimensions of sexual function and dysfunction
  5440. Psychological and interpersonal dimensions of sexual function and dysfunction
  5441. Psychological and interpersonal dimensions of sexual function and dysfunction in women: An update
  5442. Psychological and psychiatric aspects of vulval disorders
  5443. Psychological and Social Influences on Male sexual Function
  5444. Psychological approaches for low sexual arousal
  5445. Psychological aspect fo sexual dysfunction.
  5446. Psychological aspects of erectile dysfunction
  5447. Psychological aspects of Peyronie’s disease
  5448. Psychological challenges in obstetrics and gynecology: the clinical management.
  5449. Psychological characteristics of individuals who engage in online sexual activity (OSA)
  5450. Psychological determinants of erectile dysfunction: Testing a cognitive–emotional model
  5451. Psychological distress in elite adolescent soccer players following deselection
  5452. Psychological Distress in Heterosexual Couples
  5453. Psychological factors associated with male sexual dysfunction: screening and treatment for the urologist
  5454. Psychological factors involved in sexual desire, sexual activity, and sexual satisfaction: A multi-factorial perspective
  5455. Psychological factors involved in women’s sexual dysfunctions
  5456. Psychological factors predicting the distress to female persistent genital arousal symptoms
  5457. Psychological features and sexual beliefs characterizing self-labeled asexual individuals
  5458. Psychological impact of fibromyalgia: current perspectives
  5459. Psychological impact of premature ejaculation and barriers to its recognition and treatment
  5460. Psychological Inflexibility as a Predictor of sexual Functioning Among Women with Vulvovaginal Pain: A Prospective Investigation
  5461. Psychological interventions for the sexual sequelae of cancer: a review of the literature
  5462. Psychological Management of Arousal Disorders
  5463. Psychological management of hypoactive sexual desire disorder
  5464. Psychological perspectives and interventions
  5465. Psychological predictors of sexual satisfaction among married heterosexual older adults using the interpersonal exchange model of sexual satisfaction
  5466. Psychological Principles in Clinical Assessment, Explanation, and Treatment
  5467. Psychological Trauma: Theory, Research, Practice, and Policy
  5468. Psychological treatment of female sexual dysfunction: a critical review of the literature
  5469. Psychological Treatment of Low sexual desire in Women: Protocol for a Randomized, Waitlist-Controlled Trial of Internet-Based Cognitive Behavioral and …
  5470. Psychological Treatment of Major Depression: An Analysis of the sexual desire
  5471. Psychological treatment trials for hypoactive sexual desire disorder: a sexual medicine critique and perspective
  5472. Psychological well-being and relationship changes in women after obesity surgery
  5473. Psychological, relational, and biological correlates of ego-dystonic masturbation in a clinical setting
  5474. Psychological, social, and spiritual effects of contraceptive steroid hormones
  5475. Psychology and pathology of the intrinsic motivation (inner sense)
  5476. Psychology of sexual response
  5477. PSYCHOLOGY: Cues Resulting in desire for sexual Activity in Women
  5478. PSYCHOLOGY: Differences between Pre-and Postmenopausal Women in Cues for sexual desire
  5479. Psychology: Psychological and interpersonal dimensions of sexual function and dysfunction
  5480. PSYCHOLOGY: sexual desire in women: An integrative approach regarding psychological, medical, and relationship dimensions
  5481. PSYCHOLOGY: sexual Function and Satisfaction in Adults Based on the Definition of Child sexual Abuse
  5482. Psychology: The relationship between self-reported sexual satisfaction and general well-being in women
  5483. Psychology’s role in the assessment of erectile dysfunction: Historical precedents, current knowledge, and methods..
  5484. Psychometric Assessment of the Persian Version of the Hurlbert Index of sexual Compatibility
  5485. Psychometric attributes of the Cervantes short-form questionnaire for measuring health-related quality of life in menopausal women
  5486. Psychometric characteristics of individuals with sexual dysfunction and their partners
  5487. Psychometric properties of a self-report version of the sexual Interest and desire Inventory for Women (SIDI-F-SR)
  5488. Psychometric properties of Iranian version of male sexual function index
  5489. Psychometric properties of sexual Function Questionnaire: evaluation of an Iranian sample
  5490. Psychometric properties of the Female sexual Distress Scale-Revised among a sample of non-clinical Iranian women
  5491. Psychometric properties of the Iranian version of the female sexual distress scale‐revised in women
  5492. Psychometric properties of the Iranian version of the premature ejaculation diagnostic tool
  5493. Psychometric properties of the Iranian version of the sexual Modes Questionnaire (SMQ): to assess the association between automatic thoughts, emotions and sexual …
  5494. Psychometric properties of the Persian language version of the Female sexual Function index among postmenopausal women
  5495. Psychometric properties of the Persian version of the Questionnaire of Cognitive Schema Activation in sexual Context (QCSASC) in unsuccessful sexual situations
  5496. Psychometric properties of the sexual event diary in a sample of Dutch women with female sexual interest/arousal disorder
  5497. Psychometric properties of the sexual interest and desire inventory-female for diagnosis of hypoactive sexual desire disorder: the Persian version
  5498. Psychometric validation of the Female sexual Distress Scale in male samples
  5499. Psychometric validation of the Female sexual Function Index (FSFI) in cancer survivors
  5500. Psychometric validation of the sexual Distress Scale in men with prostate cancer
  5501. Psychoneuroendocrinology and sexual pleasure: The aspect of sexual orientation
  5502. Psychopathological and neuropsychological profile in the offspring of patients with bipolar disorder type I
  5503. Psychopathological Disorders
  5504. Psychopathology and classification
  5505. Psychopathology and use of the Diagnostic and Statistical Manual of Mental Disorders.
  5506. Psychopathology, sexuality, and the Partner Relationship.
  5507. Psychopathology: Foundations for a contemporary understanding
  5508. Psychopharmacological treatments in female sexual dysfunctions
  5509. Psychopharmacology of male rat sexual behavior: modeling human sexual dysfunctions?
  5510. Psychophysiological assessment in premenopausal sexual arousal disorder
  5511. Psychophysiological correlates of sexually and non-sexually motivated attention to film clips in a workload task
  5512. Psychophysiological measurement of sexual arousal
  5513. Psychophysiology of the sexuality of women with lifelong vaginismus: a matched controlled thermography and survey investigation of sexual function, behaviour, and …
  5514. Psychosexual adjustment among women receiving hormone replacement therapy for premature menopause following cancer treatment
  5515. Psychosexual aspects of men’s
  5516. Psychosexual aspects of men’s health
  5517. Psychosexual assessment of transgender individuals during the sex reassignment process: sexual desire, activity, and satisfaction
  5518. Psychosexual correlates of unwanted sexual experiences in women consulting for female sexual dysfunction according to their timing across the life span
  5519. Psychosexual development and sexual dysfunctions
  5520. Psychosexual development, intersex states, and sexual dysfunctions
  5521. Psychosexual disorders
  5522. Psychosexual disorders
  5523. Psychosexual disorders and dermatologists
  5524. Psychosexual Disorders: Social Perspective
  5525. Psychosexual dysfunction
  5526. Psychosexual function in CAPD and hemodialysis patients
  5527. Psychosexual functioning of female childhood cancer survivors: a report from the St. Jude Lifetime Cohort Study
  5528. Psychosexual functioning of partners of men with presumed non-organic erectile dysfunction: cause or consequence of the disorder?
  5529. Psychosexual health after female genital mutilation/cutting and clitoral reconstruction
  5530. Psychosexual health in gynecologic cancer
  5531. Psychosexual impact of violence against Tunisian women in marriage: Cross-sectional study about 197 consultant in family planning centre of Monastir
  5532. Psychosexual medicine
  5533. Psychosexual medicine
  5534. Psychosexual problems
  5535. Psychosexual problems
  5536. Psychosexual problems in people with HIV infection: controlled study of gay men and men with haemophilia
  5537. Psychosexual Therapy and Couples Therapy
  5538. Psychosexual therapy: A cognitive-behavioural approach
  5539. Psychosocial and professional burden of Medically Assisted Reproduction (MAR): Results from a French survey
  5540. Psychosocial aspects of andrologic disease
  5541. Psychosocial aspects of infertility: sexual dysfunction
  5542. Psychosocial Aspects of the Menopause Psychosocial Aspects of the Menopause
  5543. Psychosocial aspects related to erectile dysfunction
  5544. Psychosocial Characteristics of Pregnant and Non pregnant HIV-Seropositive Women
  5545. Psychosocial determinants of HIV-related quality of life among HIV-positive military in Nigeria
  5546. Psychosocial evaluation and combination treatment of men with erectile dysfunction
  5547. Psychosocial factors and therapeutic approaches in the context of sexual history taking in men: a study conducted among Swiss general practitioners and urologists
  5548. Psychosocial Factors Associated with Menopause: Relevance to Physical Therapist Practice in Women’s Health
  5549. Psychosocial history
  5550. Psychosocial interventions for sexual dysfunction in addictive disorders
  5551. Psychosocial issues of ART in aging male.
  5552. Psychosocial pathways to sexual dysfunction among female inmates
  5553. Psychosocial profile of male patients presenting with sexual dysfunction in a psychiatric outpatient department in Mumbai, India
  5554. Psychotherapeutic Approaches to sexual Problems: An Essential Guide for Mental Health Professionals
  5555. Psychotherapeutic interventions for treating female sexual dysfunction
  5556. Psychotherapeutic treatments for male and female sexual dysfunction disorders
  5557. Psychotherapist factors that impact self-efficacy for working with clients presenting issues related to sexuality and sexual activities
  5558. Psychotherapy and pharmacotherapy for sexual dysfunctions.
  5559. Psychotherapy and pharmacotherapy for sexual dysfunctions.
  5560. Psychotherapy for female sexual dysfunction: A review
  5561. Psychotherapy for male sexual dysfunction: A review
  5562. Psychotherapy for sexual Dysfunctions
  5563. Psychotropic drug-induced sexual function disorders
  5564. Psychotropic effects of testosterone
  5565. Psychotropic Use and sexual Dysfunction: Is There a Practical Solution
  5566. PT‐141: A melanocortin agonist for the treatment of sexual dysfunction
  5567. PTSD and sexual dysfunction in men and women
  5568. PTSD, psychological morbidity and marital dissatisfaction in colonial war veterans
  5569. Pubertal timing predicts adult psychosexuality: Evidence from typically developing adults and adults with isolated GnRH deficiency
  5570. Public epistemic trustworthiness and the integration of patients in psychiatric classification
  5571. Public interest group accuses FDA of trying to discredit whistleblower
  5572. Public Speaker Characteristics at Meetings of the Dermatologic and Ophthalmic Drug Advisory Committee and the Ophthalmic Devices Panel
  5573. Publish your work in this journal
  5574. Published as Shackelford, TK, Weekes-Shackelford, VA, LeBlanc, GJ, Bleske, AL, Euler, HA, & Hoier, S.(2000). Female coital orgasm and male attractiveness …
  5575. PUBLISHED IN THE JOURNAL OF MIND AND BEHAVIOR
  5576. Pulse pressure independently predicts major cardiovascular events in younger but not in older subjects with erectile dysfunction
  5577. Puncturevine (Tribulus terrestris L.) affects the proliferation, apoptosis, and ghrelin response of ovarian cells
  5578. Purging behavior modulates the relationships of hormonal and behavioral parameters in women with eating disorders
  5579. Putting a name to it: Diagnosis in contemporary society
  5580. Putting a Name to It: Diagnosis in Contemporary Society By Annemarie Goldstein Jutel The Johns Hopkins University Press. 2011. 200 pages. $45.00 cloth
  5581. Putting a name to it. Diagnosis in contemporary society [Book Review]
  5582. Q&a: low libido in older women
  5583. Qian lie an suppository (prostant) for chronic prostatitis: A systematic review and meta-analysis of randomized controlled trials
  5584. Quackonomics!: The Cost of Unscientific Health Care in the US… and Other Fraud Found Along the Way
  5585. Qualitative analysis of heterosexual women’s experience of sexual pain and discomfort
  5586. Qualities midlife women desire in their sexual relationships and their changing sexual response
  5587. Quality and safety assessment of sexual performance enhancement herbal medicines
  5588. Quality improvement in sexual health care for oncology patients: a Canadian multidisciplinary clinic experience
  5589. Quality of CT Colonography–Related Web Sites for Consumers
  5590. Quality of Female sexual Function After Conventional Abdominal Hysterectomy-Three Month’Observation
  5591. Quality of life after breast cancer: survivorship and sexuality
  5592. Quality of Life and Female sexual Dysfunction in Croatian Women with Stress-, Urgency-and Mixed Urinary Incontinence: Results of a Cross-Sectional Study
  5593. Quality of Life and Menopause
  5594. Quality of life and sexual function of cervical cancer patients following radical hysterectomy and vaginal extension
  5595. Quality of life and sexual function of patients following radical hysterectomy and vaginal extension
  5596. Quality of life and sexual functioning of Polish infertile couples
  5597. Quality of life and sexual functıon in obese women with pelvic floor dysfunction
  5598. Quality of Life and sexual Health in Breast Cancer Survivors
  5599. Quality of life and sexual health in patients with hidradenitis suppurativa
  5600. Quality of life assessment instruments for adults: a systematic review of population-based studies
  5601. Quality of Life in Chronic Kidney Disease
  5602. Quality of Life in Patients with Allergic Rhinitis in the North of Iran.
  5603. Quality of life of women with untreated vulval lichen sclerosus assessed with vulval quality of life index (VQLI)
  5604. Quality of life scoring systems.
  5605. Quality of life tools and their relevance for females with genital lymphedema
Related Posts

Pancreas Regeneration

Terpenoids

Fatty Liver Insulin Resistance

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping